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ABSTRACT
Hydrogen bonding is one o f the most useful interactions for the self-assembly of 
molecular subunits into well-defined supramolecular structures. Recent attention has 
been focused on systems capable o f forming strong, directional, and reversible 
quadruple hydrogen bonds. Meijer et al. have made a significant impact in this area 
with the synthesis o f stable DDAA dimers based on ureidopyrimidinones (Upy) with a
7 1dimerisation constant greater than 10 M" in chloroform. This work is reviewed in 
Chapter I o f this thesis.
A less attractive feature o f the Upy unit is the possibility o f up to three 
tautomeric forms in solution. The nature of the substituents at C-6 has been shown to 
influence the tautomeric equilibrium. Chapter II o f this thesis describes the synthesis of 
an ureidopyrimidinone compound incorporating an electron-donating group 
(/7-C6H4 NH2 ) at the C-6 position, which has led to the formation of the dimeric form 
DADA in DMSO-ak- It was the first time that the hydrogen bonded dimeric Upy was 
observed in such a polar solvent.
Chapter III describes the use o f quadruple hydrogen bonded Upy units in the 
chain extension o f various energetic (PolyGlyn) and non-energetic (polyether and 
polycarbonate based) telechelic polymers, which has led to the formation of 
supramolecular polymers with increased elastomeric properties. In addition, the 
development o f an alternative synthetic approach avoiding the use o f isocyanate has 
been successfully achieved leading to supramolecular polymers of improved quality.
In addition, the synthesis o f bifunctional Upys incorporating small chiral spacers 
has been achieved and described in Chapter IV. Notably, it was found that the use of 
diethyl L-tartrate or butane diol led to the formation o f extremely stable cyclic dimers in 
chloroform with a dimerisation constant greater than 108 M '1. The formation of new 
intramolecular hydrogen bonds within the cyclic species was observed in the crystal 
structure and was found to stabilise the dimeric form in solution.
Finally, the design of a new quadruple hydrogen bonded DDAA array based on 
cytosine has been successfully achieved via a straightforward synthetic strategy 
(Chapter V). The structure of the linear DDAA/AADD dimer was revealed in the solid 
state and in solution with a dimerization constant greater than 105 M '1 in chloroform. 
The synthesis o f the first generation of polymers based on this new unit has been 
achieved. The obtained results show great potential for the future material applications.
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15
DHP: Dihydropyrane
DMAP: Dimethylaminopyridine
DP: Degree o f Polymerisation
DMF: Dimethylformamide
DMSO: Dimethylsulfoxide
DMSO-^6 - Dimethyl Sulfoxide deuterated
DNA: Deoxyribonucleic acid
DSC: Differential Scanning Calorimetry
2D: Two dimensional
3D: Three dimensional
EDCI: 1 -(3-Dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride 
EtOAc: Ethyl Acetate 
EtOH: Ethanol
ES (+): Positive ion spectroscopy
EXSY: Exchange Spectroscopy
FTIR: Fourier Transformation Infrared Spectroscopy
G: Guanine
GAP: Glycidyl Azide
GLYN: Glycidyl Nitrate
Gn: n Generation (for dendrimers)
GPC: Gas Phase Chromatography 
h: Hour 
Hz: Hertz
HMQC: Heteronuclear Multiple Quantum Coherence 
HMBC: Heteronuclear Multiple Bond Correlation 
HOBt: Hydroxybenzotriazole 
HRMS: High Resolution Mass Spectroscopy 
I: Intensity (Fluorescence)
IMCI: Isocyanatomethyl-methylcyclohexylisocyanate 
J: Coupling constant (NMR)
J: Joules
K: Kelvin (Temperature)
Ka: Associaction constant 
Kdim: Dimerisation constant
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Chapter I
1 Introduction to Supramolecular Chemistry
1.1 Molecular Recognition
As proposed by J.-M Lehn, supramolecular chemistry can be defined as “the chemistry 
beyond the molecule” or “the chemistry of the non-covalent bond” and involves 
molecular systems in which the components are held together reversibly by 
intermolecular forces, as opposed to covalent bonds (Table I ) . 1 ,2 ,3 ,4 ,5  Supramolecular 
scientists have crossed the traditional boundaries o f their disciplines in order to address 
specific objectives. Indeed, this interdisciplinary field o f science has extended its roots 
from organic chemistry, inorganic, physics and biology, and has provided a large source 
o f inspiration for chemists involved in the building block design, as well as the 
understanding o f supramolecular structures.
Covalent Non-covalent
Building block Atoms Molecules, ions
Target Molecule Assembly
Molecular 1000 Da 100 kDa
weight
Bond type Covalent Ionic, hydrophobic, metal coordination,
hydrogen bonds
Bond energy 350-942 kJ mol ' 1 2-250 kJ mol' 1
Table 1: Differences between covalent and non-covalent synthesis
Complimentarity is a fundamental concept in this field. In 1894, Emil Fisher described 
this idea as the ‘Lock and Key principle ’ . 6 In this context, a ‘supramolecule’ can be 
visualised as a ‘host-guest complex’ where a molecule ‘host’ or ‘lock’ is bonded to 
another molecule ‘guest’ or ‘key’ by non-covalent interactions. Supramolecular host- 
guest compounds were the first structures studied as part o f this new field o f chemistry 
also known as molecular recognition. Much supramolecular chemistry has sprung from 
development in macrocyclic chemistry in the mid-to-late-1960s. Charles Pedersen made 
an important breakthrough in 1960, while attempting the synthesis of multidentate 
ligands for copper and vanadium (bis [2-(o-hydroxy-phenoxy)ethyl]ether (1)). He 
isolated instead, a macrocyclic compound, commonly known as crown ether today or 
more precisely Dibenzyl [18] crown- 6  (2) . 7 Later, Pedersen , 8 Lehn9 ’1 0 ’11 and Cram 12
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shared the Nobel prize in 1987 for their discovery o f crown ethers and cryptands (3) 
(3D crown ethers).
2
Figure 1: Examples of macrocyclic molecules synthesised by Pedersen, Cram and Lehn
Since the 1980s, several other host-guest systems have been reported . 1 3 ,1 4  Different 
classes o f supramolecular structures exist which depend on the nature o f the host and 
guest, as well as the nature o f the interactions between them. Some o f the most common 
macrocyclic structures are listed in Table 2.
Host Guest Class Example
Crown ether Metal cations Cavitand K+ [18] crown - 6
(4)
Spherand Alkyl ammonium Cavitand Spherand (CH3NH3+)
(5) cations
Calixarene Organic Clathrand /?-t-butylcalix[4]arene
(6) molecules, or
cations
Cyclodextrin Organic molecule Clathrand a-cyclodextrin.p-hydroxybenzoic
(7) acid
Cyclophane Anions or neutral Cavitand Cyclophane-durene
(8) molecules
Table 2: Classes o f macrocyclic molecules
Cavitands are hosts possessing intramolecular cavities, which allow the binding of 
guests via its specific site interactions. Crown ethers (4) and Spherands (5) are well- 
known examples for their binding with metal cations (eg. K+, Na+, Li+ ) . 15 Clathrands 
(6,7) are hosts with extra-molecular cavities and are mainly relevant in the solid state. 
Cyclophanes are generally used as receptors for apolar guests (8 ).
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Figure 2: Examples of macrocyclic structures
Host-guest chemistry is not the only area of research as part o f this growing field. In the 
last decade, work has focused on the development o f systems that are able to 
spontaneously self-assemble via non-covalent interactions in order to generate large 
supramolecular architectures . 16
1.2 Supramolecular Self-Assembly
The term ‘self-assembly’ is used to describe the thermodynamically controlled ordering 
that involves atom-specific non-covalent interactions. Self-assembly may lead to finite­
sized assemblies (e.g., hydrogen bonded dimers) or may create extended structures (one 
dimensional chains, two-dimensional sheets and three-dimensional networks). On 
mixing appropriately designed components (or synthons) in solution, the intermolecular 
forces that exist between them control their orientation, leading to the reversible 
assembly o f a specific ‘supermolecule’.
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1.2.1 Supramolecular Interactions
Supramolecular chemistry includes non-covalent bonding interactions. The term ‘non- 
covalent’ encompasses an enormous range o f attractive and repulsive forces. Several 
non-covalent interactions have been studied, such as electrostatic interactions (ion-ion, 
ion-dipole, dipole-dipole), hydrophobic interactions, 1 7 ,1 8  n-n stacking interactions, 
induction forces (Van der Waals) and hydrogen bonding interactions.
1 .2 .1 . 1  Electrostatic Interactions (100-250 kJ/rnol)19
Electrostatic interactions (ion-ion, dipole-ion or dipole-dipole) are based on the 
Coulombic attraction between opposite charges. Whilst ion-ion interactions do not 
require directionality o f the species, dipole-dipole or ion-dipole interactions must have a 
suitable alignment for strong binding. Ionic binding is comparable in strength to 
covalent bonding which makes it a valuable tool for use in supramolecular devices.
1 .2 .1 . 2  n -Interactions (0-50 kJ/mol)20a,b’21
These interactions have long been observed in the crystal structure o f aromatic rings and 
take advantage o f the electron rich molecular orbitals o f aromatic and vinyl systems. 
7r-Stacking held a prominent place in stabilizing the DNA structure through vertical 
based pair interaction, as well as for the intercalation o f potential drugs within the DNA 
double helix. There are two general types of 7i-stacking: face-to-face and edge-to-face 
(Figure 3). Hunter and Sanders have proposed a simple model to estimate the strength 
and geometric requirements for n-n stacking interactions. Their model is based on an 
overall attractive van der Waals interaction, which is proportional to the contact surface 
area o f two n systems. This attraction could be regarded as an attraction between the 
negatively charged 7i-electron cloud of one molecule and the positively charged 
G-ffamework o f an adjacent molecule. Therefore, the ary-aryl geometry is determined 
by the electrostatic repulsions between the two negatively charged 7r-systems. Clearly 
the ary-aryl interaction is not driven to maximise the orbital overlap.
23
Chapter I
face-to-face edge-to-face
Figure 3: Two examples o f n-n stacking interactions 
1.2.13 Hydrogen Bonding (4 -40 kJ/mol)22,23,24’25
Because o f its relatively strong and highly directional nature, hydrogen bonding has 
been described as the ‘master key’ interaction in supramolecular chemistry. Hydrogen 
bonds connect atoms X and Y that have electronegativities larger than that o f hydrogen, 
generally C, N, O, F, P, S, Cl, Se, Br, and I. The XH group is then referred to as the 
‘proton donor’ (D) and the Y atom as the ‘proton acceptor’ (A). The strength of a 
hydrogen bond increases with an increase in the dipole moment o f the X-H bond. 
Therefore, hydrogen bonds can be classified as strong, moderate or weak interactions as 
shown below in Table 3.
Strong Moderate Weak
Bond energy (kcal/mol) 15-40 4-15 <4
Bond length (A) 
H ...Y 1 .2 - 1 .5 1 .5-2.2 >2 . 2
X ...Y 2 .2 -2 .5 2.5-3.2 >3.2
Bond angles (°) 175-180 >130 >90
Donor: -0 +-H, 
Acceptor: F \ 'O-H
Donor: O-H, Donor: C-H, Si-H 
Acceptor: 
7r-electrons
Examples N-H 
Acceptor: 
C =0, 0 -
Table 3: Classification o f hydrogen bonds
There are different types of hydrogen bonds depending on their geometry (Figure 4). 
The simplest is a D -H ...A  arrangement with a favoured angle close to 180°. In some 
cases one hydrogen atom interacts with more than one acceptor, often called bifurcated 
arrangement, other cyclic types can also be found as illustrated in Figure 4.
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Figure 4: Different hydrogen bond types
1.2.2 Experimental Detection of Hydrogen Bonds
1.2.2.1 1H  NMR Spectroscopy26
NMR spectroscopy is probably one o f the most useful tools for the determination o f the 
supramolecular structure. The electron density decreases significantly at the proton 
involved in hydrogen bonding, leading to a shift o f the corresponding NMR signal 
towards higher frequencies . 2 7 ,2 8  The magnitude o f this chemical shift is indicative o f the 
strength o f the hydrogen bonding involved. The sensitivity o f JH NMR spectroscopy to 
changes in electronic environments make it a useful probe for the detection o f hydrogen 
bonds from weak donors, such as S-H and C-H and weak acceptors, such as multiple 
bonds and aromatic rings. Due to the complexity o f hydrogen bonding in solution, the 
use o f routine ID NMR spectroscopy is limited. To overcome these limitations, new 
NMR techniques have been developed such as EXSY, which involves measurements of 
the exchange rates. Furthermore, 2D NMR techniques such as NOESY, COSY and 
TOCSY, have greatly facilitated the characterisation o f hydrogen bonded assemblies. 
Also, dilution experiments are often a good way to measure the association constant of 
the binding system, by monitoring the changes in chemical shifts or other parameters 
(e.g. diffusion rates) due to variation o f the strength o f hydrogen bonding.
1.2.2.2 Vibrational Spectroscopy
Infrared spectroscopy is a straightforward technique to establish the existence of 
hydrogen bond since the presence o f such interactions induces an important large red
25
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shift (>100 cm '1) o f the fundamental X-H stretching vibration, and occurs as a 
consequence o f the elongation o f the X-H bond. The magnitude o f the red shift is
29directly proportional to the hydrogen bonding strength (Badger-Bauer relation). The 
strength o f the intermolecular hydrogen bond is directly related to the intensity o f the 
observed peak.
1 .2.2.3 Diffraction Methods: X-Ray and Neutron Diffraction
Single crystal structure analyses have a special role in the study o f hydrogen bonds 
because they provide direct information on their stereochemistry and local environment. 
This technique coupled with vibrational spectroscopy is an excellent tool for 
distinguishing the nature o f the hydrogen bonds, whether they are strong, moderate or 
weak.
1 .2.2.4 Theoretical
This approach includes semi-empirical and empirical calculations, and the use of 
modelling. This field is continuously growing, with the development of more powerful
'y/r
and efficient ways o f calculation.
Conclusions
Non-covalent bonding interactions define and direct the self-assembly process that leads 
to the formation o f new supramolecular architectures, and also govern any dynamic 
process that occur within the structure. Due to the reversibility and directionability o f 
hydrogen bonds they become an essential ‘glue’ for the assembly o f small molecules 
into larger aggregates. The formation and properties o f hydrogen bonded 
supramolecular structures will be discussed in the next section.
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1.3 Hydrogen Bond Directed Self-Assembly
1.3.1 Biological Self-Assembling Systems
1.3.1. 1  DNA Double helix
The idea of building supramolecular species originates from nature30 ,31 and especially 
from biological aggregates like the DNA double bond helix. The pairing of nucleic 
acid strands is perhaps the most elegant example o f self-assembly in nature. Two anti­
parallel strands are held together via complimentary hydrogen bonds betweens pairs of 
bases forming the natural polymer (Figure 5). The nucleic acid bases are arranged such 
that cytosine (C) forms three hydrogen bonds with guanine (G) (9) while adenine (A) 
forms two complamentary hydrogen bonds with thymine (T) (10).
DNA
Molecule:
Two
Views
Cytosine end 
Thymine
Adenine and 
Guanine
Phosphate 
group ®
10
Figure 5: Structure of DNA and complimentary bases3 3 8
DNA is certainly the most studied ‘strict self-assembly’ example, meaning that the final 
compound is produced directly and spontaneously when the right subunits are mixed 
together under the appropriate conditions. Any error that may occur will be 
automatically corrected.
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1.3.1 . 2  Tobacco Mosaic Virus
Another well known and widely described example o f self-assembly is the tobacco 
mosaic virus (TMV) (Figure 6 ), the first macromolecular system purified and the first to 
be shown to self-assemble in vitro . 27 3 4 The viral particle is composed of 2130 identical 
subunits, each comprising 158 amino acids which form a helical sheath around a single 
strand of RNA (6390 base pairs in length). The helical virus particle is 300 nm long and 
possesses a diameter of 18 nm. This example shows the potential of biological systems 
to create super-structures with molecular order, from originally small units through the 
self-assembly process.
iooo A
Figure 6 : (a) Representation of the TMV virus, the protein subunits are coloured yellow 
(b) Microscopic view of the cylindrical shape27
1.3.2 Synthetic Self-Assembling Systems
Developing synthetic self-assembling molecular recognition units with programmable 
strength and specificity similar to those demonstrated by DNA is a constant challenge 
particularly if  certain properties are desired. From rotaxanes and catenanes to self- 
replicating systems, advances in the understanding of the intermolecular forces have 
provided successful design of complex self-assembling systems. 35 Here, some examples 
of creative synthetic strategies are considered.
1 .3.2 . 1  Templed Synthesis: Self-Replicating Molecular Systems
Based on the concept of auto-replication found in nature, chemists have successfully 
designed molecules that can self-replicate via autocatalytic processes. A synthetic 
system that replicates in a polar solvent has been reported by Terfort and von
28
Chapter I
Kiedrowski3 6  where the product acts as a catalyst for its own formation. Strong 
hydrogen bonding between the carboxylate and amidinium (Ka = 350 M ' 1 in DMSO) 
results in close proximity o f the molecules allowing the reaction to proceed (Scheme 1).
n o 2
Scheme 1: Example of a self-replicating system
1 .3.2.2 Templed Cyclisation: Rotaxanes and Catenanes
The use o f hydrogen bonding in the formation of catenanes3 7 3 8 ,3 9  and rotaxanes4 0  has 
recently shown significant potential for the design of new ‘interlocked’ compounds. The 
formation of catenanes involves a template effect where a macrocycle complexes with 
its linear precursor to enhance the formation of the catenane. Leigh et al. have achieved 
the synthesis of a [2 ]-catenane through the reaction between acid chlorides and amines 
to form the amide bonds. 4 1 ,4 2  In this reaction, eight molecules must combine together to 
form the desired product. Hydrogen bonding between the amide groups is the driving 
force to generate the interlocked molecule and a total o f six hydrogen bonds were 
revealed by X-ray crystallography as shown in Figure 7.
Figure 7: Crystal structure of catenane423
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Stoddart’s strategy was based on the initial discovery by Pedersen that crown ethers can 
complex organic and cationic molecules, notably ammonium salts . 4 3 ,4 4  This has led to 
an efficient templated synthesis based on hydrogen bonding towards the formation of 
rotaxanes and pseudo[2]-rotaxanes. Stoddart demonstrated that dibenzo-[24]crown-8 
(DB24C8) can bind both dibenzylammonium and bis(n-butyl ammonium) in a 
pseudorotaxane-like manner as shown in Figure 8 . The superstructure is stabilised via 
hydrogen bonding between the acid proton o f the ammonium group and the oxygens of 
the crown ether.
N 
H H 
PF6
CDCL
ChLPh
|[ '  '  HNH
° '  / |V  " °
J j 0 ^  
CH-Ph
0 ""\^ 
O O
O O
db24c 8
H H PF6-
CDCL
c 4h9
I-' , - 0
HNH
O '  / | \  'O
c 4h9
Figure 8: Crown ether binding ammonium salts in a pseudorotaxane manner
1.3.2.3 Self-Assembled Capsules
Molecular capsules are formed by the self-assembly o f complimentary hydrogen 
bonding units, with the subunits displaying appropriate ‘curvature’. Rebek et al. have 
developed numerous systems based on molecular encapsulation . 4 5  A key example is the 
so called ‘tennis ball’ synthesised from the self-assembly o f two molecules of glycouryl 
with durene tetrabromide 4 6  Two molecules o f 11 (Figure 9) self-assemble in solution 
via eight hydrogen bonds to form a very stable unit. The molecular capsule formed can 
then act as a host for appropriate guests (such as methane or ethane) and bring them into 
a well defined nano-environment.
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X  A
N N
HN. .NNk
o  A _ A >
A A
Figure 9: Self-assembled capsules: an example o f the ‘tennis ball’
For these tennis ball structures, the cavity size can reach 61 A3 and decrease to 37 A3 
when the phenyl spacer is replaced by ethylene. Much longer spacers can be used as 
well, leading to a ‘soft-balF capsules of larger size (313 A3), such as found in 
compound 12 (Figure 10) . 4 7
NI
N
O O
12 R= Phenyl, C 0 2 isopentyl
Figure 10: Example o f the ‘soft-ball’ capsule
1.3.2.4 Cylindrical Structure: Peptide Nanotubes
A significant breakthrough in self-assembly o f nano-devices was made by Ghadiri et 
al., when they designed organic nanotubes from cyclic peptides . 4 8 ,4 9 ,5 0 ,5 1  The nanotube 
consisted o f hydrogen bonded stacking o f cyclic peptides with an even number o f 
alternating D/L amino acids with a conformation such that the C =0 and N-H o f the 
amide moieties are oriented perpendicular to the plane of the macrocycle52 (Figure 11). 
Control of the size of the cyclic peptide influences the pore size of the nanotube. 
Nanotubes were found to be very robust and stable over a wide pH range and in 
different solvents. These nano-devices have significant potential applications in the 
transport of ions and small molecules. Recent studies have shown that such nanotubes
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can stack inside the cell membrane of the bacteria, leading to cell permeability, and 
ultimately to the death o f the cell, highlighting their potential as antibiotics.
Figure 11: Schematic view o f Ghadiri’s peptide nanotube4 8
This last example illustrates one o f the strategies used to increase the stability o f the 
hydrogen bonded assembly where individual hydrogen bond recognition motifs are 
covalently connected to give multidentate modules that can associate via multiple 
hydrogen bonds. This approach has been investigated by Hunter et al.53,54,55 for the 
synthesis o f molecular zipper complexes (Figure 12), with an association constant (ATa) 
o f up to 103 M '1.
Figure 12: Example o f a molecular zipper55
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Similarly, Gong et al. have described the synthesis o f an extremely stable hydrogen 
bonded duplex held together via six hydrogen bonds, such as shown in duplex 13 
(Figure 1 3 ).56-57'58
C7H15 0 ^ 0  ^ C rH,5
3 H £  H H ^  H
0  H H ^
C7H c 7h
c- " ' ^ X r " ^ l!C i X a^ N' C C o " ' c,K"
C7Hi^ C H15 C7H15
13 Ka>109M-1
Figure 13: Stable duplex via six hydrogen bonds
Another approach taken in order to increase the stability o f the self-assembly, is the use 
o f hydrogen bonded complexes based on rigid linear arrays o f multiple donor (D) and 
acceptor (A) sites for hydrogen bonding. This strategy has received by far the largest 
application in material science in recent years and will be discussed in detail in the 
following section.
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1.4 The Self-Assembly of Supramolecular Architectures 
Using Hydrogen Bonding Modules
The development o f rigid heterocyclic modules that can dimerise via hydrogen bonding 
interactions has developed over the last ten years into a unique tool for the synthesis o f 
supramolecular structures. In the following section, various examples of basic modules 
are considered, which are grouped based on the number o f hydrogen bonds formed.
1.4.1 Double Hydrogen Bonded Systems
A large number o f organic functionalities can dimerise via the formation o f two 
hydrogen bonds. Dimeric assemblies are widely found as heterodimers (DD-AA, with D 
= Donor and A = Acceptor) and homodimers (DA-AD), in carboxylic acids , 5 9  amides60  
and ureas . 61 Sartorius and Schneider62  predicted a low dimerisation constant o f ~ 60 M ' 1 
for DA-AD in chloroform, which is unfortunately too low to be useful for the synthesis 
o f supramolecular polymers. Dimerisation constants were found to be higher for 
heterodimers DD-AA, with dimerisation constants reaching 102 M ' 1 in CDCI3. The 
dimerisation constant could be increased further to 3 x 103 M ' 1 with the formation o f 
‘bifurcated’ hydrogen bonds such as found in compound 14 (Figure 14). One way o f 
increasing the stability o f such dimeric assemblies is to connect multiple modules via 
covalent bonds. Following this strategy Wuest et al.63,64,65 connected two 2-pyridones 
using a rigid linker. Depending on the arrangement o f the pyridone moiety, very stable 
cyclic dimers could be obtained in CDCI3 {K& > 60000), as well as in the solid state, 
such as dimer 15. However, a polymeric aggregate (16) was obtained, where the 
orientation o f the amide bond favoured a linear shape.
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h H H
H O H
n  y -NNL ,N
K >  6 x  104 M-1K =  3 x  103 M-1
Figure 14: Examples of double hydrogen bonded systems
Although the strength of a double hydrogen bond is not sufficient enough to generate 
materials with polymeric properties, the use o f such synthetically accessible systems 
inside a polymeric matrix, enhances the material properties. Stadler et al. extended this 
concept, by studying the properties of polybutadienes functionalised with hydrogen
f\f\ fnbonded phenylurazole units (17) (Figure 15). 5 The elastomeric polybutadiene 
transformed into a thermoplastic elastomer upon functionalisation with the reversible 
units.
Figure 15: Hydrogen bonded phenylurazol unit incorporated into polybutadiene
Following this significant contribution in the field o f supramolecular polymers, further 
efforts were made towards the development of multiple hydrogen bonding systems that 
could dimerise with higher dimerisation constants.
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1.4.2 Triple Hydrogen Bonded Systems68
Triple hydrogen bonding is potentially more suitable for the generation o f stronger 
dimeric units. Three combinations of array can be envisaged, all o f them being hetero- 
complimentary (Figure 16). Heteroaromatic compounds have several advantages, 
foremost o f which is the geometrically well-defined, often linear array of hydrogen- 
bond donor and acceptor groups present. However, a key disadvantage of using 
heteroaromatic modules in self-assembly is their poor solubility in organic solvents, 
which makes it difficult to measure the association constant. Another drawback is that 
the tautomeric behaviour of heteroaromatic modules is often solvent dependant.
A A A  D A A D A D
D D D A D D  A D A
Figure 16: Three possible combinations for triple hydrogen bonded systems
The arrangement o f the donor and acceptor in the array has a crucial influence on the 
dimerisation constant. A few examples o f triple hydrogen bonded systems are described 
in the following section.
1.4.2.1 DAD and ADA Heteroaromatic Modules 69’70’71,72
The most common DAD-ADA hydrogen bonding array is found in the base pair 
between 2-aminoadenine (A’) and thymine (T) 73 (e.g dimer a, Figure 17). Such 
complexes have been shown to increase the dimer stability and specificity relative to 
adenine.thymine (AT) base pairs (Ka = 90 M ' 1 in chloroform for AT compared to 210 
M ' 1 for A ’T) . 7 4  One o f the most useful ADA arrays contains the pyrimidine-2,4-dione 
unit as shown in Figure 17 below. The A-alkylation o f thymine with allyl halide 
provides a simple method to functionalise this molecule. Example o f DAD-ADA 
complexes and their corresponding Ka values in chloroform are shown in Figure 17.
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Figure 17: Examples of some triply hydrogen bonded heteromodules based on the 
DAD-ADA arrangement
1.4.2.2 DDA and AAD Heteroaromatic Modules75,76,77
A typical example o f this system is the cytosine-guanidine base pair. These bases are 
commercially available and can be derivatised in numerous ways. The association 
constants presented in Figure 18 lies in the 104 -105 M ' 1 ranges, which are two or three 
orders of magnitude higher than those observed for the ADA-DAD arrays.
Me
Figure 18: Example o f DDA and AAD heteroaromatic modules
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1 .4.2.3 DDD and AAA Heteroaromatic Modules
Few examples of such modules have been reported in the literature. However, one of the 
most cited examples is the 1,9,10-anthyridine moiety (18, Figure 19) with an association 
constant greater than 105 M ' 1 in chloroform with its AAA complimentary unit 
dihydropyridine 19 (Figure 19).78,79
OHC
H2N
,CHO b ase
N NH,
N N
18
OPr OPr
N 0 2
K > 105 M-1
19
Figure 19: Synthesis o f the diaryl-1,9,10-anthyridine module (AAA) 18 and its 
association with dihydropyridine 19 (DDD)
1 .4.2.4 Variations in Association Constants
In the late eighties, Jorgensen et al. attributed the differences in association constants to 
the attractive and repulsive secondary interactions within the assembly . 8 0 ,8 1  
Stabilisation can arise from the electrostatic attractions o f positively and negatively 
polarised atoms in the adjacent hydrogen bond, whereas destabilisation results from 
electrostatic repulsions between two positively or negatively charged atoms (Figure 20).
A D A
)< * /)<
* V
D A D
D A A
VlV"
' 4 / \ i
A D D
D D D
VtV‘
A A A
*— ► Attractive interactions 
< ■ — >  Repulsive interactions
Figure 20: Electrostatic interactions in different triple hydrogen bonded arrays
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Complexes formed from the DAD-ADA array show a Ka in the range of 102 -103 M ' 1 in 
chloroform, whilst the DAA-ADD array has a Ka o f 104 M " 1 and exceeds 105 M ' 1 for the 
AAA-DDD complex. In the DAD-ADA complex, the number o f repulsive secondary 
interactions is at a maximum, which destabilises the system, leading to the lowest 
association constant. In contrast, the AAA-DDD array exhibits the highest association 
constant because the four secondary interactions are all attractive, which then stabilises 
the structure.
1 .4.2.5 Supramolecular Assemblies Based on Triple Hydrogen Bonding
Considerable progress has been made in the last decade on the development o f triple
• 89hydrogen bonded supramolecular assemblies, in particular for the synthesis o f discrete 
cyclic molecules as well as the development of the first generation of linear 
supramolecular polymers.
1 .4.2.6 Cyclic Oligomers
Zimmerman et a l  have described the synthesis o f a stable hexameric disk-shaped 
aggregate containing 18 hydrogen bonds in total, formed by the association of 
complimentary DDA and AAD sites . 83 The design of this particular m otif allows the 
formation o f particularly stable cyclic assemblies (20, Figure 21) over polymeric 
aggregates.
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Figure 21: Formation o f a stable cyclic assembly
1 .4.2.7 Cyclic Multimers and Linear Systems: Rosettes and Ribbons
Another interesting system is the self-assembly o f melamine with cyanuric acid units. 
Whitesides et al. have extensively studied various rosette type molecules . 8 4  When 
equimolar amounts of melamine 2 1  and cyanuric acid 2 2  were mixed together, an 
insoluble polymeric complex precipitated from the solution leading to a rosette like 
arrangement as shown in Figure 22.
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Figure 22: Formation o f cyanuric acid-melamine complex84
From NMR and GPC studies, it was established that the rosette motif was not the only 
one present in the solid state The complex displayed three motifs in the solid state 
including the ‘linear tape’, the ‘crinkled tape’ and the ‘rosette’ m otif (Figure 23).85,86
Crinkled tape
Linear tape
Figure 23: Three motifs formed in the complex of cyanuric acid and melamine86
Structural modification of the acid or amine influenced the stability o f the linear or 
wrinkled tape. In order to favour the formation of the rosette motif, Whitesides used two
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different approaches: the introduction of stereochemical control by peripheral crowding 
and covalent preorganisation. The primer was achieved using hindered groups on the 
melamine unit such as r-Bu, as opposed to small groups such as insertion of F or CH3
on 00
that leads to the formation of the linear tape. ’ However, the use o f a trigonal template 
(covalent preorganisation) linked to three melamines (M) favoured the formation of the 
rosette. Various linkers have been used depending on their rigidity as shown in Figure
2 4  89,90
Figure 24: Preorganisation using a rigid linker. M (melamine), CA (cyanuric acid) 89
Due to their hydrogen bonding capability, derivatives o f barbituric acid (23) and 
melamine (24) have been also used by Lehn et a l  for the synthesis o f molecular ribbons 
(25, Scheme 2) . 91 In this case, the formation o f a cyclic hexamer structure was not 
observed.
Et Et Et Et Et Et
25
Scheme 2: Formation o f molecular ribbons
Triple hydrogen bonding arrays were also synthesised based on 4,6-diamino 
-5-octylpyrimidin-2 (lH)-one (26), and 2-amino-5, 5-dibutylpyrimidine-4,6 (lH)-dione
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(27) which are complimentary to each other, as well as self-complimentary (Scheme 3). 
The hetero-association of 26 and 27 lead exclusively to the formation of macrocyclic 
ring (30), while the self-assembly of either 26 or 27 generated only molecular ribbons 
(28 or 29).
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.,H V V ' H  - - "  V  H 
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Scheme 3: Formation o f macrocyclic ring and molecular ribbons91
Molecular ribbons have been classed as the first generation of ‘supramolecular 
polymers’, where the length of the ribbon was directly controlled by the strength o f the 
hydrogen bond. Although called supramolecular polymers these ribbons did not show a 
high degree of polymerisation (DP) due to relatively weak hydrogen bonding 
interactions. The recent advances in the field o f self-assembly have stimulated the
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design o f a new generation of supramolecular polymers based on strong hydrogen 
bonding.
1 .4.2.8 Supramolecular Polymers Based on Triple Hydrogen Bonding
In supramolecular polymers9 2 ,9 3 ,9 4  which are formed by the reversible association of 
bifunctional monomers, the average degree o f polymerisation is dependant on the 
concentration o f the solution, as well as the association constant o f the end groups . 9 5  A 
schematic representation o f DP versus K& at two different concentrations 1 M and 0.05 
M (in the absence o f cyclisation) is shown in Graph 1.
From this graph, a single hydrogen bond with K a ~ 101 M ' 1 leads to the formation of 
very low DP, and only association constants greater than 105 M ’ 1 result in DP greater 
than 1 0 0 .
10000
r^C  r- 1 M
.2 1000
0.05 M
100  :
10
K
Graph 1: Variation o f the degree of polymerisation as a function o f K z 95
When multiple hydrogen bonding sites are combined together in a functional unit 
comprising triple hydrogen bonding, the interaction can be strong leading to a 
supramolecular polymer with unique properties in the bulk. Lehn et a l  synthesised 
hetero dimers o f bifunctional diaminopyridines (31) and difunctional uracil (32) held 
together via triple hydrogen bonding (DAD-ADA) (Scheme 4). The 1:1 ratio of the two 
units displayed liquid crystallinity over a broad range of temperatures while the pure 
compound (33) was solid and melt without displaying a liquid crystalline phase . 9 6  The
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presence of the chiral spacer induced biased helicity as observed by electron 
microscopy.
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Scheme 4: Formation o f linear supramolecular polymers
Liquid crystalline polymers were then prepared by introducing a rigid core composed of 
9,10 dialkoxyanthracene between the hydrogen bonding units (34, Figure 25).97,98
t-Bu
-H -N O C12H
t-Bu
t-Bu
O -
N —
N -H --
0 - -
t-Bu
34
Figure 25: Liquid crystalline polymer made from rigid linker
Compound 34 was not a thermotropic liquid crystal as in the previous case, but 
lyotropic meaning that the liquid crystalline properties were induced in the presence of 
apolar solvents. Despite the presence o f three hydrogen bonds with association constant 
Ka o f 103 M"1, the complex generated was unfortunately not strong enough to induce
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true polymer properties in solution. Indeed, the DP was 15 for a 0.05 M solution o f 
polymer 34. Therefore a stronger hydrogen bonding unit is necessary in order to achieve 
polymeric properties in solution.
One way o f achieving this is to increase the number o f hydrogen bonds. Using this 
approach, Lehn et a l synthesised a supramolecular material based on the self­
association o f two homoditopic hetero-complimentary monomers such as 35 and 36 
(Figure 26) through DAD-ADA hydrogen-bonding arrays." The polymer 37 formed 
fibers (a schematic representation of the linear polymerisation is shown in Figure 27).
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Figure 26: Synthesis o f supramolecular polymer 37
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Figure 27: Self-organisation o f complamentary monomeric building blocks
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As illustrated by the work of Lehn and others, the use of multiple hydrogen bonding 
systems increased the strength o f the desired self-assembly. Recently linear quadruple 
hydrogen bonding systems have shown significant potential for the synthesis of linear 
supramolecular polymers.
1.4.3 Quadruple Hydrogen Bonded Systems100,101
From a combination of donors and acceptors, six quadruple hydrogen bonded dimers 
can be envisaged, two containing self-complimentary units (DDAA and DADA) as 
shown in Figure 28.
Complimentarity 
A A A A A A A D A D A A A D D A
D D D D  D D D A  D A D D  D A A D
~ 1 0 8 ~ 1 0 6 - 1 0 * - 1 0 4
Self-complimentary 
D D A A  D A D A
A A D D A D A D  
- io 6 ~io2
Figure 28: Quadruple hydrogen bonding arrays. Orders o f magnitude of the predicted 
stability constants (in M '1) in CDCI3 are also indicated 100
The differences in Ka observed can be explained by the Jorgensen model as described 
previously. Among the hetero-complamentary arrays, AAAA-DDDD is the strongest 
with six secondary attractive interactions. The self-complimentary array DDAA-AADD 
also has a high Ka, with four attractive and two repulsive secondary interactions.
47
Chapter I
1 .4.3. 1  Complimentary Arrays
The use of quadruple hydrogen bonding complimentary arrays is still under 
investigation and few examples are cited for the DAAD/ADDA array, which was first 
reported in 1998 when Zimmerman et al. described the existence of a very stable 
complex with Ka > 107 M ' 1 in solution (38, Figure 29).102 Also, the bis-pyridylurea 39 
was described by Liming with a Ka of 2 x 103 M ' 1 . 103 The low stability was attributed to 
the presence of an intramolecular hydrogen bond in the pyridyl urea monomer which 
must break in order to form the linear DAAD array.
o
Figure 29: Examples of complimentary arrays (ADDA-DAAD)
Recently Li et a l have reported the synthesis of a complimentary ADDA-DAAD 
system based on hydrazide derivative , 104 with an association constant o f 4.7 x 1 0 4  M ' 1 in 
chloroform.
A more complex array is the DDAD/AADA hetero-dimer. Meijer et al. attempted the 
synthesis o f the module AADA, using a dipyridin-2-ylamine derivative (Figure 30) with 
the possibility o f shifting the tautomeric form of 41 to the corresponding AADA module 
40 by complexation with a complimentary DDAD array . 105 Unfortunately, only the 
tautomer 41 was found to be present both in solution and in the solid state.
r ^ N H  N 
O N N N
[| NH N 
R N ^ N ^ N
A A D A A D A
40 41
Figure 30: Tautomeric equilibrium of compound 40
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In 2002, Liining’s group reported the synthesis o f an AADA/DDAD dimer (42, Figure 
106,107 j o w  association constant (.Ka = 110 M '1) was explained by the possible 
formation o f an intramolecular hydrogen bond in the DDAD unit that needed to be 
broken prior complexation (43).
N N
AC = 110 M -1
R,
43
H^ na Na n-h ' - ° Y n ' V
Figure 31: Example o f a DDAD/AADA system (left) and self-association o f the DDAD 
unit in the folded conformation (right)
1 .4.3.2 Self-Complimentary Arrays
The development of self-complamentary arrays stems from their potential use in 
supramolecular polymers and ‘intelligent materials’. These are particularly useful class 
o f systems that offer considerable simplification o f the supramolecular design. In the 
following, some o f the typical and most widely used modules are considered.
1.4.3.3 DAD A Array
Meijer et al. have shown that acylation of both diamino-triazines and 
diaminopyrimidines generates a DADA motif. 108 The construction o f this m otif can be 
achieved by a simple addition o f an acceptor group to a DAD array. Although the 
DADA array is expected to be the least stable o f the quadruple hydrogen bonding m otif 
due to secondary repulsions based on the Jorgensen model, the synthesis o f strong 
dimers with Ka > 105 M " 1 have been reported. The increase in the Ka for molecule 44 or 
46 (Figure 32) has been possible by the synthesis o f preorganised molecules 45 and 47. 
The new intramolecular hydrogen bond fixes the array in a planar conformation 
resulting in a dimerisation constant of 2 x 104  M " 1 for 45 and 2 x 105 M ' 1 for 47.
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Figure 32: Examples of DADA quadruple hydrogen bonded arrays
1 .4 .3 . 4  Supramolecular Polymers Based on DADA Array
1 AO
The straightforward preparation o f ureidotriazines as well as the relatively strong 
dimerisation constant in CHCI3 is an attractive feature for its use in the formation of 
linear supramolecular polymers. For this purpose, Meijer et a l  have combined 
solvophobic interactions and hydrogen bonding in a bifunctional trialkoxyphenyl 
ureidotriazine derivative 48 (Figure 33) . 109
OR
OR
48 r  = o c 12h25
49 R =
= 3
Figure 33: Bifunctional ureidotriazines
The nature of the resulting compound 48 was highly dependant on the solvent. Indeed, 
in dodecane (apolar solvent), compound 48 organised into a helical columnar polymer 
(Figure 34), while in chloroform, where the solvophobic interactions were weaker, the 
final compound formed a random coil polymer. In DMSO, a highly polar solvent, the 
hydrogen bonds were broken and the compound existed as a monomeric unit. The 
length of the column was directly linked to the concentration of the solution: for a 0 . 2  
wt.% solution the length is found to be 100 A, while for a 1.0 wt.% solution the length 
increased to 190 A. Compound 49, containing a chiral oligoethylene unit instead of an
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alkyl side chain was soluble in water and surprisingly the hydrogen bonding array was 
not disrupted due to the hydrophobic environment by the stacking of the planar 
trialkoxyphenyltriazine moieties.
Figure 34: Representation of the random coil polymer and helical columnar
aggregate109
Recently, Sijbesma et a l  described the synthesis of ureidotriazine 7i-conjugated oligo 
(p-phenylene vynilene) groups for the use in electronic devices110 (Figure 35).
Figure 35: Examples of ureidotriazine 7r-conjugated systems
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Both compounds 50 and 51 formed columnar architectures in dodecane, but 51 was less 
ordered due to steric effect o f the long chain imposed by the linker and the stacking 
interactions.
1.4.3.5 DDAA Array: Ureidopyrimidinone (Upy)
In order to synthesise linear supramolecular polymers with a high DP, it was important 
to use a stronger array, such as the DDAA for which the design and synthesis of 
ureidopyrimidinone derivatives were explored.
Ureidopyrimidinone units can readily be synthesised via a two step synthesis starting 
from the condensation o f /?-keto ester with guanidine, affording the corresponding 
isocytosine (52). Reaction with an alkyl isocyanate affords the quadruple hydrogen 
bonding system 53 (Scheme 5) . 111
R
53
Scheme 5: Synthesis o f quadruple hydrogen bonded system based on
ureidopyrimidinones
Unfortunately, the self-association of ureidopyrimidinones is complicated by the 
existence o f a complex equilibrium of tautomers (Figure 36). Three forms can exist, one 
o f which is the 6 [lH]-pyrimidinone (DDA) (54) that cannot dimerise. The pyrimidinol 
form (56) dimerises via a DADA array, and the 4[lH]-pyrimidinone (55) dimerises via
NH. H NH
52 NH
DDAA.
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Figure 36: Tautomeric and dimeric equilibria in ureidopyrimidinones
The occurrence of the tautomers was observed to be highly dependant on the polarity o f 
the solvent as well as the concentration and the nature o f the substituents at the C - 6  
position. Remarkably, the pyrimidinone with alkyl groups (such as CH3) at C-6 , existed 
in CDCI3 as the DDAA tautomer (99%). In order to build supramolecular polymers 
based on pyrimidinone units, it is important to have a high dimerisation constant as well 
as a unique tautomer present in solution, otherwise the system can become highly 
complex.
The crystal structure of 57 (R = C4H 9 , R' = CH3 , Figure 35), revealed the existence of a 
linear quadruple hydrogen bonding array (DDAA), stabilised by an intramolecular 
hydrogen bonding between the carbonyl o f the urea and the pyrimidine (N-H). The 
array deviated slightly from linearity with D (N .. .N) = 2.97 A (0 = 175°) and D (N .. .O) 
= 2.76 A ( 0  = 163°).
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Figure 37: Schematic representation and structure of 57 in the solid state111
FTIR measurements (in the solid state and CHCI3) revealed the existence o f the DDAA 
array in solution. NMR studies o f compound 57 showed deshielded signals for the NH 
protons characteristic of strong hydrogen bonding at 13.15, 11.86 and 10.15 ppm for 
1-H, 7-H and 9-H, respectively, with a chemical shift for the vinylic proton at 5.88 ppm. 
In order to measure the dimerisation constant K&m, NMR dilution experiments were 
performed, but no chemical shift changes o f the hydrogen bonded protons were 
observed, even near the detection limit of a high field instrument operating at 750 MHz. 
This result was very encouraging and demonstrated that the dimerisation constant was 
very high, greater than 106 M '1.
• 119 •Meijer et al. then used a fluorescence technique with pyrene labelled compound 58 in 
order to measure K&m (Figure 38). On dimerisation a strong excimer fluorescent signal 
was observed at 478 nm, and upon dilution, signals o f the monomer appeared around 
370-400 nm.
Figure 38: Pyrene labelled compound 58
Using this technique, the dimerisation constant o f the DDAA array was found to be ~ 6  
x 107 M ' 1 in chloroform, 107 M_1 in wet chloroform and 6  x 108 M ' 1 in toluene.
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Ikegami and Arai have used an anthracenyl labelled Upy compound 59 (Figure 39), 
which exhibited exiplex emission at concentration below lO ^M '1.
i i
H H 
59
Figure 39: Anthracenyl labelled compound 59
1 .4.3.6 Supramolecular Polymers using Ureidopyrimidinone (Upy)
Bifunctional Upys
Because of their high dimerisation constant, recently ureidopyrimidinones have been 
used in the synthesis o f high molecular weight polymers. The first supramolecular 
polymer based on Upy was prepared using a bifunctional Upy derivative. The synthesis 
of the monomer involved the reaction o f a diisocyanate with the isocytosine. Two 
possible synthetic routes were envisaged as shown in Scheme 6 , one where the linker is
between the urea bond (60), and the other where the linker is connected via the C - 6
• 1 1^position (61). When these monomers were dissolved in chloroform a highly viscous 
solution was obtained.
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Scheme 6 : Two strategies towards the synthesis o f supramolecular polymers based on 
the Upy modules.
In order to obtain information on the DP in solution, a small amount o f the mono 
functional unit was added to an extremely pure solution o f the polymer 62, resulting in a 
dramatic drop o f the viscosity. The monofunctional unit played the role o f a 
polymerisation stopper, which then decreased the DP and thus the viscosity o f the 
solution . 11 4 Based on viscosity studies and taking into consideration the dimerisation 
constant o f the Upy unit, Meijer et al. estimated a DP o f 3000 for a pure solution o f 62 
(Figure 40).
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62
Figure 40: Supramolecular polymer 62
The stopper used can also be in the form of a photolabile nitrobenzyl ether (63) that 
forms a DDA array and cannot compete with Upy. Under photolytic cleavage o f  the 
protecting group the carbonyl group is liberated and form an AADD motif (64), which 
can then start the de-polymerisation as shown in Figure 41. This process is 
unfortunately not reversible.
stopper
Figure 41: Photolytic cleavage of compound 63
In order to take advantage o f the high degree o f polymerisation offered by the Upy 
groups in the synthesis of new materials, Meijer et al. used long linkers between the 
Upys, such as telechelic polymers (polysiloxanes), poly(ethylene/butylenes) (6 6 ), 
polyethers (67), polyesters (6 8 ) and polycarbonates (69) (Scheme 7) . 115 It is then 
possible to combine the mechanical properties o f covalent polymers with the low melt 
viscosity of the hydrogen bonding units. At high temperatures the end groups can 
dissociate and the viscosity decreases. Such advanced materials are of great interest for 
many applications, such as thermoplastic elastomers.
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Scheme 7: Functionalisation of telechelic polymers with ureidopyrimidinone
Compound 65 was first synthesised using 6-methyl isocystosine in hexyl diidocyanate 
and was further reacted with hydroxyl terminated polymers in chloroform in the 
presence of a tin catalyst. The final supramolecular polymers exhibit improved 
properties as a result of the self-association. For example, the functionalisation of 
telechelic poly(ethylene/butylene) copolymer (66) resulted in interesting mechanical 
properties. Whilst the telechelic polymer is a viscous liquid, the Upy end-group 
modified polymer was an elastomeric solid (Figure 42). It was shown that these novel 
materials can combine the robustness of traditional covalent macromolecules with the 
responsiveness o f reversible supramolecular polymers.
Figure 42: Telechelic polyethylene/butylene, b) telechelic polyethylene/butylene 
functionalised with Upy115
Supramolecular polymers based on telechelic polymers have also recently been used in 
polymerisation induced phase separation (PIPS). Here a polymer is dissolved in a
a
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monomer matrix, which upon polymerisation causes a phase separation, resulting in two 
polymeric phases with certain morphologies (Figure 43).
H om ogen eou s supnunolecular Pft*s» separation  into
polym er in m onom er so lu tion  tw o polym eric p h a se s
x" .y
acrylate polymer
:: '* — ------► ' " supram olecular
*.<<■* ‘ x . -  polym erization '%» t  * polym er
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Figure 43: Schematic representation of polymerisation induced phase separation
A big advantage of using PIPS is that it is a solvent free polymerisation process, leading 
to multi-phases of composite materials. Using this concept, Meijer et al. designed an 
efficient and fast PIPS using telechelic polymers such as poly-THF 
(Mn ~ 1000 g/mol) and poly-carbonate (Mn ~ 2200 g/mol) dissolved in a mixture of 
acrylate and diacrylate monomers.116 Advantage is the formation o f two polymeric 
phases in one polymerisation step. Experiments revealed that the amount o f diacrylate 
was an important factor in the morphology development. The mechanical properties o f 
the films containing the supramolecular polymer were comparable to standard films 
containing covalent high molecular weight polymers.
These results achieved by combining the low molecular weight telechic polymers and 
reversible hydrogen bonding networks has led to numerous applications. In particular, 
Meijer has combined the electronic properties o f ^-conjugated moieties o f oligo(7i- 
vinylenephenylene) oligomers with the polymeric properties offered by the Upy 
units.117,118 For example, compound 72 (Scheme 8) was obtained in 45% yield via the 
reaction o f diisocytosine 70 with isocyanate 71 in pyridine at 90 °C. It was shown that 
this and similar compounds open new possibilities for the design of electronic materials.
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Scheme 8: Synthesis o f supramolecular polymer incorporating oligo(7r-
vinylenephenylene) moieties
More recently, Hummelen’s group has synthesised a supramolecular polymer (73, 
Figure 44) based on fullerene C6 0  for use in photovoltaic applications.119,120,121
n h  o
13 '27
73
Figure 44: Supramolecular polymer incorporating a fullerene moiety
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Coates et a l have also reported the use of 2-ureido-4[lH]-pyrimidinone derivatives as 
reversible cross-links in polyolefin elastomers.122 The incorporation o f olefenic 2- 
ureido-4[lH]-pyrimidinone 74 (Scheme 9) within a main chain amorphous polyolefm 
was achieved through a coordination polymerisation route using a nickel based 
brookhart catalyst.
Scheme 9: Synthesis of compound 74
The use of 3 equivalents of monofunctional Upy was necessary in order to prevent 
precipitation of the growing polymer. The resulting copolymer showed distinctive 
mechanical properties compared to the homopolymer o f 1-hexene. Due to the 
reversibility o f the hydrogen bonding network, the solution viscosity o f the copolymer 
showed strong concentration dependence as opposed to the homopolymer. Furthermore, 
while the homopoplymer was a viscous liquid, polymer 74 showed elastomeric 
properties at room temperature.
In an attempt to produce a strong and elastic material, Guan et al. have recently reported 
the incorporation o f Upy within a linear polyurethane polymer.123 For this purpose the 
diol 78 was prepared via a three step synthesis (Scheme 10). The protected precursor 77, 
was used to prepare control polymers, which cannot dimerise. Modular polymer A and 
control polymer B were then prepared via the reaction with isocyanate terminated 
polyurethanes. Due to the loops formed, polymer A shows increased tensile strength 
and elasticity compared to polymer B.
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Scheme 10: Synthesis o f compounds 77 and 78
Trifunctional Upy Derivatives
Like the synthesis o f linear bifunctional supramolecular polymers, it is possible to form 
a supramolecular network, based on trifunctional molecules. For example, polymer 79 
(Figure 45) was found to form highly viscous solutions in CDCI3, twice as viscous than 
the bifunctional polymer, and did not lead to gelation, due to the reversibility o f the 
network.
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Figure 45: Trifunctional derivative 79
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Meijer et al. described the first 3D network supramolecular polymer based on the 
functionalisation o f trifunctional block copolymers o f propylene oxide and ethylene 
oxide (Scheme l l ) . 124 In order to link the Upy and the copolymer, a reactive and 
selective coupling agent was necessary. For this purpose, the diisocyanate (4)- 
isocyanatomethyl-methylcyclohexylisocyanate (IMCI) was used for its selectivity (one 
primary and one secondary isocyanate in the molecule) and reactivity. The telechelic 
polymer 80 can first react with the primary isocyanate functionality o f IMCI, followed 
by the reaction o f isocytosine with the secondary isocyanate moiety. Crosslinked 
polymer 81 formed viscoelastic reversible networks, while its analogue 82 was a liquid. 
Supramolecular polymer network possesses the property o f “self-healing”, i.e., they can 
reassemble to form the thermodynamically most favourable state, leading to dense and 
strong networks.
Scheme 11: Synthesis o f compound 81
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1 .4.3.7 Polymeric Versus Cyclic Species
In any polymerisation process (covalent or non-covalent), cyclisation is often observed, 
although it has been ignored for a long time. The presence o f cyclic aggregates in the 
polymer can considerably affect the mechanical properties of the final material. The 
formation of cyclic species tends to increase in dilute solutions where the ring formation 
is favoured over chain extension. Jacobson and Stockmayer predicted the existence o f a 
critical concentration,125 below which the equilibrium composition o f the system 
consists exclusively of rings, and above which the concentration of rings become 
constant and all additional material is composed o f polymers.
Like other traditional polymers, supramolecular polymers based on Upys are in 
dynamic equilibrium with cyclic species. The isolation and characterisation o f cyclic 
species is difficult due to the reversibility o f the process. However, methods such as 
NMR diffusion and viscometry have been developed recently in order to measure the 
presence o f cyclic species in supramolecular polymers.
Meijer et a l  have studied the cyclisation o f hetero-dimers between 83 and 84 (Figure 
46). The bifunctional compounds 83, 84 and 85 possess short linkers (max n = 12) to
1 Ofi 1 9*7restrict homo-cyclisation. ’ Indeed, the latter will require a folding o f the molecule 
since the Upy units have to be in an anti-parallel conformation in order to self-assemble.
Viscometry studies revealed that compounds 83 and 85 behave as polymers, but in an 
equimolar solution in chloroform the presence o f cyclic heterodimers below a critical 
concentration o f 7 mM (86) was observed. A quantitative analysis of the cyclic species 
was possible using the NMR chemical shift o f the vinylic proton in the Upy ring, which 
shows separate signals for the cyclic and polymeric aggregates.
Cyclic species are not favourable products in polymerisation process, however they can 
be particularly useful as supramolecular assemblies for the host-guest chemistry. For 
example, in the case of ‘Rosette and Ribbon’ described previously, the steric effect and 
preorganisation direct the product distribution towards the rosette shape by decreasing 
the entropy penalty for cyclisation. This principle has been applied to the Upy system. 
In order to generate cyclic species in solution, a more preorganised linker has been used, 
either with a rigid spacer or with a bulky substituted linker.
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Figure 46: Formation o f the cyclic structure 86
Preorganisation Using a Rigid Spacer
Meijer et al. have reported the synthesis o f bifunctional Upys connected by a
1 98tetramethyl m-xylene linker (87, Figure 47). These molecules appeared to form 
extremely stable cyclic dimers in solution (CDCI3) and in the solid state and even for a 
saturated solution no traces of polymeric aggregates were observed. At least three 
different isomers o f the bifunctional Upy derivative exist, and the X-ray analysis 
revealed the presence of two isomers. The first one was a ‘syn’ form, where the Upy 
groups, both in the 4-keto form, are parallel to each other. The second one was ‘antf 
with the Upy groups being in an anti-parallel conformation.
Studies in solution showed the presence o f a third form, in which one half is the keto 
tautomer, and the other one the enol form. Measurements of exchange rates were
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performed using dynamic NMR studies and the constants of exchange are depicted on 
Figure 47.
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Figure 47: Equilibrium between syn and anti conformation 128
Recently, Mendoza et al. reported the strong dimerisation of a cyclic dimer 
preorganised using a rigid calixarene [4] (8 8 , Figure 48),129 which was highly stable in 
chloroform. The dimerisation constant was estimated to be 2500 M ' 1 and 572 M ' 1 for 
solutions in chloroform containing 64% and 73% of DMSO, respectively.
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Figure 48: Ureidopyrimidinones incorporating calixarene moieties
Another way to favour the formation o f cyclic dimers is the use o f flexible linkers with 
bulky substituents.
Preorganisation Using a Biased Linker
Inspired by Hoffman’s work1 3 0 on the conformations o f alkyl chains substituted by 
methyl groups, Meijer et al. built a bifunctional Upy, linked with a flexible alkyl chain, 
substituted by methyl groups. It was rationalised that the molecule would prefer 
adopting a conformation where the methyl groups are in anti-orientation to each other, 
due to steric effects (Figure 49). This would favour a U-shape conformation promoting 
cyclisation without loss o f flexibility.
Figure 49: Conformational equilibrium
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Several different bifunctional molecules were synthesised with different substituents 
and their critical concentrations were measured in chloroform . 131 The results are shown 
in Table 4.
Critical concentration (mM)
>300
33
95
Compounds
° y v V '
C.,H, 89
.N ^ N ^ N ^ O  
O HN.
C„H,
Y y Y 'Y^NH o
90
V y YO H N ^
C,,H77
H H
N. ^N . -N. ^ O
v 'y y^ Y V Y  T t  Y
kij/NH O * * 0
C„H,7 91 C„H
H H
Y V r r O O r Yks^NH O ~ ,,k'O HN
C„H,
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Table 4: Critical concentrations determined by NMR
The results were in accordance with their hypothesis, since methyl substituted linkers 
promote the formation o f cyclic dimers compared to a linear alkyl chain. In the light of 
these results, methyl groups adopting an anti position to each other (8 8 ) promote the 
cyclisation.
Controlling the Ring-Chain Equilibrium
Bifunctional units linked by C-5 linkers (Table 4) showed a typical behaviour where the 
cyclisation is entropically favoured, i.e. on raising the temperature, the equilibrium was 
shifted towards cyclic species.
Meijer et al. found that bifunctional Upys such as compound 93 (C-6 , biased trimethyl) 
showed unexpected entropy-driven polymerisation (Figure 50).132 On heating, the 
equilibrium between cyclic and polymeric species was shifted towards the formation of 
polymer according to viscosity measurements. 133
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Figure 50: Upy incorporating a biased linker
1.4.3.8 DDAA Arrays other than Upy
In an innovative effort to build a DDAA array with tautomeric fixation and very strong 
self-association, Corbin and Zimmerman developed a new module, which meets these 
criteria . 134 Compound 94 was synthesised in two steps and dimerised via a DDAA 
regardless of tautomerism (Figure 51). Results showed that compound 94 formed very 
stable cyclic aggregates in solution (toluene), while polymeric species existed 
preferably in more polar solvents such as THF. The specific structure that was formed 
was highly dependent on the size o f the dendron and the solvent. The largest nanoscale 
assembly was hexamer, highly stabilised via 30 hydrogen bonds in total, with a 
molecular mass about 17.8 kDa.
Figure 51: Tautomeric equibria of compound 94
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In order to assess the AT^ m value in solution, the group used fluorescence measurements. 
The dimerisation constant was found to be exceptionally high with K&m > 5  x 1 0 8 M '1. 
In order to take advantage of the exceptionally high dimerisation constant for the 
building block o f nano-structure, two units o f 94 were linked together via a rigid spacer 
with a first, second and third generation dendron (Gn, 96). An important characteristic 
of compound 96 was that the linker could either adopt a symmetrical arrangement 
(head-to-head) expressing polymeric properties (95) or anti-symmetrical (head-to-tail) 
(97), leading to a cyclic aggregate (98) (Figure 52).
98
Figure 52: Self-association of compounds 96 and 97
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Unlike the DDAA arrays previously made using triazine, isocytosine or pyrimidine, 
further research by Davis et al. highlighted the use o f the A-carbamoyl squaramide
135module (99, Figure 53), which dimerises via two bifurcated hydrogen bonds.
h - n o
0 YY
7 7  ,K  R1 =Bu, R2 = cyclohexyl
h ' ' h
O N. .NHI "■
O N -H
R 2 
99
Figure 53: Quadruple hydrogen bonding of A-carbamoyl squaramide 99
No signs o f dissociation of the dimer in CDCI3 were observed by NMR, down to a 
concentration o f 0.5 mM suggesting a strong dimerisation. A study in a mixture o f 
CDCI3-DMSO (99:1) suggested a dimerisation constant o f 180 M 1.
Conclusion
Hydrogen bonding is an essential interaction for the self-assembly o f small units into 
complex supramolecular structures. A significant breakthrough was made in the field of 
supramolecular polymers, when Meijer synthesised a strong quadruple hydrogen 
bonding unit (Upy). Since then, many research groups have used the 
ureidopyrimidinone unit as a building block for the synthesis o f new materials, useful in 
areas such as electronics, cosmetics and drug delivery.
The aim o f our research was the use o f Upy derivatives for the synthesis o f energetic 
and non-energetic supramolecular polymers, as well as for the synthesis o f cyclic 
assemblies. Upy is a complex system due to the presence of tautomeric forms in 
solution, and a target was the study o f its tautomerism using functionalisable electron- 
donating groups. In addition, the synthesis o f a novel array with different complexing 
properties that could be useful for the generation of polymeric arrays was o f particular 
interest.
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2 Ureidopyrimidinones Incorporating a
Functionalisable /;-Aminophenyl Electron-Donating 
Group at C-6
2.1 Introduction
Ureidopyrimidinones (Upy) have significant potential for use as building blocks in the 
synthesis o f new supramolecular architectures. The Upy systems have the characteristic 
features to dimerise in a self-complimentary array o f four hydrogen bonds such as
7 1DDAA with a very high dirrterisation constant (Xdm) o f approximately 10 M ' in 
CDCI3 . Although the synthetic accessibility and strong hydrogen bonding arrays 
generated highlights the advantages o f using Upy, a less attractive but important feature 
is the presence of up to three tautomeric forms in solution . 111 Depending on the solvent 
and the concentration used as well as the substituents (Ri and R2 ), the three forms, ‘6 - 
keto’ (A), ‘4-keto’ (B) and ‘enol’ (C), are in equilibrium (Scheme 12).
H H
H H
H H
4[1H]-pyrimidinone monom er 
"4-keto" B
R1
4-keto dimer: DDAA
6[1H]-pyrimidone m onom er 
"6-keto" A
H H
H H
pyrimidin-4-ol monom er 
"enol" C
R.
enol dimer: DADA
Scheme 12: Three tautomeric forms of ureidopyrimidinones
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Two o f these tautomers B and C, strongly dimerise via a quadruple hydrogen bonding 
array possessing an intramolecular hydrogen bond. Both o f them have contributed to 
numerous applications in materials chemistry, including the use for the design o f 
reversible polymers that respond to external stimuli and enhance processability. Unlike 
tautomers B and C, the ‘6-keto’ form (A) cannot dimerise via quadruple hydrogen 
bonding due to the spatial arrangement o f the donor and acceptor groups within the 
molecule. Therefore, the ‘6-keto’ form (A) normally exists as a monomer in solution. 
Meijer et al., pioneers in this area, have studied the effect o f the polarity of the solvent 
as well as the nature of the substituents, at Ri and R2 , on the tautomeric equilibrium. 
Several techniques were used for the characterisation o f the tautomeric equilibria, but 
NMR measurements proved to be most useful. For example compound 100 (Figure 54), 
which possesses a phenyl group at the C-6 position shows two sets of signals in the 
NMR spectrum. One set of N-H signals (87% abundance) at 13.95 ppm (1-H), 12.06 
ppm
(7-H) and 10.23 ppm (9-H), which corresponds to tautomer (B) and the second one at 
13.6 ppm, 11.3 ppm and 10.0 ppm assigned to tautomer (C) with an abundance o f 13% 
(Figure 54). The aromatic proton 5-H o f tautomer C resonates 0.5 ppm downfield to the 
alkylidene signal found in tautomer B. Based on this observation, a series o f compounds 
(2 to 10) was studied by Meijer et al. and the relative amounts o f tautomer B and C in 
CDCI3 and toluene were determined by the integration o f peaks in the ]H NMR spectra 
(Table 5).
Figure 54: Equilibrium between tautomers B and C
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Compound Ri r 2 %  tautom er B 
CDC13
%  tautom er B 
Toluene-ds
1 0 1 c h 3 W-C4H9 >99 insoluble
1 0 2 C13H27 77-C4H9 >99 87
103 C13H27 c 6H5 >99 98
104 C13H27 />-N02C6H5 >99 insoluble
105 C,3H27 />-NEt2C6H5 >99 97
106 p - n o 2 c 6h 5 W-C18H3 7 40 insoluble
107 c f 3 W-C4H9 < 1 -
108 C6H2(OC12H25)3 p- n o 2 c 6h 5 >99 >99
109 C6H2(OCi2H25)3 /7-NEt2C6H5 85 51
Table 5: The tautomeric ratio of B/C in different solvents as a function o f Ri and R2 111
As apparent from this data, alkyl groups Ri at the C - 6  position (101-105) favoured the 
formation o f the 4-keto form (B) (> 99%) in both CDCI3 and toluene-^ and it was 
found that the nature o f the substituent (R2 ) had very little influence on this equilibrium. 
Interestingly, electron-withdrawing groups at Ri such as /?-nitrophenyl (106) and 
trifluoro (107) (R2 = M-C4H9 and W-C18H37, respectively) increased significantly the 
population o f tautomer C in CDCI3. Indeed, more than 99% of C was found for 
compound 107, and 60% for compound 106. This was explained by the electron- 
withdrawing group at C - 6  which tends to decrease the electronic density at the carbonyl 
group involved in hydrogen bonding, and then reduces the stability o f the 4-keto form B 
in favour o f the enol form C.
For compounds 108 and 109 which possess an aryl electron-donating moiety (C6H2 - 
(OC 1 3 1 1 2 7)3) at C-6 , tautomer B dominated in CDCI3 , but there was also a significant 
dependence on the nature o f the substituent R2. In particular, for compound 108 with the 
electron-withdrawing group (p-N0 2 C6H5), the 4-keto tautomer was the predominant 
form in both solvents studied, whereas the change from /?-N02 in 108 to p-NEt2 in 109 
resulted in a significant increase o f the enol form C. In the case of compound 109, the 
dependence o f the tautomeric distribution on the nature o f the solvent was also apparent. 
It is clear from these observations that the nature o f the substituent at C - 6  has a 
pronounced effect on the tautomeric form adopted by the Upy system in solution. In 
CDCI3 or toluene-Js, only dimeric species o f tautomers B and C were present. In 
mixtures of CDCI3 and T>MSO-d6 compound 1 0 1 , which existed almost exclusively as 
tautomer B in pure CDC13, was in equilibrium with a second tautomer. This second 
tautomer had one hydrogen bonded NH proton at 11.4 ppm and two non-hydrogen 
bonded NH protons at 9.4 and 7.2 ppm and was the only tautomer found in pure
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DMSO-Jtf. This new tautomer was assumed to be the 6 -keto monomer (A) (Scheme 12). 
The observation made for compound 101 was further generalised by Meijer et al. for the 
other Upys included in Table 5.
The understanding of such complex tautomeric systems in solution is of critical 
importance for the synthesis o f supramolecular polymers. Indeed, not only a strong 
hydrogen bonding network is required, but for a predictable recognition process the 
presence o f a single tautomer in solution is desirable. Here, Upys with alkyl groups 
(101-105) and trifluoro (107) at Ri meet these criteria and therefore, Upy units with 
alkyl groups at C - 6  such as CH3 and C 13H2 7  have been widely used for the synthesis of 
supramolecular architectures.
In order to design new materials with enhanced structural diversity, the incorporation of 
a functionalisable group at the C - 6  position of the ureidopyrimidinone ring has been a 
key objective in this project. In particular, to assess the influence o f functionalisable 
electron-donating groups on both the dimerisation motif and the tautomeric distribution 
of isomers, the synthesis of compounds possessing a /?-aminophenyl group and azo 
derivatives at C - 6  was investigated. A particular interest was the tautomeric distribution, 
which ultimately could allow tuning properties o f this interesting class o f materials in a 
controlled manner. It should be noted that previous studies of Upy derivatives provided 
only limited data for the characterisation o f the tautomers in solution, especially for the 
6 -keto form. Therefore, considerable effort was put into verification o f the results using 
NMR studies, both in solution and the solid state. The results o f these detailed studies 
are also included in this chapter.
2.2 Synthesis
The synthesis o f 6 -(/?-aminophenyl)isocytosine 112 was performed as shown in Scheme 
13. For simplicity, all the compounds are represented in the 4-keto form B, but it does 
not reflect the actual tautomeric form adopted in a given solvent or in the solid state.
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Reagents and conditions : (a) C6H13NCO, pyridine, reflux, 18h, 88%; (b) SnCI2, HCI, EtOH, reflux, 1 h, 55%;
(c) N aN 02, C6H5NMe2, 20%.
Scheme 13: Synthetic routes towards the formation o f compounds 112 and 113
Initially, ethyl-/?-nitrobenzoyl acetate was reacted with guanidinium carbonate to give 
the 6 -subtitutued isocytosine 110 in 32% yield as yellow needles as previously 
reported . 111 Subsequent coupling with hexyl isocyanate in dry pyridine gave compound 
1 1 1  in 8 8 % isolated yield. Reduction o f the nitro group was first carried out using
i i 'xn icatalytic hydrogenation ’ ’ with H2 over Pd/C in MeOH but was not successful due
to the very poor solubility of 111 in organic solvents. Further attempts using other 
solvents such as THF, EtOH or EtOAc did not show any traces of compound 112 either. 
Therefore, other reduction methods were investigated and the use o f tin chloride (II) in 
acidified ethanol1 3 9 ,1 4 0  successfully gave 112 in 54% isolated yield. Under such acidic 
conditions the protonated amine was first isolated which was then washed thoroughly 
with a basic solution to give the primary amine.
The synthesis o f a derivative o f 112, containing an azo moiety as an alternative 
electron-donating group, was then carried out. Formation of derivative 113 was 
achieved via diazotisation o f 112 using sodium nitrite and AUV-dimethylaminobenzene 
in acidic media . 1 4 1 ,1 4 2 ,1 4 3  Unfortunately, compound 112 had very low solubility in the 
reaction solvent (acetic acid) and compound 113 was isolated in 20% yield.
The synthesis of compounds 112 and 113 possessing an electron-donating group at C- 6  
with an alkyl chain C6H 13 at the ureido position (R2 ), had been achieved, but the very 
poor solubility o f these two compounds in most organic solvents and particularly in 
CDCI3 limited their analysis by NMR studies. These compounds were however soluble
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in DMSO-Gk and most o f the NMR experiments were then performed in this alternative 
polar solvent (Table 6).
Initial tautomerism studies were carried out on the amine 112 together with 111 and 114 
as control compounds, in CDCI3 and DM SO-^. Analogues of 111 and 114 have been 
previously studied by Meijer et al. Compound 114 was synthesised from the reaction 
between 6-methylisocytoine and hexyl isocyanate in dry pyridine and was obtained in 
82% yield (Scheme 14).
n h 2 n o 2
f ^ N H  0
H H
A ^ N H  0
cA A NA N'C‘H'3
H H
c h 3
r ^ N H  0
0  N ^ N ^ N f 0 ^ 13 
H H
112 111 114
S o lv e n ts
C D C I3
D M S O
very poor solubility 
soluble
insoluble
soluble
soluble
soluble
Table 6 : Compounds 111, 113 and 114 and their solubilities in CDCI3 and D M SO -^
A 3 i " 3[ ^ N H  + pyridine O
cA n"  NH2 + 8 8 % ’  0 T n A n X n .
H H
114
Scheme 14: Synthesis o f compound 114
2.3 NMR Spectroscopic Studies in Chloroform
2.3.1 Compound 114
Compound 114 was first studied in CDCI3 in order to establish the full chemical shift 
assignment and to compare the results with analogous compounds 101-105 (Table 5) 
reported previously.
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The *H NMR spectrum of 114 showed the characteristic hydrogen bonded protons o f 
tautomer B a t 13.13, 11.85 and 10.14 ppm for 1-H, 7-H and 9-H, respectively, as well as 
the vinylic proton 5-H at 5.81 ppm. The hydrogen bonded protons o f the enol form C 
were also observed at 13.40, 11.15 and 9.90 ppm, respectively for protons 4-H, 7-H and 
9-H (Figures 55 and 56). The chemical shift o f proton 5-H in tautomer C was shifted 
downfield to 6.15 ppm as expected. The ratio o f tautomer B/C was found to be 99/1. 
Interestingly, the enol form C was not identified previously for compound 101 (Table 
5), presumably because it was present in only very small quantities. Interestingly, on 
increasing the temperature from 298 K to 328 K the proportion o f tautomer C increased 
from 1% to 5%. This small change highlighted the effect o f temperature on the 
tautomeric equilibrium.
c h 3
*Hy v H'0
i i I I
: : h h
7 9
"B" | ;
99%
Figure 55: Equilibrium between tautomers B and C
4 [ 1 H ]  K e t o  F o r m
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E n o l  F o r m
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Figure 56: *H NMR spectrum of 114 in CDCI3 showing the two tautomers B and C
Other characteristic NMR parameters were also revealed, supporting the 4-keto 
tautomer B as the predominant form. For example, the W type configuration is present
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between protons 5-H and 1-H in tautomer B (Figure 57). A relatively large value o f the 
long-range 4 Jhh coupling was therefore expected and the measured value was 1.7 Hz. In 
addition, 4Jhh coupling between protons 5-H and CH3 was also measured (1.0 Hz).
Figure 57: Long range J-coupling paths in the 4-keto form B
Further structural information was obtained using NOE measurements. One advantage 
o f this technique is that both the structural and dynamic features can be monitored via 
(usually) positive enhancements corresponding to NOEs due to spatial proximity of 
protons or negative enhancements if  there is an exchange, either inter- or 
intramolecular, between different species present in solution. An example of results 
obtained from NOE experiments showing both o f these effects is presented in Figure 
58. Here, proton 7-H was selectively excited and a positive enhancement of proton 9-H 
was detected, which confirmed the linear arrangement o f these two protons in a DDAA 
array. The observed negative enhancements between 4-H (C), 1-H (B), and 7-H (C) (- 
80%, - 1 % and -130%, respectively) was indicative o f an exchange process, between 
tautomers B and C (Figure 58).
H H
B B B
1-H 7-H 9-H
1 4 . 0  1 3 . 5  1 3 . 0  1 2 . 5  1 2 . 0  1 1 . 5  1 1 . 0  1 0 . 5  1 0 . 0  9 . 5  p p m
b
Figure 58: a) !H NMR spectrum of compound 114. b) Selective excitation o f proton 7- 
H and enhancements observed.
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Carbon-13 NMR spectra were run in CDCI3 at 323 K in order to assign the chemical 
shifts o f the two tautomers present in solution. The temperature used for the experiment
13was dictated by the increased amount o f the enol observed at higher temperatures. C 
chemical shifts were found to vary quite significantly between the two forms B and C in 
solution, mainly due to the aromacity of the ring in the enol form B. In particular, 
carbon C-5 shifted upfield from 106.6 ppm in the 4-keto form B to 101.7 ppm in the 
enol form C.
In such complex heterocyclic systems where three different tautomers can exist, the use 
o f 15N NMR can be useful for the determination o f the tautomeric species in solution 
and the solid state. For this purpose, ]H, 15N correlation experiments were run in CDCI3 
at 298 K using a 70 mM solution of 114. As expected for tautomer B three different 
chemical shifts characteristic of secondary amines were found at -248.5, -266.0 and - 
279.9 ppm for N -l, N-7 and N-9, respectively, relative to nitromethane (0 ppm). A 
signal at -170.1 ppm was assigned to the unprotonated nitrogen N-3 (Figure 59). The 
assignment o f the 15N peaks was made using the cross peaks observed in the 'H , 15N 
HMQC and HMBC spectra.
CHU
"B" 99%
Figure 59: Compound 114 highlighting three secondary N and one tertiary N atoms
In the solid-state the 13C and 15N NMR chemical shifts were measured using the 
conventional CPMAS technique. Comparison o f I3C and I5N chemical shifts data 
observed in solution and in the solid state was made. In general, such a comparison is a 
straightforward method for detecting any tautomeric changes that may occur on 
dissolving a solid sample in a solvent. Compound 114 showed almost identical 13C and 
15N chemical shifts in the CDCI3 solution and in the solid state, suggesting that 114 
exists predominantly as the 4-keto dimer both in the solid state and in the chloroform 
solution (Table 7). Some small differences in the 15N chemical shifts (less than 3 ppm) 
can be attributed either to crystal packing effects or to stronger N1 -H .. .0  and N 9-H.. .0  
hydrogen bonds in the solid state.
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Position 13C CDCI3 i3C Solid State 15N CDCI3 1SN Solid State
1 - -248.5 -245.8
2 154.7 156.5
3 - -170.1 -171.5
4 172.8 174.7
5 106.6 108.1
6 147.9 148.5
7 - -266.0 -265.4
8 156.5 156.5
9 - -279.9 -277.4
Table 7: Comparison of 13C and 15N chemical shifts in CDCI3 and solid state.
To conclude, the experiments carried out on compound 114 confirmed the existence of 
tautomer B in the CDCI3 solution with ~ 1% (at 298 K) o f the enol tautomer C. Further 
investigation using solid-state 13C and 15N CPMAS NMR provided evidence for the 
existence of the same 4-keto form B in the solid state.
2.3.2 Study of Compound 112 in CDC13
As mentioned above, the solubility o f compound 1 1 2  was very poor in CDCI3 , and only 
trace signals were observed in the *H NMR spectrum. Nevertheless, !H chemical shifts 
were measured for a very dilute solution at 328 K and key signals indicated the 
tautomer adopted in CDCI3 : 13.72 ppm (1-H), 12.00 ppm (7-H), 10.17 ppm (9-H) and 
6.22 ppm (5-H). From this chemical shift values, and those for 114 and compound 129 
(see Table 16), compound 112 adopted the 4-keto form B in CDCI3 (Figure 60).
n h 2
NH O
112
Figure 60: Compound 112 and representation o f the 4-keto form B
Due to the poor solubility in CDCI3, a more detailed study o f this compound was then 
conducted in D M SO -^. This solvent was expected to strongly interfere with the 
hydrogen bonds o f the ureidopyrimidinone dimers, but nevertheless could provide
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additional means o f assessing the strength and nature o f the hydrogen bonding and 
indeed, whether a C-6 fimctionalised ureidopyrimidinone can exist as a quadruple 
hydrogen bonded dimer even in a DMSO solution.
Furthermore, very few studies of Upy systems have been made in such a polar solvent 
and this could be relevant for applications o f Upys in polar aqueous media.
2.3.3 Tautomeric Studies in D M SO -d6
2.3.3.1 6-Methyl isocytosine
Preliminary studies o f the starting material isocytosine, which is used in the synthesis of 
compound 114 were carried out initially.
A B C  
Figure 61: Three different tautomers of isocytosine
Isocytosine has been found to exist as the 4-keto form B in the solid state and enol form 
C in the gas phase.144 Since the tautomeric preference o f this compound in DMSO-d<$ 
solution has not been studied before, multinuclear NMR experiments were conducted in 
this solvent and in the solid-state. Since the latter was established in the solid state, the 
13C CPMAS was run and chemical shifts were measured as 158.2, 173.7, 101.6 and 
151.1 ppm for C-2, C-4, C-5 and C-6, respectively. The 13C NMR spectrum was then 
acquired in DMSO-ak and the chemicals shifts were significantly different: 164.0, 
100.4, 165.4 and 155.6 ppm. It is evident from this data, that the tautomeric form is not 
the 4-keto B but rather A or C in DMSO-g^ .
In order to determine the tautomeric form in solution, 15N chemical shifts were 
measured in the solid state and in DMSO-ak. The assignment was made using 1H-15N 
HMBC correlations, and it was clear from the data obtained that the 6-keto tautomer A 
was the one present (Figure 62, Table 8). In particular, one secondary (-232.5 ppm) and 
one tertiary (-180.6 ppm) N signals were found and a cross-peak between the lH methyl 
peak and the 15N peak at -180.6 ppm in the HMBC spectrum (at 298 K for the 170 mM
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DMSO-c^ solution) was detected, suggesting that the closest nitrogen to the Me group 
was tertiary. In addition, chemical shift o f 5-H and its 'Jch coupling constant of 168 Hz 
were also in favour of the 6-keto form (see discussion below for compounds 111, 112 
and 114)
5.39 ppm
CH.,
i 3 2
H
11.08 ppm
Figure 62: *H NMR chemical 
shifts found in 6-keto A.
position i3C 15n
1 -180.6
2 155.6
3 -232.5
4 164.0
5 100.4
6 165.4
Table 8: 13C and 15N NMR chemical 
shifts in DMSO-d^
2.3.3.2 Studies o f  Compounds 111, 113 and 114 in DMSO-d^
The ]H NMR spectroscopic data for the hydrogen bonded protons (1-H, 7-H, 9-H) as 
well as for the vinylic proton 5-H for compound 111, 112 and 114 were assessed. 
Remarkably, the *H NMR spectra were very similar for compounds 111 and 114 
(Figure 63a), but compound 112 gave rise to significantly different chemical shifts, 
suggesting that a different tautomeric form may be present (Figure 63b).
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Figure 63: a) }H NMR spectrum for compound 111, 298K, b) *H NMR spectrum of 
112,298K
Meijer et a l  have assumed that analogues o f 111 and 114, where Ri = /?-N02C6H4, R2 = 
C18H37 and Ri = Me, R2 = C4H9, exist in pure DMSO-g^ as the monomeric 6-keto form 
A. Examination o f the chemical shift data suggested that 111 and 114 adopted the 
monomeric tautomer A in DMSO-d4, but 112 existed as either tautomer B or C. Since 
the !H NMR spectrum of tautomer A has not been fully characterised, compound 114 
was studied in detail by NMR in DMSO-J^. The 6-keto form A is an interesting 
tautomer since it can exist as either conformer A or A ’ with intramolecular hydrogen 
bonding present in both of them (Figure 64).
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c h 3
N
c6h13
CH,
o - ~ » V H' X I  I  '  “ 
i  < A " ' ° W »H H
3 7
A* (ADDA)
Figure 64: Two possible conformers for 6-keto form A
2.3.3.3 Study o f  compound 114 in DMSO-d6
The assignment of the NH protons were made as following. Proton 9-H was first 
assigned without difficulty since there is a 3 J h h  coupling o f 5.7 Hz between 9-H and the 
adjacent methylene protons of the alkyl chain. The determination o f 3-H and 7-H was 
less straightforward but the results obtained from the study o f 6-methylisocytosine in 
DMS0-^6 suggested that the chemical shift at 11.46 ppm could be attributed to 3-H. 
From these observations a full *H NMR spectroscopic data was established for 
compound 114 (Table 9).
proton 114
3-H 11.46
5-H 5.77
7-H 9.76
9-H 7.44
Table 9: lH NMR Chemical shifts of 114 (79 mM solution) in DMSO-^6 at 298 K
The chemical shifts were affected slightly on increasing the concentration of the 
solution in DMSO: from 11.55 (3-H), 9.65 (7-H) and 7.39 (9-H) ppm in the 14 mM 
solution to 11.46, 9.76 and 7.44 ppm in the 79 mM solution at 298K. The latter values 
are in agreement with the monomeric 6-keto tautomer. This conclusion was further 
supported by diffusion coefficient measurements: at three different concentrations, 28 
mM, 14 mM and 7 mM, the D values were 2.66 x 10'10, 2.65 x 10'10 and 2.63 x 10'10 
mV1, respectively, at 298 K. No change of the diffusion rate on increasing the 
concentration was in favour of monomeric form, which does not dimerise on increasing 
the concentration.
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The distinction between conformer A or A’ was not straightforward. Various NMR 
experiments were undertaken in an attempt to address the issue of preferred conformer, 
and some of the NMR results described below tend to suggest that conformer A ’ could 
be predominant in the DMSO-d<* solution.
Within the limits of the ]H data, the chemical shift o f 9-H could indicate the 
involvement o f this proton in intramolecular hydrogen bonding, the strength of which is 
considerably weakened due to the high polarity of the solvent used. On the other hand 
the relatively high frequency shifts of 3-H and 7-H protons may be due to the 
intermolecular hydrogen bonding with solvent molecules, since DMSO is well known 
to be a strong hydrogen bonding acceptor (Figure 65).
Figure 65: Tautomer A and interaction with DMSO molecules
In selective NOE experiments positive enhancements o f protons 5-H and 9-H were 
observed on excitation o f protons 6-Me. Qualitatively, the observation o f the NOE 
between proton 9-H and 4-Me is in favour o f the 6-keto conformer A ’. Overall, these 
results suggest that A ’ is more likely to be the major conformer o f the 6-keto form in 
DMSO. Since compounds 114 and 111 show similar *H NMR spectra, the conformer of 
the 6-keto tautomer is also likely to be present in the D M SO -^ solution of 111. 
Complete assignments of *H and 13C NMR spectroscopic data have been summarised in 
Table 10 for compounds 111 and 114.
ii M b'II
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carbon 111 111 114 114
*HNMR 13C NMR *h n m r 13C NMR
(130 mM) (79 mM)
2 152.2 151.3
3 12.05 11.46
4 161.4 161.1
5 6 . 6 6 104.2 5.77 104.5
6 159.1 164.8
7 10.04 9.76
8 154.5 154.7
9 7.38 7.44
Table 10: !H and 13C chemical shifts for 111 and 114 in DMSO-cfc
A simple comparison of the *H NMR data for 111 and 114 with that of 112 was not 
sufficient for determination of the tautomeric form adopted by compound 1 1 2  in 
DMSO-ak, and whether the 4-keto B or enol form C is favoured. Therefore, further 
experiments were carried out such as 13C and 15N in solution and the solid state.
11The C NMR spectral analysis o f 112 and 114 highlighted some key differences in the 
chemical shift values. These differences are shown in Figure 6 6  (the region between 80 
and 180 ppm).
C-4
C-5
C-4
C-5
' I ' ' ' ' 1 I ' ' ' I • ' • • I ' I ' ' • ' I ' ' T ' I ' I ' ' ' ' I .I , , ' i I 11 11 I 11 11 I I . . . .  I 11 11 I 11 11 I ' I 1 1 1 1  I
175  170  165  160  155  150  145  140  135  130  125  120  115  110  105  100  95 90 85 ppm
Figure 6 6 : I3C NMR spectra for compound 111 (a) and 112 (b)
Assignments based on the HMQC and HMBC experiments indicated that the vinylic 
carbon at C-5 has a specific chemical shift o f approximately 104 ppm in tautomer A and
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106 ppm in tautomer B. The latter value was determined for compound 114 in CDCI3 . 
For the enol form C, an upheld shift is expected due to the aromaticity of the ring. The 
chemical shift o f C-5 for compound 112 was approximately 98 ppm, suggesting that the 
enol form C was present (Figure 67). Similarly, according to the assignments made 
based on the HMBC experiment, carbon C-4 was found at 161 ppm in the 6 -keto form, 
but for 112 it was observed at 174 ppm.
R
c A V h' ^ n ' Hn-r2
* o ^ n - h 'I
r 2Form A
II L 
H O ' 4'N  N ^ O
3 I
H
7
Form C ? to be confirmed
111: R. = p -N 02C6H4> R2 = C6H13
114: R; = CH3, R2 = C6H,3 112: R'  "  P-NH^ H-  ^  *  C°H«
Figure 67: Summary o f tautomeric forms adopted in D M SO -^
Since the number of protonated nitrogens in the enol form C is different from that in
1 r  1
tautomers A and B, the use o f N and C experiments in the solid state and in solution 
were undertaken for the determination o f the tautomeric form of 1 1 2 .
Unfortunately, the 15N HMQC and HMBC spectra in DMSO - ^ 6  did not allow detection 
of all the peaks. Only two peaks at -286 (N-9) and at -320 ppm (NH 2) were detected. In 
the solid-state, however, the 15N CPMAS spectrum of compound 112 showed all the 
peaks. In particular, two tertiary N signals were observed at -164.5 ppm and -178.5 ppm 
and attributed to N -l and N-3. Resonances around -250 ppm are characteristic for 
secondary amine groups and corresponded to N-7 and N-9 at -260.4 and -280.5 ppm. 
The primary amine signal was observed at -324.9 ppm. From this data it is clear that 
compound 112 exists as the enol form C in the solid state, since unlike the enol 
tautomer, the other two tautomers have only one tertiary nitrogen atom. A direct 
comparison of the 13C CPMAS spectrum with the 13C spectrum in the D M SO -^ 
solution was then used to determine the preferred tautomeric form of 112 in DMSO 
(Table 11).
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carbons Solid State 
Enol C
DMSO (concentrated 
solution)
C-2 157.2 158.5
C-4 176.4 174.5
C-5 98.3 98.5
C-6 159.3 159.5
C-8 157.2 155.3
t  ->
Table 11: Comparison o f C chemical shifts in D M S O -^ and in the solid state
Comparison o f this data showed a close similarity in 13C chemical shifts, confirming 
that the enol form C was also present in DMSO-c/g solution. In particular, carbon C-5 is 
found at 98.3 ppm in DMSO-J^ and at 98.3 ppm in the solid state, which is an indicator 
of the aromatic pyrimidinone ring in the enol form C.
From these 13C and 15N results, it is evident that compound 112 exists as the enol form 
both in the DMSO solution and in the solid state. An assignment of the key !H NMR 
peaks is shown in Table 12.
proton 112 (saturated)
4-OH Not observed,
very broad
5-H 5.88
7-H 8 . 0 1
9-H 10.13
Table 12: JH NMR of 112 (saturated solution) in DMSO-J^
In addition, selective NOE measurements were performed for 112 (Figure 6 8 ). On 
selective excitation of the signal due to the aromatic ortho-proton 17-H o f the p- 
aminophenyl ring, negative enhancements o f -2% for proton 9-H, -9% for the meta 
proton 18-H on the /?-amino phenyl ring, and -6 % for the 5-H were measured. The 
existence of the NOE between 17-H and 9-H can serve as another proof o f the enol form 
C in DMSO-^6 -
HO i
H
7
112
Figure 68: NOEs observed for compound 112
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Interestingly, the NOEs were negative, indicating that the effective molecular weight is 
high (combined with the high viscosity o f the solvent), which in turn suggests a 
probable dimerisation via DADA-ADAD.
Once the type o f the preferred tautomeric form was established for 112, further studies 
were undertaken in order to examine the possibility o f dimerisation. In this study, NMR 
diffusion experiments were used in order to determine the dimerisation constant of 
compound 112 in DMSO-6^. The diffusion measurement alone cannot be used for 
distinguishing different tautomeric forms since the monomeric tautomers A, B and C of 
a given ureidopyrimidinone would be expected to have similar diffusion rates. 
Therefore, the concentration dependence o f some o f the proton chemical shifts has been 
used when identification o f the tautomer involved in the dimerisation is o f interest.
In particular, NMR studies in the solid state and concentrated solution in DMSO-g^  
revealed that compound 112 exists as the tautomer C, which is capable o f dimerizing 
(DADA). Dilution experiments on compound 112 indicated a strong dependence 
between concentration and the chemical shift o f proton 7-H. This was consistent with a 
hydrogen bonded array, since an increase in the population o f the dimer occurs at higher 
concentrations (Table 13).
By contrast, the chemical shift o f 9-H at approximately 10.2 ppm was unaffected, 
consistent with the presence o f tautomer C where there is an intramolecular hydrogen 
bond. Thus it is clear that there is a dimer-monomer equilibrium and that the population 
of dimer decreases on dilution. The upfield shift for 7-H on dilution is also in favour of 
the shift o f this equilibrium towards the monomeric form.
proton 1.8 mM 25 mM Saturated
5-H 5.74 5.83 5.88
7-H 7.39 7.78 8 . 0 1
9-H 10.33 10.19 10.13
Table 13: Variation o f !H chemical shifts as a function o f the concentration in DMSO-
To further establish the tautomeric state o f the monomeric form in DMSO-d6, !JCh- 
couplings for C-5 were measured from the 13C satellites in *H NMR spectra. 
Specifically, from the analysis o f compound 111, 112 and 114, two distinct values of
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1 JCh in the keto and enol forms were found: 160 Hz in tautomer C and 170 Hz in 
tautomers A and B. This change o f !Jch reflects whether the C-H bond is aromatic 
(tautomer C) or vinylic (tautomer A and B). The values measured for saturated, 25 mM 
and 1.8 mM solutions of 112 were 160.9, 160.2 and 159.5 Hz. By comparison, ^ch  was 
169.6 Hz for tautomer A of 111 in DMSO-e^.
Based on these results, a simple two-site mono-enol/dimer-enol exchange (Figure 69) 
for 112 in DMSO-cfo was considered, rather than a possible three site equilibrium which 
also includes the monomeric tautomer A.
01
H
i
H
Y  Y
NH2
HO
Figure 69: Equilibrium between monomer and dimer (DADA.. .ADAD) in DMSO-cfo 
23.3.4 Diffusion Experiments
Having determined the nature of the tautomeric species in DMSO-cfe* diffusion 
experiments were then performed on compounds 111, 112 and 114. As expected for 
tautomer A in solution, no significant changes in diffusion coefficient was observed for 
solutions o f 111 and 114. In the case o f compound 112, the results were in accordance 
with the presence o f the DADA dimer, since a change o f diffusion was observed upon 
decreasing the concentration o f the solution, suggesting the presence o f dimeric species 
in equilibrium with monomers. The concentration of 1 1 2  in DMSO-cfc was varied from 
1.8 mM to 25 mM at 298 K, and overall seven different concentrations were studied. 
From the analysis of the diffusion experiments using the non-linear least-squares 
method, the diffusion coefficients for pure dimer and monomer were derived, which 
then were used to calculate the ratio o f dimer/monomer in DMSO-ck (Table 14).
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Compound 112 1.8 mM 25 mM Saturated
Ratio:
dimer/monomer 13:87 54:46 95:5
Table 14: The dimer-to-monomer ratio as a function o f the concentration
Calculations using the non-linear least-squares method led to a dimerisation constant o f 
46 M ’ 1 for compound 112 . 1 4 5 ’146 The low value is a consequence o f the high polarity of 
DMSO, as well as its capability to act as a strong hydrogen bond acceptor. Therefore, 
DMSO decreases the strength of hydrogen bonding in the DADA motif. However, in 
this case, the high polarity o f the solvent is not sufficient to disassemble the DADA 
array.
2.3.3.5 Study o f  Compound 113
1 ^NMR measurements were also carried out on compound 113 in DMSO-g^ . C chemical 
shifts revealed some very close similarities with compound 112. Specifically, carbons 
C-5 and C-4 resonated at 98.5 and 174.5 ppm, respectively, which is characteristic for 
the enol tautomer. By analogy with 112, the low frequency shift o f 5-H on dilution 
(from 6.13 ppm at 35 mM to 6.05 ppm at 5mM) indicated a fast mono-enol/dimer-enol 
exchange (Figure 70). Thus, both the tautomeric and dimeric behaviour o f compound 
113 were similar to that o f 112.
atom ‘H NMR 5 mM *H NMR 35 mM 13C NMR 35 mM
2 - 158.5
3 - -
4 - 174.5
5 6.05 6.13 98.5
6 - - 159.5
7 7.65 8 . 0 2 -
8 - - 155.4
9 10.19 10.06 -
Table 15: *H and 13C chemical shifts at 298K in DMSO-<4
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Figure 70: Dimerisation of compound 113
2.4 Rationalisation
Meijer et al. have reported that pyrimidinones possessing electron-withdrawing groups 
at C - 6  favour the enol form C in CDCI3 and the 6 -keto form A in DMSO-J^, while alkyl 
or ether electron-donating groups adopt the 4-keto form B in CDCI3 and again the 
monomeric form A in D M SO -^. It was shown for the first time in this work that the 
introduction o f electron-donating groups at the C- 6  position (compounds 112 and 113, 
PI1NH2 and azo derivative, respectively) lead to a DADA dimeric form in DMSO. In 
compound 112, the solvent DMSO-ck, which is a strong hydrogen bonding acceptor, 
has the capability o f forming stabilizing hydrogen bonds with the NH2 o f the amine 
group which may enhance the formation of the DADA array. Solvation o f the amine in 
DMSO through hydrogen bonding could enhance the polarisation o f the amine nitrogen, 
increasing the basicity o f the oxygen atom and N -land N-3 o f the pyrimidinone moiety 
(as indicated in the zwitterionic mesomeric representations in Scheme 15). The 
preferred formation of tautomer C, rather than A for compound 112 may therefore be 
due to a combination o f factors: higher basicity o f the oxygen atom with respect to N -l 
and N-3, a more pronounced aromatic stabilisation o f the enol form with respect to the 
pyrimidinone moiety, and a favourable intramolecular hydrogen bond between the urea 
side chain and N -l (Scheme 15). A similar rational can be invoked with the azo 
compound 113.
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Scheme 15: Mesomeric representations o f tautomers A and C
2.5 Synthesis of Novel Ureidopyrimidinone Incorporating a 
PEG chain at the Ureido Position (R2)
Since the solubility o f compounds 112 and 113 were low in a range o f organic solvents, 
the introduction o f a hydrophilic side chain at R2 was attempted in order to enhance the 
solubility and assess the effect of a hydrophobic versus hydrophilic side chain at R2 on 
the tautomeric distribution (Figure 71). For this purpose, the use o f a short PEG chain 
was initially explored.
n h 2
6
r ^ N H  O
^Solubilizing chain
U  IN N N 
H H
Figure 71: Targeted molecule
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2.5.1 Synthesis of PEG-amine
Initially the conversion of PEGsOMe into a PEGsOMe terminated amine (115) was 
explored (Scheme 16).
M eO'
Scheme 16: Synthetic strategy
Vidya Sagar Reddy et al. recently described a novel, facile one-pot synthesis for the 
conversion o f alcohols to azides and amines using sodium azide and triphenyl 
phosphine in a mixture o f CCU-DMF (1:4) . 14 7 In this procedure, the treatment of two 
equivalents o f PPI13 compared to sodium azide was used which afforded amines in 
excellent yields (85-95%), whereas the addition o f only one equivalent o f triphenyl 
phosphine afforded the azide exclusively in good yields (Scheme 17).
r - o h
Ph3P (1 eq.)
NaN3
:CI4-DMF (1:4)
Ph3P (2 eq.)
R-N,
R —NH2
Scheme 17: Conversion o f alcohol into azide or amine
Following this procedure, PEGsOMe was reacted with sodium azide (1.5 eq) and 
triphenylphosphine (3 eq) in the solvents mixture (CCI4 : DMF). Unfortunately, under 
these reaction conditions the desired compound 115 was not formed (Scheme 18).
NaN3, PPh3
M e 0 ' " - - O - - " ' 0 ' - - - - 0 H  X *  M eO'
CCI4:DMF
Scheme 18: Towards the synthesis o f 2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethylamine 
(115)
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The reaction was repeated using 2 equivalents o f sodium azide and 4 equivalents of 
triphenyl phosphine which afforded 10% of the amine 115 after purification. However, 
traces o f the bi-product triphenyphosphine oxide were difficult to separate completely 
from the amine. This method was not efficient as expected for this substrate, and 
therefore the conditions o f the reaction were not optimised further.
Therefore a less direct route via the mesylate (116) and azide (117) was explored as 
depicted in Scheme 19.
Reagents and conditions: (a) M eS02CI, Et3N, CH2CI2, 85%; (b) NaN3, DMF, 78%; (c) H2, Pd/C, EtOH, 93%. 
Scheme 19: Towards compound 115
PEGsOMe was first mesylated using methane sulfonyl chloride in the presence o f EtsN
• 148m CH2 CI2 . After a couple o f hours, the reaction was complete and led to the isolation 
of compound 116 in 85% yield. The product was dried by the azeotropic removal of 
water with toluene, and used directly in the next step. Formation of the azide was 
achieved using sodium azide in dry DMF for five days at room temperature . 14 9  The 
crude product 117 was obtained in 78% yield and used directly in the next step without 
further purification. Reduction o f the azide group was first attempted via the Staudinger 
reaction using triphenylphosphine in THF and water . 1 50 The reaction mixture was stirred 
at room temperature for three days and then purified using flash chromatography. 
Unfortunately, the separation o f products was complicated again by the presence of 
triphenylphosphine oxide and once again only a small amount of the amine 115 was 
recovered after purification. Azide derivatives are generally reduced to primary amines 
using LiAfflU 1 4 9  or other reducing agents including Pd/H2 . 151 To avoid the formation of 
undesirable by-products the reduction o f the azide was then carried out using catalytic 
hydrogenation over Pd/C in ethanol. After two days, the azide was quantitatively 
reduced and afforded the amine 115 in 93% isolated yield after purification.
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In order to attach the PEG chain to the ureidopyrimidinone, transformation o f the amine 
into the corresponding isocyanate was necessary (Scheme 20).
NO„
triphosgene
M e O ' ^ ^ ° ^ ^ 0 ^ ^ NH2 M e O ^ ^ ° ^ ^ 0
115
N 0 2
r^N H  O
O ^ N ^ N ^ N  
H H
Scheme 20: Synthetic route towards 118
In general amines can react easily with phosgene or triphosgene to afford isocyanates. 
PEG amines have been less studied in this regard and very few reports have described 
the synthesis o f PEG isocyanates. One o f the few examples encountered in the literature 
and described by Strazewski et a / . 1 5 2 ,1 5 3  is the synthesis o f diisocyanates from 
tetraethylene glycol in a five step synthesis (Scheme 21).
a b e d  e
R = OH (x) — Br (x) N3 (x) NH2 (x) —► NH1.0(SiMe3)1.2 (x) — ► NCO (x)
Scheme 21: Synthesis of PEG diisocyanate in five steps
The use o f 7V-trimethylsilylation in the last step has been previously described by 
Mironov et a / . 1 5 4  for the smooth conversion o f amines into isocyanates. In this case, the 
isocyanate was obtained in 65% yield. Previous attempts using phosgene or 
triphosgene/EtsN directly with the amine led to a certain degree of polymerisation.
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Compound 115 was however initially reacted directly with triphosgene and 
triethylamine. The reaction was followed using IR spectroscopy. After a couple of hours 
a band characteristic of the asymmetric vibration NCO at ~ 2270 cm "1 appeared in the 
IR spectrum and compound 110 was then added to the solution, but unfortunately no 
reaction occurred, and the starting material was recovered. Further attempts altering the 
reaction conditions were also unsuccessful. This could have been due to the poor 
solubility o f 110 in CH2 CI2 , or instability o f the PEG isocyanate in the reaction mixture. 
Since this synthetic approach appeared unsuccessful, another method towards the 
synthesis o f PEG isocyanate was explored starting from the 2-[2-(2- 
methoxyethoxy)ethoxy]ethanoic acid (Scheme 22) using the Curtius rearrangement, 
which has the advantage o f avoiding the use o f phosgene based reagents.
100%
121 3 122
Reagents and conditions: (a) KMn04, KOH, H20 ,  40%; (b) SOCI2, CH2CI2, 100%; (c) NaN3, acetone;
(d) Toluene, heat.
Scheme 2 2 : Synthesis o f l-[2-(2-Isocyanato-ethoxy)-ethoxy]-2-methoxy-ethane via the 
Curtius rearrangement
The alcohol was first oxidised following Heimann and Voegtle's procedure155 using 
alkaline solution and potassium permanganate as the oxidizing agent. Because o f the 
high solubility o f the acid in aqueous media, only 40% of compound 119 was recovered 
after distillation.
The carboxylic acid was then converted quantitatively into the corresponding acid 
chloride using neat thionyl chloride under reflux conditions for two hours. Completion 
o f the reaction was monitored using IR spectroscopy (band characteristic of COC1 at 
1803 cm"1). The acid chloride (120) was not isolated and was used directly in the next 
step. Reaction in DMF with a large excess o f sodium azide156 (added slowly, 
exothermic) to the cooled solution gave an orange solution, which was stirred at room 
temperature over night. The resulting mixture was then diluted with water and extracted 
with chloroform, and IR spectroscopy revealed the appearance of a new band at 2108
99
Chapter II
cm ' 1 consistent with the formation o f azide. This compound was then heated in toluene 
under reflux conditions but after 18h no IR signal characteristic o f the NCO group was 
detected. Toluene used was replaced by xylene and the solution heated under reflux for 
16 h. Once again no rearrangement was observed. Further modification o f the method 
was carried out and the acid chloride (1 2 0 ) was dissolved in dry acetone and then added 
to an aqueous solution o f sodium azide . 157 Extraction o f the aqueous solution with 
chloroform afforded an acid azide as shown by the IR signal, which this time was at 
2142 cm l, slightly higher than the signal observed previously. The azide (121) was not 
isolated and was diluted in toluene which was directly heated under reflux conditions. 
The evolution of gas was observed suggesting generation o f nitrogen. After 10 min, the 
evolution o f gas ceased, and IR spectroscopy showed the disappearance o f the CON3 
band and the appearance o f an NCO band (2252 cm '1). The isocyanate (122) was 
redissolved in dry pyridine along with compound 110 and the solution was heated at 90 
°C for another 16 h (Scheme23). The desired compound 123 was finally obtained after 
purification in 28% yield (yield calculated from the carboxylic acid 119).
n o 2
r^N H  O 
1  1  ^  ^  O ^  /
O N N N  O
H H
123
Scheme 23: Synthesis o f compound 123
Attempts to reduce the nitro group to the corresponding amine (124) under acidic 
conditions using tin chloride and hydrochloric acid led to cleavage o f the PEG chain, 
presumably due to the close proximity o f the urea and PEG oxygen moiety. Other 
methods such as catalytic hydrogenation were also unsuccessful, due to the low 
solubility o f 123 in the solvents used (Scheme 24).
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Scheme 24: Towards the formation o f compound 124
2.5.2 Introduction of an Alternative Solubilizing Moiety
A new strategy was explored involving the synthesis o f an isocyanate incorporating a 
phenyl group. The selected compound 127 (Figure 72) inserted a benzyl spacer adjacent 
to the urea, which could be more stable to the acidic reducing conditions required.
127
Figure 72: 1 -Isocyanatomethyl-4- {2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-benzene
Preliminary test reactions were performed using a hexyl chain attached to the benzyl 
group as described in Scheme 25 below. No tautomeric studies were performed on these 
compounds. The synthesis will be described in the experimental section.
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2.5.2.1 Synthesis
, , r s
MeOOC
OH
60% MeOOC t > - R
b-e
OCN
126a: R1 = C6H13
126: R, = (CH2CH20 ) 30M e
, Ox 
= J  R
127a
127
81%
NO.
NH O
O N N 
H H
O
\128a
128
63%
NH.
NH O
A Xo N
H
O\129
R e a g e n ts  an d  c o n d itio n s : (a) 126a: BrC6H13, K2C 0 3, DMF, 100°C, 16 h, 70%; 126: Br(CH2CH20 ) 30M e,
MeCN, reflux, 2d, 60%; (b) NaOH, 1N, MeOH, reflux, 55%; (a)NaOH 1N, MeOH, reflux, 70%; (c) SOCI2,
100%; (d) NaN3, acetone; (e)Toluene, heat; (f) 128: 110, pyridine, 77%; 128a, pyridine; 81%; (g) S0C I2.2H20 , HCI, 
EtOH, reflux, 1h, 63%.
Scheme 25: Synthetic route towards the formation of compound 129
First the activated PEG chain 125 was synthesised in two steps via the formation of the 
mesylate 130. Substitution of the mesylate with lithium bromide afforded compound 
125 in an overall 6 6 % yield after purification using flash chromatography (Scheme 
26).158 Reaction of methyl-4-hydroxyphenylethanoate with l-(2-bromoethoxy)-2(2- 
methoxyethoxy)ethane (125) and potassium carbonate in acetonitrile gave 126 in 60% 
yield.
M eO '
66% 125 
R e a g e n ts  an d  co n d itio n s : (a) MsCI, Et3N, CH2CI2; (b) LiBr, acetone, reflux, 66%
Scheme 26: Synthesis o f l-[2-(2-Bromo-ethoxy)-ethoxy]-2-methoxy-ethane in two 
steps
Hydrolysis o f the ester 126 under basic conditions gave the corresponding acid in a 
~ 70% isolated yield. Reaction o f the carboxylic acid with thionyl chloride gave the acid
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chloride, which was used directly in the following step. The formation of the acid azide 
was achieved via the reaction o f acyl chloride with sodium azide in dry acetone. The 
product was not isolated and was heated at 90 °C in toluene in order for the Curtius 
rearrangement to occur. The reaction was monitored by IR spectroscopy and the NCO 
band at 2270 cm ' 1 was observed after 30 min. The solvent was evaporated and the 
residue was redissolved in dry pyridine. A  solution of the nitro compound 110 in 
pyridine was added to the isocyanate solution (127), and the mixture was heated at 90 
°C for 16 h, affording compound 128 in 81% isolated yield (from compound the 
carboxylic acid). Reduction to the corresponding amine was successfully achieved using 
tin (II) chloride in acidified ethanol, with retention o f the PEG chain, in 63% yield. 
Interestingly, compound 129 (Ri = PEG 3 OMe) had an improved solubility in organic 
solvents and in particular in CDC13, compared to 112 and 113. Attempts to convert the 
amine 129 into the corresponding azo derivative (130, Scheme 27) led to the formation 
o f an inseparable mixture o f compounds.
Scheme 27: Towards the synthesis o f the azo derivative
2.5.2.2 Tautomeric Studies 
Com pound 128
The solubility o f the nitro compound 128 did not improve in CDCI3 with the 
introduction o f the PEG chain and only studies in DMSO-g^ were then possible. As 
expected, the spectrum observed in DMSO was similar to that o f compound 111 (Rj =
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PhNC>2 , R-2 = C6H 13), suggesting the presence o f the 6 -keto form A. A comparison of the 
chemical shifts for these two compounds is shown in Table 16.
n o 2
o N ^ N ' H 7  
3 O ^N 'H *I
111 : R2 = C6H12
128 : R2 = CH2Ph0(CH2CH20 )3Me
position 128
'H  298K
111 
*H 298K
128
13C 298K
I l l  
13C 298K
1 - - - -
2 - - 152.2 152.1
3 12.05 11.92 - -
4 - - 161.9 161.6
5 6 . 6 6 6.67 104.0 104.2
6 - - 159.1 159.1
7 10.04 10.07 - -
8 - - 154.5 154.5
9 7.38 7.74 - -
Table 16: Comparison o f and 13C chemical shifts for compounds 128 and 111
1 13Both the H and C chemical shifts were almost identical for these two compounds. A 
small difference o f 0.36 ppm was observed for proton 9-H, probably due to the change 
in the R 2 substituent.
Com pound 129
The introduction o f the lateral chain Ph0 (CH2 CH2 0 )3Me improved significantly the 
solubility o f the amine 129 in CDCI3 . The proton !H NMR spectrum was first run in 
CDCI3 at 298 K, which revealed the presence o f two sets o f peaks with chemical shifts 
characteristic for tautomers B and C (Figure 73).
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ppm
13 12 1114 10 9 8 47 6 5 ppm
Figure 73: !H NMR spectrum o f compound 129 in CDCI3 at 298 K
Based on the previous results found for compound 112 in CDCI3 , as well as similar 
results obtained by Meijer et al., the assignment o f peaks was straightforward. 
Nevertheless, 2D correlation techniques were additionally used in order to verify the
1 13 •assignment o f the H and C peaks. A summary of the selected proton chemical shifts 
are presented in Table 17.
NH.
His
A
Ni
H
9
4-keto "B" 58%
NH.
H
5
01
H
i
H
Figure 74: Structure o f tautomer B and C for compound 129. Populations in % were 
measured at 298 K in CDCI3.
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Position/ppm 4-keto B 58 % Enol C 42%
1 13.66 13.24
5 6 . 2 1 6.54
7 12.17 11.41
9 10.89 1 1 . 0 0
1 2 7.31 7.37
13 6.87 6.96
17 7.45 7.14
18 6.73 6.35
Table 17: *H chemical shifts for tautomer B and C in CDCI3 at 298 K
As expected for the enol form, proton 5-H showed a shift towards the higher frequency 
by about 0.3 ppm compared to the 4-keto form B. Interestingly, on decreasing the 
temperature from 298 K to 258 K, the relative population of enol form increases from 
42% to 52%.
The 13C NMR spectra gave the chemical shift o f carbon C-5 at 101.7 ppm for the 4-keto 
form B and at 95.1 ppm for the enol tautomer. These values were lower than those 
already observed for the 4-keto form in CDCI3 (e.g., compound 112). Such a change 
may be due to the redistribution o f the electronic density in the pyrimidinone ring on 
introduction o f the PI1NH 2 substituent.
The presence o f a relatively high proportion o f the enol form C in CDCI3 was surprising 
since electron-donating groups at C - 6  such as alkyl groups or ethers have favoured 
almost exclusively the 4-keto tautomer B in CDCI3 .
However, these results indicated that not only electron-withdrawing groups favour the 
enol form as mentioned by Meijer et al., but an electron-donating group such as PI1NH2 
can also shift the equilibrium towards the DADA dimeric species.
To conclude, the synthesis o f compound 112 incorporating an electron-donating group 
as C - 6  has encouraged the formation o f the dimeric form DADA in DMS0-^6- It was 
the first time that a dimeric form o f Upy was observed in such a polar solvent. The 
results obtained for compound 129 in CDCI3 highlighted the complexity o f these 
ureidopyrimidinones in solution in terms o f tautomeric distribution. Overall, the 
prediction o f the tautomeric forms still remains difficult since many factors such as 
polarity o f the solvent, the nature o f substituents, temperature and concentration, can 
influence the tautomeric behaviour of Upys.
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3 The Synthesis of Supramolecular Polymers Based 
on Ureidopyrimidinones
3.1 Introduction
The use o f ureidopyrimidinone units for the synthesis o f supramolecular polymers has 
led to a new class o f polymers where the reversibility o f the non-covalent bonds 
between the monomers gives rise to novel material properties. The high dimerisation 
constant o f the Upy dimer in chloroform means they can be used in the generation of 
high molecular weight polymers. In most cases, ureidopyrimidinones possessing an 
alkyl chain at the C - 6  position, such as CH3 or C13H27 have been used since they exhibit 
almost exclusively the 4-keto form B in chloroform, as described in Chapter II. There 
are many ways to synthesise these materials but generally the linker has been connected 
to the Upy units at the urea functionality. Three synthetic strategies X, Y and Z could be 
envisaged in order to form the urea bonds, as described in Figure 75.
+ H2N— Linker — NH. + H?N —  Linker — NH.
H
XX Ju^ nXna,
H H H H
A
z
CH.
Linker
Figure 75: Three possible routes for the formation o f linear supramolecular polymers; 
LG stands for the leaving group
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A conceptually straightforward strategy involves the reaction between an isocytosine 
isocyanate with a linker possessing amine terminated groups (route X). Unfortunately, 
this method is problematic since the formation o f the isocytosine isocyanate cannot be 
achieved easily. Gizycki et a\159 demonstrated that the reaction of pyridines and 
pyrimidines with diphenyl carbonate led to the formation of dimeric ureas. More 
recently Meijer et al. have attempted the synthesis o f isocytosine with phosgene, but 
only a covalent dimer was obtained (Scheme 28). This method was therefore not used 
and the other routes Y and Z have been mainly investigated.
c h 3
3 Cl-LI ° Y"3 c h 3 o
j ^ N H  C O C I^  | ^ n H sp o n taneously
O N NH2 O N NCO
O N N O
Scheme 28: Formation of isocytosine dimers
Strategy Y involves the activation o f isocytosine with the use o f a leaving group such as 
l , l ’-carbonyldiimidazole (CDI) 1 6 0 ’161 giving an activated amide that can react smoothly 
with both aliphatic and aromatic amines to give the corresponding ureidopyrimidinone 
derivatives in fairly good yield (Figure 76). This is an attractive method for industry 
since it does not require the use of isocyanates whose toxicity can be sometimes very 
high.
c h 3
1 ° o ch3
1  i  ♦ dmso r " NH °
o A n A n h 2 n  ,N V n  ----------► T l  A a
H 2 O N N N ^ m
H W NCDI
Figure 76: Synthesis o f activated isocytosine; the tautomeric form of the activated 
isocytosine is drawn as the 4-keto form B
Strategy Z  is the most frequently used method for the synthesis of linear supramolecular 
polymers . 1 2 7  It involves the reaction of isocytosine with a linker terminated with an 
isocyanate group. This approach has disadvantages however, since the amino group of
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the isocytosine has a low reactivity towards aromatic diisocyanates leading to 
incomplete functionalisation with a spacer.
This problem is less of an issue with aliphatic diisocyanates. Indeed the use of an excess 
o f hexyl diisocyanate afforded the monoisocyanate 131 in 80% yield (Scheme 29).
131
Scheme 29: Synthesis o f monofuntionalised Upy terminated with isocyanate
The isocyanate 131 is reasonably stable under anhydrous conditions and can react 
smoothly with linkers possessing alcohol or amine terminated functionalities, as well as 
with telechelic polymers (Scheme 30).
c h 3
r ^ N H  O
O N f^ N ^ N ' 
H H
131
.NCO HO
(NH2)
Linker
OH
(NH2)
telechelic polymer when linker = polymer
CH3
r^N H  O
O U'
H H
H.H O.
T(N) Linker
H
.O H.
<N)[I
CH3
O H N ^j
'N O
H H
Scheme 30: Synthesis o f supramolecular polymers
Meijer et al. have developed this method for the synthesis o f supramolecular polymers 
incorporating various polymers and copolymers such as polyethylene-polypropylene, or 
polyesters and polyethers as linkers. A key advantage of this approach is that many 
polymers are commercially available with hydroxyl terminated groups (telechelic 
polymers), and the synthesis is then rather straightforward and relatively cheap. 
Examples o f such supramolecular polymers have been presented in Chapter I.
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One o f the aims o f this thesis was the synthesis o f supramolecular polymers 
incorporating polyethers and polycarbonates and assessment of their properties, as well 
as the development o f supramolecular polymers following a synthetic strategy avoiding 
the use o f isocyanates. These results are presented in detail in the first part of this 
chapter. The second part will introduce the area o f energetic polymers and the synthesis 
o f energetic precursor derivatives of ureidopyrimidinones will be discussed.
Part I: The synthesis of Non-Energetic Materials:
3.2 Functionalisation of Polyethylene Glycol with UPys
Scheme 31: Functionalisation o f PEG chains
The characteristics o f the PEG telechelic polymers inserted are shown below in Table
Different polyethyleneglycols were selected with molecular weights between 280 and 
3300 g/mol for reaction with synthon 131 as shown in Scheme 31.
131 132: n = 6 
133: n = 12 
134: n = 33 
135: n = 77
18.
Length of PEG chain Mn (g/mol) Physical appearance
n = 6  
n = 1 2  
n = 33 
n = 77
282
570-630
1450-1550
3250-3550
Liquid 
Moist solid 
Waxy solid 
Powder
Table 18: Properties o f PEG chains
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The supramolecular polymers 132 to 135 (n = 6 , 12, 33 and 77, respectively) were 
prepared following Meijer’s procedure . 1 27 A solution o f the polyethyleneglycol in dry 
chloroform was heated under reflux conditions together with a four-fold excess of the 
isocyanate 131 and with a 0.5% (w/w PEG) o f the catalyst tinbutyldilaurate. The 
reaction between isocyanates and hydroxyl groups are known to be rather slow, thus 
requiring the use o f a catalyst for the reaction to proceed. The conversion of the reaction 
was followed by ]H NMR spectroscopy, and after 16 h, the reaction was complete. 
Polymers 132 to 135 were obtained after a work up procedure involving filtration of the 
excess o f isocyanate 131. Any residual isocyanate was then removed by reaction with 
silica gel in the presence o f small amount o f catalyst (~ 1 h under reflux conditions). 
Removal o f the silica gel by filtration and then evaporation of the filtrate afforded the 
desired supramolecular polymer. Further precipitation of the polymer from chloroform 
in hexane allowed removal o f any remaining catalyst.
When dissolved in chloroform, polymers 132 and 133 did not show any increase in 
viscosity. However, when the length o f the polyethylene glycol increased (polymers 134 
and 135) the formation of a highly viscous solution was then observed in chloroform. 
The thermal properties o f these polymers were assessed by Differential Scanning 
Calorimetry (DSC) in order to measure the glass transition temperature (Tg) and the 
melting point (mp). The results are shown in Table 19.
PEG  chain Glass transition 
(Tg, °C)
M elting point 
(mp, °C)
n = 6 -26.7 5.8
n =  1 2 -24.9 15.3
n = 33 -44.0 22.5
n = 77 Not well defined Not defined
Table 19: Differential scanning calorimetry results and measurement of melting points
The melting point transition is a first order transition where the transfer o f heat between 
the system and surrounding medium undergoes an abrupt change of volume. The glass 
transition is a second order transition since there is no transfer of heat. The volume does 
not change abruptly as it reflects a change in the free volume between the polymer 
chains (Figure 77).
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Crystalline domain Amorphous domain
V
Rubbery
Glass
Tg T
V
Melt
Crystalline 
solid ^
mp T
Figure 77: Differences between the crystalline and the amorphous domains
3.2.1 Results
The presence o f both a melting point and a glass transition temperature suggested that 
the materials were semi-crystalline solids. For all the polymers the Tg values were found 
below room temperature, which indicated that the mechanical properties are close to 
those found in elastomers, as opposed to plastics where the glass transition temperature 
is above room temperature. Furthermore, the results indicated that the glass transition 
temperature o f the final polymer was dependent on the length of the PEG chain: the 
longer the PEG, the lower the Tg. Unfortunately, for the material with very long chain 
(n = 77) no clear glass transition was detected. Overall, these results were in accordance 
with the observation that when the chain o f the polymer increases, there is improvement 
o f flexibility o f the material which is translated into a decrease in Tg. Polymers 
containing only an amorphous domain exhibit very interesting elastomeric properties 
and therefore preparation o f such a polymer with a Tg near -50 °C has been one of the 
targets o f this research (Note: The target o f -50 °C is British requirement for binders 
used in guns and rocket propellants). One factor that could influence the glass transition 
is the introduction o f side chains within the telechelic polymer and flexible pendant 
groups such as alkyl groups, which may act as plasticiser. Pendant groups can increase 
the free volume between polymer chains leading to a lower Tg of the final 
supramolecular polymer. Following this approach the use o f block polymers of
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polyethylene glycol such as polyethylglycol-polypropyleneglycol-polyethyleneglycole
(PEG-PPG-PEG) were investigated.
3.3 Functionalisation with a Branched Polymer
The synthesis o f supramolecular polymers incorporating block polymers PEG-PPG- 
PEG, has been achieved following a similar procedure as described previously. For our 
study two commercially available telechelic polymers were chosen:
136: Mn ~ 2000 g/mol, ca 10% PEG 
137: Mn ~ 2900 g/mol, ca 40% PEG
PEG PPG PEG
Figure 78: Functionalisation o f PEG/PPG/PEG block polymers with Upy
The supramolecular polymers synthesised showed interesting flexibilities upon analysis, 
which suggested that the Tg values were certainly lower as intended. Indeed, glass 
transitions at -60.4 °C and -63.7 °C were measured together with melting points at -29.1 
°C and 6  °C for 136 and 137, respectively. The low glass transition temperatures 
reflected the elastomeric properties o f the final materials, however the presence of a 
melting point for both supramolecular polymers suggested that some crystalline 
domains were still formed.
To conclude, the functionalisation o f PEG chains revealed that the longer the PEG 
polymer the lower the Tg. Furthermore, with block polymers containing branched 
polypropylene glycol, the Tg decreased to ~ -60 °C, with the presence of some 
crystalline domains. These studies have demonstrated the influence o f the nature of 
telechelic polyethers on the glass transition o f the final material. In an effort to 
synthesise other novel materials, the functionalisation o f a polycarbonate polymer was 
undertaken.
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3.4 Functionalisation of poly (polytetrahydrofuran 
carbonate) diol
The commercially available telechelic polymer (Mn ~ 2000 g/mol) was functionalised 
according to a similar procedure described previously (Figure 79).
c h 3 c h 3
r ^ N H  O O O O H N ^ j
o A n A n A n ' c °h - n A o ' x ' o A n ' c «h - n A n A n A o
H H H H H H
138 = -(O C H 2CH2CH2CH2)3[OCO(OCH2CH2CH2CH2)3]7 —
Figure 79: Functionalisation o f poly(polytetrahydrofuran carbonate)diol
The material generated was surprisingly rubbery and even less brittle than the polymers 
synthesised with block polymers PEG/PPG/PEG. The DSC analysis revealed a low Tg 
at -64.5 °C. Remarkably, no melting point was observed, suggesting that no significant 
crystalline domains were formed.
The polymer was further characterised using NMR spectroscopy. The proton NMR 
spectrum in CDCI3 was recorded and is shown in Figure 80. In addition, 13C (see 
experimental part) and 15N (Figure 81) NMR chemical shifts were also measured. 
According to the results previously described (Chapter I), the !H, 13C and 15N NMR 
chemical shifts were consistent with the 4-keto tautomer B in CDCI3.
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(a)
13 12 1 1 10 9 28 7 6 345 ppm
(b)
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Figure 80: H NMR spectra o f polymer 138 at 298 K in (a) DMSO-cfo and (b) CDCI3
ppm
- 3 0 0 -
- 2 9 0 -
- 2 8 0 -
- 2 7 0 -
- 2 6 0 -
- 2 5 0 -
- 2 4 0 -
1 3 12 11 10 9 68 7
Figure 81: HMQC spectrum o f 138 in CDCI3 . The 15N chemical shifts were at
-248.5 (N -l), -266.1 (N-7), -280.7 (N-9) and -299.1 (NH-COO) ppm. The N-3 site with 
no directly attached protons was not detected in this spectrum. The chemical shifts are 
similar to those measured for 114 (Chapter I), and are in favour o f the 4-keto form.
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When dissolved in DMSO-ck the hydrogen bonding system in the polymer was 
disrupted and a change o f tautomer from 4-keto B to 6 -keto A occurred. The latter 
tautomer A exists as monomer in the DMSO-g^ solution. Interestingly, proton 17-H, 
which is part o f the carbamate moiety (N//COO), was found at 7.02 ppm while it was 
found at 4.97 ppm in CDCI3. The significant shift (ca. 2 ppm) towards higher 
frequencies in DMSO-ck reflects the relatively strong hydrogen bonding between the 
solvent and 17-H. The diffusion coefficient in DMSO-J^ solution was 3.20 x 10' 11 m2 /s. 
The relatively slow diffusion o f 138 in D M S O -^ is indicative of the high molecular 
weight o f the monomeric unit (2616 g/mol), as well as high viscosity o f the solvent. 
Based on the Stokes-Einstein equation, the diffusion coefficient is inversely 
proportional to the viscosity (r|) o f the solvent. Thus, on the assumption that the 
solvation shells in two different solvents do not affect diffusion rates significantly, the 
ratio o f rj (DMSO) / ri(CHCl3 ) = 3.93 was used to estimate the diffusion coefficient of 
the monomer in CDCI3 and the value obtained was 1.26 x 10"10 m2/s. Further diffusion 
NMR studies were undertaken in CDCI3 solution where the diffusion coefficient was
11 9measured to be 2.18 x 10" m /s for a 19 mM solution, which is in agreement with a 
high molecular weight polymer. By comparison, the diffusion coefficient of a dimer 
such as 114 (Chapter I) in CDCI3 was 6.19 x 1 0 ' 10 m 2/s, significantly higher than that 
measured for polymer 138. Additional diffusion NMR measurements were undertaken 
for dilute solutions in CDCI3 . Diffusion coefficients were 1.00 x 1 0 " 10 m2/s and 1.29 x 
10' 10 m2/s for the 3.1 mM and 1.5 mM solutions. These are considerably faster than that 
measured for the 19 mM solution. In fact, the value measured for the 1.5 mM solution is 
close to that estimated for the 6 -keto monomer in CDCI3 based on the measurement in 
DMSO-d6 (1.26 x 10' 10 m 2 /s, see above). From this, polymer 138 dissociates on dilution 
in CDCI3 . It should be noted that the NMR solvent used was not dried and therefore 
contained some water. It is likely that the increase o f the water content relative to that of 
polymer on dilution may facilitate dissociation o f the polymer.
To conclude, the synthesis o f supramolecular polymers has been achieved following a 
synthetic route involving the use o f isocyanate. The physical properties of the final 
materials have been significantly improved after functionalisation of the telechelic 
polymers with Upy. This strategy has proved to be very effective for the synthesis of 
new materials, and therefore it will be used for the synthesis o f energetic materials as 
described in part II o f this chapter. The accessibility o f the starting materials is a clear 
advantage o f the synthetic approach described above. However, the use of isocyanates is
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a less attractive feature especially in view of possible industrial exploitation. With this 
prospect in mind, a more ‘environmentally friendly’ approach has been developed for 
the synthesis o f supramolecular polymers.
3.5 Alternative Methods for the Synthesis of Supramolecular 
Polymers
The novel strategy involved the synthesis o f a supramolecular polymer with an ester 
linker as opposed to a carbamate linker as previously described (Figure 82). The ester 
bond could lead to increased flexibility o f the chains, and therefore enhance elastomeric 
properties within the final material. More importantly, the synthesis of such polymer 
does not require the use of isocyanate.
Reagents and conditions: (a) CDI, DMSO, 60 °C, 2 h, 96%; (b) 6-aminohexanoic methylester chloride, Et3N, 
THF, reflux, 81%; (c) HCI (2N), THF, reflux, 4 h, 93%; (d) SOCI2, CH2CI2, 40 °C, 100%.
Scheme 32: Synthetic route towards a supramolecular polymer
CH. CH.
X= polymer 
Ester bond
Figure 82: Supramolecular polymer with ester linkage
The strategy involved a five step synthesis as shown in Scheme 32.
COOMe
139 140
COOH 100%
141 142
e
O
^  NH O O HN
o o
o
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The starting material 6 -methyl isocytosine was first activated with carbonyldiimidazole 
in DMSO at 60 °C for 2 h affording compound 139 in 96% yield after drying in vacuo at
50 °C for 16 h . 131 Compound 143 was prior obtained in 58% yield via the reaction of 6 -
162amino hexanoic acid with thionyl chloride in dry methanol at -10 °C (scheme 33). 
Compound 139 was then reacted with 6 -amine hexane methyl ester hydrochloride (143) 
in the presence o f triethylamine under reflux conditions in dry THF, affording 
compound 140 in 81% yield.
. SOCI2
H2N ^ ^ ^ ^ X O O H  ---------- ► HCI. H2N ^ ^ ^ ^ ^ ^ C O O M e
MeOH
143
58%
Scheme 33: Synthesis o f 6 -amino hexane methyl ester hydrochloride
Hydrolysis o f 140 under basic conditions (KOH / MeOH) led to cleavage of the urea 
moiety. In contrast, the use o f acidic conditions (2 N hydrochloric acid) afforded the 
corresponding carboxylic acid derivative 141 in 91% yield. Compound 141 was then 
reacted with thionyl chloride, which led to the formation of acid chloride 142 in 
quantitative yield. Compound 142 was reacted with 1,4-butanediol with a small amount 
of Et3N, as a test reaction for the synthesis o f supramolecular polymers (Scheme 34). 
The bifunctional compound 144 was successfully isolated in 46% isolated yield.
I T *  n r 1 Hr 1 H HA  A  A  L—1 .n^ o
c h 2c i2/ t h f  o  n  n  M-TAr o  AA Y Y  Y
H H '  r\ uki
ChL
o  HN
'3
Scheme 34: Functionalisation o f 1,4-butanediol
The *H NMR spectrum confirmed the formation o f the bifunctional Upy system. In 
particular, peaks in the high-frequency region were characteristic of the hydrogen 
bonded NH protons. In addition, the integration and chemical shifts of the peaks (Figure 
83) were consistent with the expected structure.
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Figure 83: NMR spectrum of 144 in CDCI3 at 298K
An estimation o f the diffusion coefficient was made in chloroform at 298 K for a 6 6
mM solution of 144 and was found to be 1.17 x 10' 10 m 2 /s. Dilution of this solution to
10 224 mM led to a significant increase o f the diffusion coefficient up to 3.60 x 10" m /s. 
Further low-temperature !H NMR measurements at 258 K o f 144 in CDCI3 (24 mM) 
revealed the presence o f two new species with relatively small populations (Figure 84). 
From the line fitting o f the 5-H region, the ratio o f the peaks at 5.82, 5.79 and 5.75 ppm
was approximately 15:77:8. Diffusion measurements at 258 K showed that the
10 2corresponding species diffused at significantly different rates: 1.05 x 10" m /s (5.82 
ppm), 1.26 x 10"10 m2/s (5.79 ppm) and 2.68 x 10' 10 m2/s (5.75 ppm). Based on the 
relationship used between diffusion coefficient and the molecular weight 
(Z)Poi ~ Af° 6 2 ) 163 the corresponding peaks at 5.82, 5.79 and 5.75 ppm could be assigned 
to trimeric, dimeric and monomeric species. These must be cyclic, as the corresponding 
NH protons resonate in the high-frequency region characteristic for the 4-keto 
quadruply hydrogen bonded array.
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5-H
9 - H  A
1 1 . 9 0  1 1 .8 5  1 1 .8 0  11 .7 5  ppm
5 .8 5  5 .8 0  5 .75  ppm
Figure 84: Peaks corresponding to protons 9-H and 5-H in the *H NMR spectrum of 
144 in CDCl3a t2 5 8 K
This result suggested that at lower concentrations the linear polymer chains were 
disrupted and certainly recombined into smaller oligomeric species or even cyclic 
species. Meijer et al. have already described similar observation for some bifunctional 
Upy systems but with shorter linkers between the Upys (e.g Chapter I). Some other 
bifunctional Upy derivatives studied in this work showed a similar behaviour on 
dilution and these results will be discussed in more detail in the next chapter.
Following this result, the telechelic block polymer PEG-PPG-PEG (Mn ~ 2900 g/mol) 
was functionalised using the same reaction conditions as previously described. JH NMR 
spectrum confirmed the presence o f the desired bifunctional material. The compound 
was dried under vacuum for two days and submitted for further DSC measurements 
(under investigation at AWE).
To conclude, the synthesis o f new polymeric materials via an alternative synthetic route 
has been achieved. One of the ultimate goals for AWE would be application of this 
strategy for the synthesis o f energetic supramolecular polymers.
121
Chapter III
PART II: Towards the Synthesis of Hydrogen Bonded Energetic 
Materials
One o f the major targets for the AWE is the preparation of supramolecular 
polymers with energetic formulations for the use in explosives, propellants or 
pyrotechnics and to generate novel supramolecular architectures, which may be 
repeatedly processed and recycled. These materials would have great advantages in 
terms o f safer handling, the reduction o f waste of expensive ingredients and aid 
demilitarisation programmes.
3.6 Introduction
3.6.1 Energetic Polymers and Plasticisers for Explosives Formulation
The design o f future energetic systems requires the use o f explosive and propellant 
formulations having enhanced performance and reduced vulnerability (storage and 
transportation). Some important criteria such as mechanical properties, the lifetime, ease 
o f disposability and environmental impact in manufacture and use have to be taken into 
consideration for the design o f such materials. In particular, extensive programmes have 
been set up worldwide for the development o f Insensitive Munitions (IM), that satisfy 
the performance expectation and that assure a reduced risk to unplanned hazardous 
stimuli.
One o f the responses to this research has been the development o f cast-cured polymer 
bonded explosives (PBX) in which the explosive ingredient is suspended in a polymeric 
binder, cured in situ into a tough elastomeric rubber which absorbs and dissipates the 
energy from hazardous stimuli. Binders are typically cross-linked polymers, and one of 
the earliest binders in energetic materials was nitrocellulose in nitroglycerine, where the 
nitrocellulose was used to thicken the nitroglycerine to reduce any impact and friction 
risk. Nowadays, the explosive is encapsulated in a binder, such as a telechelic polymer 
(Hydroxy Terminated Polybutadiene (HTPB, Figure 85), Hydroxy Terminated 
Polyethers (HTPE)) crosslinked with isocyanate, and containing a plasticiser such as 
Dioctyl Adipate (DOA).
Figure 85: Hydro Terminated Poly Butadiene (HTPB)
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The advantages o f these binders are the excellent physical properties and reduction of 
the vulnerability o f the explosive charges, however they are inert and decrease the
overall energy output o f the explosive. One solution to overcome this problem has been 
the use o f polymers/plasticisers that contribute to the overall energy of the composition. 
This could be easily improved by incorporating some energetic functional groups, such 
as nitro (C-nitro, O-nitro, N-nitro) but also azido and the difluoroamine group along the
functional polymers such as glycidyl azide (GAP) or the nitrato polyethers such as 
poly(3-nitratomethyl-3-methyloxetane) (polyNIMMO) and poly(glycidyl nitrate) 
(PolyGLYN). Other binders include fluoropolymers and polynitroaromatic.
3.6.2 Classification of the Most Common Energetic Polymers164
3.6.2. 1  Glycidyl Azide Polymer
Azido-fimctionalised polymers such as glycidyl azide polymer (GAP) (Figure 8 6 ) were 
intensively used in the early 1980s, as the safety characteristics of GAP loaded with 
explosive entities are similar to those made with inert HTBT binders.
Figure 8 6 : Glycidyl azide polymer (GAP)
Such polymers were first synthesised in 1972 by Vandenburb via the reaction of sodium 
azide in DMF with polyepichlorohydrin, PECH-triol. The functionalisation of GAP has 
been studied in order to obtain a tough and elastomeric rubber. For this purpose Frankel 
et al. patented a process where linear GAP is terminated with isocyanate groups to give 
an a,co-diisocyanate functionalised GAP (Figure 87).
polymer backbone. Recent energetic binders that satisfy these criteria include azide
H
c h 2n 3
O C N —  (CH2)6— NHCOO— CH2— f - 0 - C 0 N H ( C H 2)6- N C 0
H
Figure 87: a,co-diisocyanate functionalised GAP
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3.6.2.2 GAP Properties
The physico-chemical properties o f the polymers depend on the degree of 
polymerisation and the method o f preparation. GAP has a relatively low glass transition 
temperature (-45 °C), and this results in an energetically favourable binder system. 
However, GAP is hard and brittle at low temperatures due to the rigid, conjugated N3 
groups, limiting the flexibility o f the polymer backbone. Another problem is that GAP 
functionalised with isocyanates liberates carbon dioxide when the isocyanate reacts with 
moisture. Carbon dioxide is then trapped in the cross-linked binder and results in 
decreased mechanical properties and safety. The energetic properties are a function of 
the decomposition o f the azide group, which generates nitrogen. Also, the high 
concentration o f carbon atoms results in a high combustion potential.
3.6.2.3 Oxetane Polymers
Energetic polyoxetanes were first synthesised by Manser using the monomers 3- 
nitratomethyl-3-methyl oxetane (NIMMO, 3,3-bis-(azidomethyl)oxetane (BAMO) and 
also 3-azidomethyl-3-methyl oxetane (AMMO) (Scheme 35).
0 ' ^ V CH2° H n ^ X H , O N C L
v ^ CH3 + ACN02 ---------► ^ C H ,  + AC0H
NIMMO
° ^ ^ n w 2R + NaN3 ---------0 ^ ^ CH2N3 + NaRCH
R =CI or O Ts AMMO
CH3
+ 2NaN --------^  <0 ^ 3
n" c h 2ci  c h 2n 3
BAM MO
+ 2 NaCI
Scheme 35: Synthesis o f oxetanes
3.6.2.4 Synthesis and Properties o f  PolyNIMMO
The polymerisation o f NIMMO has been achieved via a cationic polymerisation 
employing initiators (commonly diols) and catalyst (Lewis acid). If the initiator is a diol 
such as 1,4-butanediol then the polyNIMMO prepared is bifunctional (Figure 8 8 ).
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CH,
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Figure 8 8 : PolyNIMMO
Having a primary hydroxyl terminated alcohol is a great advantage in terms of the high 
reactivity towards isocyanate. PolyNIMMO has interesting properties, as the glass 
transition temperature is around -35 °C, and can be readily cured with conventional 
isocyanates upon heating.
3.6.2.5 Oxirane Polymers
Oxirane polymers differ from the oxetane polymers by the number of methylene groups 
in the repeating unit. Glycidyl nitrate (GLYN) is a monomer used for the 
polymerisation. Slow addition o f the monomer solution (GLYN) to the initiator solution 
(tetrafluoroboric acid etherate) generates an activated monomer unit, which combines 
with the difunctional alcohol (glycerol) in a ring opening process (Scheme 36).
HORO
Poly GLYN
Scheme 36: Polymerisation o f PolyGLYN
PolyGLYN can also be functionalised with isocyanate leading to polyGLYN cured 
rubbers as shown in Figure 89.
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Figure 89: Cured PolyGLYN
When cured with isocyanates, the resulting polyurethane rubbers show poor stability. 
Indeed degradation of the network can occur due to the labile proton (Figure 90).
Figure 90: Degradation o f the cured polyGLYN
This problem has been overcome by modification o f the chain ends to give a primary 
hydroxyl terminated polyGLYN.
3.6.2.6 Properties o f  PolyGLYN
PolyGLYN is a clear, yellow liquid, with a low Tg (-30 °C). As with PolyNIMMO, its 
sensitivity is too low to be classified as a class 1 explosive in the UK.
One o f the exciting challenges would be the functionalisation o f energetic polymers 
such as PolyGLYN or PolyNIMMO with Upy groups, to form an energetic 
supramolecular polymer. The combination o f an energetic source and elastomeric 
properties could make them excellent energetic binders for future high energy 
applications. Furthermore, the presence o f non-covalent interactions would afford an 
easy way o f decommissioning the materials.
3.7 Synthesis of Energetic Supramolecular Materials
3.7.1 Functionalisation of PolyGLYN with Upy unit
PolyGLYN (Mn ~ 2000 g/mol) was reacted with synthon 131 under the same conditions 
as described in Part I (Figure 91). However, the final material was not dried in vacuo to
o
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avoid any possible decomposition reactions. Since the chemical hazards were not fully 
assessed, only DSC analysis were performed at AWE.
X = PolyGlyn, 2000 g/mol
Figure 91: Functionalisation o f PolyGLYN 
3.7.1.1 Results
The final material was a white opaque compound, and the DSC analysis showed a Tg at 
~ -22 °C and no distinctive melting point, which suggested that the final supramolecular 
polymer contained only amorphous domains. A decomposition run was performed 
showing an exotherm at 196.8 °C with an energy o f -1057 J/mol (AH). The 
decomposition process o f an energetic polymer starts with the degradation of the nitrato 
group. For polyGLYN the decomposition mechanism o f the energetic group is as 
following:
- c h 2 - o - n o 2 — ► c h 2 o* + *N02
From these results a comparison o f the physical properties of polyGLYN and the 
functionalised polymer is presented in Table 20.
Polymer Tg Decomposition Decomposition Heat
(°C) Temperature (°C) (J/g)
PolyGLYN -31.5 204 2 0 0 0
PolyGLYN+ UPy - 2 2 196 1057
Table 20: Comparison o f physical properties o f PolyGLYN and its Upy derivative
It is apparent that the presence o f the Upy units has an effect on the glass transition 
temperature, which is increased. This was probably due to the addition o f rigidity in the 
final polymer by the introduction o f heterocyclic rings. The decomposition temperature 
was not significantly affected, however the decomposition heat was much lower, which 
reflects an overall decrease in the energetic composition due to the presence of Upy 
groups and the Ce chain spacer within the supramolecular polymer.
127
Chapter III
3.8 Synthesis of Energetic Precursor of Ureidopyrimidinones
In order to synthesise Upy systems, which possess potential energetic sites, derivatives 
of Upy incorporating one or two hydroxyl groups at the C - 6  position were synthesised 
with the objective o f  introducing energetic group such as NO 2 after its synthesis (Figure 
92).
NH O
x
c r  'N '  'N  N‘ 
H H
OH
OH
NH O
A..X
ONO,
NH O
CT 'N ^ N ^ N ' 
H H
ONO.
ONO.
NH O
Figure 92: Introduction o f energetic groups at the C - 6  position o f the Upy unit
3.8.1 Synthesis 1
The first synthesis was carried out following Scheme 37 shown below.
.0 . ^Ph
9  9  o  o
80% 145 50% O N NH2
r ^ Ph ,OH 146
c X X H I  - j l *  r ' NH 0
80% O N N N 90% 0 <:?^ N ^ ^ N '^ N
H H
147 148
Reagents and conditions: (a) BnOH, NaH (60%), toluene, r.t, 80%; (b) guanidine carbonate, EtOH, 
reflux, 50%; (c) C6H13NCO, pyridine, 100 °C, 80%; (d) BCI3, CH2CI2, -78 °C, 90%.
Scheme 37: Synthesis o f compound 148
128
Chapter III
Follow ing Y asohara  et al . , 165 cloroacetoacetate w as first reacted w ith  benzyl alcohol in 
the presence o f  sodium  hydride (60% in  oil) in  d ry  TH F. The m ixture w as stirred at r.t. 
for 16 h. U nfortunately , the  desired product w as no t isolated, and it w as clear by TLC 
analysis that m any  products w ere form ed. D ry  to luene w as then used as previously 
described b y  B eck  et al.166 and this tim e the reaction  w as successful and the desired 
com pound 145 w as iso lated  in  80% yield  after purification  b y  flash chromatography. 
The reaction  o f  145 w ith  guanidine carbonate in  ethanol under reflux conditions 
afforded the desired  isocytosine 146 in  50% yield  after precipitation from the solution. 
The p roduct w as dried  thoroughly  under p ressure, and reacted further w ith 
hexylisocyanate in d ry  pyrid ine  at 100 °C for 16 h. A ddition  o f  hexane to the cooled 
solution resu lted  in  the  precip ita tion  o f  com pound 147 in  80% yield. Finally, rem oval o f  
the benzyl group w as first attem pted using  cataly tic  hydrogenation over Pd/C in THF/ 
M eO H  (5:1). C om pound 147 w as inso luble  in  m ost organic solvents and the reduction 
could not be achieved, even  w hen  heating  at 50 °C. T he use o f  an alternative m ethod 
w as then  considered using  the Lew is acid B C I3 in C H 2 CI2 at -78 °c ,16 7 ,1 6 8  which 
successfully  led  to the  deprotected  com pound 148 in  90% yield after purification. The 
final com pound w as unfortunately  insoluble in  C D C I3 and could only be studied by 
N M R  in DMSO-c?6 - T his m aterial is curren tly  b eing  tested  at AW E.
3.8.2 Synthesis 2
The synthesis w as carried  out as show n below :
o o
Cl o'
52%
0 O O
149
O'
80%
NH O
90%O
151
NH
88% O NH.
150
OH
OH
NH O
A  AO
152
Reagents and conditions: (a) Solketal, NaH (60%), toluene, r.t., 52%; (b) guanidine, EtOH, reflux, 88%; 
(c) C6H13NCO, pyridine, 100 °C, 80%; (d) HCI (1N), MeOH, THF, 90%.
Scheme 38: Synthetic route towards compound 152
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To prepare a more functionalised substrate, cloroacetoacetate was first reacted with 
solketal in the presence o f sodium hydride (60% in oil) to give 149 in 52% yield after 
purification. The reaction o f 149 with guanidine carbonate in ethanol under reflux 
conditions afforded the isocytosine 150 in 8 8 % isolated yield. Further reaction between 
150 and hexyl isocyanate in pyridine at 100 °C, followed by the addition o f hexane led 
to the precipitation o f pure compound 151 in 80% yield. The acetal protecting group 
was finally removed under acid conditions ( I N  HC1) in a mixture of methanol and THF 
(2:1) under reflux conditions for 30 min. The product 152 was isolated in 90% yield. 
Once again, the final compound had low solubility in most organic solvents and is under 
further investigation at AWE.
Conclusion
The functionalisation o f non-energetic and energetic telechelic polymers with 
ureidopyrimidinones has been achieved, opening up a new area for energetic binders. 
The development o f an alternative synthetic approach for the synthesis of such 
supramolecular polymers, avoiding the use o f isocyanates, has proved to be efficient 
although less straightforward. This method could lead to further development for 
industrial purposes. In all cases, a linear supramolecular polymer of high molecular 
weight was obtained over a range o f concentrations. Interestingly, the linear polymer 
chain was dissociated into smaller oligomeric species upon dilution. The hydrogen 
bonding system still persisted in solution according to the !H NMR chemical shifts, but 
it was more likely that cyclic species were then formed. Indeed, the bifunctional 
monomer was sufficiently long enough to form an intramolecular quadruple hydrogen 
bonding and generate a cyclic monomer (‘head-to-tail’). Since the concentration under 
which the oligomeric species are formed is relatively low (~ 5-10 mM), this does not 
affect the industrial applications o f these materials. The equilibrium between polymeric 
chains and cyclic species will be further discussed in the following chapter.
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4 Cyclic Dimers of Bifunctional Ureidopyrimidinones
4.1 Introduction
The use o f bifunctional ureidopyrimidinone systems has been investigated for the 
synthesis o f linear supramolecular polymers incorporating linear alkyl chains (62) or 
various polymers and co-polymers (6 6 ) . 1 1 5  In addition, Meijer et al. have studied
intensively the use o f rigid linkers (87) and biased linkers found in compounds 90 and
126 12893 on the formation o f stable cyclic dimers over polymers (Chapter I). ’
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Figure 93: Examples o f bifunctional Ureidopyrimidinone systems
These examples reflected the importance o f the nature of the spacer (flexible, rigid or 
biased) between two Upy units on the conformation o f the final supramolecular 
structure (polymer/cyclic dimer) (Chapter I). Interestingly, ureidopyrimidinones 
incorporating small chiral units at position ‘X ’ (see compound 6 6 , Figure 93) have not 
been reported so far. To this end, analogues o f compound 6 6  were designed to open up 
potential for a new type o f materials with greater structural diversity (Figure 94).
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Primarily, we were interested in assessing whether larger cyclic dimers could be 
generated using these new arrays and consequently study the cyclic/polymeric 
interconversion o f these supramolecular systems.
NH o
A .  AO N N N -Alkyl chain
Chiral unit 
+ H-bonding 
sites
CH3 
O HN^S
Alkyl chain - t - N ^ N ^ N  O 
H H
Flexible linker Rigid unit carbamate, amide or ester bond
Figure 94: Design o f new arrays, analogues o f compound 6 6
The desired characteristics o f the new hydrogen bonded array are as followed:
- A small chiral unit: the presence o f chirality has already been shown to induce 
helicity into polymers, and therefore could lead to interesting new 
supramolecular structures.
Potential capability o f hydrogen bonding sites within the chiral unit to generate 
further intramolecular hydrogen bonds and enhance the overall stability of the 
array.
A flexible alkyl chain where the length could be varied to alter structural 
properties.
A linker such as carbamate, amide or ester depending on the synthetic route 
used.
The insertion o f a cyclic dipeptide as well as tartrate derivatives were then investigated.
4.2 Incorporation of a Cyclic Dipetide
The cyclic dipetide (153) derivative o f L-serine was first selected since it combines 
rigidity and chirality as well as the capacity to form intramolecular hydrogen bonds 
such as a and b as shown below (Figure 95), using a carbamate linker.
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OH O
Cyclic dipeptide carbamate linker — alkyl chain — UPy
Figure 95: Structure of the cyclic dipeptide and schematic view o f the array generated
4.2.1 Towards the Synthesis of the Cyclic Dipeptide
The synthesis o f cyclic dipeptides has been reported using several methods such as 
those described by Fisher and Nitecki. 1 6 9  Both methods have advantages and 
disadvantages in terms o f the yields achieved and degree o f racemisation observed. It 
has been shown that the Fisher method involving the aminolysis o f the dipeptide ester in 
methanolic ammonia, lead to appreciable racemisation. Nitecki et al. have described a 
different procedure via the deprotection o f a Boc-dipeptide ester using formic acid and 
the subsequent reflux o f the deprotected ester formate with a mixture o f 5-butyl alcohol 
and toluene. This method lead to reduced racemisation within the final compound, 
however the yield is not particularly high as a result o f competing side reactions (40% 
for L-Ser-L-Ser-).
It has also been reported that dipeptide esters can be spontaneously cyclised by the 
hydrogenolysis o f a benzyloxycarbonyl protecting group. Cyclic peptides were obtained 
by refluxing a solution o f the deprotected dipeptide esters in methanol. A comparison of 
these methods in terms o f yield and racemisation for some cyclic dipeptides is shown in 
Table 21.
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Com pound
Yield (Racemisation)
Fisher Nitecki MeOH-Reflux
Cyclo(-L-Leu-L-Leu-) 70% (1.5%) 71% (5.5%) 76% (1.2%)
Cyclo(-L-Val-L-Val-) 20% (0.9%) 58% (0.4%) 64% (0.6%)
Cyclo(-L-Ser-L-Ser-) 53% (2.7%) 40% (1.5%) 63% (1.4%)
Cyclo(-L-Phe-L-Phe-) 8 6 % (0 .6 %) 89% (0.6%) 93% (0.1%)
Table 21: Comparison o f Fisher, Nicketi and MeOH/Reflux methods for the cyclisation 
o f dipeptides16 9
To ensure as little racemisation as possible, the MeOH-reflux method was initially 
followed (Scheme 39).
o^ oh
h 2n - ■H
\
OH 
L-serine
90%
O^/OH
OH
154
50%
O c ^ O M e
H
.N —- H
-H OH
OH
12%
155
153
R e a g e n ts  an d  co n d itio n s : (a) PhCH2OCOCI, N aH C 03, 90%; (b) L-serine-OMe, HCI, PPh3, CCI4, NEt3, CH3CN, 50%; 
(c) H2, Pd/C, MeOH, reflux, 8d, 12%.
Scheme 39: Synthesis o f the cyclic dipeptide
CBz-protected serine 154 was synthesised from L-serine and benzylchloroformate in a 
saturated aqueous carbonate solution . 1 7 0  Protected L-serine was recovered as a white 
solid in 90% yield and was used directly in the next step. Peptide couplings are 
commonly carried out using carbodiimides such as DCC with either DMAP or 
triethylamine, however this procedure did not afford the desired product. An alternative 
method is the use o f triphenylphosphine, carbon tetrachloride and triethylamine which 
can prevent side chain reactions with primary hydroxyl functional groups present in the 
peptide . 171
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The coupling reaction between 154 and L-serine methyl ester chloride using this method 
gave 155 as a white powder in 50% yield after purification.
The next step involved removal o f the CBz protecting group using catalytic 
hydrogenation over Pd/C black in methanol. In order to achieve the cyclisation, the 
deprotected dipeptide L-serine-L-serine was heated at reflux in methanol for 8  days 
(repeat experiments have highlighted the necessity o f using a dilute reaction conditions 
in order to generate the product). The first successful attempt gave the cyclic dipeptide 
in only 1 2 % yield.
In order to generate the supramolecular array (156, Figure 96) the reaction between 
hexyl diisocyanate 131 and cyclic dipeptide 153 was carried out in CHCI3 under reflux 
conditions using the method previously described by Meijer et al. and involving the use 
of tinbutindilaurate as a catalyst for the reaction (Scheme 40).115
o  CH3
V H °' H 11 H HCH3 O
156
Figure 96: Bifunctional ureidopyrimidinone incorporating a cyclic dipeptide
CH, h o  H
A *  Y f^  NH O O N OH
No reaction
H H CHCI3
131
Catalyst
Scheme 40: Towards the synthesis o f compound 156
Compound 153 was however sparingly soluble in organic solvents and an initial attempt 
in chloroform under reflux conditions was unsuccessful. A second attempt using 10% 
DMSO in chloroform also led to the isolation o f the starting material. The reaction was 
then conducted using 60% DMSO in chloroform. However, this method failed to yield 
the desired product.
Due to the poor solubility o f the cyclic peptide in organic solvents, an alternative chiral 
unit was then considered. Previously Lehn et al. have reported the synthesis of
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supramolecular polymers incorporating tartaric acid derivatives, which induced helical 
orientation o f the polymeric chains (Chapter I).96 Based on this idea, molecule 157 
(Figure 97) was selected incorporating a chiral tartaric unit linked through an amide 
bond to an alkyl chain o f variable length. Other than the chirality within the molecule, 
the free hydroxyl groups o f the tartaric unit can act as hydrogen bonding donors. They 
could also be further functionalised to form new derivatives.
157: n=5 CH3
Figure 97: New supramolecular array targeted
4.3 Incorporation of Tartaric Acid
The synthesis o f 157 could be carried out through the condensation of 139 with the 
corresponding amine salt 158 (Scheme 4 1).172
HO OH
+  TFA. TFA  *  157
139 158: n=5
Scheme 41: Synthetic strategy for compound 157
Tartaric acid can be converted to tartramide when reacted with an amine (Scheme 42). 
The formation o f the amide bond required the use of a coupling reagent such as DDC or 
EDCI/HOB/. An alternative method requires the use o f microwave activation, which 
enables the use o f  solvent free reaction conditions.
c h 3
r^N H  O
O ^ N ^ N ^ N ^ \  
H L  /  
N
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coupling agent
L- tartaric acid tartramide
Scheme 42: Synthetic strategy for tartramide compounds
Following this procedure, Massicot et al. have synthesised tartramides in good yield 
(70%) from benzylamine and aliphatic primary amine (12 min, 20-180 °C).173 In order 
to study this reaction and investigate the best procedure for the coupling step, 
butylamine (R = C4H9) was used in test reactions under the conditions shown in Table 
22. In order to avoid any intermolecular side reactions with DCC as a coupling agent, 
EDCI was first chosen, as it is well known for its high reactivity towards primary 
amines. In particular, Marastoni et al. have described an efficient method using 
EDCI/HOBt to give tartramides in good high yields (~ 70%).174
M ethod Yield
A) EDCI/HOBt/CH2Cl2 0%
B) EDCI/HOBt/DMF 45%
C) Microwave, 180 °C, 34 W, 9 min. 60%
Table 22: Different conditions used for the reaction between L-tartaric acid and 
butylamine
From these results it appeared that the microwave reaction was the most efficient 
method, giving the highest yield in the shortest time. When using EDCI, no reaction 
occurred in CH2 CI2 , while in DMF 45% o f pure product was isolated. Following these 
preliminary test reactions, the microwave activation was then applied for the synthesis 
o f tartramide 160 (Scheme 43) between tartaric L-acid and compound 15.175 However 
the desired compound was not isolated.
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HO OH
) — (. 4
HOOC * * COOH
HO OH
159 160: n=5
Scheme 43: Synthesis o f tartramide derivative 160
A decrease in the reaction temperature o f the microwave reactor did not improve the 
reaction. It was then rationalised that the Boc protecting group was unstable under the 
microwave conditions, and subsequent decomposition o f the molecule was observed.
Unfortunately, this method proved to be ineffective with this particular substrate and 
the reaction between tartaric acid and compound 159 with EDCl/HOBt in DMF was 
then carried out and 160 was isolated in 76% yield. Deprotection of BOC protecting 
group in TFA/CH 2 CI2 (1:1, v/v) afforded the corresponding salt 158 in quantitative 
yield (Scheme 44).
100%
Scheme 44: Deprotection o f the tartramide protected compound 160 and subsequent 
reaction with compound 139.
Compound 158 was unfortunately insoluble in organic solvents such as THF, CHCI3 or 
acetonitrile. However, it was reacted with 139 in the presence of triethylamine in dried 
THF under reflux conditions. Meijer et al. reported a similar reaction procedure for the 
synthesis o f compound 90.172 Unfortunately the reaction did not afford the desired 
product 157, which is likely to be due to solubility problems as the imidazole derivative 
139 also had low solubility in organic solvents.
Once again the synthetic approach was reconsidered, as the very poor solubility of such 
chiral units appeared to be a major problem.
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4.4 Incorporation of Diethyl Tartrate
A low cost derivative o f tartaric acid is the l  or d  diethyl tartrate, commercially 
available in both pure enantiomeric forms (Figure 98). One interesting characteristic is 
the presence o f ester moieties that should increase the solubility, and the carbonyl 
groups could take part in additional hydrogen bonding within the final molecule. The 
use o f diethyl tartrate was explored, one key advantage being the facile coupling 
reaction between the hydroxyl groups and the isocyanate 131 to generate a carbamate 
linker. When taking into account all these factors, this molecule appeared to be an 
excellent candidate for this study.
Figure 98: Diethyl tartrate derivatives
4.4.1 Synthesis
The isocyanate 131 was reacted with diethyl L-tartrate (the same with d )  in dry 
chloroform with a drop o f tin dibutyldilaurate using a similar method as that described
products 161 and 162 in a ratio 1:9, but not the desired bifunctionalised compounds. 
Two doublets at 5.42 ppm and 4.69 ppm (J = 2 Hz) were attributed to the non­
equivalent CH protons found in compound 161. Further verification o f the presence of 
161 was provided by mass spectroscopy (ES+) with a molecular ion m/z at 500. 
Determination o f the structure o f compound 162 was however less straightforward 
together with rationalisation o f its formation.
(R, R)-Diethyl L-tartrate (S, S)-Diethyl D-tartrate
previously (Scheme 45). Unfortunately the ]H NMR spectrum showed a mixture of the
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H COOEt
r OH 
COOEt
162
Scheme 45: Reaction o f isocyanate 131 with diethyl L-tartrate
A quartet at 4.12 ppm and a triplet at 1.10 ppm were observed showing a 
coupling and were attributed to the COOCH2CH3 groups. A broad signal around 4.50 
ppm was assigned to the NH proton o f the carbamate group. In addition, the mass 
spectrum of the mixture showed a peak at 340.32, with an abundance of 100%, 
corresponding to 162. Further confirmation was provided from the reaction o f 131 with 
ethanol, and as expected the spectroscopic data were identical to that of compound 162. 
The rational for the reaction o f 162 was unclear at first. Two sources of ethanol were 
envisaged: either the 0.5-1% ethanol present in chloroform used as a stabiliser, or 
possibly from the hydrolysis o f the diethyl ester moieties o f the tartrate unit under the 
reaction conditions. In order to establish this, an experiment was conducted between 
131 and diisopropyl L-tartrate (Scheme 46).
131
Scheme 46: Reaction between 131 and diisopropyl L-tartrate
Once again the quartet and the triplet at 4.12 ppm and 1.10 ppm, respectively, were 
observed and no traces o f isopropanol that could have been generated from the ester 
moieties were observed. This confirmed that the source o f ethanol was coming from the 
chloroform used. Although Meijer et al. never reported this problem in the synthesis o f 
supramolecular polymers, in this present case ethanol did play a crucial role and
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appeared to be a competing reagent. In order to avoid this side reaction in future, 
chloroform stabilised with amylenes was used.
The reaction was then repeated using an approximately 18.2 mM solution of the diethyl 
L-tartrate (Scheme 47) and !H NMR spectroscopy was used to monitor the progress of 
reaction over 96 h.
H COOEt
r OH
COOEtCHCI3, cat 
(amylenes)
Scheme 47: Reaction between 131 and diethyl L-tartrate using reaction conditions
After an hour the presence o f mono functionalised 161 was observed (indicated by # in 
Figure 99), along with starting materials (diethyl L-tartrate, marked as SM in Figure 99). 
Verification using mass spectrometry showed a peak corresponding to compound 161. 
Interestingly, after approximately 5 h, an additional set o f signals was observed in the 
!H NMR spectrum (marked by arrows in Figure 99). Additional MS analysis indicated a 
peak at 793 corresponding to compound 163. The reaction appeared to be relatively 
slow, and even after 72 h, there was still a substantial amount of 161 present with the 
ratio 163:161 ~ 2:3 (Figure 99, top trace).
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96h
72h
4 8h
20h
5h
j J
SM
l h
13 1112 9 6 510 8 7 ppm
Figure 99: Advance o f the reaction o f 131 with diethyl L-tartrate (18.2 mM solution) 
followed by NM R as a function o f time.
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In order to increase the rate o f the reaction and drive it to completion, parameters such 
as the concentration o f the solution can be altered. In this study, increasing the 
concentration o f diethyl L-tartrate from 18.2 mM to 55 mM had a significant effect on 
the rate o f the reaction. After 1 h almost all the diethyl L-tartrate has reacted forming 
predominantly 161. After 5 h, significant amount o f 163 was already observed, and after 
about 20 h compound 163 was the major product (Figure 100).
20h
1213 11 1 0 j pm
5h
1213 11 10 pm
lh
M JC___
i ................................ i .................................... i ................................... i ...................................i .................................... i ................................... i ...................................i .................................. i ...................................i ..................................... i
13 12 11 10 9 8 7 6 5 ppm
Figure 100: Advance o f  the reaction o f 131 with diethyl L-tartrate (55 mM solution) 
followed by lH NM R as a function o f time. Arrows indicate some of the key peaks due 
to the bifunctional Upy 163.
Even more satisfactory results were observed when the solvent o f the reaction was left 
to evaporate slowly. In this case almost no traces o f 161 were observed by !H NMR 
spectroscopy. Compound 163 was purified via flash silica chromatography and isolated 
in 30% yield.
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4.4.2 Determination of the Structure of Compound 163
Having isolated 163 the conformation o f the supramolecular structure was explored to 
assess whether a polymer (a) or a cyclic form (b) was generated (Figure 101).
a b
Figure 101: Representation of a linear supramolecular polymer (a) and a cyclic dimer 
(b)
4.4.2.1 NMR Studies o f  163
c h 3
V ^ n'h'o h Etooc. h o h
o^ n^ n^ n^ ~ ^ ^ ^ nY 0 T ' °  n^ ^ ~ ^ ny nY nY °H H O H  COOEt H q
c h 3
163
Compound 163 was initially studied in solution (CDCI3 ) using NMR spectroscopy. The 
13C NMR chemical shifts o f C-4 and C-5 at 174.0 ppm and 107.0 ppm (Figure 102a), 
indicated that the Upy units adopted the 4-keto form B and no enol form C was present 
(Chapter II). In Figure 102b, lH NMR chemical shifts and their assignments are shown. 
15N NMR chemical shifts were also measured using heteronuclear correlation 
experiments (Figure 103).
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C 4
C 5
T
200  18 0  160  140  12 0  1 0 0  80 60 40 20 0 ppm
H7
H I H5
CH2 non-equivale
H16H9
13 12 11 10 9 2 18 7 6 4 35 ppm
13 1Figure 102: a ) C spectrum and b) H spectrum of compound 163
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ppm
- 3 0 0 -
- 2 8 0 -
- 2 6 0 -
♦
- 2 4 0 -
14 13 812 11 10 9 ppm
ppm ____1___________  I________________ L
- 2 8 0 -
- 2 6 0
- 2 4 0 -
- 2 2 0 -
- 2 0 0 -
- 1 8 0 -
- 1 6 0 -
- 1 4 0
314 13 12 11 10 9 6 5 48 7 ppm
Figure 103: H M Q C  (top) and H M B C  (bottom ) spectra o f  163 in CDCI3 . The
15N  chem ical sh ifts w ere: -172.2  (N -3), -246.3 (N - l) , -266.5 (N-7) and -284.1 ppm  (N- 
9). S im ilar chem ical shifts w ere also m easu red  in  the solid state: -172.1 (N-3), -245.9 
(N -l) , -266.4  (N -7) and  -283.8 ppm  (N -9)
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Interestingly, the CH2 protons adjacent to the linkers, as well as the CH2 protons of the 
tartrate moiety were non-equivalent (Figure 104) in the *H NMR spectrum.
c h 3
O Ha Ha'
o X na n x n .-
I I
H H
.N o i
HbHb'o HCOOEt
Ha Hb H b’ H a’
3 . 9  3 . 8  3 . 7  3 . 6  3 . 5  3 .4  3 .3  3 . 2  3 . 1  3 . 0  2 . 9  2 .8  2 . 7  2 . 6  2 . 5  2 .4  ppm
Figure 104: Part o f the *H NMR spectrum showing the peaks due to non-equivalent 
CH2 groups
This first observation, showing the non-equivalence o f the hexyl chain indicated that 
compound 163 could adopt a cyclic structure. For comparison, in polymer 138 (Chapter 
III) corresponding protons Ha and Ha> are chemically equivalent with the chemical shift 
o f 3.20 ppm, which corresponds to the averaged position o f protons Ha and Ha> in 
Figure 104.
Compound 163 was dissolved in DMSO-*/* and as expected, the DDAA hydrogen 
bonding network was disrupted. The 6 -keto form A was shown to be present in 
solution, according to and 13C NMR chemical shifts (Table 23). In particular, the 13C 
NMR chemical shifts o f C-4 and C-5 at 161.85 ppm and 104.64 ppm and the !Jch 
coupling o f C-5 (168 Hz) were in favour o f the 6 -keto form A. Since the substituent at 
C - 6  is a methyl group, the tautomer A was expected in DMSO-d<j based on the previous 
results (Chapter II).
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Atom *H *h 13C 13c
position CDCI3 DMSO-d6 CDCI3 DMSO-tf*
298K 303K 298K 303K
4 - - 174.03 161.85
5 6.41 5.78 107.06 104.64
( ^ ch) (173.6 Hz) (168 Hz)
7 1 1 . 6 8 9.8 - -
9 1 0 . 2 1 7.44 - -
16 7.68 7.38 - -
Table 23: Comparison o f *H and 13C chemical shifts in CDCI3 and DMSO-ck
A comparison o f the proton chemical shifts observed in CDCI3 with those of the linear 
polymer 6 6  previously reported is shown in Table 24.
Protons Linear polymer 66 Compound 163
1-H 13.09 13.41
5-H 5.83 6.41
7-H 11.82 1 1 . 6 8
9-H 10.08 1 0 . 2 1
16-H 4.87 7.68
Table 24: Comparison o f NMR chemical shifts observed for the linear polymer and 
compound 163
Substantial deshielding effects were observed for 1-H, 5-H and 16-H in compound 163 
compared to the polymer. The drastic downfield chemical shift o f 2.7 ppm at 16-H 
strongly suggested that it was involved in hydrogen bonding. These results revealed 
that the electronic environment around these protons had been modified, possibly by 
the formation o f  cyclic species in solution.
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To assess potential hydrogen bonding between 16-H and the carbonyl group of the ester 
tartrate moiety within a molecule free o f Upy units, hexyl isocyanate was reacted with 
diethyl-L tartrate to afford 164 in 56% yield (Scheme 48).
NCO
H COOEt
H O ^ V ™
EtOOC H
O H COOEt H
-n A o W N '
H EtOOC H o
164
Scheme 48: Reaction between hexyl isocyanate and diethyl L-tartrate
The !H NMR spectrum o f 164 showed a triplet at 5.9 ppm characteristic of the NH 
proton. If the NH group formed a hydrogen bond with an ester moiety, then the 
chemical shift o f the NH proton should be close to the one found in compound 163. The 
shift o f 5.9 ppm indicated that the Upy units in 163 could act as acceptors for the 
formation o f hydrogen bonds with 16-H.
To further investigate spatial arrangement o f protons in 163, NOE and ROE 
measurements were performed in the CDCI3 solution (Figure 105). On selective 
excitation o f proton 5-H the strongest NOE o f -0.6% was found for proton 16-H. The 
corresponding ROE was 5.0%. These measurements were in favour of close spatial 
proximity o f protons 16-H and 5-H, which in turn is in agreement with the large high 
frequency shifts observed for protons 16-H and 5-H. In addition, a small negative NOE 
of -0.2% (0.6% ROE) was found between 16-H and 9-H indicating that 16-H is in close 
proximity o f the DDAA array.
- 0 .6%
CH
-0 .1%
N H 1 O
A A,
-0 .2%
Figure 105: Some o f the NOEs in 163
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4.4.2.2 Proposed Structure
The relative ratio o f the NOEs were used to estimate some of the unusual proton 
proximities described above : 2.81 A for (5-H, 16-H), 4.32 A for (5-H, 9-H) and 3.26 A 
for (9-H, 16-H). In the force field geometry optimisations using MMX, which is the 
extended version o f the MM2 force field , 176 these intemuclear separations were used as 
distance constraints. Additional torsional constraints were also imposed in order to 
retain a planar arrangement o f the two quadruple hydrogen bonded UPy fragments. The 
energy minimisation led to a cage type structure shown in Figure 106. The distances 
highlighted in Figure 106 agree with the existence o f the hydrogen bonding between 16- 
H and 4 -0  (N16-H...O), although these are longer than those for N9-H...O bond in the 
force-field optimised geometry.
Figure 106: Top: the MMX force field geometry of 163 using fixed distances from 
NOE measurements. Bottom: the upper side view of the above without the protons 
attached to carbons. The shown distances from the carbonyl oxygen compare the two 
hydrogen bonds, N 9-H .. .O and N 16-H .. .O
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= Upy unit
Figure 107: Schematic presentation o f the anti-arrangement of the cyclic dimer.
Minimisation o f the energy for other possible side chain orientations revealed that the 
ester moieties o f the tartrate units prefer to be on the outside of the cavity rather 
directed towards the space between the two Upy planes. Only a model where the two 
Upy were in an anti-conformation could be elucidated, since the high preorganisation of 
the molecule and the preferred geometry o f the additional hydrogen bonds restricted the 
syn conformation. For clarity, the anti arrangement o f the Upy fragments is shown 
schematically in Figure 107.
4.4.2.3 Structure o f  Compound 163 in the Solid State
Determination o f the structure in the solid state required the formation of a single 
crystal. Numerous attempts using solvents such as CHCI3 , CH2 CI2 , and mixed solvents 
such as CHCb/hexane, CF^C^/hexane, CHCl3/parafine and DMF/hexane gave crystals 
of insufficient quality for the X-ray analysis. Meijer et al. reported the use of 
DMSO/acetic acid when growing a single crystal o f cyclic dimers. This solvent system 
however was not suitable to grow a single crystal of 163. Finally, single crystals 
(colourless slabs) were successfully produced by the slow evaporation at room 
temperature o f a mixed solution o f dichloroethane and heptane.
Crystallographic data revealed the existence of cyclic dimers. The structure was in 
agreement with the one already proposed by the NOE and molecular modelling (Figure 
108). Data were transferred into Mercury software and representation of the cyclic 
structure is depicted below. Details o f crystallographic measurements are included in 
Appendix A.
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Figure 108: The molecular structure of compound 163 in the solid state
Analysis revealed that the cyclic dimer was maintained through a total of 16 hydrogen 
bonds in which eight were from the two DDAA-AADD arrays, four of them are the 
intramolecular hydrogen bonds in each DDAA unit, and four are the new hydrogen 
bonds formed between 16-H and the carbonyl oxygen at C-4 (Figure 109).
Figure 109: The view of the cyclic structure with the highlighted hydrogen bonds
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The C6 chain spacer appeared to form a loop to the outside of the Upy dimers planes 
which clearly explained the non-equivalence of the CH2  groups observed previously in 
the *H NMR spectrum (Figure 110). The fact that a conformation similar to that in the 
solid state is also predominant in the CDCI3 solution is apparent from the large 3Jhh 
couplings o f 11.5 and 11 Hz measured for proton pairs 10-H,11-H and 14-H,15-H, 
respectively. Based on Karplus relationship, such high values o f 3Jhh are in favour of 
-180° torsional geometry for one o f the vicinal proton pairs along C-10,C-11 or C- 
14,C-15. Significantly smaller values o f these 3JHh would have been observed in the 
case o f conformational flexibility in solution about the C-10,C-11 or C-14,C-15 bonds.
V=11.5 Hz 3J=11 Hz
Figure 110: Side view of the cyclic structure showing the non-equivalence of the alkyl 
chain. Proton pairs with large J-couplings in the CDCI3  solution are also shown
The two Upy were in an anti-conformation, similar to that found by the force field 
calculations using NOE distance constraints. The twist angle of one of the Upy plane 
relative to another was measured to be 73°.
The distances and angles of the hydrogen bonds in the cyclic dimer are given in Table 
25. The cyclic dimer is not fully symmetrical as revealed by the differences in bond 
lengths and angles between the two dimers DDAA/AADD in the cyclic structure. For 
example, O ...N -H  bond varies from 1.842 A in dimer (a) to 1.877 A in dimer (b) while 
the angle changes from 173.4° to 170.0°. The new hydrogen bonds formed between 4-0  
and 16-H are short (-2.0 to 2.1 A) and in the same order of magnitude as the NH...N 
bonds found in the Upy dimers. The distance between the two parallel planes of Upy 
dimers is approximately 3.3 A suggesting a possible stacking of the two Upy planes.
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H-bond A ...H D  (A)a A ...D  (A)a 0 (AHD) A ...H D  A ...D  0 (AHD)
(°)a (A)b (A)b (»)b
C O ...HN 1.841 2.717 173.4 1.877 2.749 170
N ...H N 2.07 2.948 175.4 2.04 2.919 176.6
N H ...N 2.068 2.946 175.9 2.105 2.974 169.7
CO ...H N 1.889 2.745 163.8 1.923 2.796 171.4
Intra C O ...H N 1.799 2.496 134.6 1.862 2.541 132.6
Intra C O ...H N 1.884 2.561 132.4 1.889 2.55 130.6
C4O ...H i6N 2.051 2.849 150.3 2.021 2.844 155.3
C4O ...H i6N 2.124 2.988 167.2 2.101 2.959 165
Table 25: Distances and angles o f the hydrogen bonds in the first (a) and the second (b) 
DD A A/A ADD arrays
Comparison with the Dimer DDAA-AADD
ch3
DDAA/AADD A...HD (A) 0 (°)
CO ...H N  1.877 175~
N ...H N  2.086 163
Table 26: Bond lengths and angles of the 
dimer
DDAA-AADD dimer
The bond lengths and angles found for the DDAA-AADD dimer 57 (Table 26) are very 
similar to those measured in the cyclic dimer 163. This indicated that the strength o f the 
DDAA-AADD dimers is conserved in the cyclic structure and possibly increased due to 
potential stacking between the two parallel Upy planes.
NH O
o N , N
! ; H H
H H 1 |
N .  / N .
O HN.
' r
57 CH3
Figure 111: Representation o f a
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C om parison w ith a cyclic dim er
Recently M eijer has described the structure o f a cyclic dimer with 12 hydrogen bonds 
formed by a short linker (91) between two Upy units (Figure 112) . 177
CH CH.
NH O CH.
A  X  . A '
Figure 112: The X-ray structure o f compound 91
The short linker induces more strain in the ring and because of the reduced flexibility 
the two Upy dimers units are not parallel to each other, but significantly deviated from 
one to the other in order to assemble into a stable cyclic dimer. This distortion leads to 
an elongation o f the O ...H -N  bond compared to compound 163. As observed for 
compound 163, the cyclic dimer 91 was not symmetrical (Table 27).
DDAA/AADD A ...H D  (A) 0 (AHD) (°) A ...H D  (A) 0 (AHD) (°)
O ....H N 1.959 176.3 2.016 176.7
N ....H N 2.023 172 2.125 177.7
N H __N 2.062 176.3 2.057 178.3
O ....H N 1.982 176.1 1.945 171.6
O ...H N  (in tra) 1.902 137.3 1.955 133.1
O ...H N  (in tra) 1.806 138.4 1.874 139.1
Table 27: Bond lengths and angles found in cyclic dimer 91
4.4.2.4 Solid State NMR
Solid-state NM R data was then acquired to confirm whether the solution conformation 
in CDCI3 was the same as that in the solid. As shown in Table 28, the chemical shifts 
are almost identical in both cases confirming that the cyclic dimer is present in CDCI3 .
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C arbon 8 C (ppm), CDCI3 8 C (ppm), solid state
C-4 174.0 174.4
C-5 107.1 107.5
C - 6 154.5 155.0
C-10 38.4 37.8
C-15 37.2 37.8
Table 28: Comparison o f C NMR chemical shifts in CDCI3 and in the solid state
In summary, this is the first time that an ureidopyrimidinone cyclic dimer, stabilised 
with 16 hydrogen bonds has been observed both in solution and in the solid state. The 
novel approach o f combining a flexible alkyl chain with an ester functionality has 
proved to be particularly effective for the formation o f the cyclic dimer. Stacking via 
71—71 interactions seems to be another stabilising factor. The role o f the small chiral unit, 
however, is less clear. Other questions related to the cyclisation remain, such as what is 
the main driving force behind the dimeric cyclisation o f bifunctional Upy’s. Also, how 
stable is the cyclic structure and is the cyclisation enantioselective.
4.4.2.5 Stability o f  the Cyclic Dimer
As previously described in the introduction, the supramolecular rings and polymers are 
normally in equilibrium and the presence o f polymeric species often occurs above a 
critical concentration, or in some cases with an increase in temperature.
Concentration dependence studies were undertaken to assess the possibility of polymer 
formation for 163. No changes in ]H NM R chemical shifts were observed on varying 
the concentration in the range from 1 mM to 500 mM in CDCI3 at 298 K. Diffusion 
experiments were also performed in CDCI3 on two samples at different concentrations: 
10 mM and 135 mM and diffusion coefficients were 4.5 x 10’ 10 m2/s and 4.4 x 10‘ 10 
m 2 /s, respectively. Furthermore, upon increasing the concentration up to 500 mM there 
was still no sign o f  polymer that could be detected by !H NMR. This result suggested 
that the cyclic structure was extremely stable in solution with a critical concentration (if 
any) above 500 mM.
The dimerisation constant o f the cyclic dimer was also assessed and for this purpose 
dilution experiments were performed in CDCI3 down to 1.4 pM. No changes of the lH
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chemical shifts were observed. The dimerisation constant was therefore estimated to be 
greater than 1.3 x 108 M '1. This estimate was derived from [d]/[m]2 and
[t] =2[d]+[m] relationships, where [t] is the total initial concentration, [d] and [m] are 
the concentrations o f dimer and monomer, respectively. It was assumed that at the 
lowest concentration examined there is 5% o f monomer that is not detected by NMR 
chemical shift measurements. This data highlighted the very high stability of the cyclic 
dimer in solution.
Temperature studies were also performed in toluenQ-dg in order to study the thermal 
behaviour o f compound 163 and the possibility of polymer formation at higher 
temperatures. The results are summarised in Table 29.
Proton 296 K 363 K 378 K
1-H 13.72 13.51 13.45
7-H 11.85 11.67 11.64
9-H 10.30 9.98 9.92
17-H 7.91 7.28 7.09
Table 29: Variation o f !H NM R chemical shifts in toluene-^ as a function of 
temperature
No traces o f the polymer were observed on raising the temperature from 296 K to 378 
K, however, a change in the hydrogen bonding behaviour was detected with all 
hydrogen bonded protons shifting up field. The largest shift was for 17-H, suggesting 
that the corresponding hydrogen bond is the weakest in the cyclic dimer.
4.4.2.6 Is the Cyclisation Enantioselective?
Meijer et a l  have described the formation o f cyclic aggregates with high selectivity 
between homochiral and heterochiral cyclic species.
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In M eyer’s study the enantioselective dimerisation, (R,R)-165 and (S,S)-165 were 
synthesised from pure cystine methyl esters and solutions of the enantiomers were 
compared to solutions o f the racemic mixture and studied by *H NMR dilutions (Figure 
113). At 30 mM, the NM R spectrum of the racemic mixture was identical to that of 
pure enantiomers, showing that only homochiral cyclic species were formed in solution. 
The four peaks observed for the pyrimidinone alkylidene 5-H were all assigned to 
cyclic assemblies.
(R,R)-165a (S,S)-165a Rac-165a
30riM
8 0  5 8  5 8 8 0  5 8  58
SCPpt**)
Figure 113: Alkylidene region o f NM R spectra o f (R,R)-165a, (S,S)-165a and a 
racemic mixture in CDCI3176
Following the same idea, cyclic compounds 163a and 163b were then synthesised using 
(R,R) diethyl L-tartrate and (S,S) diethyl D-tartrate, respectively. The !H NMR spectra 
were identical for these two molecules and were compared to a solution o f the racemic 
mixture in CDCI3. In this case, the lH NM R spectrum displayed a new set of peaks 
indicating the presence o f a heterochiral cyclic assembly along with the homochiral 
species (R,R)-163a and (S,S)-163b. The ratio o f these three cyclic assemblies was close 
to 1:1:1 (Figure 114)
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Figure 114: lH NMR spectrum o f a racemic mixture o f 163 in CDCI3 at 298K. 
Asteriks denote peaks assigned to heterochiral cyclic assembly
The presence o f heterochiral cyclic assembly in solution confirmed the fact that no 
enantioselective cyclisation was observed for 163. Thus, there is no pronounced 
selectivity between homochiral and heterochiral cyclic species, although the cyclic 
dimer is very stable in solution. However, this result is not surprising since this kind of 
phenomenon usually takes place in the crystalline state.
4.4.3 Other Analogues of Cyclic Dimer 163
In order to gain a greater understanding o f the preference for cyclisation, derivatives of 
compound 163 were synthesised using an analogous synthetic procedure as for 163. 
Initially, a mimic compound o f 163 was prepared, this time with the (2R,3R) butanediol 
as the chiral unit, and leading to compound 166 (Figure 115). Based on the NMR data 
the cyclic dimer was the only product isolated but was formed in a low yield (2 0 %) 
reflecting the poor solubility o f 166 in chloroform.
CH,,
o
o
166 CH.
Figure 115: Structure o f compound 166
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The ]H NM R spectrum was very similar to that o f 163 highlighting the presence of 
cyclic dimer in solution. The 16-H intramolecular hydrogen bonded proton was found 
this time at 7.13 ppm slightly shielded as compared to 7.63 ppm found in compound 
163. This result suggested that a change in the substituent on the chiral unit, from an 
ester to a methyl group, did not have a significant effect on the structure of the final 
molecule. In a different approach, the use o f a ring substituent on the chiral unit, was 
explored. For this purpose, the synthesis o f a chiral molecule possessing a crown ether 
(167) was carried out (Scheme 49).
100%
167
R ea g en ts and  co n d itio n s:  (a) (CH3)2CH(OMe)2, PTS, azeotrope, 100%; (b) NaBH4, EtOH, 63%; c: NaH (60%), BnBr, THF, 
40%; (d) HCI (1N), THF/MeOH,reflux, 90%; (e) NaH (60%), bis-tosylate, THF, 3d, reflux, 25%; (f) H2, Pd/C, MeOH, 85%; 
(g)lsocyanate, CHCI3, catalyst, reflux, 10%.
Scheme 49: Synthetic route towards compound 167
Diethyl L-tartrate was protected using 2,2-dimethoxy propane to form dimethyl 2,3-0- 
isopropylidene L-tartrate 168 via the azeotropic removal o f toluene-methanol in the 
presence o f a />-toluenesulfonic acid catalyst.178 The reaction was quantitative but trans 
esterification also occurred giving a mixture o f diesters. However this was not a 
problem since the ester moieties were reduced in the next step. Compound 168 was 
reduced without further purification with the use o f sodium borohydride in anhydrous 
ethanol and heating at reflux, to give 2,3-O-isopropylidene L-threitol 169 in 63% 
isolated yield.179 Compound 169 was then protected using benzyl bromide affording
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170 in 40% yield after purification.180,181 Deprotection o f the acetal group under acidic 
conditions gave 171 in 90% isolated yield. Compound 171 was then reacted with bis- 
toluene-4-sulfonic acid 2-{2-[2-(2-ethoxy)-ethoxy]-ethoxy}-ethylester182 using sodium 
hydride in THF under reflux conditions for three days. Previous attempts using bis 
mesylate (PEG4) were unsuccessful. This highlighted the fact that the tosylate was a 
better reagent for this reaction. Few examples have been described in the literature on 
the synthesis o f “chiral” crown ethers, and the synthesis o f compound 172 was reported 
in 50% yield.183 Purification o f 172 was a major problem: a first purification through a 
neutral alumina chromatography column (petroleum ether/propan-2-ol, 50:1) was 
insufficient and a second column (flash silica) using ethylacetate as the eluent appeared 
to be more effective, however a third column in this system was necessary in order to 
obtain a pure fraction o f compound 172 in only 25% yield. In the following step, the 
debenzylation of 172 using H 2 on Pd/C in MeOH at atmospheric pressure was carried 
out to afford 173 in 85% yield. The final step involved the reaction o f 3 equivalents of 
isocyanate 131 (mentioned at the beginning o f this chapter) with the free alcohol groups 
o f compound 173 in chloroform. Tinbutyldilaurate was used as catalyst, under the same 
conditions as previously used for 163. Due to poor solubility and the small quantities 
obtained, the separation o f products was difficult to perform. From the materials 
obtained after separation, it was however clear from ]H NMR that a cyclic structure was 
present, according to the distinctive chemical shifts. Traces of starting material 
(isocyanate) were also observed (Figure 116).
a)
3 ppit
Figure 116: NMR spectra o f compound 167 before (a) and after purification (b).
The arrows indicate the peaks characteristic o f the cyclic dimers.
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Although the cyclic species were not as readily formed and easy to isolate after addition 
o f the chiral unit, it was however interesting to observe that cyclisation still did occur 
despite the use o f a sterically crowded diol. Also, with the C4 versus C2 chiral unit 
inserted little effect on the formation of cyclic species was observed. To assess whether 
the nature o f the substituents might induce cyclisation, the synthesis of compound 174 
was attempted from the isocyanate 131 and pinacol using the same reaction conditions 
as before (Figure 117). Here the small unit was non chiral and possessed four methyl 
groups.
Figure 117: Structure o f compound 174 incorporating pinacol chiral unit
Unfortunately the reaction only led to the monofunctional derivative 175, which was 
probably due to steric reasons that prevent the reaction to proceed further.
c h 3
f y "  9  H H3c v c h 3
H H II . .  J V . .O h 3c  c h 3
175
4.5 Synthesis of a Supramolecular Array with an Ester 
Linkage
In order to understand further the formation o f the cyclic dimers, ureidopyrimidone 
derivatives were synthesised with the carbamate moiety replaced by an ester bond (176, 
Figure 118). This would avoid the formation o f the intramolecular hydrogen bonding 
and may suppress the formation of a cyclic structure.
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New linker bond CHa
176
Figure 118: Synthesis o f a bifunctional ureidopyrimidinone incorporating
diethyl L-tartrate using ester linkage
4.5.1 Synthesis
Diethyl L-tartrate was reacted with carboxylic acid 177 (Scheme 51), which was 
previously synthesised in 50% yield via Boc protection of 8-aminooctanoic acid in 
CH2C12 (Scheme 50).184
NaOH, CH2CI2, H20
50%
177
Scheme 50: Protection o f primary amine with Boc protecting group
Compound 178 was obtained in 50% yield, using DCC as coupling agent, in the 
presence o f  DMAP in CH 2 CI2 . The yield was not particularly high, and further 
optimisation o f the reaction could have certainly increased the yield. The amine was 
then deprotected using TFA in CH2 CI2 (1/1, v/v), which afforded the salt 179 in 95% 
yield. Finally, compound 179 was reacted with 139 in THF under reflux conditions for 
16 h in the presence o f triethylamine. The final product 176 was isolated in 80% yield.
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EtOOC COO Et a
H " )— ("H   «
HO OH 50%
HN 178
o=<
o
>=0
o
/ V
EtOOC COOEt
O
95%
179
80%
176
R e a g e n ts  a n d  co n d itio n s : (a) DCC, DMAP, CH2CI2, 50%; (b) TFA, CH2Cl2, 95%; (c) Et3N, THF, reflux, 80%.
Scheme 51: Synthetic route towards compound 176
4.5.2 NMR studies
To identify the nature o f the supramolecular structure, compound 176 was first studied 
by !H NMR spectroscopy in CDCI3 (Figure 119). Diffusion measurements were also 
performed on a series o f diluted samples (Table 30).
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13 12 11 10 9 8 1 6 5 4 3 2 1 ppm
Figure 119: NMR spectrum for compound 176 (CDCI3 , 298K) and assignments of
protons
Concentration (mM) Diffusion (m /s)
135 1.8 X  10‘ 10
8 8 3.1 x 1 0 10
41 3.8 x 10' 10
28 4.3 x 1 0 10
1 0 4.8 x 10‘ 10
Table 30: Diffusion coefficient measurements as a function o f concentration of 176 in 
CDCI3 at 298 K.
These results showed a gradual and significant increase in the diffusion rate upon 
dilution, suggesting that smaller species had been formed. Since the molecular weight 
o f 176 is almost identical to that o f the cyclic structure 163, a comparison of their 
diffusion rates was then possible. Interestingly, the cyclic dimer 163 has a diffusion 
coefficient o f 4.5 x 10' 10 m2/s (10 mM solution in CDCI3), which is close to those found 
for the diluted solution o f 176 (10 mM). This data suggested that at low concentration 
mainly cyclic dimers were present. At higher concentrations (27-135 mM), a 
considerable slow down o f diffusion was detected, which indicated the presence of 
high-molecular species (denoted as (176)n>3). The observed decrease of D on increasing
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the concentration can be explained either by the shift o f the equilibrium between (176)2 
and (176)n>3 towards (176)n>3, or simply by the increase o f n in (176)n>3 on increasing 
the concentration.
In addition, the lH NMR spectroscopic study revealed some unusual behaviour. After 
preparation o f  the sample (10 mM), the ]H NM R spectrum showed four distinct peaks 
in the region 5.5-6.0 ppm, characteristics o f 5-H and 19-H (CH tartrate unit). When the 
sample was run after 16 hours, mainly two peaks were observed in the same spectral 
region (Figure 120). No further changes were observed after longer delays.
13 12 11 10 9 68 7 ppm
13 12 11 10 9 8 7 6 ppm
Figure 120: NM R spectrum o f 176 in CDCI3 prepared by dilution of the 28 mM
solution. Bottom: 20 minutes after dilution. Top: 16 hours after dilution. Both spectra 
were recorded at 298 K.
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Surprisingly the chemical shifts were the same as those for the concentrated sample 
(135 mM). From these observations it appeared that the exchange between the cyclic 
dimer and (176)n>3 was not at its equilibrium in a freshly diluted sample, i.e., the 
equilibration process is rather slow. As shown in Table 31, lH NMR chemical shifts for 
compound 176 are very close to those found in polymer 66 and dimer 114.
protons Compound 176 
(135 mM)
Cyclic dimer 163 Linear
polymer
66
4-keto
dimer
114
1-H 13.11 13.41 13.09 13.13
5-H 5.80 6.41 5.80 5.81
7-H 11.83 11.68 11.81 11.85
9-H 10.15 10.21 10.09 10.14
10-H 3.21 2.78 & 3.68 3.20 3.23
16-H 2.38 & 2.41 (CH2) 7.68 (NH) 4.94 (NH) -
20-H 5.69 5.92 - -
Table 31: Comparison o f chemical shifts between compound 176, and cyclic dimer 
163 and linear polymer 66
The fact that the chemical shifts are identical at low and high concentrations tends to 
suggest that the same type o f species predominate in both solutions. However, based on 
the diffusion measurements, it is clear that there is dissociation on dilution into smaller 
assemblies. This behaviour could be explained by the formation of 12 hydrogen bonded 
cyclic dimer assemblies at low concentrations, which would lead to the proton chemical 
shifts close or almost identical to those found in the linear polymer.
Conclusions
The formation o f high-molecular species with n>3 is favoured when the carbamate bond 
o f 163 is replaced by the ester linkage in 176. However, due to the flexibility of the 
alkyl chain, there is a possibility o f forming a twelve hydrogen bonded cyclic dimer of 
176, which is predominant at low concentrations in CDCI3. Such behaviour of 176 is 
common and has been described for other bifunctional Upy systems. From the 
comparison o f 163 and 176, it is apparent that the presence o f intramolecular hydrogen 
bonds in 163 is critical for the formation o f highly stable cyclic dimers, even in the 
presence o f long and flexible linkers. The example or 163 and 176 presented here 
clearly show how the ‘cyclic dimer/polymer’ equilibrium can be controlled by only 
minor adjustments o f the structure.
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5 The Design of a New DDAA Array
5.1 Introduction
The design o f linear multiple hydrogen bonding arrays has been a continuing 
challenge in the field o f supramolecular self-assembly. Particular attention has recently 
been paid to systems capable of forming strong quadruple hydrogen bonds.100 Meijer et 
al. have made a significant contribution to this area with the synthesis of strong self- 
complimentary DDAA and DADA moieties based on ureidopyrimidinones and 
ureidotriazines. Since the first reports, there have been numerous applications of these 
arrays in supramolecular polymers and materials synthesis126 (see Chapter I). 
Zimmerman et a l  have also made a significant contribution to the field with the 
synthesis o f a very stable DDAA module, which dimerises regardless of its tautomeric 
form134 (see Chapter I). Recently, they have also reviewed the use of heterocyclic 
compounds in the synthesis o f stable quadruple hydrogen bonded dimers via self- 
assembly processes.68 However, the development o f linear supramolecular polymers 
based on hydrogen bonding units has been mainly restricted to the Upy modules. 
Therefore, further advances in the field o f supramolecular materials require the 
development o f new hydrogen bonding modules. Hence, the synthesis o f a new DDAA 
unit combining rigidity, accessibility and strength has been investigated and the strategy 
adopted is detailed in this chapter.
5.1.1 From Nature to Molecular Design
Pyrimidines and their various derivatives have been well studied throughout the past 
century due to their diverse pharmacological properties. In self-assembly they offer 
great potential due to the presence o f heteroatoms acting as donors and acceptors for 
hydrogen bonding. Inspired by their presence in DNA base pairs, an interesting 
approach emerged in this work, which uses cytosine as starting point for the synthesis of 
a novel DDAA motif. Cytosine or 4-amino-1H  pyrimidin-2-one, was first reported in 
1894 when isolated from the calf thymus tissues, and its structure was confirmed in 
1903. Since then, an impressive number o f derivatives o f cytosine and cytidine have
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been synthesised for the use in recognition processes, the transfer o f genetic information
185and new therapeutic agents (Figure 121).
NHL
Cytosine
OH
HO OH 
Cytidine
NH,
Y H
O
Figure 121: Structure o f cytosine and cytidine
5.1.2 The DDAA Building Block
As illustrated in Figure 122, both cytosine and 2-amino-6-methyl-l//-pyrimidin-4-one 
display the same AAD m otif in their structures and the reaction o f these molecules with 
an isocyanate leads to the formation o f the AADD array. Interestingly, among the wide 
variety o f cytosine analogues encountered in the literature, very few examples have 
described the functionalisation o f the primary amine. This is not so surprising since the 
amine, a donating group for hydrogen bonding, often plays a major role within the 
recognition process.
4-amino-1H-pyrimidin-2-one 2-amino-6-methyl-1H-pyrimidin-4-one
(cytosine)
HN NH
R-NCO
H N ^ i  O
N
A
R-NCO
CH,
X  n h - o
H H
Figure 122: Two approaches to form a DDAA array
The functionalisation o f cytosine to give the DDAA array appears to be a 
straightforward strategy at first sight. However, in reality these heterocyclic compounds
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are often more complex due to the presence o f a variety o f tautomeric forms and 
conformers in solution and in the solid state which can obscure the formation of the 
linear DDAA array.
5.1.3 Tautomers
One o f the major drawbacks encountered in the design o f quadruple hydrogen bonded 
arrays based on heteroatoms is the presence o f several tautomeric forms. As previously 
described for the Upy systems, tautomeric species can affect dramatically the 
dimerisation process and are influenced by various factors such as polarity of the 
solvent, temperature or concentration. One o f the goals in the synthesis of new arrays is 
therefore to limit as much as possible their presence.
Pyrimidines in particular can adopt several tautomeric forms . 18 6 ,1 8 7 Cytosine has been 
shown to exist in six different tautomers (Figure 123) with Ci or C3 being the most 
predominant forms in solution.
C 1 2 C3 c4 cs c6
Figure 123: Structures o f the 6  tautomeric forms found in cytosine.
When cytosine is functionalised with an isocyanate at the primary amine, the number of 
tautomers decreases to three, labelled as 180a, 180b and 180c in Figure 124 (a). One is 
a [2]-keto form (180a) that can self-dimerise via a DDAA array while the second and 
third forms can only dimerise with their complimentary arrays such as ADAA and 
DAAA, respectively, for 180b and 180c. The presence o f the DADD array is an 
attractive feature since only few groups have reported its synthesis to date and it is 
unknown whether the DADD m otif will be favoured in solution in the presence o f its 
complimentary ADAA pair.
More interestingly, functionalisation at the N -l position with a substituent R2 , should 
result in the formation o f compound 181 existing exclusively as the AADD tautomer 
(Figure 124 (b)). The presence o f a single tautomeric form in solution increases
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significantly the potential o f this array for the use in supramolecular devices and may 
enhance dimerisation properties. The synthesis and characterisation of analogues of 180 
were therefore explored and are described in this chapter.
o
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Self-complimentarity only
Figure 124: (a) three tautomeric forms for compound 180, (b) formation of the self- 
complimentary DDAA array exclusively
In the first instance, conformational aspects o f molecule 181 were examined closely in 
order to assess their possible influence on the dimerisation process.
173
Chapter V
5.1.4 Conformers
Whilst the geometry o f the Upy unit is maintained through the formation of 
intramolecular hydrogen bonding between 1-H and 0-8 , there is a possibility o f rotation 
about the C-4-N-7 bond. A lack o f controlled geometry at the DDAA hydrogen bonding 
region could inevitably have serious consequences on the formation and strength of a 
new DDAA array.
The rigidity in the structure o f //-ace ty l cytidine has been previously studied.188,189,190 
They indicated that the N4-acetyl group should be proximal to C-5, therefore leading to 
a preference for conformer A. Indeed, the repulsive interactions between N-3 and 0-8 
found in conformer B are expected to destabilise the system, and consequently shift the 
equilibrium towards A (Figure 125).
o
182
(A)
O '  N
3
182' bo
(B)
NH
Figure 125: Two possible conformers for compound 182
Compound 181, which possesses a urea fragment at C-4 position can also exhibit the 
same type o f rotations, and as indicated above conformer A should be favoured over B. 
Interestingly, further rotations along the CO-NH bond lead to a conformer C (181') 
stabilised via the formation o f an intramolecular hydrogen bond between 9-H and N-3 
(Figure 126).
r2' n^  o
cA ^ % t r ' 0 r H 
H H
181 1 8 r  R 1
(A) (C)
Figure 126: Representation o f the unfolded (left) and folded (right) conformers o f 181
A similar type o f equilibrium between the two conformers (A) and (C) has been 
previously discussed for some pyridyl urea derivatives. Indeed, Zimmerman et a l  have
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reported the dimerisation o f a naphthyridinyl urea 183 with a ^dim value of 259 M 1
(Figure 127).191 This low value was attributed to various factors including the fact that 
the linear array 183 is in equilibrium with its conformer 183' which then needs to unfold 
in order to dimerise through a DDAA array. It was also found that 183' could dimerise 
via two hydrogen bonds to form the dimer (183M 83') in solution.
Figure 127: Representation o f conformers 183 and 183' and their dimerisation into 
183.183 and 183M 83', respectively
It was also shown that bis-ureido naphthyridines 184 exist exclusively in the folded 
conformer C (184') in the solid state and give oligomeric association (184,.184')n in the 
CDCI3 solution (Figure 128).
Pr 183.183 Pr
K
183’ 183'. 183'
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184
HU ^  <^ K ,H 
N N N N
0 A N-H H -N A 0
R
184'
184.184
— -O  N -H  H - N ^ O  — -H
Figure 128: Dimer o f 184 and oligomer o f 184'
More recently, Liming et al. have reported the same phenomenon for pyridyl and 
naphthapyridyl ureas such as compounds 185 and 186. In both cases a folded conformer 
(C) was observed in the crystal structure and in solution (Figure 129).106
o !
% ^ n^ nA n' Ri ^  % A n* V h
H H H H
186
N 'O  
186' R,
Figure 129: Conformers for compounds 185 and 186
In all the examples above, the presence o f the intramolecular hydrogen bond in the 
folded structure decreases the dimerisation constant o f the quadruple linear array due to 
the energy cost during the unfolding process. Preliminary calculations in the gas phase 
using the MMX force field showed that in the case o f monomeric cytosine 181 with R2 
= Ri = Me the folded conformer is more stable than the unfolded conformer by 
approximately 7 kJ/mol. Similar calculations o f the dimeric forms showed that the
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quadruple hydrogen bonded dimer o f the unfolded conformer is more stable than the 
double hydrogen bonded dimer of the folded conformer by approximately 14 kJ/mol. 
Calculated geometries o f the two dimeric forms are shown in Figure 130.
Figure 130: Calculated geometries o f dimers o f the folded (left) and unfolded (right) 
conformers. Hydrogen bonds are shown in yellow.
In summary, in the case o f compound 181, a derivative o f cytosine, the possibility of a 
folded conformer may interfere with the formation o f the linear DDAA array. 
Nevertheless, the synthesis o f  cytosine analogues was still explored, with the 
expectation that overall the quadruple hydrogen bonding o f the unfolded conformer may 
be more stable than the double hydrogen bonding o f the folded conformer.
5.2 Synthesis of Compound 181
Initially the synthesis o f compound 181, where R =  C6H 1 3 , was explored (Figure 131 
and Scheme 52).
o
X N.R
H R = C6H13 
181
Figure 131: Targeted compound
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189 181
Reagents and conditions : (a) Ac20 ,  pyridine, 125 °C, 2.5 h, 93%; (b) K2C 0 3, brom ohexane, DMF, 
reflux, 63%; (c) NH3/MeOH, 65%; (d) C6H13NCO, pyridine, 90 °C, 65%.
Scheme 52: Synthetic strategy towards compound 181
As outlined in Scheme 52, the primary amine o f cytosine was first protected using 
acetic anhydride in pyridine to give compound 187 in 93% yield . 192 Compound 187 was 
then reacted with bromohexane in DMF in the presence o f anhydride potassium 
carbonate giving 188 in a 63% isolated yield . 193 The use o f sodium hydride instead of 
potassium carbonate led to reduction in the yield to 20%. The substitution at N-l has 
been described for the synthesis o f cytidine analogues, and in many cases the yield can 
be quite low and is dependant on the solubility and reactivity of the electrophile . 194 
Compound 188 was then deprotected in a sealed tube containing a concentrated solution 
o f ammonia in methanol to give the amine 189 in 65% yield after purification . 195 
Reaction with hexyl isocyanate in dry pyridine at 90 °C for 16 h, followed by the 
addition o f hexane led to precipitation o f crude compound 181. Further purification 
using flash silica gel chromatography gave 181 as a white solid in 65% yield. Crystals 
of 181 were grown in order to ascertain the conformation adopted in the solid state.
5.3 Study of Compound 181 in the Solid State
Compound 181 was crystallised from chloroform as white needles. Single crystal X-ray 
analysis revealed a packed structure in the unit cell composed o f dimer layers, spaced 
from each other by approximately 3.1 A (distance between Z+l and Z0 planes, Figure 
132). See as well Appendix B for more details.
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Z +l
kzo
Z -l
Z-2
a) b)
Figure 132: a) packed structure in the unit cell, b) view along the x-axis
5.3.1 Dimer in the Plane ZO
This dimer coloured in red (Figure 132) is maintained through quadruple hydrogen 
bonding (Figure 133). The crystal structure clearly identified the formation of a linear 
DDAA m otif in the solid state, and no traces o f the folded conformer C (181’, Figure
134) was observed.
Figure 133: Quadruple hydrogen bonding (dotted lines) in the X-ray structure of dimer 
181.181
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0  181' (C)
181.181
Figure 134: Schematic representation o f dimer 181.181 found in the crystal and the 
folded conformer 181* absent in the crystal structure.
As observed in the Upy system, the dimer deviates slightly from linearity since the outer 
hydrogen bond N -H ...O  (1.857 A) is shorter than the inner one N-H...N  (2.258 A) 
(Table 32).
dimer D (d ) ,A e ,° u p y D (A ) e,°
N ...N  (N -H ...N ) 3.138 (2.258) 173.3 N ...N 2.966 175.0
N ...O  (N -H ...O ) 2.737(1.857) 167.7 N ...O 2.757 163.0
Table 32: Comparison o f the bond length and angles found in dimer 181.181 and in 
Upy
The bond lengths and angles found for 181 are similar to those reported for the Upy 
dimer. 111 However, the distance (N ...N ) is slightly longer in 181 which could influence 
the dimerisation constant.
Due to steric and crystal packing effects, the alkyl chains o f the unit are not parallel to 
each other. While the C 6 chain attached to the urea bond is in the plane o f the dimer 
unit, the Ce chain attached to N -l deviates from the plane by approximately 70° (Figure
135).
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Figure 135: Side view o f the 181.181 dimer highlighting the orientation of the alkyl 
side chains
Interestingly, the X-ray structure reveals that the side chain urea carbonyl bond and the 
C5-H bond directions are nearly in the same plane. The measured dihedral angle 
C8=O...H-C5 is ca. 13°. In principle, such geometry is in favour of a C -H ...0  type of 
hydrogen bonding (Figure 136).
Figure 136: The view of 181 highlighting the proximity o f 0-8  and 5-H. The indicated 
distance d  is 2.15 A
In general, since the electronegativity o f carbon is slightly greater than that of hydrogen, 
the C-H group may in principle act as a weak hydrogen bond donor, especially in the 
vicinity o f a strong acceptor. This was recognised in a review by Hunter in 1947 and 
later by Allerhand and Schleger (1963). Sutor surveyed the crystal structures in which 
the C ...O  separations are less than 3.3 A and suggested to view these as hydrogen 
bonded separations . 196 Despite scepticism in the early 1960s in response to Sutor’s 
proposition, the existence o f the C-H ...O  hydrogen bond is now well established. 
However, because this interaction is rather weak, a set o f geometrical requirements has 
been suggested for the identification o f the C -H ...O  hydrogen bonds. The typical
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convention for the representation o f the lengths (d  and D)  and angles (0 and (p) is shown 
below (Figure 137).197
D
Figure 137: Geometrical parameters for the characterisation of the C -H ...0  hydrogen 
bond
While evaluating individual hydrogen bonds, the preference is given to those contacts, 
which occur at short distances (2 . 0  A < d  < 2.3 A) and have nearly linear geometries 
(150° < 0 < 180°). However, it has been shown that 0 can be lower than 150°, but should 
be greater than 110° in order to be considered as a hydrogen bond. In general, D  values 
span the range o f 3.0 - 4.0 A.
For the dimer 181.181, the measurements give: d  = 2.154 A, D  = 2.773 A, 0  = 121.7°, cp 
= 103.2°. The measured distances are short, but due to the nature of the intramolecular 
geometry the angles deviate from linearity, however these are still in agreement with the 
geometric requirements for the C -H ...0  hydrogen bond definition. This data suggests 
that a weak C -H ...O  interaction is indeed present. In analogy with the N -H ...0  
intramolecular hydrogen bonding in 4-keto Upy’s (Chapter II), the C-H...O interaction 
may stabilise the unfolded conformation, hence assisting the formation of the DDAA 
type o f dimer.
5.3.1. 1  Study o f  the Crystal Packing
Assessment o f the crystal packing is useful for understanding the arrangement of 
molecules in the solid state and the non-covalent interactions that maintain the three
1 ORdimensional structure. Hence, the consideration o f the crystal structure is further 
extended to the Z +l plane (Figure 131).
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Plane Z + l
The plane Z+l gives information on the arrangement between the quadruple hydrogen 
bonded dimers. These units are repeated in layers separated by only 3.1 A. This 
suggested the presence o f intermolecular interactions between the dimer units. Figure 
138 shows the Z+l plane o f the packed structure in the unit cell where dotted lines 
indicate the quadruple hydrogen bonds when the structure is extended in the plane 
direction. A schematic representation of the two dimers is also drawn in Figure 138.
Intermolecular
forces?
\ \\ \\ \\ \ \
Figure 138: View o f two molecules o f 181 in the layer Z+l
The crystallographic data suggested a weak CH ...O  hydrogen bond may exist between 
0 - 8  and H-6 , since the measured distances and angles were: d  = 2.236 A, D  = 3.165 A, 
0 = 165.7°, cp = 162° for the C6 -H ...O =C 8 . The short distances combined with a linear 
geometry indicated that these weak hydrogen bonds could be significant for the 
organisation o f the crystal motif.
5.3.2 Interactions Between the Layers
In many examples, the arrangement o f a crystal into layers strongly suggests the 
presence o f interactions between them, such as 7i-stacking, especially when aromatic 
systems are present. The distance between two layers in the crystal structure of 
compound 181, is approximately 3.1 A, a short distance that is in favour of stacking 
interactions in the solid state (Figure 139).
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z+l
zo
Figure 139: Distances between two dimer layers
On a relevant note, d the effect o f 7c-stacking interactions on multiple hydrogen bond
199 *formation for dimers o f ureido-4[lH]-pyrimidinone (190) have been studied. This 
DDAA array is similar to compound 181 (Figure 140).
f^NH o
H H
o^ nA nA n r
1 9 0  Dimerisation
Figure 140: 7i-stacking between two Upy dimers
Results from DFT calculations revealed that 7t-stacking exists in such systems and even 
strengthens the hydrogen bonds in multiple hydrogen bonded dimers. 199 This 
observation has already been made in the DNA, where stacking interactions between 
adjacent base pairs provide additional stability for the helical structure. 2 0 0
To conclude, the presence o f a linear quadruple hydrogen bonded dimer has been 
revealed in the solid state. The layered arrangement o f these dimers suggests the 
formation o f additional non-covalent interactions such as stacking interactions as well 
as intra-and intermolecular C-H ...O  hydrogen bonds.
Although the X-ray crystallographic analysis is a valuable tool for the characterisation 
o f the supramolecular systems, the conformational and hydrogen bonding preferences in
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solution may be different from that in the solid state. One simple way of assessing the 
structure o f 181 (Figure 141) in solution is the direct comparison of 13C NMR chemical 
shifts measured in the CDCI3 solution with those measured in the solid state. Both 
solution and solid-state spectra showed very similar chemical shifts for the carbons of 
the cytosine moiety (Table 33), suggesting the existence of the DDAA dimer in CDCI3 .
16 6
7 9
Figure 141: Compound 181 with atom numbering
In particular, carbon C-2, which is in close proximity o f the quadruple hydrogen 
bonding system, has a distinctive chemical shift at 157.2 ppm in solution and 157.4 ppm 
in the solid state, in agreement with the DDAA dimer. The chemical shift for C-5 at 
97.25 ppm in solution and 96.3 ppm in the solid state suggests that the close proximity 
o f this carbon to the carbonyl group o f the urea is also retained in the CDCI3 solution. 
The full assignment o f the chemical shifts is included in the experimental part.
8 c/ppm C-2 C-4 C-5 C - 6 C - 8 C-10 C-16
CDCI3  (250 mM ) 157.2 164.9 97.3 146.6 154.3 40.1 50.7
Solid S tate 157.4 165.7 96.3 150.1 155.1 40.8 49.3
Table 33: Comparison o f 13C chemical shifts in CDCI3 and in the solid state
In addition, solid-state 15N NMR chemical shifts were also measured. Using 
assignments o f 15N  resonances for compound 114 (Chapter II), peaks of 181 at -280.9, 
-253.8, -223.9 and -163.8 ppm (relative to MeN 0 2 ) were assigned to N-9, N-7, N -l and 
N-3, respectively. This assignment was further confirmed by solution !H, 15N HMQC 
and HMBC NM R spectra o f 181 in the concentrated CDCI3 solution, in which three 15N 
peaks at -282.9 (N-9), -254.0 (N-7) and -225.8 (N -l) were detected.
When compound 181 is dissolved in a solvent o f relatively low polarity, such as 
deuterated chloroform, it is likely that the secondary interactions that persist in solution
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will be the strongest, in this case the quadruple hydrogen bonds. Weaker intermolecular 
close contacts within the crystal such as C -H ...0  and stacking interactions are likely to
found in the solid state, further NMR studies o f 181 suggested that this interaction is 
retained in the CDCI3 solution (see below).
ppm and 9.0 ppm, respectively. In the Upy dimer, 7-H and 9-H were shifted further 
downfield, resonating at 11.8 ppm and 10.1 ppm, respectively. Based on the well known 
correlation between the proton chemical shift and the strength of the hydrogen bonding, 
this comparison o f chemical shifts suggest that the strength of the hydrogen bonding 
may be weaker in the cytosine dimer compared to that in the Upy dimer. Interestingly, 
proton 5-H is strongly deshielded with a chemical shift at 7.54 ppm. By comparison, the 
chemical shift at 5-H in compound 186’ (Figure 142), which adopts a folded 
conformation, was found at 6.06 ppm indicating that proton 5-H is close to the carbonyl 
group in the predominant conformation o f 181 in CDCI3 and that the weak 
intramolecular C -H ...O  interaction identified in the solid state might persist in the 
CDCI3 solution.
be broken completely on dissolving. With regard to the intramolecular C -H ...0  bond
5.3.3 Proton NMR Chemical Shifts
The !H NM R spectrum shows the two hydrogen bonded protons 7-H and 9-H at 10.9
186' R
Figure 142: Compound 186* in its folded conformation
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Further examination o f the ]H NMR spectrum revealed the presence of broad lines of 
very small intensity at 9.63, 9.42 and 6.17 ppm as highlighted in Figure 143.
x64
H6
H7
H5
H9
12 11 10 9 8 7 6 ppm
Figure 143: (a) !H NMR spectrum o f the 200 mM solution o f 181 in CDCI3 at 298 K 
(b) The same spectrum with a 64-fold increase o f intensity
In order to establish the origin o f these peaks, a 30 mM solution of 181 in CDCI3 was 
studied at different temperatures, since the observed line broadenings at 298 K may be 
caused by an exchange process (Figure 144).
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Figure 144: Bottom: !H NMR spectrum o f the 30 mM solution of 181 in CDCI3 at 256 
K. Asterisks are used to mark the peaks due to the minor conformer 181*. Top: the same 
spectrum with an eight-fold increase o f intensity
At 256 K, the broad signals became much sharper and four distinct peaks at 9.55 ppm, 
9.72 ppm, 7.40 ppm and 6.14 ppm were observed. The observed temperature 
dependence o f  the line widths confirms that line broadenings at 298 K are caused by an 
exchange process. Furthermore, the observed set o f  small peaks suggested that another 
conformer may be present such as the folded rotamer 181’. Both the dimerisation and 
conformational equilibria involved are presented in Figure 145. The change of proton 
chemical shift o f 5-H from 7.54 ppm in 181 to 6.14 ppm in 181* is very specific in this 
regard since a significant low frequency shift is expected once the C5-H...CNC 8 
proximity is lost. The effect o f the carbonyl group has been attributed to the magnetic 
anisotropy o f  the carbonyl group, i.e., the local magnetic fields experienced by protons 
can be altered by the C = 0  magnetic dipole and the resulting chemical shift change is
dependent on whether the proton o f interest is within or outside the carbonyl shielding
201cone. However, in analogy with conventional O -H .. .X or N -H .. .X hydrogen bonding
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effects on the proton chemical shift, further high-frequency shift may be expected as a 
result o f the C -H .. .O hydrogen bonding.
Figure 145: Dimerisation and conformational equilibria o f cytosine 181 in CDCI3
Overall, the observed temperature dependence suggests that there is a chemical 
exchange process. In order to estimate the barrier o f the exchange process further 
variable temperature NMR spectra were recorded in CDCI3 (400 MHz). Due to the 
overlap o f the peaks and the very small content o f the minor form, the coalescence 
temperature was determined as the temperature at which the maximum intensity 
decrease o f the 5-H peak due to the major form (181.181 dimer) is observed (Figure 
146). The measured value was 320 K. Using the procedure described previsouly2 0 2  the 
values o f free energy o f activation (AG*) were calculated to be 67 and 60 kJ m o l1 for 
the 181.181-* 181’. 181’ and 181M 811 —> 181.181 transitions, respectively.
181.181
K
r
181'.18r
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T / K
330
326
323
320
315
310
305
300
8.2 8.0 7.8 7.6 7.4 7.2 7.0 6.8 6.6 6.4 6.2 6.0 5.8 ppm
Figure 146: Variable temperature NMR spectra o f  181 in CD CI3
To further investigate the observed exchange process, NOE measurements were 
undertaken in order to confirm its nature, as well as to detect other peaks due to the 
minor form.
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5.3.3.1 NOE measurments
NOE experiments were performed and a strong negative enhancement caused by an 
exchange process was observed between 7-H (the excited site) and the proton at 9.55 
ppm, corresponding to 7’-H in the folded structure 181’ (Figure 147).
The signal at 9.72 ppm was attributed to proton 9'-H, which is involved in 
intramolecular hydrogen bonding with N-3. A positive NOE effect was observed 
between 7-H and 9-H (Figure 147), which is expected for the linear arrangement of 
these protons in the unfolded conformer o f 181.
H 9
1 1 . 5 11.0 1 0 . 5 9 .01 0 . 0 9 .5 ppm
Figure 147: NOE (bottom) and !H NMR (top) spectra at 256 K
The NOESY spectrum was also recorded. The observed negative cross-peaks allowed 
an easy identification o f the peaks due to protons 5'-H, 7'-H and 9'-H of the folded 
form.
These experiments confirmed the presence o f the folded conformer 181' as the minor 
species in solution, and integration o f peaks suggested a population ratio of 19:1 in 
favour o f 181 at 256 K. The exchange rate between the two conformers was sufficiently 
slow in the NM R timescale at low temperatures, allowing observation of the two 
distinct species. The broad signal for 5-H at 298 K becomes sharper at 256 K as the 
exchange between 181 and 181' slows down on cooling. Back at room temperature the 
exchange rate became faster approaching the intermediate regime in the NMR timescale
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and hence leading to a broader signal for proton 5-H, which showed the largest 
chemical shift difference between 181 and 181' due to its proximity to the carbonyl 
group in 181 and the absence o f such in 181'. Note that the NMR timescale in these 
experiments is determined by the chemical shift difference for a given proton in 181 and 
181*.
In addition, a strong temperature dependence o f the chemical shift of 7-H was observed 
for 181': 8.84 ppm at 298K and 9.62 ppm at 256 K. This observation favours an 
increase o f the population o f the double hydrogen bonded dimer (Figure 148) on 
lowering the temperature.
Figure 148: Monomer/dimer equilibrium for 181'
The observed strong temperature dependence o f 7-H also suggests that the double 
hydrogen bonded dimerisation o f 181' is not strong. For a similar type o f dimerisation in 
CDCI3 , Corbin and Zimmerman have reported KAim values in the range of -  15-95 
M"1, suggesting that the double hydrogen-bonded dimerisation is relatively weak. 
Further evidence in favour o f the equilibrium shown in Figure 148 was obtained by 
diffusion coefficient measurements. The measured values for the 20 mM solution in 
CDCI3 at 256 K were 2.7 x 10" 10 m2/s for the fully dimerised 181 and 3.1 x 10' 10 m2/s 
for 181'. Since the “monomer/dimer” equilibrium is fast in the NMR timescale, the 
observed diffusion coefficient for 181' is the weighted average o f the diffusion 
coefficients observed for the monomer and for the dimer, hence, faster diffusion of 181' 
relative to 181 is observed.
Finally, in some o f the very dilute solutions o f 181 in CDCI3 (-0.5 mM) additional 
peaks at 14.5, 13.23 and 6.59 ppm were observed. Appearance of these peaks in CDCI3 
was attributed to the presence o f the residual water (-10  mM) in CDCI3 and the acidity 
o f the solvent may hydrolyse 181. A possible hydrolysis scheme o f 181 is shown in 
Figure 149):
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H N ^ 0  + OH
CfiHn  H J^ s6 13 N O
6^^ *13
Figure 149: Possible hydrolysis o f compound 181
5.3.3.2 !H  NMR in DMSO-d6
Compound 181 was dissolved in DMSO-<7<j and the !H and 13C spectra suggested that 
the folded molecule 181* was the only conformer present in solution. In particular, at 
298 K the chemical shift o f proton 5'-H at 6.15 ppm in the DMSO- ^ 6  solution was 
similar to that measured in the CDCI3 solution at 6.08 ppm (Figure 150).
H ' 5
1 0 . 0. 5 9 . 5 9 . 0 8 . 5 6 . 08 . 0 6 . 5 5.5 ppm7 . 5 7 . 0
Figure 150: NMR spectrum o f compound 181 in DMSO-ck
One issue to address was whether 181’ existed as a dimer or a monomer in such a polar 
solvent. For this purpose, dilution experiments were performed at 333 K (Table 34). No 
changes in chemical shifts were observed on dilution. In addition, no changes in the 
diffusion coefficients were found for 5 and 17 mM solutions. The measured values were 
within (5.0 ± 0.1) x 10' 10 m2/s at 333 K. These results indicated that compound 181' 
existed as a monomer in DMSO, which is not surprising since DMSO is not only a 
highly polar solvent, but also is a strong hydrogen bond acceptor. Therefore, weak 
hydrogen bonds o f the double hydrogen bonded dimer o f 181' are easily disrupted in 
DMSO. The relatively high chemical shift found for 7'-H can be attributed to a 
hydrogen bonding o f this proton with DMSO.
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Proton 8 h (ppm), 
S aturated  
solution
8 h (ppm), 
5 mM
5'-H 6 . 2 2 6 . 2 0
6 '-H 7.85 7.84
7'-H 9.55 9.53
9'-H 8.81 8.81
Table 34: Concentration dependence o f *H NMR chemical shifts in DMSO-<4 at 333K
The 13C spectrum in DMSO-g^ showed the chemical shifts o f C-l and C-5 at 153.4 ppm 
and 93.8 ppm, respectively, while in CDCI3 the corresponding signals for the unfolded 
form 181 were downfield at 157.2 ppm and 97.3 ppm. These results agreed further with 
the presence o f  conformer 181' in D M SO -^.
5.3.3.3 Temperature Dependence
Variable temperature studies in to luene-^  were performed to assess the strength o f the 
hydrogen bonding network (Table 35). Upon increasing the temperature from 298 K to 
353 K, protons 7-H and 9-H shifted towards lower frequencies by 0.33 ppm, which is 
normal for relatively strong hydrogen bonds. Indeed, for the Upy system, a decrease of 
0.2 ppm and 0.3 ppm was observed for 7-H and 9-H, respectively, on increasing 
temperature from 296 K to 363 K. A comparison o f these values suggested that the 
hydrogen bond N 7-H ...N  was weaker for compound 181. This was already apparent 
from the comparison o f the hydrogen bond lengths measured by X-ray.
The interpretation o f the shifts for protons 5-H and 6 -H is more complex, since 6 -H 
shows an increase o f chemical shift by 0.24 ppm on heating from 298 K to 353 K, while 
5-H shows a decrease o f chemical shift by 0.15 ppm. Moreover, the peak due to 5-H 
becomes broader on heating. Such behaviour o f both the chemical shift and the line 
width is similar to that observed in CDCI3 and agrees with the existence of the exchange 
process between 181.181 and 181'.181', although no 5-H peak due to the minor 
181M 81' was detected in to luene-^, presumably due to the overlap with the 6 -H peak 
o f 181.181 or much lower content o f the minor form in toluene compared to the CDCI3 
solution. The temperature dependence o f the 6 -H chemical shift is less clear. However,
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comparison with the value in CDCI3 at 298K suggests that solvation in toluene is such 
that proton 6 -H is within the shielding cone o f the toluene aromatic ring, possibly due to 
a specific solvent-solute interaction. On heating, the population o f solvated species are 
expected to decrease, leading to the observed high frequency shift at higher 
temperatures.
Temperature (K) 5-H 6-H 7-H 9-H
298 7.79 6 . 2 1 11.11 9.72
330 7.75 6.38 10.95 9.53
343 7.71 6.42 1 0 . 8 6 9.46
353 7.65 6.45 10.76 9.39
Table 35: Variation o f chemical shifts ( 5 h ,  ppm) in toluene-^ depending on 
temperature.
5.4 Dimerisation Studies by NMR
To estimate the dimerisation constant o f the DDAA array, dilution experiments were 
performed in CDCI3, which was dried over molecular sieves and de-acidified through 
basic alumina (Table 36).
C (mM) 5-H 7-H 9-H
250 7.54 10.91 8.98
200 7.55 10.91 8.98
170 7.53 10.90 8.96
51 7.55 10.92 8.98
0.51 7.53 10.92 9.00
Table 36: Chemical shifts o f 5-H and hydrogen bonded protons 7-H and 9-H as a 
function o f concentration in CDCI3 (298 K, 500 MHz)
There were no significant changes in the ]H NMR spectrum upon diluting the sample 
from 250 mM to 0.51 mM, suggesting that the dimerisation constant was above 3 x 105 
M '1. NM R dilution measurements were also carried out in C6 D6 . Due to the poor
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solubility in benzene the highest concentration used was 4 mM, which was then diluted 
to 0.73 and 0.008 mM (Table 37). Again no low frequency shifts of peaks were 
observed. Based on these measurements, the value o f K^m in benzene-^ was estimated 
as > 2 x io 7 M '1.
C (mM) 5-H 6-H 7-H 9-H
4.0 7.869 6.166 11.332 9.816
0.73 7.870 6.159 11.338 9.828
0.008 7.869 11.337 11.337 9.830
Table 37: Chemical shifts o f the high-frequency peaks in benzene-^ as a function of 
concentration (296 K, 400 MHz)
Further NMR measurements were also undertaken in order to assess ATdim for a double­
hydrogen bonded analogue o f 181. The particular focus here was to compare the 
association constants o f double and quadruple hydrogen bonded cytosine derivatives.
5.4.1 Synthesis of a Mimetic Dimeric Array
One approach considered was to synthesise compound 191 in which proton 9-H was 
replaced by a CH2 group. This would give an approximate value for dimerisation via 
two hydrogen bonds and allow assessing the significance o f two additional hydrogen 
bonds in the quadruple hydrogen bonded systems. Compound 192 was first synthesised 
through the reaction between hexanoic acid and A-hydroxysuccinimide in the presence 
of DCC in THF and was obtained in 80% yield after purification (Scheme 53).203 The 
synthesis o f 191 was then achieved through the reaction of 189 with the activated acid 
192 to afford 191 in 70% yield (Scheme 54).
80% 192
Scheme 53: Activation of hexanoic acid
196
Chapter V
n  *O N NH0
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O N NCHoCI
Scheme 54: Synthesis o f compound 191
In analogy with 181, the occurrence o f proton 5-H at 7.58 ppm was in favour of 
unfolded conformer as in 191.191 and a possibility o f an alternative dimer 191'. 191' 
involving folded conformers can be ruled out (Figure 151). No trace of the folded 
conformer 191' was detected in the *H NMR spectra, for which 5-H is expected to 
resonate at ca. 6.2 ppm. In terms o f structure, unlike 181', conformer 191' is not 
stabilised via intramolecular hydrogen bonding involving N-3, hence the observation of 
the predominantly unfolded conformer in the CDCI3 solution is not surprising.
Figure 151: Representation o f the dimers 191.191 and 191M91'
Dilution experiments were performed on this sample, and evaluation of the chemical 
shifts and diffusion coefficients at different concentrations agreed with the presence of 
dimers in solution (Table 38). The association decreased upon dilution from 190 mM to 
4.7 mM and the !H NMR signal shifted upfield from 9.77 ppm to 8.20 ppm. Such a 
strong dependence o f the chemical shift on concentration is typical for weakly hydrogen 
bonded dimers. More pronounced concentration-dependent chemical shift changes for 
7-H than for the other protons, suggests that dimerisation o f 191 occurs via hydrogen 
bonding o f proton 7-H, hence larger high-frequency shifts for this proton is observed 
when the concentration is increased.
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C oncentration,
mM
6(7-H),
ppm
D,
x 1 0 10 m2/s
190.0 9.766 6 . 6 6
182.5 9.724 6.70
159.4 9.617 6.90
128.7 9.476 7.13
92.5 9.249 7.50
58.3 9.007 7.75
28.8 8.700 8.03
15.3 8.423 8.30
6 . 8 8.206 8.64
4.7 8.199 8.90
Table 38: Diffusion coefficients and !H NMR chemical shift o f proton 7-H of 191 as a 
function o f concentration in CDCI3 solution at 298 K
The measured chemical shifts were plotted against the concentration o f 191, and the 
dimerisation constant K^xm was calculated using the non-linear least squares fitting. The 
estimated value o f K&m was found to be 4 ± 1 M ' 1 with the boundary chemical shift 
values o f 8.06 ± 0.03 ppm and 11.80 ± 0.20 ppm for the mono- and dimeric species. The 
dimerisation constant calculated from the diffusion coefficients was 3 ± 2 M ' 1 with 
boundary D  values o f (8.9 ± 1.1) x 10' 10 m2/s and (3.8 ± 1.0) x 10' 10 m2/s for the mono- 
and dimeric species. The vey low value of Xdim for 191 did not allow to draw any 
conclusive evidence regarding the importance o f the quadruple hydrogen bonding 
compared to the double hydrogen bonding. Other models need to be considered for this 
purpose.
5.4.2 Dimerisation Studies in Chloroform by Fluorescence 
Spectroscopy
In order to quantify the strength o f the dimerisation, compound 193 was synthesised and 
studied by fluorescence spectroscopy (Figure 152). Meijer and Zimmerman have 
previously used this technique in the determination o f ATdim- The excimer signal of the
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pyrene dimer exhibits an emission band at ca. 480 nm that is separate from that of the 
monomer at ca. 400 nm.
193
Figure 152: Targeted fluorescent molecule 
5.4.2.1 Synthesis o f  the pyrene derivative
Compound 194 was first synthesised via THP protection o f 6 -bromohexanol2 0 4  (Scheme 
55) . 2 0 5  Reaction o f N4-acetyl cytosine 187 with compound 194 was carried out using 
K 2 CO 3 in DMF affording 195 in 70% yield (Scheme 56).
DHP, PTS
CH2CI2 
85% 194
Scheme 55: Synthesis o f compound 194
Compound 195 was then deprotected using a concentrated solution of ammonia in 
methanol. The reaction was carried out using the same conditions as for compound 189 
previously described and gave 196 in 65% yield. Further reaction with hexyl isocyanate 
in dry pyridine at 90 °C afforded an intermediate, which was not purified. Deprotection 
o f the THP group under acidic conditions then gave 197 in 30% yield after flash column 
chromatography. The low yield was attributed to the very poor solubility o f 197 in 
organic solvents, which caused partial loss o f the product during the work up and the 
purification step (Scheme 56).
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80%, 30%
O
O ^ N  N ^ N ' 0 ^ 13 
H H
197
R eag en ts  a n d  co n d itio n s :(a ) Compound 194, K2C 0 3, DMF, 70%; (b) NH3/MeOH, 65%; (c) C6H13NCO, Pyridine, 
90 °C, 80% ;(d) HCI conc., MeOH, THF, 30%.
Scheme 56: Synthetic strategy towards the formation o f compound 197
The final step consisted in the reaction between 197 and an activated pyrene unit. Two 
different methods o f activation o f the pyrene were explored as acyl chloride 198 or as 
N-hydroxysuccinamide group 199 (Scheme 57).206
Scheme 57: Reaction o f compound 197 with two activated pyrene derivatives
Mainly due to insolubility problems with 197 in solvents such as CH2 CI2 or THF, 
neither reaction with the activated acids gave the desired compound 193. Therefore, a 
second strategy involving the direct reaction o f 197 with pyrene acid 200 in the 
presence o f DCC was then investigated. This method, which is frequently used to form 
ester bonds, was not considered at first due to insolubility o f both compounds in organic 
solvents. Nevertheless, after optimisation o f the reaction conditions, DCC and HOBt
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112were used in CH 2 CI2 first at 0 °C for 1 h, then at room temperature for 16 h. The 
desired compound 193 was isolated in 25% yield and was then used in fluorescence 
studies.
DCC/HOBt
Scheme 58: Coupling reaction between compounds 200 and 197
5.4.3 Fluorescence Measurements
Fluorescence spectroscopic studies were carried out in chloroform (with amylene 
stabiliser) dried over molecular sieves, and de-acidified through neutral alumina.
The emission fluorescence was measured on a series o f diluted samples. As shown in 
Graph 2, the concentrated sample (16.4 mM) showed a strong emission band 
characteristic o f the excimer band o f the pyrene between 450-500 nm, suggesting the 
dimerisation o f the molecule (Graph 2). Upon dilution to 0.0328 mM, the bands o f the 
monomer emission gradually increased as the excimer emission band decreased in 
intensity (Graph 3).
Emission for a 16.4 mM solution
500000
400000
=  300000
«  200000
100000
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nm
G raph  2: Emission for a 16.4 mM solution o f 193
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Fluorescence em ission
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G raph  3: Emission bands for diluted samples o f 193
The procedure described previsouly207 was used for the determination of A^ im- In 
particular, the following equation was used for non-linear least square curve fitting :
r = C (1 -  (8 Kdim [Pyr] + 1)1/2) / 4
where r is the integral intensity ratio o f the excimer emission (I2 ) and the monomer 
emission (Ij) at 476 and 376 nm respectively. C is a constant and [Pyr] is the total 
concentration o f the pyrene labelled compound 193. This equation is derived on the 
assumption that ^ dim=[Pyrdim]/[Pyrmono]2 and [Pyr]=2[Pyrdim]+[Pyrm0no]. In addition, it is 
also assumed that the emission intensities I\ and h  are proportional to the concentration 
o f monomeric ([Pyrmono]) and dimeric ([Pyrdim]) forms, respectively.
6
4
2
0
0 0.002 0.004 0.006 0.008 0.01 0.012 0.014 0.016 0.018
[Py], mol/L
G raph  4: The ratio o f the intensities h  / 1\ as a function o f the concentration
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From these calculations, the value o f was found to be rather low with a large error 
margin: 365 ± 1 7 8  M"1. This result did not correlate with the !H NMR chemical shift 
measurements, according to which the value o f A^m is higher than 105 M"1. Although 
the fluorescence emission shows the excimer band which is in favour of dimerisation in 
solution, the determination of the dimerisation constant could not be established with 
reliable accuracy, and this left some doubts concerning the strength of the DDAA array. 
It is possible that the minor double-hydrogen bonded species 181' influence the pyrene- 
pyrene stacking and decrease the value o f Xdim. Other factors, such as overlap of the 
excimer and monomer bands, further limit the accuracy of the K&xm measurements. 
Another simple reason could be that the hydrolysis o f 181 at very low concentrations 
(see above) is possible. Although dried chloroform was used, the measurements were 
nevertheless carried out under normal atmospheric conditions.
Conclusions
The linear quadruple hydrogen bonded array DDAA (181.181) found in the solid state 
by X-ray diffraction was also observed in the CDCI3 solution. In addition, the 
population o f the other folded conformer 181' was approximately 5% in the CDCI3 
solution. NMR dilution experiments suggest that the dimerisation constant is higher 
than 3 x 105 M " 1 in CDCI3 and 2 x 107 M ' 1 in C6 D6 since no changes o f chemical shifts 
were observed down to 0.6 mM. In DMSO, however, the dimer breaks exclusively into 
the folded monomer 181'.
One o f the next challenges was to use this new DDAA array in the design and synthesis 
o f new new hydrogen bonded materials, as well its binding to other DDAA modules, 
such as 4-keto tautomer o f Upy.
5.5 Complexation with Ureidopyrimidinone
Ureidopyrimidinones have been used in numerous applications though mainly in the 
synthesis o f supramolecular polymers. Recently, the synthesis of copolymers 
incorporating Upy units has shown some significant potential for the design of new 
materials. Li et al. have reported the strong and selective complexation o f the 6 -[lH] 
pyrimidinone tautomeric form of 114 with 2,7 diam ido-l,8 -naphthyridines (Napy) (201) 
via the complexation between ADDA and DAAD arrays2 0 8 ,2 0 9  (Figure 153).
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Figure 153: Complexation of Upy unit with a DAAD array (201)
The use o f 1 equivalent o f Napy in CDCI3 disrupted the formation of the Upy dimer 
114.114 and the use o f Upy-Napy heterodimers appears attractive for the synthesis of 
complamentary copolymers. Note that the Upy unit undergoes a 4-keto-to-6-keto 
tautomeric transformation on binding with Napy.
Following a similar approach, the disruption o f the Upy dimer 114.114 was explored 
with the addition o f compound 181 in solution. A solution of a 1:1 mixture of 
compound 181 and 114 (Upy) in CDCI3 was then prepared and the resulting solution 
was studied using ]H NMR spectroscopy (Figure 154).
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Figure 154: Complexation between Upy 114 and compound 181 in a 1:1 ratio
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The !H NMR spectrum (at 298 and 283 K) revealed a set o f broad peaks. In order to 
obtain a better resolution for assignment, a *H NMR spectrum was run at 256 K (Figure 
155). As expected all the peaks became sharper and 10 different hydrogen bonded 
protons were identified.
283K
201.201
25 6K
114.114 181.114
114.114
114.18] 181.114
114.181 114.181181.181
181.181
6 ppm13 12 8 711 10 9
Figure 155: *H NMR spectra o f a 1:1 mixture o f 181 and 201 at 283 K and 256 K
The assignment o f these peaks was straightforward since the chemical shifts for the 
hydrogen bonded protons found in the homodimers 114.114 and 181.181 have been 
already established. Therefore, the new peaks at 13.0 ppm, 11.40 ppm, 9.78 ppm, 11.16 
ppm and 9.78 ppm were attributed to the heterodimer. A summary of the chemical shifts 
for 1-H, 7-H and 9-H is included in Table 39. For the equimolar solution of 114 and 
181, the ratio 114.114:181.181:114.181 was approximately 5:5:6.
205
Chapter V
dimer 1-H 7-H 9-H
114.114 13.16 11.88 10.24
114.181 (114) 13.03 11.42 9.80
181.181 - 11.09 9.04
114.181 (181) - 11.18 9.58
Table 39: Proton chemical shifts ( 5 h ,  ppm) for the hydrogen bonded protons found in 
the homodimers and heterodimer.
In summary, the new DDAA array based on cytosine partially disrupts the strong Upy- 
Upy dimer and this result may be of critical importance for the synthesis of new co­
polymers.
5.6 Synthesis of supramolecular incorporating the cytosine 
module
To further evaluate the ability o f the new module to polymerise via intermolecular 
quadruple hydrogen bonds, a bifunctional derivative 202 was synthesised (Figure 156). 
A structurally similar UPy derivative 203 was also made for comparison (Figure 157). 
In analogy with other UPy derivatives, 203 is expected to form mainly cyclic dimers at 
millimolar concentrations, with an equilibrium between cyclic dimers and higher 
molecular weight species on increasing the concentration. For a straightforward 
synthesis, an amine terminated polyethyleneglycol (~ 3400 g mol’1) was reacted with 
the corresponding imidazole (131) activated units to prepare 202 and 203.
202
Figure 156: Synthesis of polymer 202
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n h  o
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H H 0  HN
Figure 157: Polymer 203 synthesised using the same procedure as for 202
Both materials are solids with close melting points (46 °C and 43 °C for 202 and 203, 
respectively). Proton NMR analysis o f 202 revealed the presence o f the two hydrogen 
bonded protons (at 10.7 and 9.2 ppm) as found in dimer 181.181 suggesting that the 
linear DDAA array was preserved. Diffusion coefficient (D) measurements in the 6.5 
mM CDCI3 solutions were undertaken in order to compare the degree of self-association 
o f 202 and 203. The measured values were 7.0 x 10'11 m2 s ' 1 for 202 and 1.11 x 10'10 m 2 
s" 1 for 203. Both the lH spectra and the high diffusion rates are therefore consistent with 
the presence o f presumably cyclic oligomers o f 202 and 203 in dilute chloroform 
solutions. As expected, further polymerisation occurred on increasing the concentration 
and this was confirmed by a considerable slow down of diffusion in 37 mM solutions: 
1.9 x 1 0 11 mV1 for 2 0 2  and 4.4 x 10'11 m 2 s" 1 for 203. This and other similarities o f 
bifunctional derivatives suggested that a new cytosine module could be used 
successfully for the generation o f new supramolecular materials. Further investigations 
are currently underway aimed at preparation o f linear polymers and cyclic dimers based 
on the cytosine module.
207
Chapter VI
Chapter VI
208
Chapter VI
6 Experimental Part 
6.1 Materials and reagents
Unless otherwise specified, all regeants, were purchased from commercial suppliers and 
used without further purification. Acetonitrile was distilled over phosphorous pentoxide. 
THF was distilled over sodium and benzophenone. Triethylamine and dichloromethane 
were distilled over calcium hydride. Chloroform was dried over molecular sieves (4 A). 
Hexane is described as a fraction boiling between 67-70 °C. Water used in reactions and 
for washings was deionised water. All reactions using anhydrous solvents were carried 
out under a nitrogen atmosphere.
Melting points were determined using a Gallenkamp melting point apparatus and are 
uncorrected.
DSC were measured on a V2.4F TA instrument.
Infra-red (I.R) spectra were recorded on a FT-IR Shimidasu 8700 spectrophotometer. IR 
spectra were obtained either using a neat film on KBr discs for liquid compounds or 
KBr pellets for solids.
Solution 1H, 13C and 15N spectra were recorded on Bruker NMR spectrometers 
AMX300, AMX400 and AVANCE500 spectrometer. Data acquisition and processing 
was performed using standard Bruker XwinNMR software (version 2.6). !H and 13C 
chemical shifts are given relative to TMS and 15N chemical shifts are given relative to 
MeNC>2 .. Coupling constants J  were measured in Hertz (Hz). Multiplicities for 1H are 
shown as a s (singlet), d (doublet), t (triplet), dd (doublet o f doublets), dt (doublet of 
triplets), m (complex multiplet). Variable temperature NMR measurements were carried 
out using either AMX400 or AVANCE500 spectrometers. Deuterated solvents were 
used as received unless specified.
Solid-state 13C and 15N spectra were recorded at 75.5 MHz and 30.1 MHz, respectively, 
using a standard 7 mm double-resonance magic-angle spinning (MAS) probe on 
MSL300 (Bruker).
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Mass spectra (El, FAB) were recorded using the spectrometer UG70FE. Electrospray 
(ES+) were performed on a Micromass Quattro LC electrospray (MassLynx software). 
High resolution mass spectra (HRMS) were recorded on a MAT 900 XP.
Microanalysis were determined, where possible, using a Perkin Elmer 2400 Elemental 
Analyser (CHN). However, for the majority o f the compounds, the purity was 
determined by accurate mass NMR spectroscopy analysis.
Optical Rotations were recorded on Optical Activity: PolAAR2000 polarimeter, with 
concentration (c.) in g/ 1 0 0  ml.
Fluorescence measurements were performed on a FluoroMax3. The excited wavelength 
was fixed at 341 nm.
Flash Silica Chromatography was performed using silica gel for flash chromatography 
Si60, purchased from Merck Ltd.
TLC were performed using TLC aluminium sheets, silica gel 60 F2 5 4  purchased from 
Merck Ltd., and were visualised using UV (254 nm), Phosphomolybdic acid hydrate 
(PMA 12 g, ethanol 250 ml, conc. Sulphuric acid) and potassium permanganate (6.25 g 
sodium bicarbonate in 125 ml water, 1.25 g potassium permanganate in 125 ml water) 
and Ninhydrin (100 ml ethanol, 0.2 g ninhydrin, 4.5 ml water, 0.5 ml acetic acid).
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6.2 Ureidopyrimidinone Derivatives
2-Amino-6-(4-nitro-phenyl)-lH-pyrimidin-4-one (110)111
n o 2
17
< ^ N H i
Guanidine carbonate (2.43 g, 13.50 mmol) and /?-nitrobenzoylacetate (5.93 g, 25.0 
mmol) were dissolved in absolute ethanol (25 ml) and heated at reflux for 18 h. The 
brown solid formed was then filtered off and washed thoroughly with cold acetone ( 2 0  
ml), water (20 ml) and finally cold ethanol (20 ml). The solid was then triturated from a 
mixture o f water/ethanol (1:1) to afford compound 110 as yellow micro-needles (0.95 g, 
30%).
mp > 300 °C (ethanol);
Vmax /cm -1 (KBr pellets) 3500 (N-H, s, NH2), 3379 (N-H, s, NH2), 3089 (C=C-H, s);
'H NMR (300 MHz; DMSO-rf*) 5 10.96 (1H, s, NH), 8.29 (2H, d, J  8.9 Hz, 9-H), 8.18 
(2H, d, J 8 .9  Hz, 8 -H), 6.70 (2H, broad s, NH2), 6.27 (1H, s, 5-H);
I3C NMR (75 MHz; DMSO-rfd) 6  163.0 (C=0), 160.2 (C-2), 155.9 (C-6 ), 148.1 (C- 
1 0 ), 143.5 (C-7), 127.8 (C-8 ), 123.4 (C-9), 99.5 (C-5); 
mlz (ES+) 233 [(MH+), 25%], 136 [(MH+- 97), 100%];
HRMS calculated for C 1 0H 8N 4 O3 (MNa+) 255.04945, found 255.04944.
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iV-Hexyl-iV“(l,4-dihydro-4-oxo-6-/j-nitrophenyl-2-pyrimidinyl)-iirea
A suspension o f 6 -(p-nitrophenyl)isocytosine 110 (0.840 g, 3.62 mmol) and hexyl 
isocyanate (1.01 g, 7.90 mmol) in dry pyridine (15 ml) was heated at reflux for 4 h. 
After cooling, acetone (10 ml) was added and the product was collected by filtration to 
give 111 (1.16 g, 8 8 %).
mp > 300 °C (pyridine);
vmax /cm ' 1 (KBr pellets) (enol tautomer C) 3495 (O-H, 5) ,  3386 (N-H, s ) ,  3134 (C=C-
H, s), 3075-2932 (C-H, s), 1660 (C=0, s);
*H NMR (500 MHz; DMSO-rf6) (6 [lHl-pyrimidinone tautomer A) 5 12.05 (1H, s, 3- 
H), 10.04 (1H, s, 7-H), 8.31 (2H, d, J 8 . 8  Hz, 18-H), 8.21 (2H, d, J 8 . 8  Hz, 17-H), 7.38 
(1H, s, 9-H), 6 . 6 6  (1H, s, 5-H), 3.16 (2H, m, CONHCtf2), 1.47 (2H, m, NHCH2 C //2),
I.28 (2H, m, NH(CH 2 )2 C //2)), 1.27 (4H, m, NH(CH 2 )3 Ctf2 C tf2), 0.85 (3H, t, J 6 .2  Hz, 
CH3);
13C NMR (125 MHz; DMSO-rf*) 8  161.9 (C-4), 159.1 (NHCONH), 152.3 (C-2), 148.3 
(C-19), 142.5 (C-16), 127.9 (C-17), 123.6 (C-18), 104.0 (C-5), 39.0 (CONHCH2), 30.8 
(NH(CH 2 )3 CH2), 29.0 (NHCH2 CH2), 25.8 (NH(CH2)2 CH2), 21.9 (NH(CH2)4 CH2), 13.7 
(CH3);
,5N NMR (51 MHz, DMSO-rfd) 8  -182.3 (N -l), -223.5 (N-3), -285.6 (N-9);
13C CPMAS NM R (75 MHZ) (pyrimidin-4-ol tautomer C) 8  172.5 (C-4), 160.5 (C- 
6 ), 157.0 (br, C-2), 156.0 (br, NHCONH), 146.3 (C-19), 139.5 (C-16), 126.0 (C-17),
124.5 (C-18), 42.0 (br, CONHCH2), 16.1 (CH3);
(111)
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15N CPMAS NMR (30 MHZ) 6  -167.7 (N-5), -257.5 (N-7), -275.6 (N-9), -14.8 (N 02); 
m/z (ES+) 383.03 [(MNa+), 50%];
HRM S calculated for C |7H 2 i0 4 N 5 (MNa+) 382.14912, found 382.13981;
Elemental analysis calculated for C 17H2 1 O4N 5  C, 56.82%; H, 5.89%; N, 19.49%; found 
C, 55.88%; H, 5.80%; N, 19.08%.
7V-Hexyl-iV-(l,4-dihydro-4-oxo-6-p-aimnophenyl-2-pyriinidmyl)-urea
(112)
NH O
n h 2
HO
B C
in chloroform in DMSO and solid sta te
Tin (II) chloride (1.88 g, 8.30 mmol) was added to a solution o f 111 (0.50 g, 1.39 
mmol) in conc. HC1 (15 ml) and absolute ethanol (7 ml). After stirring the mixture at r.t. 
for 15 min, the solution was heated at reflux for 1 h. When cooled down to r.t. The 
product precipitated out o f solution. The product was collected by filtration and washed 
with (5 N) NaOH (5 ml) and water (5 ml) to give 112 as a yellow solid (0.25 g, 55%).
mp > 300 °C (Methanol);
vmas /cm ' 1 (K B r pellets) 3340 & 3320 (N-H, NH2, s), 1677 (C=0, s);
'H NMR (500 MHz; CDCI,; 328K) (4-keto tautomer B) 5 13.72 (1H, s, 1-H), 12.00 
(1H, s, CH2NHCONH), 10.17 (1H, s, CH 2N//CONH), 7.49 (2H, d, / 8 .4  Hz, 17-H), 
6.75 (2H, d, J  8.4 Hz, 18-H), 6.22 (1H, s, 5-H), 4.00 (2H, broad s, NH2), 3.30 (2H, 
broad q, CH 2 NHCONH), 1.66 (2H, m, CH2 CH2NHCONH), 0.90 (3H, t, J  7.1 Hz, CH3); 
'H NMR (500 MHz; DMSO-rfa) (pyrimidin-4-ol tautomer C) 6  10.13 (1H, s, 
NHCON//CH 2 ), 8.01 (1H, s, NHCONHCH2), 7.51 (2H, d, J  8.4 Hz, 17-H), 6.57 (2H, d, 
J  8.4 Hz, 18-H), 5.87 (1H, s, 5-H), 5.34 (2H, s, NH2), 3.20 (2H, m, NHCONHCH2),
1.51 (2H, m, NHCONHCH2CH2 ), 1.35 (2H, m, NH(CH2)2 C7/2), 1.28 (4H, m, 
NH(CH 2 )3C7/2 C7/2), 0.85 (3H, m, CH3);
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13C NMR (125 MHz; DMSO-</6) 5 174.5 (C-4), 159.5 (C-6 ), 158.5 (C-2), 155.4 
(NHCONH), 149.7 (C-19), 126.9 (C-17), 125.8 (C-16), 113.3 (C-18), 98.6 (C-5), 38.8 
(NHCONHCH2), 31.1 (NH (CH2)3 CH2)), 29.6 (NHCH2 CH2), 26.3 (NH(CH2)2 CH2),
22.1 (NH(CH 2 )4 CH2), 13.9 (CH3);
1SN (500 MHz; DMSO-rf*) 6  -186.5 (N -l), -286.0 (N-9), -319.7 (NH2)
13C CPMAS NMR (75 MHZ) 6  176.4 (C-4), 159.3 (C-6 ), 157.2 (NHCONH), 146.5 
(C-4’), 130.0 (C - r ) ,  129.0 (C-2’), 115.0 (C-3’), 98.5 (C-5), 41.7 (CONHCH2), 33.1 
(NH(CH2 )3 CH2), 28.0 (NHCH2 CH2), 24.5 (NH(CH2 )2 CH2), 23.9 (NH(CH2 )4 CH2), 16.0 
(CH3);
1SN CPMAS NMR (30 MHZ) 6  -164.6 (N-3), -178.3 (N-l), -260.3 (N-7), -280.5 (N-9), 
-324.0 (NH2);
mJz (ES+) 352 [(MNa+), 100%];
HRMS calculated for Ci7H 2 4 0 2N 5 (MH+) 330.19299, found 330.19288.
l-{6-[4-(4-Dimethylamino-phenylazo)-phenyl]-4-oxo-l,4-dihydro- 
pyrimidin-2-yl}-3-hexyl-urea (113)
The amino compound 112 (0.10 g, 0.30 mmol) was dissolved in a mixture o f acetic acid 
(2 ml) and conc. HC1 (0.7 ml). The solution was then cooled to 5 °C. To this solution 
was added sodium nitrite (0.03 g, 0.03 mmol) in water (0.6 ml) at 0 °C, resulting in the 
formation o f  a yellow solution. The reaction was stirred for 15 min at 0 °C. A solution 
o f AyV-dimethylaniline (0.036 g, 0.30 mol) in acetic acid (0.1 ml) at 0 °C was then 
added resulting in the formation o f a red solution. The mixture was stirred for 30 min at 
r.t. A saturated sodium acetate solution was then added to the mixture in order to
\  /  
N
N
N
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increase the pH close to 6 , resulting in the precipitation o f the azo compound. 
Recrystallisation from methanol afforded 113 (0.030 g, 20%).
'H NMR (400 MHz; DMSO-</«) (pyrimidin-4-ol tautomer C) 8  10.21 (1H, s, 
NtfCONHCH2), 7.96 (2H, d, J  7.9 Hz, 17-H), 7.80 (2H, d J9 .1  Hz, 21-H), 7.78 (2H, d, 
J  7.9 Hz, 18-H), 6.83 (2H, d, J  9.1 Hz, 22-H), 6.04 (1H, s, 5 -H), 3.18 (2H, m, 
N H C ftC H j), 3.06 (6 H, s, N CH3\  1.51 (2H, m, NHCH2C ft) , 1.34 (2H, m, 
NH(CH 2 )2 C7/2), 1.26 (4H, m, NH(CH2 );sCtf2C //2), 0.82 (3H, m, CH2CH,);
13C NMR (100 MHz; DMSO-rf*) 8  175.5 (C-4), 159.5 (C-6 ), 158.7 (C-2), 155.8 
(NHCONH), 153.0, 152.97, 143.1, 140.1, 127.1, 125.1, 122.2, 112.0, 102.0 (C-5), 39.0 
(NHCH2), 30.0, 26.7, 22.4, 14.2 (CH2 CH3); 
m/z (ES+) 461 [(MH*), 30%], 484 [(MNa+), 100%];
HRMS calculated for C 2 5H 3 ,0 2N7 (MNa+) 484.24368, found 484.17341.
;V-Hexyl-;V-(1,4-dihydro-4-oxo-6-methyl-2-pyrimidinyl)-urea (114)
c h 3
i^ N H  O
O ^ N ^ - N ^ N ' 
H H
A suspension o f 6-methyl-4-hydroxyl-2-amino pyrimidinone (0.50g, 4.0 mmol) and 
hexyl isocyanate (0.76 g, 6.0 mmol) in dry pyridine (15 ml) was heated at reflux for 16 
h. After cooling, the addition o f hexane resulted in the precipitation of the product, 
which was isolated and washed with hexane to give 114 (0.826 g, 82%).
mp: 184-185 °C (Hexane);
vmax / cm’1 (KBr pellets) 3338 (N-H, s), 3213 (N-H, s), 3100 (C O -H , s), 2952 (C-H, 
s), 2860 (C-H, s), 1706 ( C O , s), 1664 ( C O , s), 1581 (C O , s);
NMR (500 MHz; CDC13) (4[lH]-pyrimidinone tautomer B) 5 13.13 (1H, s, 1-H),
11.85 (1H, s, N //CONHCH2), 10.14 (1H, broad t, NHCON//CH2), 5.81 (1H, s, 5-H), 
3.23 (2H, m, CONHCtf2), 2.22 (3H, s, CH3), 1.59 (2H, m, NHCH2 C //2), 1.32 (2H, m, 
NH(CH 2 )2 C/72), 1.30 (4H, m, CH2CH2CH3), 0.87 (3H, t, J 6 . 2  Hz, CH2CH3);
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13C N M R (125 M Hz; CDCfe) 173.0 (C-4), 156.5 (NHCONH), 154.7 (C-2), 148.1 (C- 
6 ), 106.6 (C-5), 40.0 (CONHCH2), 31.5 (NH(CH2 )3 CH2), 29.5 (NHCH2 CH2), 26.6 
(NH(CH 2 )2 CH2), 22.5 (NH(CH2 )4 CH2), 18.9 (CHj), 14.0 (CH2 CH3); 
m!z (ES+) 253 [(MH+), 45%], 275 [(MNa+), 100%];
H RM S calculated for Ci2 H2 i0 2N4 (MNa+) 275.14785, found 275.14704.
Methanesulfonic acid 2-[2-(2-methoxy-ethoxy)-ethoxy]-ethyl ester 
(116)148
c h 3
M e O ^ " ^  ' S ' q
O
To a cooled solution o f methyltriethylene glycole (0.98 g, 6.0 mmol) and triethylamine 
(1.87 ml, 13.38 mmol) in CH2 CI2 (10 ml) was added dropwise at 0 °C, a solution of 
methanesulfonylchloride (0.93 ml, 1 2 . 0  mmol) in CH2 CI2  (5 ml). After addition, the 
reaction mixture was stirred at r.t. until completion o f the reaction. Dichloromethane (20 
ml) was then added to the solution and the mixture was washed with saturated solution 
o f NaHCC>3 (2 x 30 ml) and a saturated sodium chloride solution (2 x 30 ml). The 
organic phases were combined together and dried (MgSC>4 ). The solvent was evaporated 
in vacuo and water was removed via azeotropic distillation with toluene to afford 116 as 
an oil (1.24 g, 85%), which was used directly in the next step without further 
purification.
‘H NM R (300 M Hz; CDCI3) 5 4.32 (2H, m, CH 2 O S 02), 3.73 (2H, m, CH2OMe), 3.62 
(6 H, m, CH 2 0 ) , 3.57 (2H, m, C //2 CH2 0 S 0 2), 3.49 (3H, s, CH3 S 0 2), 3.03 (3H, s, 
OCHj);
l-[2-(2-Azido-ethoxy)-ethoxy]-2-methoxy-ethane (117)149
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To a solution o f 116 (3.82 g, 15.70 mmol) in anhydrous DMF (45 ml) was added 
sodium azide (6.15 g, 94.7 mmol). The mixture was stirred at r.t. until completion of the 
reaction. After 5 days, the solvent was evaporated and washed with water (20 ml) then 
with a saturated solution of sodium chloride (20 ml). The organic phase was dried 
(MgSCT*) and the solvent evaporated. Compound 117 was obtained as an oil (2.31 g, 
78%).
Vmax/cm"1 (KBr film) 2160 (N=N=N, s);
*H N M R (300 M Hz; CDC13) 6 3.64-5.59 (8H, m, CH20 ), 3.52 (2H, m, CH2OMe), 
3.33-3.35 (5H, m, CH3, CH2N3);
13C N M R (75 M Hz; CDC13) 5  71.9 (CH20 ), 70.7 (2 x CH20), 70.6 (CH20), 69.9 
(CH20 ), 58.9 (CH20 ), 50.7(CH2N3);
HRM S calculated for C7H 150 3N3 (MNa+) 212.10056, found 212.10071.
2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethylamine (115)151
M eO'
Compound 117 (2.3 lg, 12.2 mmol) was hydrogenated over Pd/C (10% w/w) in ethanol 
(45 ml) at r.t. under 1 atm. The reaction was monitored by TLC and after two days the 
reaction was completed. The catalyst was filtered off through celite and the solvent was 
evaporated to afford compound 115 as an oil (1.86 g, 93%).
Vmax/cm"1 (KBr film): 3400 (N-H, NH2, 5 ), 2877 (C-H, s), 1103 (C-O, s);
‘H N M R (300 M H z; CDCI3) 5 3.55-3.60 (6H, m, CH2CH2NH2, 2 x CH20), 3.45 (4H, 
m, CH20 ) , 3.28 (3H, s, OMe), 2.75 (2H, t, 7  5.2 Hz, C //2NH2), 2.27 (2H, s, NH2);
13C N M R (75 M Hz; CDCI3) 8 73.0 (CH20 ), 71.8 (CH20 ), 70.5 (CH20 ), 70.4 (CH20),
70.2 (CH20 ) , 58.8 (OCH3), 41.5 (CH2NH2);
mlz (ES+) 164 [(MH+), 100%], 186 [(MNa+), 20%];
HRM S calculated for C7H 170 3N (MH+) 164.12812, found 164.12794.
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2-[2-(2-Methoxy-ethoxy) ethoxy]-ethanoic acid (119)155
O
2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethanol (2.0 g, 12.1 mmol), KOH (1.36 g, 24.3 
mmol) and KM n0 4  (3.84 g, 24.3 mmol) were mixed together in water (100 ml) and 
stirred at r.t. for 18 h. The reaction mixture was then filtered and the distillat was 
acidified with conc. HC1 until pH ~ 2-3. The aqueous layer was evaporated under 
reduced pressure and the remaining solid was dissolved in a saturated sodium chloride 
solution (100 ml). The aqueous phase was then extracted with chloroform (3 x 100 ml). 
The organic phase was then dried over NaSC>4 and evaporated in vacuo. Fractionated 
distillation afforded compound 119 as an oil (0.875 g, 40%).
vmax/cm"1 (KBr film) 4300 (O-H, s);
lU  N M R  (300 M Hz; CDC13) 5 8.81 (1H, broad s, COOH), 4.16 (2H, s, C //2 COOH)), 
3.74 (2H, m, C //2 OCH2 COOH)), 3.67 (4H, m, 2 x CH2 0 ), 3.55 (2H, m, Ctf2 OMe), 3.37 
(3H, s, OCH3);
13C N M R  (75 M Hz; CDC13) 5 173.2 (COOH), 71.7 (CH2 COOH), 71.3 (CH2 OMe),
70.5 (CH 2 0 ), 70.2 (CH2 0), 6 8 . 6  (CH2 0 ), 59.0 (OCH3);
m/z (ES+) 133.03 [(M-COOH), 100%],179.03 [(MH+), 20%];
HRM S calculated for C7 H 1 40 5 (MH+) 201.07334, found 201.07308.
2- [2-(2-Methoxy-ethoxy)ethoxy] -acylchloride (120)
O
Thionyl chloride (0.90 ml, 0.12 mol) was added dropwise to a solution of 2-[2-(2- 
methoxy-ethoxy)ethoxy]-ethanoic acid (0.50g, 2.80 mmol) in dichloromethane (5 ml) 
and the solution was heated at reflux for 12 h. The solvent and excess thionyl chloride 
were removed in vacuo to afford compound 1 2 0  in quantitative yield as an oil.
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vmax/cm-1 (KBr film) 1803 (C O , s);
'H  N M R (300 MHz; CDCI3 ) 8  4.48 (2H, s, CH2 C0C1), 3.78 (2H, m, 
C //2 OCH 2 COCI), 3.68 (2H, m, CH2 0), 3.63 (2H, m, C //2OCH2 OMe), 3.55 (2H, m, 
C tf2 OMe), 3.38 (3H, s, OCH3);
13C N M R  (75 M Hz; CDC13) 5  172.0 (COC1), 71.7 (CH2 C0C1), 71.2 
(CH2 OCH 2 COCl), 70.7 (CH2 0), 70.5 (CH20 ), 58.9 (OCH3).
1 -(2-Isocyanatomethoxy-ethoxy)-2-methoxy-ethane (122)
M e O ^ ^ ° ^ ^ O ^ N C O
To a solution o f the acid chloride (120) (2.81 mmol) in freshly distilled acetone (3 ml) 
was added, dropwise at 0  °C, a solution o f sodium azide (0.728 g, 1 1 . 2  mmol) in water 
(5 ml). The solution was stirred for 30 min at 5 °C. The mixture was then extracted with 
chloroform ( 3 x 1 0  ml) and the organic phase washed with water (5 ml) and saturated 
sodium chloride solution (5 ml). Anhydrous toluene (3 ml) was added to the organic 
phase, which was dried (MgSCU) for 1 h. The filtrate was partially concentrated in 
vacuo to give [2-(2-methoxy-ethoxy)]-actetyl azide (121) (vmax 2140 cm '1). The solution 
was directly heated at reflux for 30 min until the evolution of the nitrogen had ceased, 
then the solvent was evaporated in vacuo to give the isocyanate 122 (vmax 2260 cm’1) 
which was then used immediately in the next step.
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1 - [2-(2-Methoxy-ethoxymethyl] -3-(l ,4-dihydro-4-oxo-6-/7-nitrophenyl-
2-pyrimidinyl)-urea (123)
A suspension o f 6 -(p-nitrophenyl)isocytosine (110) (150 mg, 0.645 mmol) and 122 
(2.80 mmol) in dry pyridine (10 ml) and DMF (15 ml) was heated at 90 °C for 16 h. The 
solvent was removed in vacuo and the product purified using flash silica gel 
chromatography (CHCl3/MeOH, 35:1) to give 123 as a solid (32 mg, 28%).
1H NMR (300 MHz; DMSO-^) (6 [l H]-pyrimidinone monomeric A) 5 11.92 (1H, s,
3-H), 10.30 (1H, s, N/7CONHCH2), 8.32 (2H, d, J  9.1 Hz, Ar 3-H), 8.23 (2H, d, J  9.1 
Hz, Ar 2-H), 7.86 (1H, broad s, CON//CH2), 6.72 (1H, s, 5-H), 4.67 (2H, d, J  6 . 6  Hz, 
N H C //2 0 ), 3.48-3.55 (6 H, m, CH2 0 ), 3.42 (2H, m, CH2 0 ), 3.21 (3H, s, OCH3);
13C NMR (100 MHz; DMSO-^) 5 164.0 (C-4), 155.2 (NHCONH), 148.5 (Ar C-4),
142.4 (Ar C -l), 128.1 (Ar C-2), 123.8 (Ar C-3), 104.8 (C-5), 74.6 (NHCH2 0 ), 71.3 
(CH2 0 ), 69.7(CH20 ), 69.6 (CH2 0 ), 67.0 (CH2 0 ), 58.0 (OCH3); 
mlz (ES+) 408 [(MH+), 10%], 430 [(MNa+), 90%].
NO.
OMe
220
Chapter VI
(4-{2-[2-(2-Methoxy-ethoxy)-ethoxy)-ethoxy]-ethoxy}-phenyl)-ethanoic 
acid methyl ester (126)
COOCH.
Methyl-4-hydroxy phenyl ethanoate (3.33 g, 2 0  mmol), l-(2 -bromo ethoxy)-2 -(methoxy 
ethoxy)-ethane (9.07 g, 40 mmol) and potassium carbonate (11.04 g, 0.08 mol) were 
heated at reflux in acetonitrile (100 ml) for 18 h. The solvent was evaporated in vacuo 
and the residue was redissolved in EtOAc (100 ml) and washed with ( I N)  HC1 solution 
(100 ml) and (5 N) NaOH solution (50 ml). The organic phase was dried over (MgS0 4 ) 
and the solvent evaporated in vacuo. The crude product was purified using flash 
chromatography column (Hexane/EtOAc, 1:1) to give compound 126 as an oil (4.28 g, 
77%).
Vmax/cm'* (K B r film) 2880 (C-H, s), 1736 (C =0, s), 1614 (C=C-H, s), 1514 (C-O, s);
'H  N M R (400 M Hz; CDCIj) 8  7.15 (2H, d, J  8.7 Hz, Ar 2-H, 6 -H), 6.90 (2H, d, 78 .7  
Hz Ar 3-H, 5-H), 4.08 (2H, t, J  5.1 Hz, C i/2 OAr), 3.82 (2H, t, J  8.7 Hz, C //2 CH2 0Ar), 
3.71 (2H, m, CH 2 0 ), 3.53-3.65 (11H, m, C 0 2 CH3, 4 x CH2), 3.35 (3H, s, OCH3);
13C N M R (100 M Hz; CDC13) 8  172.3 (COO), 157.9 (Ar C-4), 130.2 (Ar C-2, Ar C- 
6 ), 126.2 (C -l), 114.7 (Ar C-3, Ar C-5), 71.9 (CH2 OMe), 70.8 (CH2 CH2 OAr), 70.6 
(CH2 CH2 0 ) , 70.6 (CH2 CH2 0 ), 69.7 (CH2 CH2 0 ), 67.4 (CH2 CH2 0), 59.0 (OCH3), 52.0 
(COOCHj), 40.3 (CH2 COOCH3); 
mJz (ES+) 335 [(MNa+), 100%];
HRM S calculated for Ci6 H2 5 0 6 (MH+) 313.16511, found 313.16512.
l-Bromo-2-[2-(2-methoxy-ethoxy)-ethoxy]-ethane (125)158
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To a solution of mesylate (2.904 g, 0.012 mol) in acetone (30 ml) was added portion- 
wise lithium bromide (1.56 g, 0.018 mol). The solution was heated under reflux 
conditions for 18 h. To this solution was added a saturated sodium chloride solution (60 
ml). The solution was then extracted with chloroform (60 ml) followed by diethyl ether 
(60 ml). The combined organic phases were dried over MgSCU and the solvents 
evaporated in vacuo. The crude product was then purified using flash chromatography 
column to afford 131 as an oil (1.843 g, 6 8 %).
vmax/cm"* (K B r film) 2875 (C-H, s), 663 (C-Br);
'H NMR (400 MHz, CDClj) 5 3.77 (2H, t, J  6.3 Hz, O C//2 CH2Br), 3.66-3.63 (8 H, m, 
CH2 C //2 0 ) , 3.54 (2H, m, CH2Br), 3.36 (3H, s, CHjO);
13C NMR (75 MHz, CDCIj) 8  71.9 (BrCH2 CH20 ), 71.2 (CH20 ), 70.6 (CH2 0), 70.5 
(CH2 0 ), 59.0 (OCH3), 30.3 (CH2Br); 
mlz (ES+) 249 [(MNa+), 100%];
HRMS calculated for C7 H i5B r0 3 (MNa+) 249.00968, found 249.00965. 
(4-Hexyloxy-phenyl)-acetic acid methyl ester (126a)
COOMe
To a solution o f 4-hydroxyphenylacetate (1 g, 6  mmol) in DMF (30 ml) and methanol 
( 6  ml) was added bromohexane (1.98 g, 12 mmol) and potassium carbonate (3.31 g, 24 
mmol). The solution was heated at 100 °C for 16 h. The solid was filtered off and the 
filtrate was evaporated in vacuo. The residue was redissolved in a mixture of 
(EtOAc/CHCls/hexane/lN HC1). The organic phase was then washed with water (20 
ml) then with 5N NaOH (20 ml) and the organic phase was dried (MgSOzj). Evaporation 
o f the solvents under reduced pressure afforded crude 126a, which was purified using 
flash silica gel chromatography (hexane/EtOAc, 3:1). Compound 126a was obtained as 
an oil (1.05 g, 70%).
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vm„/cm'‘ (KBr film) 2931(C-H, s), 2856 (C-H, s), 1740 (C=0, s), 1610 (C=C-H, 5 ), 
1514 (C=C-H, .s'), 1153 (C-O, s);
‘H NMR (400 MHz, CDCI3) 8 7.16 (2H, d, 7  8.5 Hz, Ar 2-H, 6-H), 6.86 (2H, d, 7  8.5 
Hz, Ar 3-H, 5-H), 3.93 (2H, t, 7 6 .6  Hz, ArOCH2), 3.68 (3H, s, COOCHS), 3.56 (2H, s, 
C ftC O O M e), 1.76 (2H, m, C //2CH2OAr), 1.45-1.31 (6H, m, CH2CH2), 0.91 (3H, s, 
CH2C H});
13C NMR (100 MHz, CDCI3) 8 172.4 (COOMe), 158.3 (Ar C-4), 130.2 (Ar C-2, C-6),
125.8 (Ar C -l), 114.6 (Ar C-3, C-5), 68.0 (CH2OAr), 52.0 (COOCH3), 40.3 
(CH2 COOMe), 31.6 (CH2 CH2OAr), 29.2 (CH2), 25.7 (CH2), 22.6 (CH2 CH3), 14.0 
(CHj);
HRMS calculated for C 15H 2 2 0 3 (MNa+) 273.14612, found 273.14579.
(4-Hexyloxy-phenyl)-acetic acid (126a (b))
COOH
Compound 126a (0.7 g, 2.8 mmol) was dissolved in a solution o f MeOH (10 ml) and 
(IN ) NaOH (5.6 ml). The solution was heated at reflux for 1 h 30 min. The solvent was 
then evaporated in vacuo and the residue was redissolved in water. A solution of (IN) 
HC1 was added to the mixture in order to bring the pH to ~ 2 which led to the 
precipitation o f a white solid. The solid was filtered off in vacuo and dried carefully 
affording compound 126a(b) (0.362 g, 55%).
mp: 90-91 °C (methanol);
v max/cm"1 (K B r pellet) 2950 (C-H, s), 2860 (C-H, s), 1700 ( C O , s);
'H NMR (300 MHz, CDC13) 8  7.15 (2H, d, 7  8.5 Hz, Ar 2-H, 6 -H), 6 . 8 8  (2H, d, 7  8.5 
Hz, Ar 3-H, 5-H), 3.93 (2H, t, 7 6 .6  Hz, C //2 OAr), 3.57 (2H, s, C //2COOH), 1.76 (2H, 
m, C //2 CH 2 OAr), 1.47-1.30 (6 H, m, C76CH2), 0.91 (3H, t, 77 .0  Hz, CH}CH2);
13C NMR (75 MHz, CDCI3) 8  177.9 (COOH), 158.4 (Ar C-4), 130.4 (Ar C-2, C-6 ),
125.1 (Ar C -l), 114.6 (Ar C-3, C-5), 68.0 (CH2 OAr), 40.1 (CH2 COOH), 31.6 
(CH2 CH 2 OAr), 29.2 (CH2), 25.7 (CH2), 22.6 (CH2 CH3), 14.0 (CH3);
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mJz (ES+) 259 [(MNa+), 100%];
HRMS calculated for C 14H 2 0 O3 (MH+) 236.14124, found 236.14230.
l-Hexyloxy-4-isocyanatomethyl-benzene (127a)
Thionyl chloride (0.46 ml, 6.3 mmol) was added dropwise to a solution of (4-hexyloxy- 
phenyl)-acetic acid (0.30 g, 1.27 mmol) and the solution was heated at reflux for 12 h. 
The excess o f thionyl chloride was removed in vacuo to afford the acid chloride (vmax 
1800 cm '1) in quantitative yield. To the acid chloride (0.323 g, 1.27 mmol) in freshly 
distilled acetone (1.3 ml) was added, dropwise at 0 °C, a solution of sodium azide (0.33 
g, 5.08 mmol) in water (4 ml). The solution was stirred for 30 min at 5 °C. The mixture 
was then extracted with chloroform (3 x 5 ml) and the organic phase washed with cold 
water (5ml) and with a saturated sodium chloride solution (5 ml). Anhydrous toluene ( 6  
ml) was added to the organic phase, which was dried (MgS0 4 ) for 30 min. This was 
directly heated at reflux until gas evolution ceased, then the solution was evaporated in 
vacuo to give the isocyanate 127a (VmaX 2260 cm '1), which was used directly in the next 
step.
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1 -(4-Hexyloxy-benzyl)-3- [4-(4-nitro-phenyl)-6-oxo-l ,6-dihy dro- 
pyrimidin-2-yl]-urea (128a)
n o 2
NH
NH
The isocyanate 127a (1.27 mmol) was added to a solution of the amine 110 (0.1 g, 0.43 
mmol) in dry pyridine (5 ml). The mixture was then heated at reflux for 16 h. The 
product was precipitated by addition o f hexane and filtration afforded 128a as a pale 
yellow solid (0.153 g, 77%).
mp: 274 °C (hexane);
v _ ,/c m '' (K B r pellet) 3230 (N-H, s), 3125 (N-H, s), 3100 (C=C-H, s), 3000 (C-H, s), 
2943 (C-H, s), 1663 (C =0, s), 1610 (C=C, s), 1560 (C=C, s), 1520 (N 02, s);
’H N M R (300 M Hz; DMSO-rf<) (6 [lH ]-pyrim idinone tautom er A) 8  11.87 (1H, s, 3- 
H), 10.03 (1H, s, N//CONHCH2), 8.25 (2 H, d, J  8 . 8  Hz, 17-H), 8.13 (2H, d, J 8 . 8  Hz, 
16-H), 7.74 (1H, broad t, NHCON//CH2), 7.26 (2H, d, 7 8 .5  Hz, 12-H), 6.93 (2H, d, 7
8.5 Hz, 13-H), 6.67 (1H, s, 5-H), 4.30 (2H, d, 7 5 .4  Hz, CONHCH2), 3.92 (2H, t, 76 .5  
Hz, CH2OAi ), 1.68 (2H, m, C //2 CH2 OAr), 1.40-1.25 (6 H, m, CR2CH2), 0.85 (3H, t, J
7.0 Hz, CH 2 CH3);
i3C  N M R (100 M Hz; DMSO-rf6) 8  163.1 (C-4), 157.8 (Ar C-14), 154.1 (NHCONH),
148.2 (Ar C - l 8 ), 142.2 (Ar C -l5), 130.1 (Ar C -ll) , 128.5 (Ar C -l2), 127.6 (Ar C -l6 ),
123.3 (Ar C - l7), 114.4 (Ar C-13), 103.9 (C-5), 67.4 (CH2OAr), 42.3 (NHCH2Ar), 30.6 
(CH2), 28.3 (CH2), 24.8 (CH2), 21.6 (CH2), 13.4 (CH3);
E lem ental analysis calculated for C24H27O5N5 C, 61.92%; H, 5.85%; N, 15.04%; found 
C, 61.95 %; H, 6.01%; N, 14.69%.
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(4-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-phenyl)-ethanoic acid 
(126 (b»
COOH
The methyl ester (0.560 g, 1.80 mmol) was mixed with a solution of (IN) NaOH (3.6 
ml, 3.60 mmol) in methanol (10 ml). The solution was heated at reflux for 3 h, then the 
solvent was removed in vacuo, and the solid was redissolved in water. The aqueous 
phase was then acidified with (IN) HC1 (15 ml) and extracted with chloroform ( 5 x 1 0  
ml). The combined organic phase was dried over MgSC>4 and the solvent was 
evaporated in vacuo to give 126(b) as an oil (0.37 g, 69%).
Vmax/cm'1 (KBr film) 3400 (O-H, s), 2880 (C-H, s), 1720 (C=0, s), 1614 (C=C-H, s), 
1585 (C-O, s), 1514 (C -0 ,5 );
'H NMR (400 MHz; CDC13) 5 7.15 (2H, d, J  6 . 6  Hz, Ar 2-H, 6 -H), 6.90 (2H, d, J  6 . 6  
Hz, Ar 3-H, 5-H), 4.08 (2H, t, J  5.1 Hz, C7?2OAr), 3.82 (2H, t, J  5.1 Hz, C //2 CH2 OAr), 
3.70 (2H, m, CH 2 0 ), 3.63 (4H, m, 2 x CH2 0 ), 3.54 (4H, m, CH20  + CH2 COOH), 3.35 
(3H, s, OCHj);
13C NMR (100 MHz; CDCI3) 5 177.2 (CO), 158.0 (C-4), 130.4 (C-2), 125.7 (C-l),
114.8 (C-3), 71.9 (CH2 OAr), 70.8 (OCH2), 70.6 (OCH2), 70.5 (OCH2), 69.7 (OCH2),
67.4 (OCH2), 59.0 (OCH3), 40.1 (CH2 COOH); 
miz (ES+) 321 [(MNa+), 100 %].
HRMS Calculated for C i5H 2 2 0 6 (MNa+) 321.13086, found 321.13094.
l-Isocyanatomethyl-4-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}- 
benzene (127)
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Thionyl chloride (1.44 ml, 19.8 mmol) was added slowly to a solution of (4-{2-[2-(2- 
methoxy-ethoxy)-ethoxy]-ethoxy}-phenyl)-ethanoic acid (1.00 g, 3.36 mmol) in 
dichloromethane (5 ml) and the solution was heated at reflux for 18 h. The solvent and 
excess thionyl chloride were removed in vacuo to afford (4 -{2 -[2 -(2 -methoxy-ethoxy)- 
ethoxy]-ethoxy}-phenyl)-acetyl chloride (vmax 1800 cm '1) in quantitative yield. To the 
acid chloride (1.05 g, 3.30 mmol) in freshly distilled acetone (3 ml) was added, 
dropwise at 0 °C, a solution o f sodium azide (0.858 g, 13.2 mmol) in water (10 ml). The 
resulting red solution was stirred for 30 min at 5 °C. The mixture was then extracted 
with chloroform (3 x i o  ml) and the organic phase was washed with water ( 1 0  ml) and 
saturated sodium chloride solution (10 ml). Anhydrous toluene was added to the organic 
phase, which was dried (MgS0 4 ) for 1 h. The filtrate was partially concentrated in 
vacuo to give (4-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-phenyl)-ethanoyl azide 
(vmax 2140 cm '1). This was directly heated at reflux for 30 min until the evolution of 
nitrogen had ceased, then evaporated in vacuo to give the isocyanate 127 (vmax 2260 
cm '1), which was used immediately in the next step.
l-(4-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy }-benzyl)-3-[6-(4-nitro- 
phenyl)-4-oxo-l,4 dihydro-pyrimidin-2-yl]-urea (128)
n o 2
NH
NH
The isocyanate 127 (3.30 mmol) was added to a solution o f the amine 110 (0.255 g, 
1.10 mmol) in dry pyridine (10 ml). The mixture was then heated at reflux for 18 h. The 
product was precipitated with the addition o f hexane and filtration of the solid afforded 
compound 128 as a colourless solid (0.469 g, 81%).
227
Chapter VI
mp: 238-240 °C (hexane);
vmax / cm'1 (KBr film) 3216 (N-H, s), 3079 (C=C-H, s), 2979 (C-H, s), 2931 (C-H, s), 
1667 (C =0, i) , 1613 (C=C, s), 1559 (C=C, s);
111 NMR (400 MHz; DMSO-d*) (6[lH]-pyrimidinone tautomer A) 8  11.92 (1H, s, 3- 
H), 10.07 (1H, s, N/7CONHCH2), 8.25 (2H, d, J  8 . 8  Hz, 17-H), 8.13 (2H, d, J  8 . 8  Hz, 
16-H), 7.74 ( 1 H, broad t, CON//CH2), 7.26 (2H, d, J 8 .5  Hz, 12-H), 6.93 (2H, d, 78 .5  
Hz, 13-H), 6.67 (1H, s, 5 -H), 4.31 (2H, d, J  5.4 Hz, CONHC//2), 4.06 (2H, m, 
C7/2 OAr), 3.73 (2H, m, CHiO), 3.56 (2H, m, CH20 ), 3.51 (4H, m, 2 x CHiO), 3.42 
(2H, m, CH20 ), 3.35 (3H, s, OCH3);
13C NMR (125 MHz; DMSO-rf<) 8  161.6 (C-4), 159.1 (C-6 ), 157.7 (C-14), 154.5 
(NHCONH), 152.1 (C-2), 148.4 (C -l8 ), 142.3 (C -l5), 130.7 (C -ll), 128.9 (C-12), 
127.9 (C -l6 ), 123.7 (C-17), 114.5 (C-13), 104.2 (C-5), 71.3 (CH2OAr), 69.9 (CH20 ),
69.8 (CH2 0 ), 69.6 (CH 2 0 ), 68.9 (CH2 0 ), 67.1 (CH2 0 ), 58.1 (OCH3), 42.4 (NHCH2Ar); 
mlz (+FAB) 550 [(MNa+), 100%];
HRMS calculated for C2sH2 9N 5 0 8 (MNa+) 550.19083, found 550.19059.
l-(4-{2-[2-(2-Methoxy-ethoxy)-ethoxy]-ethoxy}-benzyl)-3-[6-(4- 
aminophenyl)-4-oxo-l, 4-dihydro-pyrimidin-2yl]-urea (129)
NH O
_  A  A
O '  N ^ N  N 
H H
0(CH2CH20),0M e
NH.
Tin II chloride (0.857 g, 3.80 mmol) was added to a solution of 128 (0.334 g, 0.634 
mmol) in conc. HC1 (7.5 ml) and absolute ethanol (3.75 ml). The solution was heated at 
90 °C for 2 h. The yellow solution was then poured into ice and the pH adjusted to 8-9 
by addition o f sodium hydrogen carbonate. The aqueous layer was then extracted with 
chloroform (5 x 10 ml) and the organic phase was washed with saturated sodium 
chloride solution (10 ml) and then dried (MgS0 4 ). The solvents were evaporated in
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vacuo and the product was purified using flash silica gel chromatography 
(CHCls/MeOH, 7:1) to give 129 as an oil (200 mg, 63%).
Vmax / cm'1 (KBr film) 3448 (N-H, s, NH2), 3363 (N-H, s, NH2), 3219 (N-H, j), 2937 
(C-H, s) 1693 (C =0, .s), 1667 (C=0, s), 1623 (C=C, s), 1600 (C=C, s), 1512 (C-O, s);
!H NMR (500 MHz; CDCI3) (4[lH]-pyrimidinone, tautomer B) 8  13.66 (1H, s, 1-H), 
12.17 (1H, s, N //CONHCH2), 10.89 (1H, s, C 0N //C H 2), 7.45 (2H, d, J  7.3 Hz, 12-H),
7.31 (2H, d, J 8 .2  Hz, 16-H), 6.87 (2H, d, J 7.3 Hz, 13-H), 6.73 (2H, d, J8 .2  Hz, 17-H), 
6.21 (1H, s, 5-H), 4.46 (2H, s, CONHCtf2), 4.16-3.44 (12H, m, Cf/2 0), 3.36 (3H, s, 
OCH3 ); (pyrimidin-4-ol, tautomer C) 8  13.24 (1H, s, OH), 11.41 (1H, s, 
NffCONHCH2), 10.19 (1H, s, CON//CH2), 7.37 (2H, d, J  8.2 Hz, 16-H), 7.13 (2H, d, J
8 . 2  Hz, 17-H), 4.43 (2H, s, CONHCH2 ), 4.16-3.44 (12H, m, CH20 \  3.41 (3H, s, 
OCH3 );
13C NMR (125 MHz, CDCI3) (4[lH]-pyrimidinone, tautomer B) 8  173.1 (CO), 157.9 
(C -l4), 157.0 (NHCONH), 149.7 (C-18), 131.3 (C -ll) , 128.7 (C-12), 127.1 (C-16),
120.0 (C-l 5), 115.2 (C-18), 114.6 (C-13), 101.7 (C-5), 71.9-67.4 (CH2 0 ) (signal 
overlap), 60.4-38.7 (several signals not assignable to each tautomer); 
l3C NMR (100 MHz; DMSO-rf«) (pyrimidin-4-ol, DADA, tautomer C) 165.5 (C- 
OH), 161.0 (C-6 ), 157.7 (C-14), 154.6 (NHCONH), 153.2 (C-2), 151.0 (C-18), 131.0 
(C -ll) , 129 (C-12), 127.7 (C-16), 123 (C-15), 114.5 (C-13) 113.3 (C-18), 98.0 (C-5),
71.3 (CH2 0 ), 67.0 (CH 2 0 ), 69.8 (CH2 0 ), 69.0 (CH2 0 ), 67.2 (CH2 0 ), 58.1 (OCH3), 42.4 
(NHCH2);
HRMS calculated for C i5H2 2 0 6 (MH+) 498.23471, found 498.23376.
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6.3 Synthesis of polymers and energetic precursors
2(6-Isocyanatohexylaminocarbonylamino)-6-inethyl-4[lH]pyrimidone 
(131)127
A solution o f 2-amino-4-hydroxy-6-methyl-pyrimidine (0.20 g, 1.60 mmol) in 
hexyldiisocyanate (2.77 g, 11.0 mmol) was heated at 100 °C under a nitrogen 
atmosphere for 16 h. Hexane was added and the resulting precipitate was filtered and 
washed thoroughly with hexane in order to remove the unreacted diisocyanate. The 
white powder was dried at 50 °C under reduced pressure for 24 h to give 131 (3.75 g, 
80%).
mp: 210 °C (chloroform, lit. 215 °C);
vmax /c m ' (K B r pellets) 3100-3350 (N-H, s), 2277 (N=C=0, s), 1702 (C=0, s), 1668 
(C =0, s, urea);
'H NMR (300 MHz; CDCIj) S 13.10 (1H, s, 1-H), 11.85 (1H, s, NHCONHCH2), 10.16 
(1H, s, NHCHNT/CHj), 5.81 (1H, s, 5-H), 3.28 (4H m, NHCONHCft, C //2NCO), 2.28 
(3H, s, CH3), 1.62 (4H, m, NHCH 2C7/2, C //2 CH2NCO), 1.40 (4H, m, CH2);
13C NM R (75 MHz; CDCI3) 8  172.4 (C-4), 157.0 (NHCONH), 155.1 (C-2), 148.6 (C- 
6 ), 121.5 (N=C=0), 107.1 (C-5), 43.3 (CH2NCO), 40.2 (CH2NH), 31.6 (CH2CH2NH), 
29.7 (CH2), 26.6 (CH2), 26.5 (CH2), 19.3 (CH3); 
m/z (ES+) 294 [(MH+), 100%];
HRMS calculated for C i3H 19 0 3 N 5 (MH+) 316.13855, found 316.13470.
6.3.1 Synthesis of Polymer
General procedure
CH
H H
To a solution o f  polyethyleneglycol (n = 6 ) (48.0 mg, 0.17 mmol) in chloroform (12 ml), 
was added compound 131 (0.20 g, 0.68 mmol) with the addition o f one drop of
230
Chapter VI
dibutyltindilaurate, and the reaction mixture was heated at reflux for 20 h. Chloroform (10 
ml) was then added and the mixture was filtered off in vacuo to remove the excess of 
isocyanate. The filtrate was concentrated down to 10 ml, and silica gel (200 mg) was added 
together with a drop of dibutyldilaurate. The solution was heated to 60 °C for 1 h. The 
silica gel was then removed by filtration and the chloroform was evaporated in vacuo. 
Precipitation o f the polymer from chloroform with hexane gave polymer 132, which was 
then dried in vacuo at 50 °C (95 mg, 63%). The absence of isocyanate in the final 
compound was confirmed by JR.
Vmax /cm ' 1 (K B r pellets) 3500 (N-H, s), 3440 (N-H, s), 3000 (C=C-H, s), 1700 (C=0, s, 
amide), 1667 (C =0, s, urea);
Tg: -26.7 °C;
*H NMR (300 MHz; CDC13) 5 13.10 (1H, s, 1-H), 11.82 (1H, s, N//CONHCH2), 10.24 
(1H, s, NHCON//CH2), 5.84 (1H, s, H-5), 5.14 & 4.84 (1H, s, NHCOO), 4.16 (2H, m, 
C 0 0 C // 2CH 2 0 ), 3.59 (10H, m, CH2 0 ), 3.24 (2H, m, CH2 CH2NHCO) 3.14 (2H, m, 
C //2 NHCOO), 2.21 (3H, s, CH3), 1.56-1.26 (8 H, m, CH2);
l3C NMR (75 MHz; CDCI3) 6  173.1 (C-4), 156.9 (NHCONH), 156.8 (NHCOO), 155.7 
(C-2), 148.6 (C-6 ), 107.0 (C-5), 73.0 (NHCOOCH2), 70.9 (NHCOOCH2 CH2), 70.9 
(OCH2), 70.6 (OCH2), 62.0 (OCH2), 41.2 (NHCONHCH2), 40.0 (CH2NHCOO), 30.1 
(NHCONHCH2 CH2), 29.6 (CH2), 26.5 (CH2), 19.2 (CH3); 
mlz (ES+) 869.66 [(MH+), 15%], 891.66 [(MNa+), 20%].
Polymer 133 
Tg: -24.9 °C;
Vmax /cm ' 1 (K B r pellet) 1699 (C=0, s), 1667 (C =0, s);
'H NMR (300 MHz; CDCI3) 5 13.10 (1H, s, 1-H), 11.82 (1H, s, N//CONHCH2), 10.09 
(1H, s, NHCON7/CH2), 5.81 (1H, s, 5-H), 5.11 & 4.85 (1H, s, NHCOO), 4.17 (2H, m, 
C 0 0 C // 2 CH 20 ) , 3.57 (26H, m, CH2 0 ), 3.25 (2H, m, CH2 C //2NHCO), 3.15 (2H, m, 
CHNH CO O ), 2.20 (3H, s, CH3), 1.48-1.25 (8 H m, CH2).
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Polymer 134 
T g: -44 °C;
vmax /cm ' 1 (K B r pellet) 1694 (O O , s), 1661 (C =0, s);
'H  N M R (300 M Hz; CDCIj) 8  13.10 (1H, s, 1-H), 11.83 (1H, s, N//CONHCH2), 10.11 
(1H, s, NHCON//CH 2), 5.81 (1H, s, 5-H), 5.0 & 4.89 ( 1 H, s, NHCOO), 4.17 (2H, m, 
C 0 0 C // 2 CH 20 ) , 3.61 (62H, m, CH2 0 ), 3.21 (2H, tn, CH2C //2NHCO), 3.08 (2H, m, 
C i/2NHCOO), 2.20 (3H, s, CH3), 1.48-1.25 (8 H m, CH2).
Polymer 135
Vmax /cm ' 1 (K B r pellet) 3342 (N-H, s), 1700 (C=0, s), 1660 (C=0, s, urea);
'H  NM R (300 M Hz; CDC13) 6  13.10 (1H, s, 1-H), 11.82 (1H, s, NHCONHCH2), 10.09 
(1H, s, NHCON7/CH2), 5.81 (1H, s, 5-H), 4.94 & 4.71 (1H, s, NHCOO), 4.17 (2H, m, 
C 0 0 C // 2CH 2 0 ), 3.50 (178H, m, CH2 0 ), 3.36 (2H, m, CH2Gf/2NHCO), 3.12 (2H, m, 
C /6 NHCOO), 2.19 (3H, s, CH3), 1.48-1.24 (8 H m, CH2);
13C N M R (75 M Hz; CDCI3) 172.5 (C-4), 156.5 (NHCONH), 154.7 (NHCOO), 148.2 (C- 
6 ), 106.1 (C-5), 70.5 (OCH2), 69.6 (OCH2), 69.6 (OCH2), 29.7 (CH2), 29.3 (CH2), 26.1 
(CH2), 18.8 (CH3);
Polymer 136
T g: -60.4 °C;
■H NM R (300 M Hz; CDCI3) 8  13.10 (1H, s, 1-H), 11.84 (1H, s, NHCONHCH2), 10.11 
(1H, s, NHCON//CH2), 5.83 (1H, s, 5-H), 4.95 & 4.76 (1H, s, NHCOO), 4.19 (2H, m, 
C 0 0 C // 2 CH 2 0 ), 3.63 (12H, m, CH2 0 ), 3.59 (21H, m, C //2CHCH3), 3.38 (12H, m, 
C //C H 1), 3.31 (2H, m, NHC0NHC/72CH2), 3.15 (2H, m, CH2NHCOO), 2.21 (3H, s, CH3), 
1.59-1.26 (8 H, m, CH2), 1.13 (33H, m, C//jCHCH 20);
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Polymer 137
Tg: -63.7 °C;
'H  NM R (300 M Hz; CDCI3 ) 5 13.10 (1H, s, 1-H), 11.84 (1H, s, NHCONHCH2), 10.11 
(1H, s, NHCON//CH2), 5.83 (1H, s, 5-H), 4.96 & 4.73 (1H, s, NHCOO), 4.19 (2H, m, 
COOCH2CH2O), 3.63 (60H, m, CH2 0 ), 3.59 (38H, m, C //2CHCH3), 3.41 (22H, m, 
CHCH3), 3.30 (2H, m, NHCONHC//2CH2), 3.14 (2H, m, CH2NHCOO), 2.21 (3H, s, CH3), 
1.49-1.26 (8 H, m, CH2), 1.13 (57H, m, C //2CHCH2 0);
13C NM R (75 M Hz; CDCI3) 5 173.0 (C-4), 156.5 (NHCONH), 155.7 (NHCOO), 148.2 (C- 
6 ), 106.6 (C-5), 75.5 (CHCH2 0), 75.3, 75.1, 73.3, 72.8, 70.5, 69.6, 68.5, 41.7, 39.6, 30.1, 
29.7, 29.2, 18.8, 17.4, 17.3.
Polymer 138 
Tg: -64.5 °C;
'H  NM R (500 M Hz; CDClj) 5 13.10 (1H, s, 1-H), 11.85 (1H, s, NHCONHNH2), 10.11 
(1H, s, NHCONHCH2), 5.83 (1H, s, 5-H), 4.94 (1H, s, NHCOO), 4.11 (32H, m, 
OCOCH2), 3.43 (64H, m, OCH2), 3.24 (2H, m, NHCONHCH2), 3.13 (2H, m, 
CH2NHCO), 2.21 (3H, s, CH3), 1.73-1.62 (96H, m, OCH2 CH2CH2), 1.36-1.22 (8 H, m, 
CH2);
13C NM R (125 M Hz; CDCI3 ) 8  173.0 (C-4), 156.6 (NHCOO), 156.4 (NHCONH),
155.2 (OCOO), 154.6 (C-2), 148.2 (C-6 ), 106.5 (C-5), 70.2 (CH2 0 ), 70.1 (CH2), 70.0 
(CH20 ), 69.9 (CHzO), 67.8 (CH2 0 ), 67.6, 67.2, 67.0, 64.3, 40.5 (CH2NHCOO), 39.5 
(NHCONHCH2), 29.6 (CH2 CH2NHCOO), 29.2 (NHCONHCH2 CH2), 26.4 (CH2), 25.9 
(NHCONHCH2 CH 2 CH2), 25.8 (CH2), 25.5 (CH2), 18.8 (CH3).
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Pyrrole-1-carboxylic acid (6-methyl-4-oxo-l ,4-dihydro-pyrimidin-2- 
yl)-amide (139)131
4-hydroxy-methyl-pyrimidinone (0.5 g, 4.0 mmol) and CDI (1.03 g, 6.40 mmol) were 
suspended in anhydrous DMSO (10 ml) and the solution was heated at 60 °C for 2 h. To 
this solution was then added acetone, and the solid was filtered in vacuo, and washed 
thoroughly with acetone to afford compound 139 as an insoluble solid (0.840 g, 96%).
Vmax/cm"1 (K B r pellets) 3176 (N-H, s), 3089 (C=C-H, s), 2933 (C-H, s), 1708 (C=0, s), 
1653 (C=N, s)), 1608, 1508 (N-H, d), 1481, 1377.
6-Amino-hexanoic acid methyl ester hydrochloride (143)162
Thionyl chloride (0.55 ml, 7.6 mmol) was added slowly to anhydrous MeOH (10 ml) at 
-10 °C. After 15 min, 6 -aminohexanoic acid was added dropwise and the mixture was 
stirred at r.t. for 16 h. The solution was then concentrated in vacuo and the residue was 
dissolved in MeOH (5 ml). To this was added ether (25 ml) to precipitate the salt. 
Filtration o f the solid afforded pure compound 143 as white crystals (0.560 g, 81%).
mp: 116-118 °C (methanol, lit. 118-122°C);
Vmax/cm' 1 (K B r peUet) 3100-2900 (NH3+, j) , 2530 (NH3+, s), 1996 (NH3+, s), 1732 
(C =0, s), 1620 (NH3+, d, asym), 1581 (NH3+, d, sym), 1521 (NH3+, d);
‘H N M R (300 M Hz; CD3 OD) 8  3.65 (3H, s, COOCH3), 2.91 (2H, t, J  1A  Hz, 
C //2NH 2), 2.35 (2H, J  7.3 Hz, CHjCOOCHj), 1.66 (4H, m, Ctf2 CH2 COOCH3, 
C //2 CH2NH2), 1.42 (2H, m, CH2);
CH.
HCI. H,N COOCH.
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13C N M R (75 M Hz; CD3 OD) 5 175.6 (COOCH3), 52.0 (COOCH3), 40.6 (CH2NH2),
34.4 (CH 2 COOCH 3 ), 28.2 (CH2 CH2NH2), 26.9 (CH2 CH2 CH2NH2), 25.4 
(CH 2 CH2 COOCH3); 
mIz (ES+) 216 [(MH+ + C1‘), 100%].
6- [3-(6-Methyl-4-oxo-l ,4-dihy dro-py rimidin-2-yl)-ureido] -hexanoic 
acid methyl ester (140)
Compound 143 (0.248 g, 1.36 mmol) was dissolved in THF (15 ml) and triethylamine 
(0.141 g, 1.4 mmol). To this solution was added compound 139 (0.20 g, 0.91 mmol) and 
the reaction mixture was heated at reflux for 16 h. The solution was cooled down to r.t. 
and the solvents were evaporated in vacuo. The residue was redissolved in chloroform 
and the organic phase was washed with water (2 x 15 ml) then saturated sodium 
chloride solution (15 ml) and the organic phase was dried (MgSCU). The solvent was 
evaporated in vacuo and the residue was purified through flash silica gel 
chromatography (CHC^/MeOH, 7:1) to afford compound 140 as a solid (0.220 g, 81%).
mp: 140-142 °C (methanol);
Vmw/cm'1 (K B r pellets) 3213 (N-H, j), 3151 (N-H, s), 3020 (C=C-H, s), 2960 (C-H, s), 
2866 (C-H, 5 ), 1726 (C =0, s), 1700 (C=0, s), 1664 (C=0, s, urea), 1583 (C=C, s).
'H  N M R (400 M Hz; CDC13) 5 13.08 (1H, s, 1-H), 11.83 (1H, s, 7-H), 10.16 (1H, s, 9- 
H), 5.83 (1H, s, 5-H), 3.63 (3H, s, COOCH3), 3.21 (2H, q, J7 .1  Hz, NHCONHCH2),
2.29 (2H, t, J  7.5Hz, C //2 COOCH3 ), 2.21 (3H, s, CH3), 1.61 (4H, m, NHCH2 CH2 , 
NHCH 2 CH2 CH2 ), 1.36 (2H, m, CH2);
13C N M R (100 M Hz; CDCI3) 174.0 (C-4), 173.0 (COOCH3), 156.6 (NHCONH), 154.7 
(C-2), 148.1 (C-6 ), 106.7 (C-5), 51.4 (COOCH3), 39.8 (NHCH2), 34.0 (CH2 COOCH3),
29.1 (NHCH 2 CH2), 26.5 (NHCH2 CH2 CH2), 24.6 (CH2CH2 COOCH3), 18.9 (CH3); 
mIz (ES+) 297 [(MH+), 70%], 319 [(MNa+), 100%], 593 [(2MH+), 20%], 615 
[(2MNa+), 65%];
H RM S calculated for C13H20N4O4 (MH+) 297.15573, found 297.15522.
CH.
COOCH.
H H
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6-[3-(6-Methyl-4-oxo-l,4-dihydro-pyrimidin-2-yl)-ureido]-hexanoic
acid (141)
Compound 140 (0.60 g, 2.0 mmol) was dissolved in THF (2.5 ml) and (2 N) HC1 (4 ml). 
The solution was heated at reflux for 2h and then cooled down to r.t. allowing the 
precipitation o f  a white solid. The solid was filtrated and washed with water then 
acetone affording compound 141, which was used directly without further purification 
(0.33 g, 58%).
mp: 216-218 °C (acetone);
V m ax/cm ' 1 (K B r pellets) 3400 (O-H, s), 3215 (N-H, s), 3142 (N-H, s \  3041 (C=C-H, s), 
2931 (C-H, s), 2858 (C-H, s), 1726 (C =0, s), 1703 (C=0, s), 1662 (C O , s), 1595 
(C O , s);
mJz (ES+) 283 [(MH+), 100%], 305 [(MNa+), 80%], 565 [(2MH+), 20%];
HRM S calculated for C 12H 1 8O4N 4  (MH+) 283.14008, found 283.13933.
6- [3-(6-Methyl-4-oxo-l ,4-dihydro-pyrimidin-2-yl)-ureido] -hexanoic 
acid 4-{6-[3-(6-methyl-4-oxo-l,4-dihydro-pyrimidin-2-yl)-ureido]- 
hexanoyloxy-butyl ester (144)
To a solution o f 141 (0.22 g, 0.78 mmol) in CH2 CI2 was added thionyl chloride (0.34 
ml, 4.7 mmol). The solution was stirred at r.t. for 4 h, and the solvent and excess of 
thionyl chloride were evaporated in vacuo. The formation of the acid chloride was
CH.
COOH
H H
CH.
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confirmed by IR (Vmax ~ 1800 cm '1). The crude acid azide (0.78 mmol) was dissolved in 
THF ( 1  ml) and a solution o f 1,4-butanediol (0.26 mmol) in CH2 CI2 (1 ml) was added. 
To this solution was added a drop of triethylamine and the solution was stirred at r.t. for 
16 h. The solvents were evaporated in vacuo and the crude material was purified 
through flash silica gel chromatography (CHCb/MeOH, 9:1) affording compound 144 
(0.230 g, 48%) as a solid.
mp: 114-115 °C (methanol);
Vmax/cm-1 (K B r pellets) 3211 (N-H), 3149 (N-H), 3030 (C=C-H), 2958 (C-H), 1733 
(C =0), 1703 (C =0), 1666 (C=0);
'H  N M R (500 M Hz; CDC13) 5 13.09 (1H, s, 1-H), 11.82 (1H, s, 7-H), 10.15 (1H, s, 9-
H), 5.81 (1H, s, 5-H), 4.07 (2H, t, COOCH2CR2), 3.23 (2H, m, NHCONHCft), 2.30 
(2H, t, CH2 COO), 2.23 (3H, s, CH3), 1.67 (2H, m, COOCH2Ctf2), 1.65 (2H, m, 
C //2 CH2 COO), 1.62 (2H, NHCONHCH 2 CH2), 1.41 (2H, m, NHCH2CH2 Ctf2);
13C N M R (125 M Hz; CDCI3 ) 5 173.5 (COO), 172.9 (C-4), 156.4 (NHCONH), 154.6 
(C-2 ), 148.2 (C-6 ), 63.6 (COOCH2), 39.7 (NHCH2), 34.1 (CH2 COO), 29.1 
(NHCH 2 CH2), 26.4 (NHCH2 CH 2 CH2), 25.2 (COOCH2 CH2 ), 24.5 (CH2 CH2COO), 18.8 
(CH3);
mJz (ES+) 144 [(MH+), 100%];
H RM S calculated for C2 8 H4 2 O 8N 8 (MNa+) 641.30178, found 641.30229. 
4-Benzyloxy-3-oxo-butyric acid ethyl ester (145)165
CX^ oJkX0^
To a suspension o f sodium hydride (60% in parrafine oil, 0.210 g, 5.29 mmol) in 
toluene (5 ml) was added dropwise over 1 h, benzyl alcohol (0.50 g, 4.60 mmol) in 
toluene (2 ml). The solution was stirred at r.t. for 2 h. To this slurry solution was then 
added chloroacetoacetate (0.377 g, 2.3 mmol) in toluene (2 ml) over 30 min. The 
reaction mixture was stirred at r.t. for 16 h. To this reaction was then added (2 N) citric 
acid ( 8  ml). The organic phase was then separated and the aqueous phase was extracted 
with toluene (3 x 10 ml). The organic phases were combined and dried (MgS0 4 ) to give
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an orange oil. The crude m aterial w as further purified using flash silica gel 
chrom atography (hexane/E tO A c, 4:1) to afford com pound 145 as a yellow oil (0.43 g, 
80% ).
Vmax/cm*1 (KBr film) 2979 (C-H, s), 2923 (C-H , s), 2867 (C-H, s), 1744 (C = 0 , s), 1726 
(C = 0 , s), 1657 (C = 0 , s), 1452, 1317, 1262 (C-H, d);
!H NMR (400 MHz; CDC13) 5 7.31 (5H , m , A r-H ), 4.56 (2H, s, CH 2Ar), 4.16-4.12 
(4H, m , C O O C tf2 CH 3, O C H 2 CO), 3.51 (2H , s, C O C //2 CO O C H 2CH3), 1.20 (3H, t, 7 7 .7  
H z, C O O C H 2 CH3);
13C NMR (100 MHz; CDC13) 5 201.8 (CO ), 167.1 (COO ), 136.9 (Ar C -l) , 128.6 (Ar),
128.1 (A r), 127.0 (Ar), 74.8 (O C H 2 CO ), 73.5 (C H 2Ar), 61.5 (COO CH 2CH3), 46.1 
(C O C H 2 C O O C H 2 C H 3), 14.1 (C H 3); 
m Iz (ES+) 259.07 [(M N a+), 100% ];
HRMS calcu lated  for C i3H i60 4  (M N a+) 259.09408, found 259.09422.
2-Amino-6-benzyloxymethyl-lH-pyrimidin-4-one (146)
^ P h  
NH2
p -k e to  ester 145 (0.358 g, 1.51 m m ol) and guanidine carbonate (0.136 g, 0.758 mmol) 
w ere d isso lved  in  ethanol (5m l) and the m ixture w as heated at reflux for 18 h. The 
so lu tion  w as then  cooled  dow n to r.t. and the product crystallised from the solution. 
C rystals w ere filtered o f f  and w ashed thoroughly  w ith  cold w ater and acetone. The 
crude p roduct w as then  purified  through flash silica gel chrom atography 
(C H C l3/M eO H , 5:1) to afford com pound 146 as a solid  (0.175 mg, 50%).
mp: 182-184 °C (m ethanol);
v max/c m "1 (KBr pellet) 3342 (N-H, s, N H 2), 3142 (N -H , s), 2951 (C-H, j) , 2857 (C-H, 
s), 1675 (C =C , s), 1619, 1596, 1475, 1447, 1350, 1119, 989;
*H NMR (300 MHz; DMSO-rf*) 6  7.33 (5H , m , A r-H ), 6.49 (2H, broad s, N H 2), 5.61 
(1H , s, 5-H ), 4.53 (2H , s, C H 2Ar), 4.15 (2H , s, C / / 2 O C H 2Ar);
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13C NMR (75 MHz; D M S O -^ )  $ 166.4 (C -6 ), 162.8 (C-2), 155.6 (C-4), 138.0 (Ar C-
1), 128.2 (A r C-3), 127.4 (A r C-2, A r C-4), 97.7 (C-5), 71.9 (CH 2Ph), 71.1 
(C H 2 O C H 2 Ph);
miz  (E S + ) 232 [(M H +), 100% ], 254 [(M N a+), 60% ];
HRMS (FAB) calculated  for C i2H i30 2N  (M H +) 3232.10805, found 232.10750.
l-(6-Benzyloxymethyl-4-oxo-l,4-dihydro-pyrimidin-2-yl)-3-hexyl-iirea
To a so lu tion  o f  the am ine 146 (0.034 g, 0.15 m m ol) in  dry pyridine (1 m l) w as added 
hexyl isocyanate  (0.043 g, 0.22 m m ol). The solution w as then heated at 90 °C for 18 h. 
T he so lu tion  w as cooled  dow n to r.t. and a w hite solid  precipitated out o f  the solution. 
T he so lid  w as then  filtered o f f  and w ashed thoroughly  w ith  hexane to afford com pound 
147 as a  so lid  (0 .042 g, 80% ).
mp: 186-187 °C (hexane);
V m ax/cm ' 1 (KBr pellet): 3203 (N -H , s), 3137 (N -H , s), 3035 (C=C-H, s), 2960 (C-H, s), 
2856 (C -H , s), 1696 (C = 0 , s), 1667 (C = 0 , urea, s);
*H NM R (300 MHz; CDC13) (4-keto tautomer) 5 13.47 (1H, s, 1-H), 11.82 (1H, s, 7-
H), 10.03 (1H , s, 9-H ), 7.4 (5H , m , A r-H ), 5.91 (1H , s, 5-H), 4.67 (2H, s, CH 2Ar), 4.39 
(2H , s, C / / 2 O C H 2A r), 3.28 (2H, m , N H C O N H C H2), 1.61 (2H, m, N H CO N H CH 2C //2),
1.32 (6 H , m , C H 2), 0 .90 (3H, m , C H 2 C tf3); 
mIz (ES+) 381 [(M N a+), 100% ], 740 [(2M N a+), 10%];
HRMS (FAB) calcu lated  for C i9H 2 6 0 3N 4 (M N a+) 381.18971, found 381.18900; 
Elemental analysis calculated  for C i9H 2 6 0 3N 4 C, 63.67% ; H, 7.31% ; N, 15.63%; found 
C, 63 .44% ; H , 7 .37% ; N , 15.44%.
(147)
cr /Ph
H H
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l-Hexyl-3-(6-hydroxymethyl-4-oxo-l,4-dihydro-pyrimidin-2-yl)-iirea
(148)
OH
NH
NH
To a suspension  o f  com pound 147 (0.120 g, 0.335 m m ol) in  CH 2 CI2 (12 ml) was added 
slow ly  at -50 °C a so lu tion  o f  B C I3 ( IN , in  C H 2 CI2 , 0 .67 m l, 0.67 mmol). The solution 
w as stirred  at low  tem peratu re  for 1 h. The solution w as then  w arm ed to r.t. and hexane 
w as added. T he resu lting  precip ita te  w as then  filtered off. The crude m aterial w as 
purified  using  flash silica  gel chrom atography (C H C h/M eO H , 7:1) to afford com pound 
148 as a solid  (0.03 g, 90% ).
mp > 250 °C (m ethanol);
vmax/cm"1 (KBr pelle t) 3375 (O -H ), 3209 (N -H ), 3051 (C=C-H), 2937 (C-H), 1706 
(C = 0 ) , 1664 (C = 0 ), 1584 (C = 0 ) , 1520 (C=C);
*H NMR (400 MHz; DMSO-</<) (6-keto tautomer A) 5 7.84 (1H, t broad, 
N H C O N //C H 2), 6.13 (1H , s, 5-H), 4.35 (2H , s, C H 2Ar), 3.13 (2H, q, J  6 . 6  Hz, 
N H C O N H C ft) , 1.40 (2 H, m , N H C O N H C H 2 C // 2), 1.26 (6 H , m , C H 2), 0.85 (3H, t, J 6 . 8  
H z, C H 3);
13C NMR (100 MHz; DMSO-d«) 8  164.7 (C -6 ), 163.0 (C-4), 154.5 (NHCONH), 151.7 
(C -2), 100.6 (C -5), 61.0 (C H 2 O H ), 39.7(N H C O N H C H 2), 30.8 (CH 2 C H 2C H 3), 28.9 
(N H C O N H C H 2 C H 2), 25.8 (N H C O N H C H 2 C H 2 CH2), 21.9 (C H 2C H 3), 13.8 (CH3); 
m Iz (ES+) 269 [(M H +), 100% ];
HRMS calcu la ted  for C i2H 2 0O 3N 4 (M H +) 269.16082, found 269.16062.
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4-(2,2-Dimethyl-[1,3] doxolan-4-ylmethoxy)-3-oxo-butyric acid ethyl 
ester (149)165
—)— o  0  O
H H
To a suspension  o f  sodium  hydride (60%  in parrafine oil, 1.32 g, 33.0 m m ol) in dry  
to luene (32 m l) w as added  slow ly  over 1.5 h  a solution o f  solketal (4.0 g, 30.0 m m ol) in 
to luene ( 8  m l). T he so lu tion  w as stirred at r.t. for 1 h, and chloroacetoacetate (2.48 g,
15.13 g) in  to luene  ( 8  m l) w as added. The solution w as stirred at r.t. over 16 h. The 
so lu tion  w as acid ified  w ith  (2 N ) citric acid and the organic phase was separated. The 
aqueous phase  w as extracted  w ith  to luene (3 x 50 m l) and the organic phases w ere 
com bined  together and dried  (M gS 0 4 ). The solvent w as evaporated in vacuo and the 
crude m ateria l w as purified  through flash silica gel chrom atography (C H C b/E tO A c, 
4:1) to afford  com pound  149 as an oil (1.8 g, 46% ).
Vmax/cm' 1 (K B r  film ) 2985 (C -H , s), 2935 (C-H , s), 2879 (C -H , s), 1750 (C = 0 , s), 1724 
( C = 0 ,s ) ,  1456, 1371, 1217;
'H  N M R  (300 M H z ; CDC13) 8  4 .26  (1H , m , C 7/C H 20 ) ) ,  4.21-4.19 (4H, m, O C H 2CO, 
C O O C //2 C H 3), 4 .08 (1H , dd, J  6.5 H z, J  8.3 H z, C //H O C (C H 3)2), 3.79 (1H, dd, J  6.4 
H z, J  8.3 H z, C H H O C (C H 3)2), 3 .56 (2H, d, J  5.3 H z, C H C //2O C H 2CO), 3.50 (2H, s, 
C O C //2 C O O C H 2 C H 3), 1.40 (3H , s, C -C H 3), 1.34 (3H , s, C -C H 3), 1.24 (3H, t, J  7.1 Hz, 
C O O C H 2 C //j) ;
,3C  N M R  (75 M H z ; CDC13) 8  201.4 (C O ), 166.9 (C O O C H 2 C H 3), 109.6 (C-CH 3), 76.3 
(C H ), 74 .6  (O C H jC O ), 72.5 (C H 2 0 (C H 3)2), 66.5 (O C H 2 C H 3), 61.4 (CH CH 2 0 ) ,  45.9 
(C O C H 2 C O O ), 26.7 (C -C H 3), 25.3 (C -C H 3), 14.1 (C O O C H 2 C H 3); 
m Iz (E S + ) 283 [(M N a+), 100% ].
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2-Amino-6-(2,2-dimethyI-[l,3]dioxolan-4-ylmethoxymethyl)-lH- 
pyrimidin-4-one (150)
C om pound  149 (1 .74 g, 6.7 m m ol) and guanidine carbonate (0.605 g, 3.3 m m ol) w ere 
m ixed  together in  e thanol (20 m l) and heated a reflux for 16 h. The solution w as cooled 
dow n to r.t. lead ing  to  precip ita tion  o f  a w hite solid, w hich w as filtered o ff  and w ashed 
tho rough ly  w ith  co ld  w ater, acetone and cold ethanol. The product was further purified 
using  flash  silica  gel chrom atography (CH C ls/M eO H , 7:1) to afford com pound 150 
(1.51 g, 6 8 % ).
m p: 125-126 °C (m ethanol);
vmax/cm -1 (K B r  pellets) 3377 (N -H , 5 , N H 2), 3118 (N -H , s), 2987 (C-H, s), 2870 (C-H, 
s);
'H NM R (300 MHz; CDClj) 8  6 .60 (2H , broad s, N H 2), 5.83 (1H , s, 5-H), 4.28 (3H, m , 
C H = C C f tO , OCH2CHO), 4 .04  (1H , dd, J  6.1 H z, J  8.3 H z, CH H O C(CH 3)2), 3.72 ( 1 H, 
dd , J  6.3 H z, J  8.3 H z, C 7/H O C (C H 3)2), 3.55 (2H, dd, J  2.9 H z, J  5.7 Hz, 
CH2OCH2CH), 1.40 (3H , s, C -C H 3), 1.34 (3H , s, C -C H 3);
13C NMR (75 MHz; CDC13) 8  168 (broad, C -6 ), 160.5 (C-4), 156.0 (C-2), 109.7 (C- 
C H 3), 100.0 (C -5), 74.6 (C H ), 72.1 (C H 2O C H 2 C H , C H 2 OCH 2 CH), 66.4 (CH CH 20 ) ,  
26 .7 (C H 3), 25.3 (C H 3);
HRMS calcu lated  for C iiH i7 0 4N 3 (M H +) 256.12918, found 256.12919.
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1 - [6-(2,2-Dimethyl- [1,3] dioxolan-4-ylmethoxymethyl)-4-oxo-l ,4- 
dihydro-pyrimidin-2-yl] -3-hexyl-urea (151)
To a so lu tion  o f  com pound 150 (1.30 g, 5.09 m m ol) in  dry  pyridine (20 m l) w as added 
hexyl isocyanate  (1 .52 g, 7.1 m m ol) and the solution w as heated at 90 °C for 16 h. The 
so lu tion  w as coo led  dow n leading to the precipitation o f  a w hite solid, w hich w as 
filtered off. T he solid  w as thoroughly  w ashed w ith  hexane and dried in vacuo to give 
com pound 151 as a w hite  solid  (1.547 g, 80% ).
mp: 141-143 °C (hexane);
VnVcm ' 1 (KBr pe lle ts )  3203 (N -H , s), 3142 (N-H, s), 3034 (C=C-H, s), 2960 (C-H, s), 
2933 (C -H , s), 2860 (c-H , s), 1697 (c = 0 , s), 1662 (C = 0 , urea, s);
'H  N M R  (300 M H z; CDC13) 5 13.38 (1H, s, 1-H), 11.76 (1H, s, N //C O N H C H 2), 9.91 
( 1 H , s, N H C O N //C H 2), 5.88 ( 1 H, s, 5-H), 4.45 (2H , d, J  3.7 H z, C H = C C //20 ) ,  4.31 
(1H , m , C H 2 C //O ), 4 .08 (1H , dd, J  6 .4  H z, J  8.4 H z, C //H O C (C H 3)2), 3,78 (1H, dd, J
6.3 H z, J  8.4 H z, C « H O C (C H 3)2), 3.60 (2H, d, J 5.3 H z, C H 2O C //2CH), 3.23 (2H, q, J
6 . 6  H z, N H C O N H C # 2), 1 5 8  (2 H, m , C / / 2C H 2N H ), 1.41 (3H, s, C H C /fj), 1.36 (3H, s, 
C H C //2), 1.30 (6 H, m , C / / 2 C H 2), 0.86 (3H, t, J  6.4 H z, C H 2C //3);
13C  N M R  (75 M H z; CDC13) 5 172.6 (C-2), 156.3 (N H CO N H ), 154.7 (C-2), 109.6
148.4 (C -6 ), 109.6 (C -C H 3), 105 (C-5), 74.5 (C H 2 CH O), 72.1 (CH 2OCH 2CH), 68.3 
(C H 2 O C H 2 C H ), 66.5 (C H 2 O C (C H 3)2), 40.1 (C H 2N H ), 31.5 (C H 2 CH 2NH), 29.4 (C H 2),
26.7  (C -C H 3), 26 .6  (C -C H 3), 25.3 (C H 2), 22.6 (C H 2), 14.0 (C H 2 CH 3);
H R M S  calcu la ted  for C i8H 3oN4 0 5  (M N a+) 405.21084, found 405.21155.
H H
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1 - [6-(2,3-Dihydroxy-propoxymethyl)-4-oxo-l ,4-dihy dro-pyrimidin-2-
ylJ-3-hexyl-urea (152)
C om pound  151 (0 .200 g, 0.523 m m ol) w as d issolved in  m ethanol ( 6  m l), TH F (3 m l) 
and (1 N ) HC1 so lu tion  (1.5 m l). The m ixture w as heated at reflux for 1 h. To this 
cooled  m ix tu re  w as added ( I N )  N aO H  to bring  the pH  close to 7. The solvents were 
then  evaporated  in vacuo to afford com pound 152 as a  solid (0.160 g, 80%).
mp: 126-127 °C (chloroform );
Vmax/cm' 1 (KBr pellets) 3367 (O -H ), 3253 (N -H ), 3042 (C=C-H), 2929 (C-H ), 1706 
(C = 0 ) , 1663 (C = 0 , urea), 1567 (C=C);
'H NM R (400 MHz; DMSO-rf4) (6-keto tautomer A) 8  10.13 (1H, broad s, 
N //C O N H C H 2), 8.03 ( 1 H , s, N H C O N //C H 2 ), 5.95 (1H, s, 5 -H), 4.21 (2H, s, 
C / / 2 O C H 2 C H ) 4 .02 (2H , broad  s, OH), 3 .60 (1H , m , C //O H ), 3.50 (1H, dd, 7  4.4 Hz, 7
9.8 H z, C H C /7H O H ), 3.39 (1H , dd, 7  6.1 H z, 7 9 .8  H z, CH CH HO H), 3.35 (2H, d, 7 5 .7  
H z, C H 2 OCJ72 C H ), 3 .10 (2 H, q, 7 6 .7  H z, N H C O N H C //2), 1.41 (2 H, m , N H CH 2 CH2),
1.24 ( 6 H , m , C H 2), 0 .84 (3H , t, 7  6.2 Hz, C H 3);
13C NM R (100 MHz; DMSO-rf„) 8  165.1 (C -2), 161.0 (broad, C-4), 102.1 (C-5), 72.6 
(C H 2 O H ), 71 .4  (C H 2 O C H 2 CH )), 70.5 (C H ), 62.8 (C H 2 O C H 2CH ), 30.8 (N H C H 2), 29.0 
(C H 2), 25 .9  (N H C H 2 CH 2 ), 2 2 . 0  (CH2), 13.8 (C H 3);
m /z (E S + ) 343 [(M H +), 50% ], 365 [(M N a+), 100% ], 685 [(2M H+), 80% ], 707 
[(2M N a+), 100% ].
OH
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6.4 Synthesis towards the formation of cyclic dimers
2-Benzyloxycarbonylamino-3-hydroxy-propionic acid (154)
B enzylch loroform ate  (4.86 m l, 2 .80 m m ol) in  to luene (9.6 m l) was added to a solution 
o f  L-serine (2 .00  g, 1.90 m m ol) in  a  saturated aqueous sodium  hydrogen carbonate 
so lu tion  (80 m l). T he m ixture  w as stirred v igorously  for 4h. W ater (80 m l) was then 
added and the aqueous phase w as extracted w ith  ether ( 2  x 1 0 0  m l) and acidified w ith 
conc. HC1 to pH  3. The acidified  solution w as extracted w ith  ethyl acetate (3 x 100 ml) 
and the organic phase w as dried  (N a2 SC>4) and concentrated in vacuo to afford crude 
com pound 154 as an oil (0 .74 g, 90% ).
Vma. /cm ' 1 (KBr film) 3450 (O -H , 5 ), 3320 (O -H , 5 ), 3190 (N-H, s), 1747 (C = 0 , s, 
C O O H ), 1685 (C = 0 , s, ester);
'H  N M R  (300  M H z ; DM SO-rf«) 8  7.45 (5H , m , A r-H ), 5.15 (2H, s, CH 2Ar), 4.20 (1H, 
m , C 7/C O O H ), 3 .80  (2H , m , C f tO H ) ;
13C  N M R  (75  M H z; DM SO-rf«) 8  171.1 (C O O H ), 156.0 (NHCOO Bz), 138.0 (Ar C -l) ,
128.32 (A r C -3), 127.65 (A r C-2, A r C-4), 65 .44 (C H 2Ar), 61.31 (CHCOO H), 56.63 
(C H 2 O H );
m Iz (E S + ) 262 [(M N a+), 100% ];
H R M S  calculated for C iiH I30 5N (MNa+) 262.06914, found 262.06965.
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2-(2-Benzyloxycarbonylamino-3-hydroxy-propionil amino)-3-hydroxy- 
propionic acid methyl ester (155)169
O -^OMe
C om pound  154 ( 1 . 0 0  g, 4.18 m m ol) and triphenylphosphine (1.32 g, 5.01 m m ol) were 
d isso lved  in  acetonitrile  (15 m l) together w ith  L-serine m ethyl ester (0.98 g, 6.30 mmol). 
T rie thy lam ine (1 .20  m l, 8.82 m m ol) and carbon tetrachloride (0.50 m l, 5.20 m m ol) for 
16h. T he so lvents w ere evaporated  and the residue w as dissolved in EtOA c (50 m l) and 
w ater (10 m l). T he organic layer w as w ashed  w ith  citric acid (10%  solution, 3 x 5  ml) 
then  w ith  a  sodium  hydrogen  carbonate solution ( 3 x 5  m l) and saturated sodium  
chloride so lu tion  (5 m l). The organic phase w as dried (N a2 S 0 4 ) and the solvent was 
evaporated  in vacuo. The crude m aterial w as then purified  by  flash silica gel 
ch rom atography  (C H C ls/M eO H , 40:1) to afford 155 as a  w hite solid (0.68 g, 50%).
mp: 137 °C  (m ethanol);
Vm^/cm' 1 (KBr pellets) 3445-3405 (O -H , s), 3307 (N -H , s), 3272 (N-H, s), 3084 (C-H, 
s), 2949  (C -H , s), 1745 ( C O ,  s), 1670 ( C O ,  s);
'H  N M R  (300  M H z ; DM SO-rf*) 5 8.07 (1H , d, J 7 .7  H z, N /7CO O CH 2Ph), 7.31 (5H, 
m , A r-H ), 7.18 (1H, d, J  8.0 H z, N H C H C O O M e), 5.26 (3H, m , C / / 2 Ph, 
C H //C H N H C O O ), 4.83 (1H , broad t, C H H C H C O O M e), 4.32 (1H, m , CHNH CO O), 
4 .12 (1H , m , C ffN H C O O M e), 3.68 (1H , m , C H H C H N H C O O ), 3.60 (3H , s, C H 3OCO), 
3 .56 (1H , m , C H H C H N H C O O );
,3C  N M R  (75 M H z; D M SO -rf6) 8  170.8 (C H C O N H ), 170.3 (COO M e), 157.6 
(C O O B z), 136.9 (A r C - l) , 128.3 (A r C -3), 127.7 (A r C-2, A r C-4), 65.5 (C H 2Ph), 61.7 
(C O B zC H C H 2 O H ), 61.7 (C O O M eC H C H 2 O H ), 57.0 (CH N H C O O Bz), 54.8 
(C H C O O M e), 51.8 (C H 3); 
mlz (E S + ) 363 .12  [(M N a+), 100%];
H R M S  calcu la ted  for C i5Hig0 7 N 2 (M N a+) 363.11682, found 363.11744.
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(S)- cis-3,6-Bis hydroxyl methyl-piperazine-2,5-dione (153)169
H O - 'Y  Y °
I
H
D ipep tide  155 (0 .20 g, 0.59 m m ol) in  m ethanol (3 m l) w as added to a suspension o f  
Pd /C  (0 .02  g, 10%  w /w ) in  m ethanol (4 m l). The m ixture was hydrogenated w ith a 
ba llon  o f  H 2 at r.t. for 2 d. The catalyst w as rem oved by  filtration through Celite and 
w ashed  w ith  m ethanol. The filtrate w as then  evaporated  in vacuo and the crude m aterial 
w as red isso lved  in  M eO H  (13 m l). The solution w as heated at reflux for ca. 5 d. The 
solvent w as evaporated  in vacuo and the product w as recrystallised from M eO H /Et2 0  to 
give com pound  153 as colourless crystals (15.30 m g, 15%).
*H NMR (300 MHz; DMSO-rf*) 8 7.95 (2H , broad  s, N H ), 4.96 (2H, t, J 5 2  H z, OH), 
3 .76 (2H , m , C //C H 2O H ), 3.66 (2H , m , C/ZHOH), 3.64 (2H, m , C H //O H );
13C NMR (75 MHz; DMSO-rf*) 8 166.3 (C = 0 ), 63.7 (CH), 57.5 (CH 2OH); 
m /z (ES+) 106.94 [(M H +- 97), 100% );
HRMS calcu lated  for C 6H 10O 4N 2 (M N a+) 197.05382, found 197.05386.
-Dibutyl-2,3-dihydroxy-succinamide
HO OH
Method A 174
To a so lu tion  o f  L-tartaric acid (0.427 g, 2.8 m m ol) in  dry D M F (8 m l) w as added at 0 
°C E D C I (1.18 g, 6.2 m m ol) follow ed b y  H O B t (0.83 g, 6.2 m m ol). To the cooled 
so lu tion  w as th en  added butylam ine (0.5 g, 6.8 m m ol) and the solution w as stirred at r.t. 
for 16 h. T he so lven t w as then evaporated in vacuo and the residue was redissolved in 
ch lo ro fo rm  (10 m l) and w ashed w ith w ater (10 m l) then w ith a  saturated sodium  
ch loride so lu tion  (10 m l). The organic phase w as then  dried (M gS 0 4 ), and the solvent
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w as evapora ted  in vacuo. The solid w as purified  using flash silica gel chrom atography 
(C H C l3/M eO H , 8:1) to afford the desired com pound as a solid (0.332 g, 45% ).
Method B 173
T artaric  acid  (0 .10 g, 0.66 m m ol) and buty lam ine (0.12 g, 1.66 m m ol) w ere m ixed 
together in  a  special vessel. The tube w as then placed in the m icrow ave reactor 
(tem pera tu re  reached  180 °C and held for 9 m in. m ax power).
The b row n  so lid  w as then  redissolved in chloroform  and w ashed w ith  w ater (10 ml) 
then  sa tu ra ted  sodium  chloride solution (10 m l). The organic phase w as then dried 
(M g S 0 4) and the  solvent w as evaporated  in vacuo. The crude sam ple w as then purified 
using  flash  silica  gel chrom atography (C H C l3/M eO H , 8:1) to afford the tartram ide (0.10 
g, 60% ).
*H NMR (400 MHz; CDC13; 313 K) 5 7.09 (2H, s, N H ), 5.43 (2H, broad s, OH), 4.24 
(2H , s, C //O H ), 3.25 (4H , q, J 6.9 H z, C / / 2N H C O ), 1.49 (4H, q, J1 .2  Hz, N H C H 2CH2), 
1.35 (4H , q, J  7.4 H z, C H 3CH2), 0.91 (6 H, t, J  7.3 H z, C H 3);
13C NMR (100 MHz; CDC13; 313 K) 5 173.7 (CO ), 70.2 (CH), 38.8 (N H C H 2), 31.4 
(N H C H 2 C H 2), 19.9 (C H 2 C H 3), 13.6 (C H 3);
HRMS calcu lated  for C i2H 2 40 4N 2 (M N a+) 283.16283, found 283.16228. 
(6-Amino-hexyl)-carbamic acid tert-butyl ester (159)175
o
To a so lu tion  o f  hexanediam ine (5.0 g, 43 .0  m m ol) in chloroform  (25 m l) w as added 
d ropw ise  at 0 °C, B oc20  (1.0 g, 4.3 m ol) in  chloroform  (25 m l). The solution w as stirred 
at r.t. fo r 16 h, then  w ashed  w ith  w ater (30 m l). Saturated sodium  chloride solution (30 
m l) and  the  organ ic  phases w ere com bined together and dried (M g S 0 4). The solvents 
w ere  rem o v ed  in vacuo. The crude oil w as then  purified  through flash silica gel 
ch rom atog raphy  (C H C l3/M eO H /E t3N  (5:1:0.4)) to afford 159 as an oil (0.786 mg, 
85% ).
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Vmax /cm ' 1 (KBr film) 3361(N-H, s, N H 2), 3242 (N -H , s), 2933 (C-H , s), 2856 (C-H, s), 
1700 (C = 0  ,s ) ,  1520;
NMR 'H (400 MHz; CDC13) 8  4 .57 (1H , s, N H ), 3.07 (2H, m, C H 2N H ), 2.54 (2H, t, J
6 . 8  H z, C H 2N H 2), 1.45-1.40 (13H, m , 3 *  C H 3, 2 x C H 2), 1.3 (4H, m , CH2), 1.22 (2H, s, 
N H 2);
NMR 13C (100 MHz; CDCI3) 8  155.8 (CO ), 78.9 (C C H 3), 42.0 (CH 2N H ), 40.4 
(C H 2N H 2), 33 .6  (C H 2 CH 2N H 2), 29.9 (C H 2 C H 2N H ), 28.3 (C H 3), 26.5 (C H 2), 26.4 
(C H 2).
{6-[3-(6-tert-Butoxycarbonylamino-hexylcarbamoyl)-2,3-dihydroxy- 
propionylamino)-hexyl}-carbamic acid fcrf-butyl ester (160)
To a so lu tion  o f  L-tartaric acid  (0.231 g, 1.50 m m ol) in  dry D M F (10 m l) w as added at 0 
°C, E D C I (0 .690  g, 3.6 m m ol) follow ed by  H O B t (0.486 g, 3.6 m mol). To the cooled 
so lu tion  w as then  added com pound 159 (0.8 g, 3.7 m m ol) and the reaction was stirred at 
r.t. fo r 16 h. T he solvent w as then evaporated in vacuo and the residue w as redissolved 
in  ch lo ro fo rm  ( 1 0  m l) and w ashed w ith  w ater ( 1 0  m l) then saturated sodium  chloride 
so lu tion  (10 m l). T he organic phase w as then  dried  (M gS 0 4 ), and the solvent w as 
evapora ted  in vacuo. The solid  w as purified  using  flash silica gel chrom atography 
(C H C ls/M eO H , 10:1) to  afford com pound 160 as a solid  (0.609 g, 74%).
mp: 148-149 °C (chloroform );
Vmax /cm ' 1 (KBr pellets): 3365 (O-H, s), 2982 (C-H , s), 2930, 1690;
‘H NM R (400 MHz; CDC13) 8  7.03 (2H, broad t, N //C O C H ), 5.31 (2H, broad s, OH), 
4 .66  (2H , b ro ad  t, N H C O O ), 4.30 (2H, s, C H ), 3.22 (4H, q, J  6.4 Hz, C ftN H C O C H ),
3.08 (4H , b ro ad  q, C ftN H C O O ), 1.47 (4H, m , C f/2 C H 2NHCOO,
C / / 2C H 2N H C O O C H ), 1.41 (9H, m , C H 3), 1.30 (4H, m , 2 x C H 2);
HO OH
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I3C NMR (100 MHz; CDClj) 8  173.5 (C O N H C H 2), 156.0 (NHCOO ), 79.0 (C'-CHj), 
70.5 (C H O H ), 40.2 (C H 2N H C O O ), 38.9 (C H 2N H C O C H ), 29.8 (CH 2C H 2NH CO O),
29 .2  (C H 2 C H 2N H C O C H ), 28.4 (C H 3), 26.2 (C H 2); 
m /z  (ES+) 547 [(M H +), 100%], 569 [(M Na+), 98% ], 1116 [(2M Na+), 60% ].
A,jV'-Bis-(6-ainino-hexyl)-2,3-ilihydro\y-.succinamide (158)
HO OH
h2n nh2
C om pound 160 (0 .540 g, 0.98 m m ol) w as dissolved in  CH 2 CI2 (10 ml) and TFA  was 
added (10 m l). T he so lu tion  w as stirred at r.t. for 2 h. The solvents were evaporated in 
vacuo and  the residue w as redissolved in TH F. Triethylam ine was added and the 
so lu tion  w as heated  allow ing p recip ita tion  o f  com pound 158 (0.374 g, 100%).
mp: 143-144 °C (m ethanol);
vmax /cm -1 (K B r  pellets) 3409 (N -H , 5 , N H 2), 3294 (O -H , s), 3124 (N-H, s), 2935 (C-H, 
s), 2856 (C -H , s), 1705 (C = 0 , s);
'H NM R (400 MHz; CD3OD) 8  4 .42 (2H , s, CH ), 3.25 (4H, t, J  7.0 Hz, CH 2N H CO ), 
2 .90  (4H , t, J  7 .7  H z, C H 2N H 2), 1.63 (4H, q, J  7.1 H z, C //2 C H 2N H CO ), 1.57 (4H, q, J
6 . 8  H z, C / / 2 C H 2N H 2), 1.37 (8 H, m , C H 2);
l3C NM R (100 MHz; CDjOD) 8  174.6 (C O ), 74.0 (CH ), 49.6 (CH 2N H C O ), 39.8 
(C H 2N H 2), 30.2 (C H 2C H 2N H C O ), 28.5 (C H 2 C H 2N H 2), 27.1 (CH2), 27.0 (C H 2);
HRMS ca lcu la ted  for CK5H 3 4 O 4N 4  (M H +) 347.26526, found 347.26499.
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2,3-Bis-{6[3-(6-methyl-4-oxo-l,4-dihydro-pyrimidin-2-yl)-ureido]- 
hexylcarbamoyloxyj-succinic acid diethyl ester (163)
ch 3
• r ^ N - H'o H EtOOC H o  H H0^ NANAnW v NY° / oAn^ X . N  N N^°
H H O HCOOEt H » HN
CH
D iethyl L-tartrate (0.3 g, 1.4 m m ol) w as dissolved in dry  chloroform  (15 m l) (am ylene 
stab iliser) in  the  p resence o f  tinbutyldilaurate as catalyst (0.5%  w/w). Com pound 131 
(1 .0  g, 3.5 m m ol) w as then  added and the solution w as heated at 60 °C under a flux o f  
nitrogen. T he reaction  vessel w as opened to the air allow ing a slow evaporation o f  the 
so lvent over 2-3 h. The residue w as redissolved in chloroform  (30 ml) and the solution 
w as then  filtered  off. The filtrate  w as concentrated  in vacuo until 10 m l and 0.20 g o f  
silica  w as added to the solution together w ith  a drop o f  catalyst. The m ixture w as heated 
at reflux  for 2 h. The solution w as then  filtered o ff  to rem ove the silica and the filtrate 
w as concen trated  in vacuo. The crude product w as then purified  using flash silica gel 
chrom atography  (C H C T /M eO H , 7:1) to afford com pound 163 as a glassy solid (220 
m g, 30% ).
mp: 142-143 °C (chloroform );
v m„  /cm ' 1 (KBr pellet) 3333 (N -H , s), 3220 (N -H , s), 2925 (C-H, s), 2850 (C-H, 5), 
1738 (C = 0  ester, 5), 1700 (C = 0  am ide, 5), 1669 (C = 0  urea, 5);
'H NM R (500 MHz; CDC13) (4-keto tautomer B) 5 13.41 (1H, s, 1-H), 11.68 (1H, s, 
7-H ), 10.21 (1H , s, 9-H ), 7.68 (1H, s, 16-H), 6.41 (1H, s, 5-H), 5.92 (1H, s, 18-H), 4.17 
&  4 .34  (2H , m , C O O C H 2), 3.68 (1H, m , 10-H), 3.40 (1H, m , 15-H), 2.86 (1H, m , 15-
H ), 2 .78  (1H , m , 10-H), 2.23 (3H, s, C H 3), 1.72 (1H , m , 11-H), 1.66 (1H, m , 14-H), 
(1H , m , 13-H ), 1.51 (2H , m , 12-H, 13-H), 1.37 (1H, m , 11-H), 1.30 (1H, m , 14-H), 1.26 
(3H , t, J 7 .1  H z, C O O C H 2 C //j)  1.12 (2H, m , 12-H, 13-H);
13C NM R (125 MHz; CDC13) 6  174.0. (C-4), 167.4 (CO O Et), 156.5 (NH CO N H ), 
155.0 (N H C O O ), 154.5 (C-2), 148.6 (C-6 ), 107.0 (C-5), 71.1 (C-18), 61.7 (CO O CH 2),
38.4 (C -10), 37.1 (C -15), 28.9 ( C - l l ) ,  28 .7  (C -14), 22 .84 (C-12), 22.81 (C-13), 18.20 
(C H 3), 14.0 (C O O C H 2 CH3);
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1SN N M R  (500 M H z; C D C I3) 5 -299.2 (N -17), -284.1 (N -9), -266.5 (N-7), -246.3 (N-
1), -172 .2  (N -3);
'H  N M R  (500 M H z; DM SO-rf„) (6 -k e to  ta u to m e r  A ) 6  11.4 (1H, s, 3-H), 9.8 (1H, s, 
7-H ), 7 .44  (1H , s, 9-H ), 7.38 (1H, s, 17-H), 5.44 (1H , s, 18-H), 4.08 (4H, m , 
C O O C //3 C H 3 ), 3 .10  (2H, m , 10-H), 2.95 (2H , m , 15-H), 2 .09 (3H, s, C H 3), 1.41 (2H, m ,
11-H), 1.36 (2H , m , 14-H), 1.24 (4H , m , 12-H, 13-H), 1.12 (3H, t, J  7.1 Hz, 
C O O C H 2 C H3);
,3C  N M R  (125  M H z; DM SO-rf<) 5 166.8 (C O O Et), 164.8 (C -6 ), 161.9 (C-4), 155.0 
(N H C O N H ), 154.8 (N H C O O ), 151.6 (C-2), 104.6 (C-5), 71.0 (C-18), 39.2 (C-10), 38.7 
(C -15), 29 .2  (C -l 1, C -14), 26 .0  (C-12), 25.8 (C -13), 23.2 (C H 3);
1SN  N M R  (500  M H z; DM SO-rf*) 8  -296.2 (N -17), -285.8 (N -9), -174.8 (N -l);
13C  C P M A S  N M R  (75 M H Z ) 8  174.4 (C-4), 168.0 (C O O Et), 156.6 (NHCON H), 155.0 
(C -18, C -2), 149.3 (C -6 ), 107.5 (C -5), 37.8 (C-10, C-15), 29.8 ( C - l l ,  C-14), 23.7 (C12, 
C 13), 18.4 (C H 3);
15N  C P M A S  N M R  (30 M H Z ) 8  -299.0  (N -17), -283.8 (N -9), -266.4 (N-7), -245.9 (N-
1),-172 .1  (N -3);
m /z (E S + ) 793.28 [(M H +), 100% ], 815.26 [(M Na+), 40% ];
[ cc] d  for L-tartrate: + 365 (c = 0.1, 21 °C, chloroform), for D-tartrate: -339 (c = 0.54, 21 °C, 
chloroform).
Mixture of Compounds 161 and 162
c h 3
j NH O H H COOEt
N N N N Y "0  OH
H H ^ * COOEt
161
NH O
O '  ' N ^ N ^ N  
H H
162
Vmax / cm - 1 (K B r  p e lle t)  3342 (N-H), 3415 (N-H), 1700 (C=0 ), 1669 (C= 0  urea);
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‘H NMR (500 MHz; CDCI3) 8  13.09 (2H, s, C H jC N //) , 11.82 (2H, s, C H 2N H (C = 0)N //),
10.08 (2H , s, C H 2 N //(C O )N H ), 5.82 (2 H, s, C tf= C C H 3), 5.40 (1H, s, C //(C O O E t) (161)), 
5.34 (1H , s, C H 2N //C O O ), 4.82 (1H, s, C H 2N //(C 0 )0 ) ,  4.68 (1H, s, C //(C O O E t) (162)),
4 .24  (2H , q, J 1 .2  H z, C H 3 C tf 2O CO ), 4 .10 (2H, q, J  6 . 8  H z, C H 3C //2 OCO), 3.23 (4H, m, 
N H (C O )C //2 C H 2), 3.14 (4H, m , C f tN C O ), 2 .20 ( 6 H , s, C H 3C=CH), 1.56-1.34 (16H, m, 
C H 2 C H 2 C / / 2 C7/2C H 2), 1.26 (3H, t, CH3CH2 (CO )O ), 1.20 (3H, t, CH3CH 2 ( C 0 ) 0  (162)); 
13C NMR (125 MHz; CDClj) 8  173.0, 170.9, 156.7, 154.61, 148.2, 106.6, 73.1, 71.8, 62.7, 
62.2, 41 .1 , 39.9, 30.1, 29 .7 , 26.5, 19.2, 14.4, 14.4; 
m!z (ES+) 340 [(M H +), 50% ] for (162)
2,3-Bis-hexylcarbamoyloxy-succinic acid diethyl ester (164)
o H COOEt
O
EtOOC H
H exyl isocyanate  (0 .20 g, 1.57 m m ol) w as added to a  solution o f  diethyl L-tartrate (0.80 
m g, 0 .49 m m ol) in  ch loroform  (10 m l). T inbutyl dilaureate w as added as catalyst (1%  
w /w  diethyl L-tartrate). The solution w as heated  at reflux for 16 h. The excess hexyl 
isocyanate  w as reacted  w ith  silica gel (0.2 g) for 2 h  at reflux tem perature. The solution 
w as then  filtered  and the solvent rem oved in vacuo to afford a w hite solid w hich was 
pu rified  using  flash silica gel chrom atography (CH C ls/M eO H , 15:1) to give 164 (0.74 g, 
56% ).
mp: 40-42  °C (m ethanol);
Vma* /c m ' 1 (K B r  pellets) 3348 (N -H , s), 1739 (C = 0  ester, s), 1722 (C = 0  am ide, s);
*H NMR (300 MHz; CDCI3) 8  6 .00 (1H , t, N H ), 5.65 (1H, s, CH CO O Et), 4.13-4.23 
(2H , m , C O O C H 2), 3.13 (2H, m , C H 2N H CO O ), 1.39 (2H, m , CH 2 CH 2N H CO O ), 1.23 
(9H , m, 4  x C H 2, C O O C H 2C //j) , 0.83 ( 6 H, m , CH3);
n C NMR (75 MHz; CDClj) 8  167.6 (C O O C H 2 C H 3), 154.8 (NHCOO ), 71.1 
(C H C O O E t), 62 .0  (O C H 2 C H 3), 41.2 (C H 2N H C O O ), 31.4 (C H 2 CH 2 CH3), 29.6 
(C H 2 C H 2N H C O ), 26.9 (C H 2 CH 2 C H 3), 26.3 (C H 2C H 3), 22.5 (CH 3 CH 2 OCO), 13.9 
(C H 2 C H 3);
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m /z (E S + )  483.21 [(M N a+), 100%];
H R M S  calcu lated  for C 2 2O 8N 2H 4 0 (M N a+) 483.26822, found 483.26911.
{6-[3-(6-Methyl-4-oxo-l,4-dihydro-pyrimidin-2-yl)-ureido]-hexyl}- 
carbamic acid l-methyl-2-{6-[3-(6-methyl-4-oxo-l,4-dihydro- 
pyrimidin-2 -yl)-ureido]-hexylcarbamoyloxy}-propyl ester (166)
CH,
j ^ N ' H O 
C T ^ N ^ N  N'I I
H H
H1C, H O
cr X _ A
y t ch°O Hch N
CH,
Sam e procedure  used for com pound 163. C om pound 166 w as obtained in 25%  yield, 
m p: 122-124 °C ;
Vmax/cm-1 (KBr pellets) 3338 (N -H ), 3220 (N -H ), 3035 (C =C -H ), 2935 (C-H), 2856 (C- 
H), 1701 (C = 0 ) , 16662 (C = 0 , urea), 1582 (C = C ) ;
‘H  N M R  (400 M H z; C D C I3 ) 5 13.50 (1H, s, 1-H), 11.66 (1H, s, N H C O N H C H 2),
10.14 (1H , s, N H C O N H C H 2), 7.13 (1H, s, N H C O O ), 6.06 (1H, s, 5-H), 5.20 (1H, q, J  
5.68 H z, C /7C H 3) 3.61(1H , m , N H (C O )C H //C H 2), 3.31 (2H , m , CHHN HCOO), 2.96 
(2H , m , C H H N H C O O , N H (C O )C H //C H 2), 2.23 (3H , s, C //,C = C H ), 1.0-1.80 (11H, m, 
C / / 2 C H 2 , C H C //3 );
13C  N M R  (125 M H z, C D C I3) 8  173.6 (C-4), 156.4 (N H CO N H ), 156.3 (NHCOO ),
154.6 (C -2), 148.3 (C -6 ), 106.6 (C-5), 71.4 (C H C H 3), 38.8 (C-10), 37.4 (C-15), 28.9 
(C -l 1), 28 .4  (C -14), 23.3 (C -12), 22.4 (C-13), 18.7 (C H 3), 18.0 (C H 3)
H R M S  calcu lated  for C 3oH4 8Nio0 8 (M N a+) 699.35488, found 699.35678;
[a ]o : + 217 (c =  0.34, 2 1  °C, chloroform ).
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Dimethyl 2,3-CMsopropylidene L-tartrate (168)177
COOEt
D iethyl L-tartrate (5 .30 g, 0.025 m m ol), 2 ,2-dim ethoxypropane (3.00 g, 0.028 m m ol) 
and PT S  (0 .03g, 25%  w /w ) w ere d issolved in to luene (20 m l) and the m ixture was 
heated  at reflux  tem perature. The m ethanol generated w as rem oved via a D eans stark 
apparatus. T he advance o f  the reaction w as follow ed by  TLC analysis (EtO Ac/Hexane,
p ropane w ere  rem oved  in vacuo. A  m ixture o f  the diesters w as obtained during the 
reaction  and the  m aterial w as carried directly  through to the next step.
*H NMR (300 MHz; CDC13) 8  4 .81-4.73 (2H , m, CH ), 4.28 (4H, q, J  7.1 Hz, 
C / / 2 C H 3), 3 .78 (3H , s, C O O C H 3), 1.50 (6 H, s, C-CH3\  1.20 (6 H, t ,  J  7.1 Hz, 
C O O C H 2 C //3 );
13C NMR (75 MHz; C D C I3) 8  170.45 ( C O O E t ) ,  170.00 ( C O O M e ) ,  114.18 ( C - C H 3) ,  
62.23 ( C H C O O E t ) ,  26.74 ( C O O C H 2 C H 3) ,  21.75 ( C O O C H 3 ) ,  14.44 ( C - C H 3) ;
2,3-CMsopropylidene D-threitol (169)178
A  so lu tion  o f  168 (7.35 g, 0.02 m ol) in anhydrous ethanol (15 m l) w as added dropwise 
to a m ix tu re  o f  N aB H 4 (3.41 g, 0.09 m ol) in anhydrous ethanol (40 m l) under vigourous 
stirring  at such  ra te  to  m aintain  reflux and evolution o f  H 2. The m ixture was then heated 
at reflux  tem pera tu re  for 4 h. The reaction w as m onitored by  TLC analysis 
(E tO A c/hexane, 1:1). The reaction w as concentrated  in vacuo and chloroform  (20 m l) 
w as added, fo llow ed  by  the addition o f  w ater (dropw ise) w ith  vigorous stirring until the 
so lu tion  b ecam e clear. The solution w as then  stirred for an additional hour. The organic 
phase  w as separa ted  and dried (M g S 0 4). The solvent w as evaporated and the product
1:1) and the reac tion  w as com pleted  after 3-4 hours. T oluene and excess o f  2,2-dim ethyl
H
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w as purified  through flash silica gel chrom atography w ith  (C l^C h /M eO H , 8:1) to give 
169 as co lourless oil (1.86 g, 57%).
V max /  cm’’(KBr film) 3400 (O-H, s) 2950 (C-H , 5 );
*H NMR (300 MHz; CDCI3) 8  3.92 (2H, m , CNCH2), 3.73 (4H, m, C f tO H ) , 2.77 (2H, 
s, O H ), 1.38 ( 6 H, s, C H 3);
,3C NMR (75 MHz; CDCIj) 5 109.6 (C -C H 3), 78.6 (CH ), 62.5 (CH2), 27.3 (C H 3); 
m /z (CI+) 147 [(M H +- C H 3), 40% ], 163 [(M H +), 10%];
[« d ] 22 +  3 (c =  0.1, m ethanol).
(4S, 5S)-4,5-Bis ben/yloxyincthyl-2,2-dimethyl-[l ,3] dioxolane (170)181
To a so lu tion  o f  com pound 169 (0.530 g, 3.30 m m ol) dissolved in  dry TH F (10 m l) was 
added  s low ly  at 0 °C, sodium  hydride (60%  in parafine oil, 0.330 g, 8.00 m m ol). The 
so lu tion  w as stirred  for 30 m in  and benzyl brom ide (0.4 m l, 9.9 m m ol) was added. The 
reac tion  m ix tu re  w as stirred  at r.t. for 16 h. The solvent w as evaporated in vacuo, and 
the  residue  w as red isso lved  in  chloroform . The organic phase w as w ashed w ith  w ater 
( 1 0  m l) then  saturated  sodium  chloride solution ( 1 0  m l), and the organic phase was then 
d ried  (M gS 0 4 ). T he solvent w as evaporated in vacuo and the product w as purified 
th rough  flash  silica  gel chrom atography (C H C b/E tO A c, 1:10) to afford com pound 170 
as pa le  o il (0 .442 g, 40% ).
vmax /c m '1: 3065 (C -H , A r), 3028 (C-H , Ar), 2984 (C -H ), 2868 (C-H), 1498 (C=C), 
1454, 1373 (C -H , C (C H 3)2);
'H NMR (300 MHz; CDC13) 8 7.31 (5H, m, A r-H ), 4.39 (2H, d, J  2.7 Hz, CH 2Ar),
4 .04  (1H , m , C H O ), 3.61 (2H, m , C / / 2 O C H 2 Ar), 1.43 (3H, s, C H 3);
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,3C NMR (75 MHz; CDCI3) 8 137.9 (A r C - l) ,  128.3 (A r C -3), 127.6 (A r C-2, C-4),
109.6 (C C H 3), 77.4 (CH O ), 73.4 (C H 2Ar), 70.6 (C H 2 O C H 2 Ar), 26.9 (C H 3);
HRMS calcu lated  for C 2 ]H 260 4  (M N a+) 365.17233, found 365.17190.
(2S, 3S)-l,4-Bis-benzyloxy-butane-2,3-diol (171)181
C om pound  170 (0 .440 g, 1.31 m m ol) w as d issolved in  a TH F/M eO H /H Cl (1 N ) (5 
m l: 10 m l:5 m l) and heated  at reflux for 16 h. The solution w as cooled dow n and (5 N) 
N aO H  w as added  to b ring  the pH  close to 8 . The solvents w ere then evaporated and the 
residue w as red isso lved  in  chloroform . The organic phase w as w ashed w ith w ater (2 x 
10 m l) and  then  dried  (M gS 0 4 ). The solvent w as evaporated to afford com pound 171 as 
a  so lid  (0 .38 g, 90% ).
m p : 40 -50  °C (m ethanol);
vmax /c m ' 1 (K B r  peU ets) 3316 (O -H , s), 2926 (C -H , s), 2857 (C-H, s), 1451, 1387;
■H NMR (300 MHz; CDC13) 8  7 .32 (5H, m , H -A r), 4.55 (2H, s, CH 2Ar), 3.87 (1H, 
b road  t, C //O H ), 3 .60  (2H , m , C H 2 O C H 2Ar), 2.85 (1H , broad s, OH);
13C NMR (75 MHz; CDC13) 8  137.8 (A r C - l) , 128.5 (A r), 127.9 (Ar), 127.8 (Ar), 73.6 
(C H 2A r), 72 .0  (C H 2 O C H 2Ar), 70.6 (CH O H );
HRMS ca lcu la ted  for C i8 H 2 20 4  (M N a+) 325.14103, found 325.14131.
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(2S, 3S)-2,3-Bis-benzyloxymethyl-l,4,7,10,13 pentaoxa-
cyclopentadecane (172)181
To a suspension  o f  sodium  hydride (60%  in  parafine oil, 0.30 g, 7.5 m jnol) in dry THF 
(45 m l) w as added com pound 171 (0.52 g, 1.72 m m ol) and the solution was heated at 70 
°C for 1 h. A  so lu tion  o f  bis toluene-4-sulfonic acid 2 -{2 -[2 -(2 -ethoxy)-ethoxy]- 
ethoxy}-ethy l ester (0.90 g, 1.79 m m ol) w as then  added at once, and the solution was 
stirred  at 75 °C for 3 days. The solution w as then filtered o ff  and the filtrate vaporated in 
vacuo. T he crude m aterial w as purified  through (neutral) alum ina chrom atography 
(gradient: petro l ether/propan 2-ol (50:1) then (10:1)). A  second flash silica gel 
chrom atography  in  E tO A c w as perform ed to afford 172 (0.20 g, 25%).
‘H  N M R  (400 M H z; C D C I3) 8  7 .28-7 .24 (5H , m , A r-H ), 4.49 (2H, d, J  7.9 Hz, 
C H 2 A r), 3.83 (2H , m , C H 2 O C H 2Ar), 3.62-3.68 ( 8 H, m , C H 2 CH 2 0 ) ,  3.47 (1H, m, 
C H O );
I3C  N M R  (100  M H z; CDCI3) 8  138.3 (A r C - l) , 128.2 (A r C-3), 127.5 (A r C-2, A r C- 
4), 79 .6  (C H 2 Ar), 73.2 (C H O ), 71.3 (C H 2 0 ) ,  71.0 (C H 2 0 ) ,  70.5 (CH 2 0 ) ,  70.2 (CH 2 0 ) ,
69.8 (C H 2 0 ) ;
m h  (E S + ) 483 .4  [(M N a+), 100% ];
H R M S  calcu lated  for C 2 6H 36 0 7 (M N a+) 483.23667, found 483.23532.
((2 S, 3 S)-3-hy droxy methyl-1,4,7,10,13 pentaoxa-cy clopen tadec-2-y I)- 
methanol (173)18'
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C om pound  172 (0.085 g, 0.17 m m ol) w as d issolved in M eO H  (5 m l) and was 
h ydrogenated  over Pd/C  (20 m g) at r.t. for 16 h. T he solution w as then filtered through 
celite  and  the  solvent w as evaporated to afford  com pound 173 as an oil (0.040 g, 85%).
vmax /cm -1 (KBr film) 3338 (O-H, s), 3217 (O -H , s), 3043 (C-H, s), 2933 (C-H, s), 
2856, 1585, 1251;
*H N M R  (400  M H z ; CDC13) 6  3.75 (2H, m , C H 2 OH), 3.68-3.60 (7H, m , CH 2CH 20 ,  
C H O ), 3.3 (1H , b road  s, OH);
13C  N M R  (125 M H z; CDC13) 6  80.1 (CH O ), 72.5 (CH 2 CH 2OCH), 71.3 
(C H 2 C H 2 O C H ), 70.3 (C H 2 0 ) ,  70.0 (C H 2 0 ) ,  69.4 (C H 2 0 ) ,  60.8 (CH 2OH); 
m /z  (E S + ) 303.2  [(M N a+), 100%];
H R M S  calcu la ted  for C i2H 2 40 7 (M N a+) 303.14142, found 303.14179.
Bis-toluene-4-sulfonic acid-2-{2-[2-(2-ethoxy)-ethoxy]-ethoxy}-ethyl 
ester 181
ch3
P E G 4  (1 .0  g, 5.1 m m ol) w as dissolved in C H 2 C12 (10 m l) w ith  triethylam ine (4 ml). The 
so lu tion  w as cooled  at 0 °C and a solution o f  tosyl chloride (5.9 g, 30.1 m m ol) in 
C H 2 C12 (5 m l) w as added dropw ise. The m ixture w as then stirred at r.t. for 16 h. The 
organ ic  ph ase  w as then  w ashed w ith  w ater ( 2  x 2 0  m l) follow ed by  a saturated sodium  
ch loride so lu tion  (20 m l). The organic phase w as dried (M g S 0 4) and the solvent 
evapora ted  in vacuo. The crude m aterial w as purified through flash silica gel 
ch rom atography  (E tO A c/hexane, 2:1) and the final com pound was azeotroped with 
to luene  to  affo rd  the desired  com pound as an oil (1.87 g, 84%).
vmax /cm -1 (KBr film) 3022 (C-H, s), 2875 (C-H , s), 1597 (C=C, s), 1452 (C=C, s), 
1360;
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*H NMR (400 MHz; CDCI3 ) 5 7.53 (2H, d, J  8.0 H z, A r 2-H), 7.30 (2H, d, J  8.0 Hz, 
A r 3-H ), 4.13 (2H , t, J  4.7 Hz, CH 20 S 0 2A r), 3.65 (2H, t, 7  4.7 Hz, CH 2CH 20 S 0 2Ar), 
3 .55 (4H , m , C H 2 C H 2 0 ) ,  2.41 (3H, s, C H 3Ar);
13C NMR (125 MHz; CDCI3 ) 5 144.7 (A r C-4), 132.8 (A r C -l) , 129.8 (Ar C-3), 127.8 
(A r C -2), 70 .6  (C H 2 0 ) ,  70.4 (C H 2 0 ) ,  69.2 (C H 2 C H 2 0 S 0 2Ar), 6 8 . 6  (C H 2 S 0 2Ar), 21.5 
(C H 3);
HRMS calcu lated  for C 2 2H 3o0 4 S2 (M N a+) 525.12235, found 525.12268.
{6-[3-(6-Methyl-4-oxo-l,4-dihydro-pyrimidin-2-yl)-ureido]-hexyI}- 
carbamicacid l,l,2-trimethyl-2-{6-[3-(6-methyl-4-oxo-l,4-dihydro- 
pyrimidin-2-yl)-ureido]-hexylcarbamoyloxy}-propyl ester (175)
c h 3
r ^ N H  O H H3C CH3
o ^ n^ n ^ n ^ - ^ ^ n Y ° ^ oh
H H Jl lO h 3c  c h 3
Sam e p rocedure  as for com pound 163. C om pound 175 w as obtained in 52%  yield, 
m p : 117-119 °C (chloroform );
Vmax/cm"* (KBr pellets) 3419 (O-H, s), 2925 (C-H , s), 2854, 1701 (C = 0 , s), 1670 ( C = 0 ,s), 
1585 (C = C , s), 1525 (C=C, s) ;
*H NMR (400 MHz; CDC13) 6  13.12 (1H, s, 1-H), 11.83 (1H, s, N //C O N H C H 2), 10.12 
(1H , s, N H C O N //C H 2), 5.83 (1H, s, H -5), 5.10 (1H, s, NH CO O), 3.24 (2H, m , 
N H (C O )N H C //2), 3 .10 (2 H, m , CH2N H C O O ), 2 . 2 1  (3H, s, C //5 C=CH), 1.60-1.28 ( 8 H, m , 
C H 2), 1.16 (6 H , s, C -CH3);
13C NMR (125 MHz; CDC13) 5 173.1 (C-4), 156.9 (N H C O N H ), 156.5 (NHCOO ), 154.7 
(C -2), 148.3 (C -6 ), 106.6 (C-5), 88.7 (C -C H 3), 40.7 (C-10), 39.6 (C-15), 29.7 (CH2), 29.3 
(C H 2), 29 .2 , 26 .1 , 25.5 (C H 3), 23.0 (CH 2), 18.9 (C H 3);
HRMS calcu la ted  for C i0H 33O 5N 4 (M N a+) 434.23739 found, 434.23831.
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8-to7-Butoxycarbonylamino-octanoic acid (177)183
To a  so lu tion  o f  am inocaprilic  acid (1.5 g, 9.4 m m ol) in  w ater (5ml) and C H 2CI2 (5 ml) 
w as added  sod ium  hydroxide (0.752 g, 18.8 m m ol). The solution w as cooled to 0 °C and 
a so lu tion  o f  B oc20  (2.05 g, 9.4 m m ol) in  C H 2 CI2 ( 1 0  m l) was added slowly. The 
so lu tion  w as stirred  at r.t. fo r 16 h. The m ixture w as acidified w ith conc. HC1. The 
organic  layer w as separated  and the aqueous phase w as extracted w ith CH 2 CI2 ( 2  x 2 0  
m l). T he organ ic  phase w ere com bined and dried (M gS O ^. The solvent w as evaporated 
in vacuo and  the crude m aterial w as purified  through flash silica gel chrom atography 
(C H C I3/C H 3C N /C H 3O H , 18:1:1) to afford com pound 177 as a  solid (0.733 g, 30%).
m p: 54-56 °C (chloroform );
vm„  /cm ' 1 (K B r pe lle ts) 3365 (O -H , s, C O O H ), 2934 (C-H , s), 2843, 1714 (C = 0 , s, 
C O O H ), 1683 ( C O ,  s), 1520;
'H  N M R  (400 M H z; CDC13) 8  11.5 (1H , broad s, CO O H ), 4.56 (1H, broad t, 
N H C O O ), 3 .07 (2H , m , C ftN H C O O ), 2.32 (2H, t, J 7 .4  Hz, C / / 2 C 0 0 H ), 1.60 (2H, q, J
7.2 H z, C / / 2C H 2N H C O O ), 1.41 (1 1H, m , C H 3, C H 2), 1.30 (6 H , m, C H 2);
13C  N M R  (100 M H z; CDC13) 8  179.3 (C O O H ), 155.9 (N H CO O ), 79.0 (C-CH 3), 40.4 
(C H 2N H C O O ), 33.9 (C H 2 C O O H ), 29.8 (C H 2 CH 2N H C O O ), 28.9 (C H 2 CH 2COOH, 
C H 2), 28.3 (C H 3), 26.5 (C H 2), 24.5 (C H 2);
H R M S  ca lcu la ted  for C i3H 2 50 4N  (M N a+) 282.16758, found 282.16736.
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(2R, 3S)-2,3-Bis-(8-tert-butoxycarbonylamino-octanoyloxy)-siiccinic 
acid diethyl ester (178)
To a so lu tion  o f  111 (0 .30 g, 1.16 m m ol) in C H 2 C12 ( 1 2  m l) w as added at 0  °C, DCC 
(0 .262 g, 1.27 m m ol) and D M A P (0.052 g). The solution w as stirred at 0 °C for 1 h  and 
d iethyl L-tartrate (0.103 g, 0.50 m m ol) in  C H 2 C12 (3 m l) w as added. The resulting 
so lu tion  w as stirred  at r.t. for 16 h. The solution w as filtered o ff  and the filtrate was 
evapora ted  in vacuo. T he residue w as w ashed w ith  w ater (10 m l) and saturated sodium  
chloride so lu tion  (10 m l) and the organic phase w as dried (M gS 0 4 ). The solvent was 
evapora ted  in vacuo and the crude m aterial w as purified  through flash silica gel 
ch rom atography  (C H C ls/M eO H , 10:1) to give com pound 777  as an oil (0.140 g, 50%)
Vmax /c m ' 1 (K B r  film ): 3370-3360 (N -H , s), 2930 (C-H , s), 1858 (C-H, 5 ), 1755 ( C O ,  
s, ester), 1697 (C = 0 , s), 1529 ,1365 ;
'H NMR (300 MHz; CDCI3 ) 8  4 .55 (1H , broad  t, N H C O O ), 4.18 (2H, q, J  7.1 Hz, 
COOCH2CH3), 3.01 (2H , q, J  6.4 H z, C7/2 N H CO O ), 2.42 (2H, q, J  8.1 H z CH 2 COO), 
1.60 (2H , m , C7/2 C H 2 C O O ), 1.41-1.42 (12H , m , C / /2 C H 2NH CO O , C-CH 3), 1.28 (6 H, 
m , C / / 2 C H 2 C H 2C O O , C H 2), 1.22 (3H , 1 ,7 7 .1  H z, C H 2 C tfj);
,3C NMR (75 MHz; CDCI3 ) 8  172.4 (C O O C H ), 165.9 (C O O C H 2C H 3), 156.0 
(N H C O O ), 79 .0  (C -C H 3), 70.6 (CH ), 62.1 (C H 2C H 3), 40.5 (CH 2NH), 33.6 
(C H 2 C O O C H ), 30.0 (C H 2 CH 2N H C O O ), 28.8 (C H 2C H 2 C H 2CO O ), 28.4 (C-CH 3), 26.5 
(C H 2), 24 .6  (C H 2), 14.1 (C H 2 CH3);
mIz (ES+) 689.7  [(M H +), 100% ], 711.7 [(M N a+), 20% ];
HRMS ca lcu la ted  for C34H 6oOi2N 2 (M N a+) 711.40385, found 711.4048.
EtOOC H COOEt
O H-y— o 
V o  o^ :
o o
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2,3-Bis-{8-[3-(6-methyl-4-oxo-l,4-dihydro-pyrimidin-2-yl)-iireido]-
octanoyloxyj-succinic acid diethyl ester (176)
ch3
C om pound  178 (0.131 g, 0.19 m m ol) w as dissolved in  C H 2CI2 (10 m l) and TFA (10 
m l). T he so lu tion  w as stirred at r.t. for 2h, and the solvents w ere evaporated in vacuo. 
T he rem ain ing  salt (179) w as dried under reduced pressure for 16 h. Com pound 179 
(0.121 g, 0 .17 m m ol) w as dissolved in  TH F (15 m l) and triethylam ine (0.2 ml). To this 
so lu tion  w as added diethyl L-tartrate (0.192 g, 1.0 m m ol), and the solution w as heated at 
reflux  for 16 h. The solid w as filtered o f f  and the filtrate w as evaporated under reduced 
pressure. T he residue w as purified  through flash silica gel chrom atography 
(C H C l3/M eO H , 10:1) to g ive 176 as a solid  (0.107 g, 80% );
m p: 100-102 °C;
vmax /c m ' 1 (K B r  pe lle ts) 3478 (N-H, s \  3415 (N -H , s), 3227 (N-H, 5), 2935 (C-H, s), 
2856  (C -H , 5 ), 1751 (C = 0 , 5, ester), 1701 (C = 0 , 5, ester), 1666 (C = 0 , 5, urea), 1589, 
1521, 1256;
*H N M R  (500 M H z; CDC13) 5 13.11 (1H, s, 1-H), 11.83 (1H, s, 7-H), 10.15 (1H, s, 9- 
H ), 5 .80 (1H , s, 5-H ), 5.69 (1H, s, CH ), 4.21 (2H, q, J 7.1 H z, C O O C //2 CH3), 3.21 (2H, 
b road  t, N H C O N H C //2), 2.38 (2 H, m , C H 2 CO O), 2 . 2 2  (3H, s, CH 3), 1.62 (2 H, m, 
C / / 2 C H 2 C O O ), 1.58 (2H , m , C / / 2 C H 2N H C O N H ), 1.33 (6 H, m , CH 2), 1.24 (3H, t, J 7 .2  
H z, C O O C H 2 C //3);
13C  N M R  (75 M H z ; CDC13) 6  172.9 (C-4), 172.4 (CO O ), 165.9 (CO O CH 2 C H 3), 156.5 
(N H C O N H ), 154.7 (C-2), 148.2 (C-6 ), 106.6 (C-5), 70.6 (CH), 62.2 (CO O CH 2C H 3), 
39.9  (N H C O N H  CH 2), 33.8 (C H 2 CO O ), 29.4 (C H 2CH 2N H CO N H ), 28.9
(C H 2 C H 2 C H 2 C O O ), 28.8 (C H 2 CH 2 CH 2 C H 2N H C O N H ), 26.7 (CH 2CH 2 CH 2NH CO N H ),
24.7  (C H 2 C H 2 C O O ), 18.9 (C H 3), 14.1 (C H 2 CH 3); 
m /z  (E S + ) 791.6  [(M H +), 100%], 813.5 [(M N a+), 40% ];
H R M S  calcu la ted  for C 36H 54 0 i2N 8 (M N a+) 813.37534, found 813.37343.
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6.5 Synthesis of Cytosine Derivatives
^ -(2 -0 x 0 -! , 2-dihydro-pyrimidin-4-yl)-acetamide (187)191
C ytosine (2 .0  g, 1.8 m m ol) w as m ixed  w ith  acetic anhydride (8.2 m l, 8.7 m m ol) in 
p y rid ine  (10 m l) and the solution w as heated at 125 °C for 2.5 h. The solution was then 
coo led  dow n to r.t. and E tO A c (15 m l) w as added. The resulting m ixture was stirred at 
r.t. fo r an  additional 3 h  and the solid  w as filtered o f f  in vacuo. The w hite pow der was 
w ashed  tho rough ly  w ith  E tO A c and dried in vacuo to afford 187 as a white solid (2.97
m p  >  300 °C (EtO A C );
v r a / c m '( K B r  p e lle t)  3140 (N -H ,s ) , 3130 (N -H ,s ) , 3025 (C=C-H, s), 2 9 6 9 (C -H ,s), 
2838 (C -H , s), 1722 (C = 0 , s), 1702 (C = 0 , s), 1610 (N-H am ide, d), 1503, 1462 (C-H, 
<0 ;
I3C  N M R  (100  M H z; D M SO -rf*  353 K ) 5 170.1 (N H C O C H 3), 162.6 (C-4), 155.5 
(N H C O N H ), 146.3 (C -6 ), 94.1 (C-5), 23.7 (C H 3); 
m /a  (E S -) 152.02 [(M -H +), 100% ];
H R M S  calcu lated  f o rC 6H 7 0 2N 2 (M N a+) 176.04305, found 176.04279.
A-( 1 -Hexyl-2-oxo-l ,2-dihydro-pyrimidin-4-yI)-acetaniide (188)
To a so lu tion  o f  com pound 187 (0.5 g, 3.2 m m ol) in dry DM F (15 m l) w as added 
po rtionw ise  anhydrous potassium  carbonate (0.675 g, 4.9 m m ol) followed w ith
g, 93% ).
N M R  (400 M H z; DM SO-rf*) 5 11.49 (1H, s, NT/), 10.75 (1H, s, N //C O C H 3), 7.80 
(1H , d, J  7 .0  H z, C7/CH N H ), 7.08 (1H , d, J  7.0 H z, C //N H ), 2.23 (3H, s, CH3);
H
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b rom ohexane  (0.70 m l, 4.9 m m ol). The solution w as heated at 80 °C for 16 h. The 
residua l solid  w as then  filtered o ff  and the filtrate evaporated under reduced pressure. 
T he so lid  w as then redissolved in CHCI3 and w ashed  w ith ( I N )  HC1 (10 ml) then w ater 
( 1 0  m l) and finally  w ith saturated sodium  chloride solution ( 1 0  m l) and the organic 
phase  w as d ried  over M gSCV The solvents w ere evaporated in vacuo and the crude 
so lid  w as pu rified  over flash chrom atography (C H C f/E tO A c, 5:1) to give com pound 
188 as a  w h ite  solid  (0.57 g, 75% ).
m p : 129-130 °C (chloroform );
Vmax/cm' 1 (K B r  p e lle ts )  3232 (N -H , s), 2950-2920 (C-H, s), 2848 (C-H, s), 1704 (C = 0 , 
s), 1660 (C = 0 , s);
*H N M R  (400  M H z ; C D C I3 ) S 10.34 (1H, s, N H), 7.56 (1H, d, J  7.2 Hz, 5-H,), 7.38 
(1H , d , J  7 .2  H z, 6 -H), 3 .84 (2H , t, J  7.0 H z, C H 2C // 2N ), 2.33 (3H, s, COCH3), 1.74 
(2H , m , C7/2 C H 2 N), 1.32 (6 H, m , 3 x C H 2 CH2), 0.85 (3H, t, J  7.1 Hz, C7/2CH2);
13C  N M R  (75 M H z ; C D C I3 ) 8  171.3 (C O C H 3), 162.9 (C-4), 155.8 (C-2), 148.6 (C-6 ),
96.8 (C -5), 51.0 (C H 2N), 31.3 (C H 3 C H 2 CH 2 ), 29.0 (C H 2 CH 2N), 26.1 (CH 2C H 2 CH 2N),
24.8 (C H 3 CO ), 22.4 (C H 3 CH 2 ), 13.9 (C H 3 C H 2);
m /z  (E S + ) 238 [(M H +), 20% ], 260 [(M N a+), 50% ], 497 [(2M N a+), 100%];
H R M S  calcu lated  for C 12H 19N 3O 2 (M H +) 238.1500 found 238.15544.
4-Amino-l-hexyl-l/f-pyrimidin-2-one (189)
C om pound  188 (0 . 1 0  g, 0 .40 m m ol) w as d issolved in a solution o f  am m onia in M eOH 
(7N ) (15 m l). T he solution w as stirred a t r.t. in  a sealed tube for 48 h. T he com pletion o f  
the  reac tio n  w as follow ed by  TLC (C H C f/M eO H , 5:1) and the solution was evaporated 
in vacuo to  a ffo rd  a  crude solid. Purification over flash chrom atography (CH C li/M eO H , 
7 :1) affo rded  com pound 189 (0.052 g, 63% ).
m p : 216-217 °C  (m ethanol);
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Vmax/cm'^KBr pellets) 3350 (N-H, prim ary am ine, 5 ), 3105 (C=C-H, s), 2930 (C-H, s), 
2856, 1664 (C = 0 , s), 1620 (N-H, d);
' H N M R  (300 M H z; C D C b ) 6 7.22 (1H, d, J  7.2 Hz, C //C H N ), 5.68 (1H, d, J 1 2  Hz, 
C H C //N ), 5 .67 (2H , broad s, N / /2), 3.73 (2H, t, J  7.3 Hz, C f tN ) ,  1.68 (2H, m , 
C 7 /,C H ,N ), 1.28 (6H , m, C f tC H j) ,  0.88 (3H, t, J  1 2  H z, C H 3);
13C  N M R  (75 M H z; CDC13) 6  165.4 (C-4), 156.4 (C = 0 ), 145.8 (C-6), 93.7 (C-5),
50.3 (C H 2N ), 31.4  (C H 3 C H 2 CH 2), 29.1 (C H 2 C H 2N), 26.2 (CH 2 CH 2 CH 2N), 22.6 
(C H 3 C H 2 ), 14.0 (C H 3);
m /z (E S + ) 196.15 [(M H +), 100% ], 218.15 [(M Na+), 95% ], 391.5 [(2 M H +), 80% ], 413.5 
[(2M N a+), 85% ], 586.74 [(3MH+), 5% ], 508.74 [(3M Na+), 20% ];
H R M S  calcu lated  for C 10H i7O N 3 (M H +) 196.14444, found 196.14486.
l-Hexyl-3-(l-hexyl-2-oxo-l,2-dihydro-pyrimidin-4-yl)-urea (181)
O N N N
To a so lu tion  o f  com pound 189 (0.10 g, 0.51 m m ol) in dry  pyridine (5 m l) w as added 
hexy lisocyanate  (0 .110 m l, 0.769 m m ol). The resulting yellow  solution w as heated at 90 
°C fo r 16 h. The solution w as then cooled dow n to r.t. and addition o f  hexane (5 ml) 
a llow ed  precip ita tion  o f  a  w hite solid w hich w as then filtered o f f  in vacuo. The solid 
w as pu rified  through flash chrom atography colum n (CH Cls/M eO H , 15:1) to give 
com pound  181 as w hite  needles (0.128 g, 78%).
mp: 210-211 °C (chloroform );
v max/cm-1 (KBr pellet) 3221 (N -H , s), 3057 (C=C-H, s), 2925 (C-H, s), 2856, (C-H, s), 
1701 (C = 0 , s), 1658 (C = 0 , s), 1620 (N -H , d), 1564 (N-H, d);
'H N M R  (500  M H z; CDC13; 298 K) (conformer 181) 6  10.90 (1H, s, 7-H), 8.98 (1H, 
s, 9-H ), 7 .54 (1H , broad  d, 5-H), 7.42 (1H , d, J  7 .4  H z, 6 -H), 3.79 (2H, t, J 7 .2  Hz, 16-
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H ), 3 .22 (2H , broad  q, 10-H), 1.71 (2H, m , 17-H), 1.54 (2H, m , 11-H), 1 . 3 3  (2 H , m ,  18- 
H ), 1.32 (2H , m , 12-H), 1.29 (12H, m , 13-H, 14-H, 19-H, 20-H), 0.87 (3H, m, 15-H), 
0 .85 (3H , m , 21-H );
'H NM R (500 MHz; CDCh; 254.6 K) (conformer 181 (19:1)) 8  11.08 (1H, s, 7-H),
9.03 (1H , s, 9-H ), 7.53 (1H , broad d, 5-H ), 7.46 (1H , d, J  7.4 H z, 6 -H), 3.81 (2H, t , J 7 . 2  
H z, 16-H ), 3.21 ((2H , broad  q, 10-H), 1.70 (2H, m , 17-H), 1.28 (8 H, m , 13-H, 14-H, 19- 
H , 20-H ), 0 .86 (3H , m , 15-H), 0.84 (3H, m , 21-H ); (conformer 181' (1:19)) 8  9.72 (1H, 
s, 9-H ), 9 .65 (1H , s, 7-H ), 7.40 (1H, broad d, 6 -H ), 6.14 (1H, broad d, 5-H);
13C NMR (125 MHz; CDC13; 298 K) (conformer 181) 8  164.9 (C-4), 157.2 (C-2),
154.3 (N H C O N H ), 146.6 (C -6 ), 97.2 (C-5), 50.7 (C-16), 40.1 (C-10), 31.53 (C-13),
31.3 ( C - l9), 29 .3  ( C - l l ) ,  28 .9  (C -17), 26.6 (C-12), 26.10 (C-18), 22.6 (C-14), 22.4 (C- 
2 0 ), 14.0 (C -2 1 ), 13.9 (C-15);
‘H NMR (500 MHz; DMSO-rf4; 333 K) (conformer 181') 8  9.55 (1H, s, 7-H), 8.81 
(1H , s, 9-H ), 7.85 (1H , d, 6 -H), 6.22 (1H, broad d, 5-H), 3.72 (2H, t, 16-H), 3.16 (2H, 
m , 10-H), 1.60 (2H , m , 17-H), 1.47 (2H, m , 11-H), 1.31 (4H, m , 12-H, 18-H), 1.29 (4H, 
m , 13-H, 14-H), 1,27 (4H , m , 19-H, 20-H ), 0.86 (6 H, m , 15-H, 21-H);
15N NMR (51 MHz, CDC13) (conformer 181) 8  -2 8 2 .9  (N-9), -254.0 (N-7), -225.8 
(N - l) ;
l3C NMR (125 MHz; DMSO-rf*; 333 K) (conformer 181') 8  162.1 (C-4), 153.8 
(N H C O N H ), 153.3 (C -2), 147.9 (C -6 ), 93.8 (C-5), 48.9 (C-16), 38.8 (C-10), 30.5 (C- 
13), 30 .4  ( C - l9), 28.9 ( C - l l ) ,  27.9 (C-17), 25.6 (C-12), 25.1 (C-18), 21.6 (C-14), 21.5 
(C -20), 13.4 (C -21), 13.3 (C-15);
,3C CPMAS NMR (75 MHZ) (conformer 181) 8  165.7 (C-4), 157.4 (C-2), 155.1 
(N H C O N H ), 150.1 (C -6 ), 96.3 (C-5), 49.3 (C -16), 40.8 (C-10), 34.1 (C-13, C-19), 32.3 
(C -l 1), 31.8 (C -17), 29.5 (C-12, C-18), 24.7 (C -14), 24.2 (C-20), 15.0 (C-15, C-21);
15N CPMAS NMR (30 MHZ) (relative to M e N 0 2) 8  -280.9 (N-9), -253.8 (N-7), -223.9 
(N - l) ,  -163 .8  (N -3);
m /z (ES+) 323 [(M H +), 100% ], 280 [(M H +-C 3H 7), 55% ];
HRMS ca lcu la ted  for C 17H 30O 2N 4  (M H +) 323.24469, found 323.24362.
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6-Brom o-hexan-l-ol203
To a solution o f borane sulfide (2 N in THF, 1.6 ml, 3.3 mmol) was added at 0 °C a 
solution o f 6 -bromohexanoic acid (0.5 g, 2.5 mmol) in THF (5 ml). The solution was 
stirred at r.t. for 16 h. The solution was quenched by addition of EtOH (10 ml) followed 
by water (10 ml). The solution was then extracted with CH2 CI2 (3 x 10 ml) and the 
combined organic phases were dried (MgS0 4 ). The solvent was evaporated in vacuo 
and the crude material was then purified through flash chromatography column 
(hexane/EtOAc, 8:1) to afford the desired compound as an oil (0.36 g, 80%).
vm„/cm‘' (KBr film) 3300 (O-H, s), 2922-2850 (C-H, s), 1460 (C-H, d), 561 (C-Br, s); 
'H NMR (300 MHz; CDCI3) S 3.60 (2H, t, J 6.5 Hz, C tf2OH), 3.39 (2H, t, J  6 . 8  Hz, 
C tf2Br), 1.85 (2H, m, C //2 CH2 OH), 1.65 (1H, s, OH), 1.56 (2H, m, Ctf2 CH2Br), 1.41 
(4H, m, CH2CH2);
13C NMR (75 MHz; CDCI3) 5 62.7 (CH2OH), 33.8 (CH2Br), 32.7 (CH2CH2 OH), 32.5 
(CH 2 CH2 Br), 27.9 (CH2 CH2 CH2 Br), 24.9 (CH2 CH2 CH2 OH);
HMRS calculated for C6H 14OBr (MH+) 181.02280, found 181.02316.
2-(6-Bromo-hexyloxy)-tetrahydro-pyran (194)204
To a solution o f 6 -bromo hexan-ol (2 g, 11 mmol) in CH2 CI2 (50 ml) was added 
dropwise DHP (1.6 ml, 16.5 mmol) followed by PTS (0.075 g). The reaction mixture 
was stirred at r.t. for 16 h. The dark blue solution was then washed with water (2 x 25 
ml) then saturated hydrogen carbonate solution (25 ml) and finally with a saturated 
sodium chloride solution (25 ml). The organic phase was then dried (MgSCU) and the 
solvent was evaporated under reduced pressure. The crude material was then purified
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through flash silica gel chromatography (hexane/EtOAc, 10:1) to afford compound 194 
as an oil (0.5 g, 70%).
v „ / c m ‘' (KBr film) 2937-2864 (C-H, s), 1136 (C -0 , 5 ), 1118 (C-O, s);
'H NMR (300 MHz; CDCI3) 6 4.52 (1H, dd, J  4.3 Hz, OCHO), 3.81 (1H, ddd, 
CH/TOCH), 3.67 (1H, dt, CHTTOTHP), 3.41 (1H, ddd, CHTTOCH), 3.36 (3H, m, 
CHTTOTHP, C/T2Br), 1.82 (2H, m, C7T2CH2Br), 1.36-1.56 (12H, m, CH2C7T2CH2);
13C NMR (75 MHz; CDCI3) 5 98.8 (OCHO), 67.3 (CH2OTHP), 62.5 (CH2OCH), 34.6 
(CH2Br), 33.8 (CH2CH2Br), 31.5 (CH2CHO), 30.7, 29.5, 27.9, 25.4, 20.7; 
m/z (ES+) 287.08 [(MNa+), 100%];
HMRS calculated for Cn H2,0 2Br (MNa+) 287.06171, found 287.06140.
Ar-{2-Oxo-l-[6-(tetrahydro-pyran-2-yloxy)-hexyl]-l,2-dihydro- 
pyrimidin-4-yl}-acetamide (195)
O' 'U' ^  ^  "'XN''5V  O
H
To a suspension o f compound 187 (0.56 g, 3.00 mmol) in DMF (40 ml) was added 
anhydrous potassium carbonate (0.62 g, 4.50 mmol). The mixture was stirred at r.t. for 
30 min and compound 194 (1.2 g, 4.5 mol) was added. The solution was then heated at 
80 °C for 48 h. The solution was cooled down, the residue was filtered off and the 
filtrate was concentrated in vacuo. The residue was redissolved in chloroform (50 ml) 
and washed with water (2 x 3 0  ml), then saturated sodium chloride solution (2 x 30 ml). 
The solution was dried (MgSCU) and the solvent was evaporated under reduced 
pressure. The crude material was then purified through flash silica gel chromatography 
(CHCls/MeOH, 10:1) to afford compound 195 as a yellow oil (0.690 g, 68%).
Vmax/cm-1 (KBr film) 3014 (C=C-H, s), 2862 (C-H, s), 1712 (C=0, s), 1660 (C = 0 ,.?);
'H NMR (300 MHz; CDC13) 6 10.57 (1H, s, NTT), 7.56 (1H, d, J  7.3 Hz, 5-H), 7.36 
(1H, d, J  7.2 Hz, 6-H), 4.50 (1H, m, OCTTO), 3.82 (3H, m, CTTHOCH, CTT2N), 3.63
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(1H, m, C //H 2 OTHP), 3.40 (1H, m, C//HOCH), 3.30 (1H, m, CH//OTHP), 2.20 (3H, s, 
CH3), 1.70 (4H, m, C //2 CH2N, CH2 (THP)), 1.50-1.30 (10H, m, C //2CH2);
13C N M R (75 M Hz; CDCI3) 8  171.56 (COCH3), 163.04 (C-4), 155.82 (C-2), 148.6 (C- 
6 ), 98.8 (OCHO), 96.9 (C-5), 67.28 (CH2OTHP), 62.41 (CH2 OCHO), 50.91 (CH2N), 
30.74 (CH 2 CHO), 29.50, 28.84,26.29,25.83,25.42,24.76,19.70 (CH3); 
m/z (ES+) 360.28 [(MNa+), 100%], 697.69 [(2MNa+), 20%];
H RM S calculated for C 17H 2 8N 3 0 4  (MNa+) 360.18938, found 360.18940.
4-Amino-l-[6-(tetrahydro-pyran-2-yloxy)-hexyl]-lH-pyrimidin-2-one
(196)
x  XO ^ N  NH2
Compound 196 (0.44 g, 1.3 mmol) was dissolved in a solution o f ammonia in MeOH (7 
N) (50 ml). The mixture was stirred at r.t. for 16 h. After completion o f the reaction the 
solvent was evaporated under reduced pressure and the crude material was purified over 
flash silica gel chromatography (CHCl3/MeOH, 10:1) to give compound 196 as a semi­
solid (0.25 g, 65%).
V m ai/cm '1 (K B r film) 3480 (N-H, primary amine, s), 3400 (N-H, primary amine, 5 ), 
2950 (C-H, s) 2860 (C-H, 5 ), 1651 (C=0, s);
'H  N M R (400 M Hz; CDC13) 8  7.14 (1H, d, J  7.2 Hz, 6 -H), 5.76 (1H, d, J  7.2 Hz, 5- 
H), 4.51 (1H, m, OC//HO), 3.80 (1H, m, C//HOCH), 3.68 (3H, m, C//HOTHP, Ctf2N), 
3.41 (1H, m, CH7/OCH), 3.33 (1H, m, CH/70THP), 1.29-1.66 (14H, m, CH2 C //2 CH2); 
13C N M R  (125 M Hz; CDCI3) 8  166.0 (C-4), 156.8 (C-2), 145.1 (C-6 ), 98.8 (CH), 94.5 
(C-5), 67.3 (CHjOTHP), 62.4 (CH2 OCH), 50.3 (CH2 N), 30.6 (CH2 CHO), 29.4, 29.0, 
26.3, 25.8, 25.3, 19.6;
m/z (ES+) 296.21 [(MH+), 20%], 318.21 [(MNa+), 100%], 591.49 [(2MH+), 60%]; 
H RM S calculated for Ci5H2 6N3 0 3 (MNa+) 360.17881, found 360.17997.
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l-H e x y l-3 -[ l- (6 -h y d r o x y -h e x y l)-2 -o x o - l,2 -d ih y d r o -p y r im id in -4 -y l]-  
u r e a  (1 9 7 )
To a solution o f compound 196 (0.50 g, 1.70 mmol) in dry pyridine ( 6  ml) was added 
dropwise hexylisoycanate (0.32 g, 2.5 mmol). The solution was heated at 90 °C for 16 h. 
The solvent was then evaporated in vacuo. The crude solid was redissolved in CHCI3 
(10 ml), washed with water (5 ml) then saturated sodium chloride solution (5 ml) and 
dried (MgSC^). The solvent was evaporated under reduced pressure to afford a crude 
solid (0.50 g). The solid was dissolved in a mixture o f MeOH (15 ml), THF (3 ml) and 
conc. HC1 (3 ml). The solution was stirred at rt. for 16 h and the solvents were 
evaporated in vacuo. The residue was purified through flash silica gel chromatography 
(CHCb/MeOH, 9:1) to afford compound 197  (0.170 g, 30%).
mp: 166 °C (methanol);
Vmax/cm' 1 (KBr pellet) 3219 (O-H, s), 3055 (C=C-H, s), 2929 (C-H, s), 2856 (C-H, s), 
1701 (C = 0, s), 1654 (C =0, s), 1622 (C=C, s), 1430 (O-H, d), 1053 (C -0 ,s, OH);
‘H NMR (400 MHz; CDC13) 5 10.91 (1H, s, 7-H), 8.94 (1H, s, 9-H), 7.54 (1H, d 
broad, 5-H), 7.42 (1H, d, 7 7.4 Hz, 6 -H), 3.81 (2H, t, J 7 .2  Hz, CHjN), 3.62 (2H, t, J 6.4 
Hz, C //2 OH), 3.23 (2H, broad q, Ci^NHCONH), 1.74 (2H, m, C7/2CH2N), 1.55 (4H, 
m, C //2 CH 2NHCONH, C //2 CH2 OH), 1.41-1.28 (12H, m, C //2CH2), 0.86 (3H, t, J  6 . 6  
Hz, CH3);
13C NM R (100 M Hz; CDCI3) not concentrated enough 
m/z (ES+) 362.46 [(MH+) 100%];
HRMS calculated for C i7H3 oN4 0 3  (MH+) 361.22101, found 361.22137.
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4-Pyren-l-yl-butyric acid 6-[4-(3-hexyl-ureido)-2-oxo-2H-pyrimidin-l- 
yl]-hexyl ester (193)
To a solution o f pyrene butyric acid (0.05 g, 0.17 mmol) in CH2 CI2 (5 ml) was added at 
0 °C, DCC (0.044 g, 0.210 mmol) and DMAP (4 mg). The mixture was stirred for 1 h. 
Compound 197 was then added to the mixture and the solution was stirred at r.t. for 16 
h. The solid was filtered off and the filtrate washed with water (2 x 10 ml) then 
saturated sodium chloride solution (5 ml). The organic phase was then dried (MgS0 4 ) 
and the solvent evaporated in vacuo. The crude solid was purified using flash silica gel 
chromatography using a gradient: 1) (CHCI3 ) 2) (CHCE/EtOAc, 5:1) and 3) 
(CHCls/EtOAc/EtsN, 5:1:0.2). Compound 193 was obtained as a yellow solid (0.025 
mg, 23%).
mp: 114-115 °C (chloroform);
Vmw/cm' 1 (KBr pellet) 3212 (N-H, s), 3047 (C=C-H , s), 2927 (C-H, s), 2857 (C-H, 5 ), 
1736 (C = 0, s), 1702 (C = 0 ,s), 1659 (C=0, s), 1620 (C=C, d);
'H NM R (400 MHz; CDCI3) 6  10.87 (1H, s, 7-H), 8.97 (1H, s, 9-H), 8.28-7.82 (10H, 
m, Pyrene-H), 7.50 (1H, broad d, 5-H), 7.27 (1H, d, J  7.2 Hz, 6 -H), 4.05 (2H, t, J  6 . 6  
Hz, CH2OCO), 3.70 (2H, t, J  7.2 Hz, CH2N), 3.38 (2H, t, J  7.6 Hz, C //2 -pyrene), 3.23 
(2H, m, C //2NHCONH), 2.44 (2H, t, J  7.4 Hz, CH2COO), 2.18 (2H, t, J  7.6 Hz, 
C //2 CH 2 COO), 1.66-1.55 (6 H, m, C7/2 CH2OCO, C7/2CH2N, C //2 CH2NHCONH), 1.32- 
1.27 (10H, m, C //2 CH2), 0.85 (3H, t, J  6.7 Hz, CH3);
,3C NMR (100 MHz; CDC13) 8  173.5 (COO), 165.0 (C-4), 154 (NHCONH), 146.4 (C- 
6 ), 135.6 (C-33), 131.3, 130.7, 129.9, 128.6, 127.4, 127.3, 127.2, 126.6, 125.8, 125.0, 
124.0, 124.8, 124.7, 124.6, 123.2, 98.9 (C-5), 64.1(COOCH2), 50.4 (CH2N), 40.0 
(CH 2NHCONH), 33.8 (CH2-Ar), 32.6 (CH2COO), 31.5 (NHCONHCH2CH2 CH2), 29.3 
(CH 2 CH 2N), 28.7 (CH2), 28.3 (CH2), 26.7 (CH2), 26.6 (CH2), 26.0 (CH2CH2CH2N),
25.5 (CH2), 22.5 (CH2), 14.0 (CH3);
HRMS calculated for C3 7H4 4 0 4N4  (MH+) 631.32548 found 631.32640.
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202Hexanoic acid 2,5-dioxo-pyrrolidin-l-yi ester (192)
o
To a solution o f hexanoic acid (0.2 g, 1.7 mmol) in THF (5 ml) was added at 0 °C DCC 
(0.391 g, 1.890 mmol). The solution was stirred for 30 min and NHS (0.215 g, 1.870 
mmol) was added to the cooled solution. The mixture was stirred at r.t. for and 16 h. 
The solid was filtered off in vacuo. Ether (15 ml) was added to the filtrate solution to 
precipitate residual urea and the solid was filtered off. The solvent was evaporated in 
vacuo to give crude compound 192 (0.290 g, 80%) as a white solid, which was used in 
the next step without further purification.
Vmax/cm'1 (KBr pellet) 2935 (C-H, s), 2860 (C-H, s), 1728 (C=0, s), 1787 (C =0-N, a); 
'H NM R (CDC13; 300 MHz) 8  2.72 (4H, s, C7/2 CON), 2.50 (2H, t, q J  7.4 Hz, 
CH2COO), 1.64 (2H, q, 7  7.4 Hz, CH2CH2COO), 1.30 (4H, m, CH2CH2CU3), 0.83 (3H, 
t, J 7 .0  Hz, CH3).
Hexanoic acid (l-hexyl-2-oxo-l,2-dihydro-pyrimidin-4-yl)-amide (191)
H
Compound 189 (0.22 g, 1.13 mmol) was added to a solution of 192 (0.29 g, 1.36 mmol) 
in CH 2 CI2 ( 8  ml). The solution was stirred at r.t. for 16 h. The solvent was evaporated in 
vacuo and the residue was redissolved in chloroform and washed with water ( 1 0  ml) 
then saturated sodium chloride solution (10 ml). The organic phase was dried (MgS0 4 ) 
and the solvent evaporated in vacuo. The crude material was purified through flash 
silica gel chromatography (CHCls/MeOH, 7:1) to give compound 191 as a white solid 
(0.33 g, 70%). 
mp: 178-180 °C;
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Vmax/cm'1 (KBr pellet) 3276 (N-H, 5), 3236 (N-H, s), 3045 (C=C-H, s), 2953 (C-H, s), 
2923 (C-H, s), 2856 (C-H, s), 1701 (C=0, s), 1650 (C = 0 ,5 ), 1570 (C=C-H, d);
'H NMR (CDCb; 400 MHz) 6 10.21 (1H, s, NH), 7.56 (1H, d, J  7.3 Hz, 5-H), 7.37 
(1H, d, 7 7 .2  Hz, 6-H), 3.81 (2H, 1,7 7.4 Hz, CH2N), 2.50 (2H, t, 77 .6  Hz, CftCONH),
1.68 (2H, m, C //2CH2N), 1.60 (2H, m, C //2CH2CONH), 1.25 (12H, m, C7/2CH2), 0.81 
(6H, m, C'H2C //j);
13C NMR (CDCI3 ; 75 MHz) 8 174.4 (CONH), 162.8 (C-4), 155.7 (C-2), 148.6 (C-6),
96.6 (C-5), 49.9 (CH2N), 37.1 (CH2CONH), 31.2 (CH2), 31.1 (CH2), 28.7 (CH2CH2N), 
26.0 (CH2), 24.4 (CH2CH2CONH), 22.3 (CH2), 22.2 (CH2), 13.9 (CH3), 13.7 (CH3); 
mlz (ES+) 294 [(MH+), 100%];
HRMS calculated for Ci6H27N30 2 (MNa+) 316.19955, found 316.1999.
4- Pyren-l-yl-butyric acid 2,5-dioxo-pyrrolidin-l-yl ester (199)205
To a solution o f pyrene butyric acid (0.50 g, 1.73 mmol) in DMF (8 ml) was added at 0 
°C DCC (0.357 g, 1.73 mmol) and NHS (0.219 g, 1.90 mmol). The solvent was 
evaporated under reduced pressure. The residue was purified through flash silica gel 
chromatography (EtOAc) to give compound 199 as a pale yellow solid (0.40 g, 60%).
mp: 128-130 °C (EtOAc);
vmax/cm_1 (KBr pellets) 3030 (C-H, s), 2935 (C-H, s), 1818, 1788 (C=0, s), 1728 (C O ,
s);
'H NMR (300 MHz; CDC13) 8 8.30-7.80 (9H, m, pyrene-H), 3.47 (2H, t, 7  7.3 Hz, 
CH2-Ai ), 2.84 (4H, broad s, CH2C.ON), 2.74 (2H, t, 77 .3  Hz, CH2COO), 2.28 (2H, q, 7  
7.3 Hz, C //2CH2COO);
13C NMR (75 MHz; CDCI3) 8 169.2 (NCO), 168.6 (COO), 134.9 (Ar C -l), 131.4, 
130.9, 130.2, 128.7, 127.6, 127.5, 126.9, 125.9, 125.1, 125.0, 124.9, 124.8, 123.2, 33.8 
(CH2-Ar), 32.2 (CH2COO), 26.4 (CH2CH2COO), 25.6 (CH2CON);
HRMS calculated for C 2sH2 i0 4 N (MNa+) 408.12063, found 408.12073.
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Polymer incorporating the cytosine moiety (202)
To a solution o f compound 189 (0.400 g, 2.0 mmol) in dry CH2 CI2 (35 ml) was added 
7V,vV-carbonyldiimidazole (0.52 g, 2.05 mmol). The solution was stirred at r.t. for 16h. 
The solvent was evaporated and the residue was redissolved in dry chloroform. Hexane 
was added to precipitate the final material, which was dried in vacuo and was used 
directly without further purification. PEG terminated amine (0.58 g, 0.17 mmol) was 
dissolved in dry THF (35 ml) and the imidazole intermediate (0.200, 0.70 mmol) was 
added. The solution was stirred at reflux for 16 h. The solvent was evaporated and the 
residue was redissolved in chloroform. The organic phase was washed with water (25 
ml), followed with saturated sodium chloride solution (25 ml). The organic phase was 
dried over MgSC>4 and the solvent evaporated in vacuo. Purification over flash silica gel 
chromatography (CHCb/MeOH, 7:1) gave polymer 202 (0.380 g, 60%).
mp: 46 °C;
Vmaj/cnT1 (K B r pellets): 3230 (N-H, s), 3010, 2880 (C-H), 1721 (CO, s), 1651 (CO, 
urea), 1568 (C-H), 1504;
'H  N M R  (CDClj, 500MHz) 5 10.73 (1H, s, N//CONHCH2), 9.15 (1H, s, 
N H CO N //CH 2), 7.42 (1H, d, J  7.3 Hz, 6 -H), 3.78 (2H, t, J  7.4 Hz, CH2N), 3.75-3.60 
(170H, m, CH 2 C //,0 ) , 1.70 (2H, m, C //2 CH2N), 1.30 (6 H, m, CH2CH2), 0.87 (3H, t, 
C/7,);
l3C N M R  (CDCI3 , 125 M Hz) 8  164.2 (C-4), 156.7 (C-2), 154.3 (NHCONH), 146.7 (C- 
6 ), 96.7 (C-5), 70.4 (CH2 0), 70.3 (CH2 0 ), 69.4 (CH2 0), 50.5 (CH2N), 39.4 
(NHCONHCH2), 31.1 (CH2), 28.7 (CH2), 25.9 (CH2), 22.2 (CH2 0 ), 13.98 (CH3);
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Polymer incorporating the Upy moiety (203)
c h 3
i |_ | |_|
o^ n^ nA n^ M ^ NY NY NT °O H N ^ J
CH3
Compound 139 (0.5 g, 2.3 mmol) was suspended in dry THF (30 ml) and PEG 
terminated amine was added (1.94 g, 0.57 mmol). The solution was heated under reflux 
conditions for 16 h, and the solvent was evaporated in vacuo. The residue was 
redissolved in chloroform and washed with water (30 ml) then with a saturated sodium 
chloride solution (20 ml). The organic phase was then dried over MgSCU and the 
solvent evaporated in vacuo to give compound 203 (0.80 g, 40%).
mp: 43 °C;
Vmax/cm'1 (K B r pellets): 3223 (N-H, s), 2883 (C-H, s), 1721 (CO, s), 1662 (CO, urea, 
s), 1620, 1589, 1465;
*H N M R (CDC13, 500 M Hz) 8  13.0 (1H, s, 1-H), 11.9 (1H, s, N//CONHCH2), 10.2 
(1H, s, NHCONtfCHj), 5.79 (1H, s, 5-H), 3.75-3.60 (m, 170 H, CH2C //20 ), 3.46 (4H, 
m, NHCONHC//3 , NHC0NHCH 2C //20), 2.22 (3H, s, CH3);
13C N M R (CDClj, 125 M Hz) 8  172.9 (C-4), 156.8 (NHCONH), 154.6 (C-2), 148.2 (C- 
6 ), 106.7 (C-5), 70.5-68.4 (CH20 ), 39.6 (NHCONHCH2), 29.6 (CH2), 18.9 (CH3);
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6.6 Specific Physical methods
6.6.1 Fluorescence Measurements
Fluorescence spectra were recorded on a Fluoro Max3 spectrophotometer (Birkbeck 
College) equipped with a thermostated cell, using quartz cuvett with a path length of 1 
cm. The excited wavelength was fixed at 341 nm.
Chloroform used as solvent was o f analytical grade, passed through basic alumina and 
dried over molecular sieves. The fluorescence cells were cleaned thoroughly with water, 
acetone and chloroform until a clear baseline without residual pyrene emission was 
obtained. The sample was diluted several times, from 16.4 mM to 0.033 mM. The ratio 
o f the intensities at 476 nm and 376 nm were then calculated for each concentration and 
the data was analysed using a non-linear least square fitting technique: 2 0 7
r = C (1 -  (8 Kdim [Pyr] + 1 )1/2) / 4
where r  is the integral intensity ratio o f the excimer emission (.h ) and the monomer 
emission (//) at 476 and 376 nm, respectively. C  is a constant and [Pyr] is the total 
concentration o f the pyrene labelled compound 193. The results of fitting are shown in 
Graph 4 in the text. The data used in Graph 4 is listed below.
Concentration, mol/L Ratio r
0.00033 0.250
0.00023 0.426
0.00033 0.703
0.00164 1.412
0.00206 1.682
0.00411 2.906
0.00822 4.572
0.01640 6.631
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6.6.2 Diffusion Coefficient Measurements
All diffusion NMR experiments were carried out on a Bruker Avance 500 NMR 
spectrometer, equipped with z-gradient facilities. The convection compensated pulse 
sequence was used in this work . 2 1 0  Convection in solution is usually caused by small 
changes o f temperature along the NMR sample tube and its effect is similar to that of 
fast diffusion. Therefore, for accurate measurements o f diffusion coefficients the effects 
o f convection must be suppressed, especially in the case of non-viscous solutions (e.g., 
in CDCI3). The standard Bruker pulse sequence dstegs3s was used for the convection 
suppression.
In the diffusion NMR experiment used, the change o f the NMR signal depends on the 
gradient strength according to:
/,. = 70exp D(27rygiS) A -  
v 3
(1)
where y is the gyromagnetic ratio, gi is the amplitude o f the gradient pulse (in the range 
from 0.7 to 33 G cm '1), 8  is the duration o f the gradient pulse pair (3-4 ms for small 
molecular weight species, up to 1 2  ms for polymers), 7/ is the signal intensity in the 
NM R spectrum measured for a given I0 is the signal intensity in the absence of 
gradient pulses, A is the diffusion delay [A = (200 + 8) / ms in our experiments] and D  is 
the diffusion coefficient. In each D  measurement, a set o f 16 or 32 separate spectra were 
acquired as a function o f gradient amplitude. The majority o f the diffusion 
measurements were performed for solutions in DMSO-d6 or CDCI3 at 298K. Data 
acquisition and processing were performed using standard Bruker XwinNMR software 
(version 2.6). The diffusion coefficients were determined from Eq. (1) using T 1/T2 
utility o f XwinNMR. The mean deviation was in the range ±0.03 - ±0.08x 10‘ 10 m2 s' 1 
for the diffusion coefficient measurements.
In order to account for viscosity changes due to concentration changes, the solvent 
corrected D  values are reported in the text: D=7)meas x ( Dpure / Dmeas )> where Aneas and
7y ° leas are the measured values for the solute and the residual solvent peak (e.g., CHCI3),
respectively, and D s°Jre is the diffusion coefficient measured for the residual CHCI3 in
pure CDCI3 ( D sp°„re =23.66 x 10' 10 m 2 s '1) or for the residual DMSO-ds in pure DMSO-ck
( ^ 1 = 6 -4 3  x 10-'° m V ) .
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The value o f the dimerization constant (Kdim) for 112 was obtained from the 
concentration dependence of the diffusion coefficients using the non-linear least squares 
fitting as implemented in the ASSOCIATE program (provided by Dr B R Peterson, 
Pennsylvania State University).145’211
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7 Conclusions and Future Work
7.1 Conclusions
The synthesis o f an ureidopyrimidinone compound incorporating an electron-donating 
group (PhNH2) at the C - 6  position has led to the formation of the dimeric form DADA 
in DM SO -J6 - It was the first time that dimeric species were observed in such polar a 
solvent. The polarity o f the solvent combined with its ability to act as a hydrogen bond 
acceptor appeared to be the main reason for the tautomeric change towards the enol 
form. Further work has been conducted to incorporate a solubilizing side chain at the 
ureido position. Finally, the analysis has revealed the presence o f both the 4-keto and 
the enol form in CDCI3 . These results highlighted the complexity of the Upy systems in 
solution in terms o f the prediction o f the tautomeric distribution. It is clear that factors 
such as polarity o f the solvent, nature o f the substituent at C - 6  have a strong influence 
on the tautomeric equilibrium and that a combination o f these factors can sometimes 
lead to unpredictable results. The formation o f dimeric species that exist in a polar 
solvent appears particularly interesting for the design o f materials that are intended to 
survive in biological media.
Futhermore, the use o f Upy modules for the synthesis o f supramolecular polymers has 
been achieved with the particular objective to synthesise a new class o f energetic 
supramolecular polymers based on PolyGlyn, for use as energetic binders. In addition, 
the development o f an alternative synthetic approach avoiding the use of isocyanate has 
been successfully developed leading to supramolecular polymers o f appreciable quality. 
The synthesis o f energetic precursors based on Upy has been investigated with the 
intention o f forming supramolecular polymers incorporating these energetic modules.
In addition, the synthesis o f bifunctional Upys incorporating small chiral spacers has 
been achieved. Notably, it was found that the use o f diethyl L-tartrate or butane diol led 
to the formation o f extremely stable cyclic dimers in chloroform with a dimerisation 
constant greater than 108 M"1. The formation o f new intramolecular hydrogen bonds 
within the cyclic species was observed in the crystal structure and was found to stabilise 
the dimer in solution. Upon increasing the concentration up to 500 mM in chloroform, 
no trace o f  polymeric species were observed, which suggested that the critical 
concentration was well above 500 mM. The incorporation of a more crowded spacer 
(crown ether derivative) generated the formation o f cyclic species as well, although the
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results were less clear due to poor solubility. These examples clearly showed how the 
“cyclic dimer/polymer” equilibrium can be controlled by only minor adjustments of the 
structure.
Finally, the design o f a new quadruple hydrogen bonded DDAA array based on cytosine 
has been successfully achieved via a straightforward synthetic strategy. The structure of 
the linear DDAA/AADD dimer was revealed in the solid state with the observation of a 
weak intramolecular C -H ...O  close contact, which is believed to stabilise the dimer in 
addition to a strong quadruple hydrogen bonding network. A similar dimer was also 
observed in chloroform, with the presence o f 5% of the folded conformer. Dilutions 
experiments suggested that the dimerisation constant K&m is greater than 107 M '1 and 
105 M"1 in benzene and chloroform, respectively. In addition, when mixed with Upy in a 
1:1 ratio, the formation o f heterodimer was observed, which showed that the new 
DDAA array compete well with very strong dimers in solution, such as Upy. This result 
is especially important for the design o f supramolecular co-polymers. In order to 
investigate further the use o f the new DDAA module, a supramolecular polymer 
incorporating a PEG chain (Mn ~ 3400 g/mol) was synthesised. On comparison with 
the U py analogue, it was found that both supramolecular polymers adopted very similar 
behaviour both in solution and in the solid state. This last result is especially promising 
for the generation o f novel materials based on the novel cytosine module.
7.2 Future Work
The potential o f Upy units has been well studied by various research groups in the past 
few years. A new challenge in the field o f quadruple hydrogen bonded modules is 
therefore the design o f new arrays that can offer similar or better advantages than the 
Upy module. In this regard the cytosine module can play an important role in the 
synthesis o f  supramolecular materials with useful properties. Therefore, the synthesis of 
supramolecular polymers based on the cytosine unit is o f particular interest, and 
especially for the AWE if  energetic supramolecular polymers can be made.
The cytosine unit is particularly attractive since it only exists as one tautomer in 
solution. Furthermore, the possibility o f functionalisation at N -l can be very interesting 
since it can lead to the design of material with desired properties. Besides, it could form 
supramolecular polymers with two different DDAA-linker attachments (Figure 158 A 
and B).
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Figure 158: Possible ways of linking cytosine modules to generate bifunctional 
derivatives
Also, since the cytosine unit can efficiently dimerise with the Upy unit, the next 
challenge would be to synthesis a bifunctional system possessing different units at each 
end (Figure 159). This may be useful for adjustments of polymer properties.
Me
C y to s in e  U p y
Figure 159: Supramolecular polymer incorporating both cytosine and Upy units
Futhermore, it would be interesting to study the ring/chain equilibrium with this new 
cytosine system and design arrays that could form exclusively cyclic species both in 
solution and solid state.
Clearly, the development o f supramolecular arrays around the cytosine or DNA base 
units is one o f the most promising directions o f studies in the forthcoming furture. 
Indirectly, these studies could allow to advance our understanding of the structure and 
function o f DNA and other related systems.
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Crystal data and structure refinement of compound 163
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R e f le c t io n s  c o l le c t e d  
In d e p e n d e n t  r e f le c t io n s  
C o m p le t e n e s s  to  0 =  2 7 .4 8 °  
A b s o r p t io n  c o r r e c tio n  
M a x . a n d  m in . tr a n s m is s io n  
R e f in e m e n t  m e th o d  
D a ta  /  r es tr a in ts  /  p aram eters  
G o o d n e s s - o f - f i t  o n  F2 
F in a l R  in d ic e s  [F2 >  2 o ( F 2)]  
R in d ic e s  (a ll d a ta )
A b s o lu te  stru ctu re  p a ram eter  
L a r g e s t  d if f .  p e a k  a n d  h o le
04src0614
C 3 4 H 5 2 N 1 0 O 1 2  
7 9 2 .8 6  
1 2 0 (2 )  K  
0 .7 1 0 7 3  A 
M o n o c lin ic  
P2\
a =  2 0 .7 7 6 ( 5 )  A 
b =  1 9 .8 0 0 (4 )  A 
c =  2 1 .0 0 1 ( 7 )  A 
8 6 3 9 (4 )  A3
a = 9 0 °
P ~  9 0 .0 5 (2 )°  
y  =  9 0 °
1 .2 1 9  M g  / m 3 
0 .0 9 3  m m -1 
3 3 7 6
S lab ; C o lo u r le s s  
0 .4 4  x  0 .1 8  x  0 .0 8  m m 3 
2 .9 4  -  2 7 .4 8 °
- 2 6  < h <  2 5 , - 2 5  < k <  2 5 , - 2 7  <  / <  2 6  
5 6 1 3 9
3 6 1 3 5  [Rinl =  0 .0 4 8 0 ]
9 5 .6  %
S e m i- e m p ir ic a l  fro m  e q u iv a len ts  
0 .9 9 2 6  and 0 .9 6 0 0  
F u ll-m a tr ix  lea st -sq u a r e s  o n  F2 
3 6 1 3 5 / 2 6 6 4 / 2 0 2 9  
1 .5 3 6
R1 -  0 .1 9 0 0 ,  wR2 = 0 .4 5 1 7  
R1 =  0 .2 4 9 3 ,  wR2 =  0 .4 7 6 6  
0(2)
0 .7 1 9  a n d - 0 .8 4 1  e A “3
Diffractometer: Nonius KappaCCD area detector (^ scans and a> scans to fill asymmetric unit sphere). Cell determination: DirAx 
(Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. Hooft, Nonius 
B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology (1997) Vol. 276: 
Macromolecular Crystallography, part A, pp. 307-326; C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). Absorption 
correction: SORTAV  (R. H. Blessing, Acta Cryst. A51 (1995) 33-37; R. H. Blessing, J. Appl. Cryst. 30 (1997) 421-426). 
Structure solution: SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467-473). Structure refinement: SHELXL97 (G. M. 
Sheldrick (1997), University of Gottingen, Germany). Graphics: Cameron - A Molecular Graphics Package. (D. M. Watkin, L. 
Pearce and C. K. Prout, Chemical Crystallography Laboratory, University of Oxford, 1993).
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APPENDIX B
R'N ^ 1  O
O N N N r  — p h
H H K “  6 1
181
Crystal data and structure refinement of compound 181
I d e n t if ic a t io n  c o d e  
E m p ir ic a l fo r m u la  
F o r m u la  w e ig h t  
T em p e ra tu r e  
W a v e le n g th  
C ry sta l s y s te m  
S p a c e  g r o u p  
U n it  c e l l  d im e n s io n s
V o lu m e
Z
D e n s i t y  (c a lc u la te d )  
A b s o r p t io n  c o e f f ic ie n t  
F(000)
C ry sta l  
C r y sta l s iz e
G r a n g e  fo r  d a ta  c o l le c t io n  
I n d e x  r a n g e s  
R e f le c t io n s  c o l le c t e d  
I n d e p e n d e n t  r e f le c t io n s  
C o m p le t e n e s s  to  0 =  2 7 .4 8 °  
A b s o r p t io n  c o r r e c t io n  
M a x . a n d  m in . tr a n s m is s io n  
R e f in e m e n t  m e th o d  
D a ta  /  r es tr a in ts  /  p a ra m eters  
G o o d n e s s - o f - f i t  o n  F 2 
F in a l R  in d ic e s  [ F 2 >  2  c< F 2)]  
R  in d ic e s  (a l l  d a ta )  
E x t in c t io n  c o e f f ic ie n t  
L a r g e s t  d if f .  p e a k  an d  h o le
04src0943
c 17h 30n 4o 2
322.45 
120(2) K  
0.71073 A 
T ric lin ic  
P - 1
a  = 4.5636(12) A a  =
b = 9 .979(3) A p =
c = 20.116(6) A y  =
903.2(5) A3 
2
1.186 M g / m 3 
0.079 m m -1 
352
P la te; C o lo u r le s s  
0.15 x 0 .1 0 x 0 .0 2  m m 3 
3.08 -  27.48°
- 5  < h < 5 ,  - 1 2  < k <  12, -2 6  < / <  26 
15490
3976 [Rinl = 0.0511]
96.5 %
S e m i-e m p ir ic a l  fro m  e q u iv a len ts  
0.9984 and  0.9882 
F u ll-m a tr ix  le a st-sq u a res  o n  F 2 
3 9 7 6 /0 /2 1 1  
1.077
R1 = 0 .0586, wR2 = 0.1424 
R1 =  0 .0808, wR2 =  0.1584 
0.023(8)
0.249 and -0 .271  e A“3
8 1 .1 0 (3 )°
8 6 .4 6 (2 )°
8 8 .4 8 (3 )°
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